The Common Sense Model, Quality of Life and Symptom Frequency in Irritable Bowel Syndrome (IBS) by Jacobs, Carly Sarah
The Common Sense Model, Quality of Life and 
Symptom Frequency in Irritable Bowel Syndrome 
(IBS) 
Carly Sarah Jacobs 
Thesis submitted for the degree of Doctor of Philosophy 
Department of Psychology 
School of Human Sciences 
University of Surrey 
2007 
ABSTRACT 
In this thesis the application of the Common Sense Model (CSM) of illness 
representations (Leventhal et al., 1890; 1984) to Irritable Bowel Syndrome (IBS) was 
investigated. A systematic literature review and three empirical studies were 
conducted to investigate the factors that influence the illness representations, explore 
the relationship between illness representations and illness outcomes (health related 
quality of life (HRQOL) and symptom frequency) and to potentially alter illness 
representations and illness outcomes. 
Study 1 was an exploratory cross sectional study with 116 participants (n = 58 
doctors, n= 58 IBS sufferers). Patients reported significantly more negative 
perceptions of the consultations than doctors; however patients perceived 
communication was not predictive of illness representations, or illness outcomes. 
Independently of perceived communication an internal locus of control was found to 
be predictive of illness outcomes. 
Study 2 was a cross sectional study with 301 participants (n = 239 general 
population, n= 62 IBS sufferers). IBS sufferers' perceptions of the general 
populations' attitudes were significantly more negative than reported attitudes. 
Perceived attitudes towards witnessing symptoms were predictive of 
HRQOL. Independently of perceived attitudes, emotional representations were 
predictive of HRQOL, and illness identity was predictive of diarrhoea. 
Study 3 was a longitudinal intervention study with 62 IBS sufferers. Significant 
findings were as follows: reductions in symptom frequency from pre intervention to 
immediately post, and two months post intervention; improvements in HRQOL from 
pre intervention to two months post intervention; improvements in perceived social 
support immediately post intervention; improvements in illness representations from 
pre intervention to immediately post, and two months post intervention. There were 
no significant predictors of change in total symptoms or HRQOL post the 
intervention. 
Overall these studies demonstrate the utility of CSM in IBS research. Further 
investigation of the CSM in IBS is recommended. 
ACKNOWLEDGEMENTS 
The last few years have seen some of the most rewarding and some of the most stressful 
moments of my life so far. Although the process of studying for a PhD can be a solitary 
experience I would not have been able to write this thesis without the help of some very 
special people. In some respects this is the hardest part of the thesis to write as there are 
so many people to thank that I am worried that I am going to miss someone out. If you 
helped me in anyway then please know how grateful I am and if you are not on this list 
than please accept the oversight, it is most probably caused by sleep deprivation, and it 
by no means indicates a lack of gratitude. Therefore I would like to say a general thank 
you to all my friends and family for any help they have given me, and also for just 
`putting' up' with me when I have been too stressed or too busy to give them the time 
they deserve. Special thanks go to: 
My supervisor Professor Richard Shepherd. Dick you have been an excellent supervisor 
to me over the last few years, with your gentle guidance sowing the seeds helping me to 
develop my ideas. I am grateful to you for allowing this thesis to be truly mine from the 
initial stages through to the final write up. Thank you providing support whenever 
needed, in particular thank you for responding so quickly to e-mails and drafts of 
chapters over the last few years, and especially in the final week! I know that it is your 
efficiency and indeed your care that has allowed me to submit at this time. Thank you 
for making me feel capable even when I doubted myself and for ensuring that my time 
was never wasted. You are a wonderful supervisor. 
My stage two supervisor Dr Marie Clarke. Marie, although you were not directly 
involved with the thesis I still wanted to say a few words of thanks, partly for the help 
regarding the systematic literature review (chapter 3) and also in general for your time 
throughout the last few years. Your motherly approach complemented Dick perfectly, 
and I always felt that you cared how I was achieving as a friend rather than just a 
supervisor. You always made me feel that I was handing in work above your 
III 
expectations, and where criticisms were necessary they were always broached in the 
nicest way. So thank you. 
To my participants. I am extremely grateful to all of my participants, to my friends and 
family who filled in the questionnaires on my attitude study and to all the kind people I 
approached, who had no reason to help me but filled in the questionnaire any way. A big 
thank you to all the medical professionals who took the time out of their busy schedules 
to take part in the doctor-patient communication study, I am extremely grateful as many 
people told me I would never get any doctor's to fill in the forms, but with your help I 
managed to conduct the study, so thank you. And of course the biggest thank you to my 
IBS participants, to whom I owe such a debt of gratitude I do not quite know how to put 
it into words. I hope the success of the intervention goes someway towards repaying 
your kindness. Thank you so much for having the same commitment to understanding 
and improving this condition as I do. 
To the IBS Network. There is simply no way that I could have conducted the research in 
this thesis without your support, from allowing me to advertise at reduced rates, to 
talking at support groups. I am extremely grateful, and I hope that I will be able to repay 
your kindness in the future, in the advancement of IBS research for a long time to come. 
To the MREC and University Ethics committees. Thank you for allowing me to conduct 
the research, and for helping me in the initial stages to clarify my aims and hypothesis. 
To all the people who helped me collect data through snowballing, although there are 
too many to list special thanks go to: 
My mum. Thank you for putting you loquacious nature to good use and finding me 
many participants for each of my studies, and for providing useful comments at each 
stage over the last few years. Talking to you over the last few years have been some of 
the only times I have managed to stop thinking about the PhD and for that I am grateful, 
thank you. 
iv 
To Jody and Aimee for helping me recruit participants, particularly for the attitude 
study. To Jody for actually being interested in my research and for taking time to read it 
and discuss it with me. To Aimee thank you for always making me feel that I am the 
smartest person in the world, despite the fact that you are clearly the cleaver sister, you 
just don't realise it yet! 
To Papa Alan, for pretty much dedicating himself to my every request over the last few 
years, and asking any body and everybody to fill in my questionnaire, in particular for 
your help in getting doctors to participate. And of course to nana too, for making sure 
Papa did as I requested. Thank you both for your faith in me, the way you look at me 
with such pride helped me to keep on going when I was getting disheartened. 
To Rosemary for her support and her interest to David for the lap top which has helped 
me considerably. To Tracy for her networking skills, and her laptop in Thailand, and to 
the rest of my family thank you. To all my friends who I have neglected for reminding 
my to find time to relax, special thanks go to Matt, Stuart, Shash, Martin, Tushna, Helen 
Shumona, Ryan and Ed. 
To the University of Surrey for funding my PhD there is no way I could have studied 
over the last few years without your support so special thanks to Marc Cropley for 
believing in my abilities, offering me a PhD place and for suggesting me for funding. To 
Evanthia Lyons for deciding to give me funding, and any body else involved in the 
decision to fund me I am so very grateful. A final work of thanks to everyone who helps 
behind the scene in the department, for being organised at times when I haven't been! I 
am especially grateful to Carole, Nigel and Andrew for always going that extra mile. 
My special thanks go to men who have been most important in my life over the last few 
years to my best friend David and my ever so supportive loving father, Earl. There is no 
way I can put into words how grateful I am to you both, hopefully my gratitude will be 
in some way shown by the fact this thesis is jointly dedicated to you. 
V 
DEDICATIONS 
The first dedication is to my father: thank you for always making me feel special, for 
having an unwavering belief in my ability to succeed, and for being proud of everything 
I have achieved no matter how insignificant. Without your support, both financially and 
emotionally I would never have been able to undertake this PhD and for that I will 
always be grateful. Thank you for always making my wishes come true, no matter what 
cost to yourself. You may not know this but without your faith in my abilities from a 
child I would never have even considered that I was capable to doing a PhD. 
The second dedication is to my wonderful David, although listing the ways you have 
supported me would constitute a second thesis I think everything I need to say is 
summed up best by saying thank you for always keeping your promises. You are my 
inspiration, and my hero. There is no way I would have got to this point without your 
support, which was always exactly what I needed, even though I may not have realised it 
at the time. I may not have said it enough throughout the last few years but I am so 
grateful to you. No matter what happens in life I will always remember how selfless you 
were when I needed help. Thank you. 
vi 
In loving memory of Clifford Irons, it was your inspirational teaching and faith in my 
ability as an A level student which set the wheels in motion for this thesis long before I 
even knew what a psychologist was. Thank you. 
vii 
TABLE OF CONTENTS 
ABSTRACT 
ACKNOWLEDGEMENTS iii 
DEDICATIONS vi 
TABLE OF CONTENTS viii 
INDEX OF TABLES xx 
INDEX OF FIGURES xxii 
CHAPTER 1: IRRITABLE BOWEL SYNDROME: AN 
OVERVIEW 1 
Aim 1 
Normal Digestive Processes and Bowel function 1 
Over View of the Digestive System 1 
Large intestine 2 
Enteric Nervous System (ENS) 2 
Irritable Bowel Syndrome 4 
Definition 4 
Diagnosis 5 
Symptom manifestations 5 
The Rome II diagnostic criteria 7 
The diagnostic criteria 7 
Sub-types of IBS 8 
Critique of the Rome II criteria 8 
Implications of the diagnostic processes 9 
viii 
Aetiology 10 
Psychological causes 11 
Personality type 13 
Stress 14 
Abuse 14 
Domestic Violence 15 
Epidemiology 16 
Co-morbidity (and extra intestinal symptoms) 17 
Other functional gastrointestinal disorders 18 
Organic disorders 18 
Psychological co-morbidity 18 
Stress and relaxation 19 
Depression 21 
Current treatment options in IBS 23 
Medical management 23 
Complementary and alternative medicine (CAM) 24 
Dietary interventions 24 
Exercise interventions 25 
The need for the development of treatments in IBS 25 
The need for biopsychosocial based treatments in IBS 28 
The biopsychosocial model 28 
Biopsychosocial conceptualisations of IBS 29 
Ix 
CHAPTER 2: PSYCHOLOGICALLY BASED ILLNESS 
INTERVENTIONS IN IRRITABLE BOWEL SYNDROME (IBS): 
A SYSTEMATIC REVIEW 34 
Aim 34 
Introduction 34 
Method 35 
Search terms 35 
Inclusion criteria 36 
Intervention types 36 
Study categorisation 37 
Results 37 
Discussion 69 
CHAPTER 3: THE COMMON SENSE MODEL OF ILLNESS 
REPRESENTATIONS (CSM) AND IS APPLICATION TO 
IRRITABLE BOWEL SYNDROME (IBS) 83 
Aim 83 
Common sense model of illness representations - overview 83 
Common sense model - stage 1 interpretation 85 
Common sense model - stage 2 coping / action plans 87 
Common sense model - stage 3 appraisal 87 
Common sense model -justification for use in IBS research 88 
Consideration of other theoretical models 91 
Health Belief Model 91 
Transtheoretical model of behaviour change 92 
X 
CHAPTER 4: DOCTOR-PATIENT COMMUNICATION, 
ILLNESS REPRESENTATIONS AND OUTCOMES IN 
IRRITABLE BOWEL SYNDROME (IBS) 95 
Aim 95 
Introduction 96 
Method 106 
Participants 106 
Doctors 106 
IBS participants 106 
Measures 107 
Procedure 109 
Data treatment 110 
Results 110 
Comparison of doctors' and patients' perceptions of doctor-patient 
communication 110 
Patients' perceptions of doctor-patient communication and illness 
representations 113 
Patients' perceptions of doctor-patient communication and HRQOL 114 
Patients' perceptions of doctor-patient communication 
and symptom frequency 114 
Illness perceptions and HRQOL 114 
Illness perceptions and symptoms 116 
Relationship between HRQOL and symptoms 117 
Exploration of the relationship between 
locus of control and illness outcomes 118 
Discussion 119 
Study limitations and suggested modifications 124 
Xi 
Participants 124 
Measures 125 
Design 126 
Conclusions and further research 127 
CHAPTER 5: ATTITUDES TO IRRITABLE BOWEL 
SYNDROME (IBS), ILLNESS REPRESENTATIONS AND 
OUTCOMES 128 
Aim 128 
Introduction 128 
Attitudes of the general population 129 
Attitudes towards epilepsy 130 
Potential impact of IBS sufferers' perceptions 
of other people's attitudes towards them 133 
Method 139 
Participants 139 
General population 139 
IBS participants 139 
Measures 140 
Procedure 144 
Data treatment 145 
Results 145 
Attitudes of the general population 
towards discussing illness symptoms 145 
Attitudes of the general population 
towards witnessing illness symptoms 147 
Attitudes of the general population towards 
X11 
discussing IBS, asthma and epilepsy 148 
Attitudes of the general population towards 
witnessing IBS, asthma and epilepsy 148 
Comparison of the general population attitudes towards 
discussing and witnessing IBS, asthma and epilepsy 148 
Attitudes of the general population regarding the 
perceived physical consequences of IBS, asthma and epilepsy 149 
Attitudes of the general population regarding the 
perceived social consequences of IBS, asthma and epilepsy 150 
Social support concessions scale 
Social activity scale 
151 
152 
Knowledge of IBS from the general population 153 
Comparison of IBS sufferers perceived attitudes with 
the general populations reported attitudes 155 
The relationship between IBS sufferers perceptions 
of the general populations attitudes and 
illness representations, HRQOL and symptom frequency 156 
Illness perceptions and HRQOL 156 
Illness perceptions and symptoms 156 
Discussion 157 
Research aim 1- to investigate the attitudes that 
the general population hold towards sufferers of IBS 
(in comparison with other illnesses) 157 
Research aim 2- to compare the general populations' 
attitudes towards IBS sufferers, with IBS sufferers' perceptions 
of the general populations' attitudes towards them 159 
Research aim 3- to assess the potential impact of IBS sufferers' 
perceptions of the general populations' attitudes on their illness 
representations and illness outcomes 160 
Significant findings 160 
Non significant findings 160 
Research aim 4- To explore the role of illness representations 
Xlii 
and illness outcomes independently of perceived attitudes to IBS 162 
Study limitations and suggested modifications 163 
Participants 163 
Measures 164 
Design 164 
Further research 165 
Conclusions 165 
CHAPTER 7: A SELF-HELP BOOKLET INTERVENTION 
STUDY FOR IRRITABLE BOWEL SYNDROME (IBS) 
BASED ON THE COMMON SENSE MODEL (CSM) 166 
Aim 166 
Introduction 166 
Aims 171 
Method 172 
Participants 172 
Phase 1- pre intervention stage 172 
Phase 2 -intervention stage 174 
Phase 3 -post intervention stage 174 
Phase 4 -two months post intervention stage 174 
Design 176 
Measures 176 
Materials 178 
The IBS intervention booklet 180 
Procedure 184 
Pre intervention stage, intervention, 
immediate post intervention stage 184 
xiv 
Two months post intervention stage 185 
Data treatment 185 
Results 186 
Descriptive statistics 186 
Symptom frequency 207 
Total symptoms -7 day diary 207 
Individual symptoms -7 day diary 208 
Total symptoms - ISS questionnaire 208 
Individual symptoms - ISS questionnaire 209 
HRQOL 209 
The relationship between HRQOL and symptoms 209 
Medication 209 
Changes in perceived social support (PSS) 209 
Perceived attitudes to discussing symptoms 209 
Perceived attitudes to witnessing symptoms 210 
Perceived social support concession scale 
and perceived social activity scale 210 
Perceived social support and illness outcomes 210 
Changes in the illness representation components 211 
Reported changes at two months post intervention 213 
The relationships between illness representations 
and illness outcomes 214 
Illness representations and total symptoms 215 
Illness representations and individual symptoms 215 
Illness representations and HRQOL 215 
Inter - item correlations between 
xv 
illness representation components 216 
Discussion 218 
Summary of findings 218 
Study limitations 222 
Modifications and further research 226 
Conclusions 226 
CHAPTER 7: GENERAL DISCUSSION 227 
Aims 227 
Overall findings of the thesis 227 
Doctor-patient communication 227 
Attitudes towards, IBS sufferers 230 
Illness representations and illness outcomes 232 
Intervention 233 
Strengths of the research 235 
Limitations of the research 237 
Theoretical implications 240 
Practical implications 242 
Future directions 242 
Conclusion 243 
REFERENCES 244 
xvi 
APPENDICES 
Appendix 1- disease specific version of the IPQ-R (Moss-Morris et al., 2002) 
Appendix 2- IBS-36 (Groll et al., 2002) 
Appendix 3- 7-day symptom diary (instructions and sample pages) 
Appendix 4 -1BS specific version of the MISS-21 (Meakin & Weinman, 2002) 
Appendix 5- doctor specific version of the MISS-21 (Meakin & Weinman, 2002) 
Appendix 6- MHLC (Wallston et al., 1994) 
Appendix 7- demographic questionnaire for IBS participants 
Appendix 8- demographic questionnaire for doctors 
Appendix 9- letter to doctors and information sheet 
Appendix 10 - ethics approval and consent form for doctors 
Appendix 11- letter to IBS sufferers and information sheet 
Appendix 12 - consent form for IBS participants 
Appendix 13 - general population version of 
attitudes to chronic illness questionnaire 
Appendix 14 -perceived social support scale (PSSS) 
Appendix 15 - demographic questionnaire for general population 
Appendix 16 - letter and information sheet for attitudes study, general population 
Appendix 17 - consent form for general population 
Appendix 18 - information sheet for attitudes study, IBS participants 
Appendix 19 - ethics approval and consent form for IBS participants 
in the attitude / intervention study 
Appendix 20 - short questionnaire for people who 
did not return their intervention packs 
Appendix 21 - lBS symptom scale (ISS) 
xvii 
Appendix 22 - short post intervention questionnaire 
Appendix 23 - IBS self-help booklet 
Appendix 24 - letter and information sheet to IBS participants 
for the intervention research 
Appendix 25 - letter to IBS participants for two months post intervention stage 
xviii 
INDEX OF TABLES 
Table 1- Manning Criteria 6 
Table 2- The biopsychosocial view of health and illness 29 
Table 3- Coding of intervention components 37 
Table 4- Systematic review of psychologically 
based interventions in IBS: summary table 40 
Table 5- Coding for measures used in the systematic review 64 
Table 6- Further details on participant numbers 65 
Table 7- Assessment of retrieved papers 66 
Table 8- Summary of main findings for symptoms 67 
and psychosocial factors 
Table 9- Summary of psychological models 68 
identified from the review 
Table 10 - Additional demographic information (doctors) 106 
Table 11 - Multiple regression predicting illness representation: 
perceived consequences of having IBS 113 
Table 12 - Multiple regression of illness representations 
predicting health related quality of life (IBS-36) 115 
Table 13 - Multiple regression of MHLC 
predicting health related quality of life (IBS-36) 115 
Table 14 - Multiple regression of illness representations 
predicting symptoms 116 
Table 15 - Multiple regression of locus of control 
predicting total symptoms 116 
Table 16 - Multiple regression of locus of control 
predicting abdominal pain 117 
Table 17 - Multiple regression of locus of control 
predicting diarrhoea 117 
Table 18 - Stepwise multiple regression HRLOC 
predicting symptoms mediated by HRQOL 119 
xix 
Table 19 - Knowledge of IBS symptoms 154 
Table 20 - Significant differences between groups 
on attitude variables 155 
Table 21 - Reasons why people did not return 
their completed research packs 173 
Table 21 - Descriptive statistics of IBS symptom frequency 
at pre-intervention, immediately post intervention 
and at two months post intervention 186 
Table 22 - Illness representation components pre intervention 
and significant changes immediately post the intervention 211 
Table 23 - Illness representation components pre intervention 
and significant changes at two months post intervention 212 
Table 24 - Reported changes at two months post intervention 213 
Table 25 - Inter-item correlations between illness representation 
components immediately post intervention 216 
Table 26 - Inter-item correlations between illness representation 
components at two months post intervention 217 
xx 
INDEX OF FIGURES 
Figure 1- The human digestive system 2 
Figure 2- The brain-gut axis 12 
Figure 3- The common sense model of illness representations 85 
Figure 4- Doctors' and IBS sufferers' 
perceived efficacy of communication 111 
Figure 5- HRQOL and total symptoms 118 
Figure 6- Potential relationships between 
illness representations, HRLOC and illness outcomes 119 
Figure 7- Attitudes of the general population 
towards discussing illness symptoms 146 
Figure 8- Attitudes of the general population 
towards witnessing illness symptoms 147 
Figure 9- Comparison of discussing and witnessing symptoms 149 
Figure 10 - Means of physical consequences scale 150 
Figure 11 - Means of social support consequences scale 151 
Figure 12 - Means of social support concessions scale 152 
Figure 13 - Means of social activity scale 153 
xxi 
Irritable bowel syndrome: overview 
CHAPTER 1 
IRRITABLE BOWEL SYNDROME: AN OVERVIEW 
Aim 
The aim of chapter one is to demonstrate the suitability of psychological approaches 
in irritable bowel syndrome (IBS). In order to provide a background to IBS a brief 
overview of the normal digestive system will be provided, followed by the current 
definition of IBS and the diagnostic criteria used. The rest of the chapter will detail 
proposed aetiological factors, epidemiology, co-morbidity and treatment options. In 
each of these areas the suitability of psychologically based approaches will be 
demonstrated. By the end of this chapter the utility of psychological methods to the 
study and treatment of IBS should be clear. 
NORMAL DIGESTIVE PROCESSES AND BOWEL 
FUNCTION 
OVERVIEW OF THE DIGESTIVE SYSTEM 
The information presented in this section is extrapolated from Silk (1997) and Case 
(1979). The purpose of the digestive system is to convert food and drink into 
nutrients that can be used to enable functioning of bodily systems. The digestive 
system comprises both the gastrointestinal tract (gut) and other supportive organs 
(tongue, salivary glands, pancreas, liver and gall bladder, nerves and blood). The 
gastrointestinal tract runs from the mouth to the anus and is essentially a long 
twisting muscular tube connecting a series of hollow organs (mouth, oesophagus, 
stomach, small intestine, large intestine, rectum and anus). This tube is 
approximately 7-8 meters long (in adults) and its function is to process the food and 
fluids consumed. Essentially the process involves ingestion, digestion, absorption 
and elimination. Various organs contribute to each stage of the process and these are 
labelled in figure 1. 
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Figure 1- The human digestive system 
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In the context of irritable bowel syndrome (IBS) the areas of the normal digestive 
system of greatest relevance are the large intestine (bowel / colon) and the enteric 
nervous system (ENS). 
LARGE INTESTINE / BOWEL (Colon) 
This is the final section of the digestive tract. At this stage the breaking down of 
nutrients is considered to be complete and the indigestible food and fluid pass from 
the small intestine to the large intestine (approximately 4ft) where the process of re- 
absorption of water and excretion of ions (calcium, magnesium and iron) occurs. 
This is one of the most important processes involved in digestion. In normal 
digestion the excess water passes through the wall of the large intestine and into the 
blood stream. This means that as material passes though the large intestine it 
becomes progressively more solid allowing for the formation of waste matter in the 
form of faeces. 
ENTERIC NERVOUS SYSTEM (ENS) 
The ENS is the intrinsic nervous system of the gut (Saffrey, 2006) and therefore 
influences all digestive processes. Without it the digestive organs would be unable to 
2 
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function, a rather crude example could be of a machine without electricity. ENS 
dysregulation will therefore unsurprisingly have an impact on digestive processes; 
this is suggested to be through alterations in smooth muscle contractibility (Saffrey, 
2006). Current conceptions suggest that the ENS is essentially an extensive network 
of millions of neurons, which are dispersed throughout the gut. There are many 
different types of neurons (e. g. sensory, motor, inter) and it is the coordination of 
these neurons that regulate the gastrointestinal processes (McMillin et al., 1999). The 
central nervous system (CNS) influences the ENS and in turn the ENS influences the 
CNS; this is through both nerve reflexes and neuropeptides (McMillin et al., 1999). 
However, if the CNS-ENS interaction is suspended the ENS is capable of 
functioning autonomously, it is the only peripheral system capable of this and is most 
likely a result of anatomical similarity to the autonomic nervous system (ANS). A 
quotation that gives a clear indication of the current conceptualisations of the ENS is 
provided by Wood (1994): 
"A minibrain placed in close proximity to the effector systems it controls. Rather 
than crowding the hundred million neurons required for control over the gut into the 
cranial cavity as part of the cephalic brain, and transmitting signals over long, 
unreliable pathways, natural selection placed the integrative microcircuits at the site 
of the effectors " 
Although, the ENS is capable of functioning autonomously, normal digestion 
generally requires effective communication between the ENS and CNS, with 
potentially negative effects on the functioning of either system if the synergy is 
disrupted (see Brain-gut axis, Drossman et al., 1999). Communication is via 
parasympathetic and sympathetic fibres; these can either connect the CNS and ENS 
or even the CNS directly with the digestive tract. A basic example of this would be 
the stimulation of secretion in the stomach as a result of the CNS receiving sensory 
messages about the presence of food (Bowen, 2004). 
Irritable bowel syndrome: overview 
IRRITABLE BOWEL SYNDROME 
DEFINITION 
The broad definition of Irritable Bowel Syndrome (IBS) is that it is a `chronic 
functional digestive disorder' (Corazziari, 2004), affecting approximately 20% of 
western populations (Dancey et al., 1999) which is characterised by abdominal pain 
and altered bowel functioning. However when defining IBS it is important to 
recognise the limitations in current levels of understanding (Simren, 2006). As 
Simren (2006) notes "current conceptualisations about every aspect of the illness are 
controversial and as new research emerges our conceptions of IBS may alter". In fact 
recent research by Holtmann (2004) suggests that future conceptualisations of IBS 
may actually divide its many components into different disorders. It is therefore not 
possible to provide a standard outline of the illness; instead the most widely accepted 
definitions will be presented along with justification and discussion of alternatives 
where appropriate. 
The definition of IBS as a "chronic functional gastrointestinal disorder" (FGID, 
Corazziari, 2004) is generally considered as the gold standard in terms of its medical 
categorisation. This label describes a number of characteristics of the illness that are 
important to consider. The first factor is that the label of a FGID is not unique to IBS, 
in fact the Rome II criteria (Drossman et al., 2000) list 47 different kinds of FGIDs. 
The categorisation of a patient as being an IBS sufferer, or suffering from another 
FGID is dependent on the combination of gastrointestinal symptoms (GI) the patient 
presents. 
The second facet of this definition that is of importance is the labelling of IBS as 
`chronic' (as opposed to either terminal or acute). A broad definition of a chronic 
illness would be that in contrast to an acute illness, it is a permanent state of ill 
health, but one that does not (usually) result in mortality as a direct consequence. 
Although the illness itself is permanent the specific symptoms or degree of severity 
may be may be either permanent or cyclic (whereby the periods of symptom 
presentation and remission alternate). This is one of the facets common to IBS 
(Camilleri, 2004). Regardless of whether the symptoms are permanent or cyclic the 
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main distinction between chronic and acute illnesses is that rather than adopting the 
`sick role' (Suchman, 1965) for an extended period of time the effects of the illness 
must be incorporated into everyday functioning in order to maintain health related 
quality of life (e. g. Gralnek et al., 2000). Therefore the long-term management of any 
chronic illness becomes a central part of the patient's life. The categorisation of lBS 
as a chronic illness therefore implies an acceptance by the medical community that 
alterations to both cognitions and behaviours are likely to play a role in the everyday 
functioning of the IBS sufferer (Drossman et al., 2000). Therefore research with IBS 
sufferers should take into account cognitive and emotional factors rather than 
adopting a merely symptomatic approach. 
DIAGNOSIS 
The classification of IBS as a functional disorder affects the nature of the processes 
that need to be employed in initial diagnostic investigations (Olden, 2002). If an 
illness has an established organic cause diagnostic tests can be relatively simple and 
standardised, such as blood tests, X-rays etc. In Irritable Bowel Syndrome (and the 
other functional illnesses) the absence of an objective marker results in a diagnosis 
based on both symptom presentation and exclusion criteria (Corazziari, 2004). It is 
not sufficient to define IBS purely on its symptomatic presentation as many other 
illnesses (both functional and organic) have similar features (Camilleri, 2001). It has 
been suggested that the illnesses most likely to be misdiagnosed in a purely symptom 
based examination are celiac disease, Crohn's disease, bowel cancer, food 
intolerance, disaccharide intolerance, ulcerative colitis, infection, bacterial 
overgrowth, diverticular disease of the colon and bile acid induced diarrhoea (Gilkin, 
2005; Hatlebakk & Hatlebakk, 2004). For this reason a diagnosis of IBS is not given 
until all other possibilities have been excluded. 
SYMPTOM MANIFESTATIONS 
As the name Irritable Bowel Syndrome suggests factor analytic studies of reported 
symptoms can be used to categorise patients into either IBS or one of the other 
FGIDs. One problem with factor analytic studies is that different researchers report 
different symptoms as comprising IBS (this can be for both overall symptom 
presentation for subcategories within IBS e. g. Silk, 1997). An additional problem 
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with using factor analytic studies is that unlike objective medical procedures many 
doctors are reluctant to use these procedures, and in fact many may still report being 
unaware of their existence (Drossman et al., 1999). However, there are two main 
classification systems that are used to elucidate diagnosis of IBS, these are the 
`Manning Criteria' (Manning et al., 1978) and the `Rome Criteria' (Drossman et al., 
2000). Although both of these criteria are used in the literature, it should be noted 
that the most recent revision of the Rome criteria, the Rome II criteria (Drossman et 
al., 2000) is generally regarded as being superior (Camilleri, 2001). This is somewhat 
unsurprising as the Rome criteria are actually a revision to the Manning criteria and 
were specifically designed and reformulated for clinical use (Hatlebakk & Hatlebakk, 
2004). This is in contrast to the Manning criteria where the main purpose was to 
define differences between lBS and potentially organic bowel disorder. Table 1 lists 
the criteria defined by Manning et al. (1978). 
a aua i- iviauwuu Li uci Ia 
Abdominal pain relieved by defecation 
More frequent stools at the onset of pain 
Looser stools at the onset of pain 
Visible abdominal distension 
Passage of mucus 
Sensation of incomplete evacuation 
The current version of the Rome criteria, Rome II (Drossman et al., 2000), is 
therefore essentially the classification system used to diagnose IBS. Because this is a 
factor analytic approach in addition to diagnosing lBS this classification system 
necessarily defines our current conceptualisation of IBS. It is only when full 
consideration of these criteria is given that it is possible to move away from the 
broad definition of lBS as a `functional gastrointestinal disorder, with abdominal 
pain and altered bowel habit' and move towards a structured definition of the illness. 
Broadly the Rome II criteria state that there is a cluster of eight primary symptoms 
comprising irritable bowel syndrome. These are: abdominal pain or discomfort plus 
altered defecation; abdominal pain or discomfort relieved by defecation; abdominal 
pain associated with a change in the frequency or consistency of stool; altered stool 
frequency, altered stool form, altered stool passage, passage of mucus and bloating 
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and visible distension (Rome Diagnostic Criteria II, Drossman et al., 2000). 
Presentation of symptoms within the syndrome manifests in three distinct subtypes. 
The subtypes are diarrhoea predominant (IBS-D), constipation predominant (IBS-C) 
and alternating. As the categories suggest sufferers are classified according to their 
symptom profile. The particular category a sufferer is classified into is related to 
their primary symptom, though the other seven symptoms will generally be 
experienced to a lesser extent. One of the key facets in the definition of this illness is 
that even within these defined subcategories idiosyncratic differences are prevalent. 
More detail on these criteria is given in the following sections. 
THE ROME II DIAGNOSTIC CRITERIA 
The Rome classification system is based on the rationale that for each functional 
disorder there are a number of symptoms that tend to cluster together, as factor 
analytic studies have shown (Drossman et al., 2000). Although there can be 
exceptions to this rule the criterion is robust enough to provide the framework for 
identification of research participants. The commitment to development and 
improvements by the Rome group ensures that the criteria are updated as new 
scientific data emerges, accordingly the current criteria are the Rome II, published in 
the Rome II book (Drossman et al., 2000) and the Gut supplement (Drossman et al., 
1999). 
The diagnostic criteria 
At least twelve weeks, which need not be consecutive, in the preceding 12 months of 
abdominal discomfort or pain that has two of three features: 
1) Relieved with defecation 
2) Onset associated with a change in frequency of stool 
3) Onset associated with a change in form (appearance) of stool 
Supportive Symptoms 
A) Abnormal bowel frequency: for research purposes is classified as 
having fewer than three bowel movements per week (1)*, or greater 
than three bowel movements per day (2). 
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B) Abnormal stool form: hard / lumpy stools (3) or loose (mushy) / 
watery stools (4) 
C) Abnormal stool passage: straining during a bowel movement (5), 
urgency i. e. rush to have a bowel movement (6), feelings of 
incomplete evacuation (7). 
D) Passing mucus (white material) during a bowel movement (8) 
E) Abdominal fullness, bloating or swelling, actual or perceived 
abnormal distension (9). 
*numbers in brackets refer to the symptoms that make up the IBS-subtypes. 
Sub-Types of IBS 
According to the Rome II criteria, the symptom patterns of the different subgroups 
for a typical week are as follows: 
IBS-D (Diarrhoea) one or more of 2,4,6, and none of 1,3,5. 
IBS-C (Constipation) one or more of 1,3,5, and none of 2,4,6. 
If the symptom presentation does not fit into either category the person is 
considered to have IBS-A (Alternating). 
This subgroup classification guideline is a useful tool for research purposes, both 
because it stipulates a minimum requirement of experiencing at least one symptom 
per week to be considered to be suffering from IBS, and also because it provides a 
framework for checking the accuracy of self-reported subgroup if a 7-day dairy is 
used to assess symptom frequency. It is important, however, to reiterate that 
symptom presentation is idiosyncratic (Naliboff et al., 1999), ranging from mild to 
intense both within and between sufferers and ranging from continuous, to infrequent 
and cyclical, in particular in women, due to the menstrual cycle (Heitkemper et al., 
2003). 
CRITIQUE OF TIIE ROME II CRITERIA 
Although the Rome II are recognised to be the gold standard for identification of 
symptoms in IBS, it should be noted that they are not without their limitations. The 
limitations of the criteria are obviously noted by the research group as the revisions 
to the criteria show (Drossman et at, 2000). However, the fact that a superior version 
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may emerge in the future does not negate the criticisms at this current time. The first 
criticism is that the accuracy of any symptom led approach can never by established, 
a problem that is exemplified by the amount of `IBS sufferers' who are categorised 
incorrectly (Olden, 2002). In addition if an objective biological marker is discovered 
then these criteria will be largely rendered unnecessary (Hatlebakk & Hatlebakk, 
2004). Other criticisms have been suggested by Camilleri (2001) who comments that 
although the criteria are fairly robust they are still not comprehensive enough to 
encompass the range of idiosyncrasies in IBS seen in a clinical population. This is a 
view that is shared by Silk (1997), who adopts his own categorisation system of IBS 
for his work with the IBS research appeal. Although one could argue that allowing 
for all of these idiosyncrasies would make the model unmanageable in a clinical 
sense, it is of importance when considering that the benefits of differing treatment 
options might be a function of specific aspects of different types of 1BS (Camilleri, 
2001). Alongside this one of the major criticisms suggested by Camilleri (2001) is 
that the necessity for abdominal pain in the diagnosis of IBS precludes those patients 
for whom bowel dysfunction is predominant. The Rome II criteria have also been 
criticised by those researchers investigating postprandial exacerbation of symptoms 
(e. g. Delvaux, 2004) for not considering that this might be a subgroup of IBS. It 
therefore seems likely that further revisions of the criteria will address these issues, 
however they are currently the best available option for research studies as they are 
considered to be robust and despite some limitations largely comprehensive 
(Drossman et al., 2000). 
IMPLICATIONS OF THE DIAGNOSTIC PROCESSES 
In addition to the specific critique of the Rome II criteria there are a number of issues 
that need to be considered regarding the diagnostic procedures for IBS. 
The first is that the lengthy procedures employed in this style of diagnosis in 
particular the embarrassing nature of many of the procedures, coupled with the 
potential of them exacerbating the symptoms (particularly for diarrhoea predominant 
patients having to take laxatives) means that many sufferers are likely to suffer from 
increased stress and anxiety. As these emotions have been shown to exacerbate 
symptoms (Dancey et al., 1998) it is likely that the diagnostic process itself will, at 
least in the short term, increase the frequency and severity of the symptoms for some 
sufferers. Secondly if doctor-patient communication is poor and patients feel 
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frustrated with their medical consultation this may also have a negative impact on 
both the prognosis of the illness and the associated quality of life (Bertram et al., 
2001). The use of exclusion processes in diagnosis also has its own problems with 
many patients being frustrated at being told there is not an organic cause due to 
potential worries over being considered hypochondriacs (Bertram et al., 2001), or 
due to the mere frustration of not being able to comprehend the aetiological factors 
(Brennan et al., 2005). The final point of consideration, as briefly mentioned earlier, 
is that neither exclusion criteria nor symptom presentation is sufficient to ensure 
accuracy of diagnosis, and even when diagnosis is accurate concerns are still 
prevalent. This is especially concerning when diagnoses are given by doctors based 
on their own assessment with very little attempt to refer the patient to colleagues or 
consultants (Drossman et al., 1999). In fact Hatlebakk & Hatlebakk (2004) report 
that only 3% of lBS sufferers are referred to secondary care. Franklin (2006) 
suggests that the low percentage of sufferers being referred to gastroenterologists is 
because referrals are generally only made if the GP is concerned over the possibility 
of the patient actually having "cancer, ulcerative colitis or Crohn's disease". 
AETIOLOGY 
There is currently no unifying consensus on the aetiology of IBS. However the 
majority of hypothesised causes can be sub categorised into three main perspectives. 
These are: persistent organic, non-persistent organic, and psychological. Proponents 
of an organic aetiology suggest that our current knowledge of the bowel is 
insufficient and therefore organic causes cannot be discounted until every part of the 
digestive system has been explored (Corazziari, 2004). According to this argument 
the suggestion of an organic cause cannot be dismissed, however at this current time 
all research aimed at identifying a structural defect or pathogenic cause have not 
yielded significant findings (e. g. Franklin, 2006; Mättö et al., 2004; D'anchino et al., 
2002). 
Slightly more support has been provided for a non-persistent aetiology (that is where 
bowel disruption was initially caused organically, but that that this is no longer 
present at the time of lBS diagnosis). A non-persistent aetiology is plausible as there 
is often a delay (in some cases for a very long time) from the initial experiencing of 
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bowel disruption to the diagnosis of IBS. There are two suggested non-persistent 
organic causes for which support is emerging; these are changes in gut physiology 
due to hormone replacement therapy (HRT, Ruigömez et al., 2003) and inflammation 
caused by gastrointestinal infections (e. g. Spiller, 2004; Camilleri, 2001; Thompson, 
2005; Hunt & Tougus, 2002; Gwee, 2001). It may therefore be the cause that a non- 
persistent organic aetiology is responsible for the development of IBS in some 
sufferers. Prevelance estimates for inflammation range from one in ten (Spiller, 
2004) to as many as one third (Drossman et al., 1999). In conclusion whilst it does 
therefore seem likely that inflammation is a cause of IBS in some patients it is by no 
means the only cause. It therefore seems necessary to move away from a rigid 
biomedical view if the aetiology of IBS is to be identified, therefore the next section 
will detail suggested psychological causes. 
PSYCHOLOGICAL CAUSES 
There are many single psychological causes that have been suggested, however, it is 
only relatively recently that theoretical developments have suggested a common 
mechanism underpinning all of the psychological triggers. This `mechanism', 
suggested by proponents of the biopsychosocial approach (e. g. Silk, 1997; Drossman 
et al., 1999) does seem to provide a plausible route to explain how experience of 
psychological `trauma' can result in the symptoms required for classification of IBS. 
The model is termed the brain-gut axis (Drossman et al., 1999). 
The brain-gut axis (figure 2) is theoretically derived from current levels of 
understanding of the interaction between the ENS and the CNS. It is a multifactorial 
approach that can encompass idiosyncratic differences. The model is therefore robust 
and allows for the gaps in current understanding of these processes at a physiological 
level. 
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Figure 2- The brain-gut axis 
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Broadly the model proposes, as pictorially represented on figure 2, that there is a 
reciprocal relationship between psychological factors and gut functioning. This 
model forms the basis of the justification for studying biopsychosocial approaches to 
IBS (discussed later). Essentially the model proposes that psychological factors, such 
as anxiety and stress are processed by the central nervous system (CNS) as expected, 
but from this system a reaction to the ENS is initiated. In addition the model also 
suggests that this process can be reversed, that is that gut processes in the ENS can 
evoke psychological reactions in the CNS. In normal brain-gut processing as 
described by Delvaux (2004) the CNS is continuously receiving information from the 
gut and has the responsibility of integrating this information with that received from 
other organs. It should be noted however that in physiological conditions most of the 
information relating to digestion is processed by the hypothalamus below the level of 
conscious perception. However, sensations, which serve to initiate a particular 
behaviour, such as hunger, gastric distension and the need to defecate will be 
consciously perceived. In the context of IBS this has important implications for the 
processing of food; in normal digestion this occurs autonomously, governed by the 
ENS, but as the `brain' and the `gut' are connected then CNS moderation of an 
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otherwise autonomic process may be an important aetiologic factor in the 
pathophysiology of IBS. If this is indeed found to be the case then it provides logical 
explanations to many of the main areas of controversy regarding IBS. Briefly it 
provides a model to explain disordered bowel functioning without the need for a 
structural defect, but does not preclude it. Secondly it explains why aetiologic factors 
may differ between sufferers and why symptoms and food tolerances are 
idiosyncratic and dynamic. Finally it provides a plausible explanation for the role of 
psychological factors in both the aetiology and daily experience of IBS, and suggests 
the need to use a psychological model which takes these aspects into account. The 
evidence for the main psychological factors will be detailed in the following sections. 
PERSONALITY TYPE 
Presence of a personality type, or types that predisposes development of IBS has 
been suggested by Dancey et al. (1995). As with many other disorders, such as 
schizophrenia, the conception of a personality predisposition does not necessarily 
mean that all people of a personality type will develop IBS or that people without the 
personality type will not develop it. However it does suggest an increased likelihood 
of developing the illness. The personality types that are most often found in people 
presenting with 1BS are anxiety disorders: such as panic and generalised anxiety 
disorders, mood disorders: such as major depression and dysthmic disorders, and 
somatoform disorders: such as hypochondriasis and somatizaton disorders. They are 
present in 42-61 % of patients seen in gastroenterology clinics compared with 25% in 
the control groups (Drossman et al., 1999). Whilst this figure does seem persuasive it 
is important to consider that there is no guarantee that it is trait rather than state 
personalities that cause the high scores on these dimensions. In this respect it is 
therefore possible that these personality characteristics develop as a function of the 
illness rather than prior to it. In order to assess this properly epidemiological 
research is needed. In addition it is common for many medical disorder patients to 
have higher trait anxiety and neuroticism scores than people without health 
problems, taking this into account it seems currently unlikely that there is a specific 
personality profile unique to IBS. 
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STRESS 
Stress is the most often cited contributing factor to the aetiology of IBS (e. g. Dancey 
et al., 1995). Although stress caused by a single traumatic event has been suggested 
(Drossman et al., 1999) as an etiologic factor stress is generally considered to be 
persistent in the form a series of severe life stressors, within this abuse is also 
included but is distinct from general stress. Support for severe life stress in the 
aetiology of lBS comes from studies that report severe life stress prior to the onset of 
lBS (e. g. Craig & Brown, 1984). In particular high social stress is an important 
contributory factor to the exacerbation of symptoms and subsequent treatment 
seeking (Drossman et al., 1999). Although stress has been shown to play a role in 
symptom presentation (Dancey et al., 1998) there is currently no research that has 
recorded occurrence of stressful life events from reliable historical data, that is to say 
it is only the subjective experience of stress rather then specific factors that have 
been investigated. Therefore, sufferers of IBS may in fact have enhanced perception 
of stressors (possibly as a result of personality trait, or as a result of their IBS), rather 
than a history of events. Further epidemiological research is needed to clarify this 
issue. 
ABUSE 
Related to the high stressor hypothesis is the possible aetiologic factor of abuse 
(either sexual or physical). Frequency rates of abuse range from 30-56% of people 
with functional gastrointestinal disorders (including IBS). Although some researchers 
(e. g. Drossman et al., 1999) suggest this figure to be high it should be noted that even 
at the top end of this range only 50% of the sample report abuse, whilst this figure is 
considerably higher than the percentage of the general population who report abuse, 
it would not be sufficient to be considered a single source explanation for developing 
IBS (as psychodynamic therapists posit) as it leaves the aetiology of 44-70% of the 
sample unexplained. In addition, whilst not discounting the possibility of abuse as a 
contributing factor in some patients it should also be considered that all studies to 
date have relied on self-reports to elicit this information. It is therefore difficult to 
confirm whether prior history of abuse has actually occurred, or whether the 
information received is due to dishonesty, or false memory syndrome, this is of 
particular relevance for patients with co-morbid psychosocial difficulties (Blanchard 
et at., 2004). Even if the highest percentage of abuse can be accepted as accurate this 
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does still not necessarily mean that abuse history is an IBS specific aetiological 
factor. It has often been reported as being associated with poorer health status, and in 
particular with other chronic pain disorders, and it would therefore seem more likely 
that sufferers of abuse who go on to develop IBS do so as one of a number of ways 
that psychological distress is communicated through physical symptoms (Baccini et 
al., 2003). 
DOMESTIC VIOLENCE 
Perona et al. (2005) investigated the presence of functional gastrointestinal disorders 
(including IBS, diagnosed by Rome II) in a sample of 70 women who had reported 
domestic violence to the police. They discovered that 71% of their sample had a 
FGID and of these 47% had irritable bowel syndrome. An interesting finding is that 
in two thirds of the cases the FGID either occurred simultaneously with the reported 
abuse, or within a short enough time period to make the suggestion of causation, 
rather then mere correlation seem plausible. When comparing the characteristics of 
the groups with and without a FGID the authors did not find any significant 
difference in the women's ages, nor in type or duration of the abuse. A significant 
finding was however observed in the levels of reported psychological distress, with 
higher distress being associated with presence of a FGID. This study therefore 
suggests that women who suffer from physical abuse are more likely to suffer from 
IBS (or another FGID) and importantly that the mediator of this relationship is the 
level of psychological distress experienced. This study therefore provides support for 
the plausibility of the brain-gut axis. 
Unfortunately the research on the aetiology of IBS does not easily fit into one of the 
psychological categories either, and although the brain-gut axis model is plausible 
the difficulty in producing accurate research means that it has largely focussed on 
either the daily exacerbation of psychological factors in IBS, or correlating factors 
(both organic and psychological) rather than directly as aetiologic factors. For this 
reason any further discussion on aetiological factors would be circular without 
resolution and in this respect it is important to focus on the issues that can be 
identified despite problems in identifying a causal factor. 
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EPIDEMIOLOGY 
There is a very small amount of epidemiological data available for IBS, as is 
unfortunately the case for all the FGIDs. The lack of established epidemiological 
data is due to the fact that study in this area is still in its infancy (Corazziari, 2004). 
Accordingly the epidemiological data that does exist shows a wide range in estimates 
of incidence and prevalence (Saito et al., 2002: Sanders et al., 2001). There are a 
number of contributing factors to the differential reporting including: delay in help 
seeking; the embarrassment of admitting suffering from IBS in general population 
surveys, especially those which are telephone based; the bias towards treatment 
seeking amongst females; and the different types of diagnostic criteria used 
(Boekema et al., 2001). On the balance of the current evidence it would appear that 
prevalence of IBS in western countries is around 15-22% (Dancey et al., 1999). 
Drossman et al. (1999) show support for the similar prevalence rates in western 
countries by showing that reported rates of the United States, England and France are 
nearly identical (Drossman et al., 1999). However, Boekema et al. (2001) elicited a 
much lower prevalence rate of 5.8% with his Dutch population based research. 
Methodological considerations in this research, primarily due to its telephone based 
nature, mean that it is plausible that the low prevalence was due to embarrassment 
concerning discussing bowel habits on the phone, and accordingly further research is 
needed to establish if prevalence rates are actually much lower in Holland. 
Although Dancey et al. (1999) state that prevalence rates are considerably higher in 
non-western populations, (Dancey et al., 1999), this does not mean that all non- 
western populations show this. Drossman et al. (1999) also note that the prevalence 
rates for the eastern countries Japan, China, Nigeria and in the Indian subcontinent 
are similar to western countries, with the only distinction being Thailand, where it is 
less. Prevalence rates in the Middle East may also be lower with Babak et al. (2006) 
reporting prevalence rates of 7.1 % with their community sample of 4762 Middle 
Eastern participants. The prevalence rates are also suggested to be lower for black 
ethnic groupings compared with whites (Wigington et al., 2005), but increased 
prevalence has been observed amongst Hispanics and some Asian groups (Drossman 
et al., 1999). 
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It is often reported that there is a gender bias with females being more likely to have 
IBS than males but this issue is contentious. It is a reasonable observation that the 
proportion of females in primary care in western countries is greater than males 
(Drossman et al., 1999) but it is still unclear whether this represents an actual gender 
bias, or merely differential help seeking. This is of particular note when you consider 
that the proportion of people who seek help for their symptoms is considerably less 
than those who would fulfil the diagnostic criteria (Boekema et al., 2001). Taking 
this controversy into account it is unsurprising that no common consensus has yet 
been reached. Some studies e. g. Heaton et al. (1992), report a ratio of 2: 1 (women: 
men) whereas others report no difference (e. g. Saito et al., 2002). On the balance of 
the evidence it seems plausible to conclude that IBS does have a majority of female 
sufferers (Dancey et al., 1999), but that this gender bias is overestimated. In addition 
Drossman et al. (1999) suggest that in Sri Lanka and India males are predominant 
with females only representing 20-30% of the lBS population. 
The final epidemiological factor is age: there is a widespread belief amongst and the 
general population that IBS is an illness of ageing. Whilst older adults do seem more 
likely to participate in research, this is most likely due to a sampling bias, perhaps 
because older adults have more time to participate in research, rather than a true 
representation of the population. To clarify this issue Saito et al. (2002) conducted a 
systematic review on all the available research. The results showed age related 
difference in prevalence to be minimal. This view is supported by Drossman et al. 
(1999) and Dancey et al. (1995) who state that IBS generally develops in early 
adulthood. 
CO-MORBIDITY (AND EXTRA INTESTINAL SYMPTOMS) 
The high frequency of IBS assures that at least a proportion of sufferers will have at 
least one other illness. In teams of co-occuring conditions theoretically the full range 
of illnesses are possible, however, there are some conditions which show a greater 
than chance association in this illness group and these can be considered to be co- 
morbid. 
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OTHER FUNCTIONAL GASTROINTESTINAL DISORDERS 
The first area of co-morbidity is between IBS and other FGIDs, in some cases the 
boundary between a diagnosis of constipation-predominant IBS and functional- 
constipation is very difficult to establish, and theoretically due to the cyclical nature 
of IBS a dual diagnosis could be made. The FGID that is most frequently co-morbid 
with IBS is dyspepsia, with a reported range of 23-50% of sufferers satisfying 
criteria for both conditions (Corazziari, 2004). 
ORGANIC DISORDERS 
The second area of co morbidity is between lBS and organic disorders. In fact this 
occurs so frequently that is has been suggested by one of the members of the Rome 
team (Corazziari, 2004) that the categorisation of lBS as a functional disorder is 
misleading. Corazziari (2001) argues that although the `functional' definition is 
technically accurate due to the lack of (identification of) IBS specific structural or 
biochemical abnormalities as was seen earlier, it is misleading as it implies that no 
other organic abnormalities will affect the presentation of the IBS symptoms. The 
most frequently recorded organic co-morbid `illnesses' in research reports are gastric 
reflex disease, and prolapsed rectum. However, although a general search will 
provide commentary on the co-occurrence of these illnesses there has been to date no 
scientific evidence for specific co-morbidity. The two main illnesses that have been 
researched are coeliac disease (Sanders, 2001) and asthma (e. g. Roussos et al., 2003, 
Ekici et al., 2005 and Babak et al., 2006) 
PSYCHOLOGICAL CO-MORBIDITY 
In addition to the physical co-morbidity, IBS is also considered to show co-morbidity 
with psychological conditions. However, this relationship is potentially more 
complex than for physical co-morbidity as many of the co-morbid psychological 
conditions proposed are conditions that were implicated in the aetiology of IBS. This 
is indicative of an inability to show cause and effect with cross-sectional research 
and points to the need for prospective epidemiological research. In our current state 
of understanding it does, however, appear that whilst these may be aetiologic factors 
for some sufferers, for others, especially in the case of depression, they are likely to 
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occur following the disorder. Regardless as research on the brain-gut axis suggests, 
they are likely to interact with digestive functioning on a daily basis. 
STRESS AND RELAXATION 
Stress is one of the primary psychological factors that has been researched in IBS. It 
is unsurprising that high levels of stress are found in IBS populations, because in 
most instances where health related quality of life are affected there is likely to be an 
increase in levels of stress and depression (Wong et al., 2001). In IBS the experience 
of stress has been found to correlate with symptom presentation. In fact research by 
Stam et al. (1999) shows objective biological evidence that stress and 
psychoneurogastroenterology are inherently linked. Although their research is not 
heavily generalisable to humans their discovery that stress can actually induce 
colonic motility in animals is highly relevant. Interestingly in their discussion they 
also note how their research does not disprove the concept of coping strategies (e. g. 
Rutter & Rutter, 2002), but merely gives additional information. They concluded, 
that the colonic response to stress is related to both basal motility status and 
individual coping strategies. The directionality of this research suggests that stress 
exerts an influence on gastrointestinal functioning, and although the style of the 
research cannot prove that a serial dependency is present, their comments regarding 
coping strategies suggests that certainly in humans rather than a unidirectional route 
from stress to symptoms there is actually a complex interaction between the two 
factors. Research by Dancey one of the most influential researchers in this field, 
certainly suggests this to be the most likely (Dancey et al., 1993; 1995). Support for 
the role of stress in IBS is also offered by Gwee (2001) and Drossman et al. (1982). 
The most informative research so far which suggests stress to be not just a predictor 
of symptoms but also that symptom can influence stress levels was conducted by 
Dancey et al. (1998). They used time series procedures to investigate the relationship 
between daily stress and symptoms. Their cohort was recruited via the IBS Network, 
on the rationale that it is particularly important to study non-clinical samples of IBS 
(Phillips et al., 1992). Although their sample was somewhat small at N=31 the 
participants were required to answer lengthy questionnaires every evening for a 
month. Therefore due to the extremely rich level of data that this design yields it is 
not only understandable to have a low cohort but arguably acceptable. The 
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methodology utilized two questionnaires, both of which were designed for the study, 
and no reliability estimates were given. It is therefore possible that the questionnaires 
are not valid psychometric instruments; however, their simple structure means that 
they probably did yield reliable data. 
The first questionnaire, entitled the `Daily Symptom Questionnaire' involved a seven 
point Likert scale (0 - do not suffer from this symptom at all, to 7- most 
troublesome this symptom has been) of the seven most experienced symptoms: 
diarrhoea, constipation, pain, wind, an urgent need to defecate, feelings of 
incomplete evacuation and bloating. The ratings for symptoms on each day were 
summed to give a total symptom score. This was based on the findings of Dancey et 
al. (1995) that it is the cumulative effect of symptoms that correlates with stress, 
rather than any individual symptom. Dancey et al. (1998) claim that rather than stress 
solely influencing symptoms a serial dependence exists between stress and 
`symptomlogy' for a statistically significant proportion of sufferers. In fact multiple 
regression analysis carried out on same day and lagged relationships up to and 
including four days revealed the best regression model was one in which symptoms 
were a function of hassles and symptoms on the previous 2 days and hassles on the 
same day. Multiple regression analyses on each participant individually revealed that 
stress was a predictor for 67% of participants. As an exploratory study this research 
is a springboard for disentangling the relationship between stress and symptoms. 
The main criticism with this research is that although the within-subjects design is 
good for establishing idiosyncratic factors, it would have been more prudent to 
conduct a between subjects analysis with type of IBS as a grouping variable. 
Although this is not necessary in the context of this research because they used the 
summed symptom score rather than individual symptoms, it is plausible that it might 
not be just the cumulative affect of symptoms that shows an effect as they assert 
(Dancey et al., 1995; Dancey et al 1998), but rather individual symptoms do show 
the same relationship between stress, and that this has merely been obscured due to 
IBS being analysed as a homogonous population, which it is not. Future research 
should take this into consideration. Although the results of this study cannot be 
considered as conclusive it does seem likely that stress levels and symptom 
presentation are inherently connected. 
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Further support for the notion of stress affecting symptoms is provided by the 
success of relaxation intervention programmes (see systematic review). An example 
of this is the study by Heymann-Mönnikes et al. (2000). Support for stress 
influencing symptoms is demonstrated by intervention experiments because a 
decrease in symptoms after a decrease in stress shows the reduction in symptoms to 
come directly from the reduction in stress. It is clear that it is this reduction in stress, 
which has directly caused the improvement in symptoms because it is the effect of 
stress as the independent variable that the relaxation programmes target. Relaxation 
programmes are therefore able to isolate this causation in the way that simple 
correlations are not. The main research into relaxation strategies is that produced by 
Keefer & Blanchard (2001; 2002). They conducted two experiments into the efficacy 
of relaxation interventions, using, Herbert Benson's (1975) Relaxation Response 
Meditation (cited in Keefer & Blanchard, 2001; 2002). One of the key features of 
their research is the use of high quality psychometric instruments and daily symptom 
diaries (considered the gold standard, Meissner et al., 1997). One tailed independent 
samples t-tests revealed the reduction of symptoms in the meditation group to be 
significantly greater than in the control group for flatulence, and belching at initial 
post treatment assessment. A three-month follow up was also conducted, which 
revealed sustained improvements on these symptoms and also an improvement in 
bloating and diarrhoea, with constipation approaching significance, with ten of the 
original participants and concluded that symptom reduction was maintained in the 
long term. They concluded that relaxation response meditation appears to be an 
effective and viable treatment option. An interesting feature of their research was that 
they paired their sample on the basis of axis one disorders, providing support for the 
notion that they are common in this population (Blanchard et al., 2001). On the basis 
that one of the most common axis one disorders observed in this population is 
depression (Swiatkowski & Rybakowski, 1993) it seems plausible that depression 
might exert the same impact on IBS symptoms as stress. 
DEPRESSION 
Another psychological candidate, much less researched then stress, is depression. 
Unfortunately due to current controversy regarding the efficacy of specific diagnostic 
tools for measuring the co-morbidity of depression in IBS it is not possible to 
ascertain exactly what percentage of sufferers also have clinically significant levels 
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of depression. Blanchard et al. (2001) suggest this is particularly problematic when 
researching possible gender differences in depression. Their research utilised 341 
IBS patients, 223 females, and 83 males, a very high number of respondents. In 
addition they held structured psychiatric interviews on 250 of their sample. 
According to the diagnostic interviews (which are considered the gold standard) they 
found 65.5% of sufferers to be classifiable under axis one of psychiatric disorders. 
Most importantly they did not find any gender difference. However, when classified 
according to the Beck Depression Inventory (BDI), the Trait Anxiety scale of the 
State-Trait anxiety inventory (STAI) and scales 2 and 3 of the MMPI significantly 
higher scores were found for females (compared with males). The differential 
findings relative to the measuring tool used means that it is currently not possible to 
ascertain gender differences in regard to depression and this research is useful in 
alerting the researcher not to use these measures in research with IBS until more 
validation studies have been performed. It is however clear that depression remains 
an important facet of the psychological aspects of IBS and as such should be 
included in any analysis. As the relationship between stress and depression may well 
be based around the subjective experience of depression affecting symptoms it would 
seem practical, until further clarifications have been made to the existing diagnostic 
instruments to use a simple Likert scale method of assessing self-perceived level of 
depression. 
Further support for the role of depression as a significant predictor of symptom 
severity has also been provided by Drossman et al. (1999). His paper looks at the 
impact of psychosocial factors from a number of angles and concludes that 
psychological difficulties, such as depression, impact on severity of experienced 
symptoms. As with stress one method for establishing whether a factor has an effect 
on symptoms is by assessing symptoms after an intervention has occurred, if there is 
a reduction in the factor, and a consequent reduction in the symptoms then we can 
fairly safely conclude that the level of the factor affected the level of the symptoms. 
This method has been employed in the context of depression by Lydiard & Falsetti 
(1999) with their systematic review. Though limited to three primary articles their 
research suggests that treatment of depression shows a subsequent marked reduction 
in symptoms and as such should be treated in addition to the symptoms, rather than 
22 
Irritable bowel syndrome: overview 
merely treating the symptoms alone (Clouse et al., 1994; Heffner et al., 1978, Lydiard 
et al., 1986). 
Two main areas supported by research are enhanced perception of pain amongst IBS 
sufferers (Verne et al., 2003; Lembo et al., 2000) and the role of serotonin in the 
enhancement of bowel motility, the peristaltic reflex and facilitating intraluminal 
secretions (Crowell., 2001). This has important implications for the co-morbidity of 
depression, as this suggests that depressive state will necessarily increase abdominal 
pain, and tendency towards diarrhoea, creating a vicious cycle making it difficult for 
the person it elevate their current mood. It should be noted that the relationship 
between psychological factors and symptoms exists even when the psychological 
factors are not severe enough to meet DSM classification. 
CURRENT TREATMENT OPTIONS IN IBS 
There are four primary (non-psychological) categories of treatment in IBS, these are 
medical management, complementary and alternative medicine, dietary interventions 
and exercise interventions. However, as this section will demonstrate, none of these 
treatments are effective. 
MEDICAL MANAGEMENT 
Treatment traditionally takes place within primary care following diagnosis. IBS 
sufferers are the highest proportion of those seen by gastroenterologists and one of 
the more common illnesses seen by GPs (Camilleri, 2001). The main medications 
used in IBS are Antispasmodics, Antidiarrhoeals, Fibre supplements and 
Antidepressants. Despite their widespread use (Tally, 2001) many researchers remain 
sceptical of their usefulness (e. g. Heitkemper et al., 2002; Parsbns & Whittle, 2004). 
The first criticism is that the medications focus on symptoms rather than aetiological 
factors, and therefore they merely mask the intensity of the symptoms rather then 
preventing them from occurring (Hussain & Quigley, 2006). The second criticism is 
that medical management is restricted to the specific times when the symptoms are 
experienced. This is highly unsuitable as IBS is characterised by alternating periods 
of symptoms and remissions, with potentially distinct triggers for symptom 
occurrences (Camilleri, 2001). It is therefore unsurprising that some psychologists' 
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view the current pharmacological treatments as simply not capable of alleviating the 
idiosyncratic, multiple, and often alternating symptoms associated with IBS (Talley, 
2001; Tougas, 2001). The third, and most worrying criticism of medical management 
in IBS is that the side effects of many of the main medications are at least as bad 
(often opposing IBS symptoms) if not drastically worse than the symptoms the 
patient experienced in the first place (e. g. Farthing, 2004; 1999). This is exemplified 
most strongly by controversial debate surrounding the licensing of Alosetron. 
COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) 
Unsurprisingly the failure of traditional medicines in many cases leads sufferers to 
look for non-traditional therapies, although this is usually in conjunction with 
traditional medication (complementary), rather than instead of it (alternative) 
(Hussain & Quigley, 2006). Koloski et al. (2001) suggest use of CAM is more 
prevalent amongst those sufferers who report a greater frequency of abdominal pain, 
and perhaps unsurprisingly by those who report dissatisfaction with medical 
professionals. Preliminary research for traditional Chinese medicine (TCM, 
Bensoussan et al., 1998), and peppermint essential oil (e. g. Pittler & Ernst, 1998; 
Grigoleit & Grigoleit, 2004) suggest that CAM methods may be useful for some 
sufferers, however further (high quality) research is needed before any firm 
conclusions can be drawn (Makk et al., 1995). 
DIETARY INTERVENTIONS 
As IBS patients commonly report postprandial precipitation of their symptoms 
dietary interventions (inclusions and exclusions) are common. The success of 
elimination diets have varied markedly from 6% to 58% (Zar et al., 2005; Niec et al., 
1998; Atkinson et al., 2004) as a consequence no general recommendations can be 
made. Various inclusions have been suggested; however the main suggestions are to 
increase `healthy bacteria' and fibre. Although both have been found to be important 
for normal digestion (e. g. Thompson, 2001) their efficacy in IBS is unfounded. In 
fact Bosaeus (2004) suggests that increasing fibre can be damaging to sufferers of 
diarrhoea predominant IBS. Whilst there are no reported adverse effects of probiotics 
the evidence for their utility in IBS is inconclusive with some studies reporting 
beneficial effects (e. g. Nobeak et al., 2000), and others finding no significant 
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difference from placebo (e. g. Franklin, 2006; Bausserman & Michial, 2005; Niv et 
al., 2005). 
EXERCISE INTERVENTIONS 
Although exercise is undoubtedly beneficial to general health (e. g. Bull et al., 1999) 
and therefore advising IBS sufferers to exercise is likely to improve their symptoms 
there is currently only one study investigating its efficacy in IBS (Levy et al., 2005). 
Although this study offers preliminary support for the efficacy their cohort was 
restricted to an obese population and therefore more research is needed before the 
results can generalised. 
THE NEED FOR DEVELOPMENT OF TREATMENTS IN IBS 
From the previous review it is clear that none of the treatment options are currently 
effective at providing lasting cure or even controlling the multiple and fluctuating 
symptoms of IBS (Talley, 1995), 
If effective treatments are going to be devised there is a clear need for a perspective 
which takes a holistic approach to the patient, rather that a merely symptomatic 
approach. In fact some researchers have suggested that the only way to successfully 
treat patients is to "identify which particular cause or causes are applicable to each 
individual patient" (Franklin, 2006). Although this method is undoubtedly superior to 
a general pharmacological intervention (e. g. Talley, 2001) there are obviously 
serious practical limitations, such as time, money and resources. Therefore one of the 
major challenges in the future of IBS treatment is to devise interventions that can 
encompass its idiosyncratic and potentially multifaceted aetiology without being 
impractical. There are many reasons why effective treatments in IBS should be 
developed. Firstly "IBS is associated with a substantial burden on individual patients, 
health care systems and society as a whole" (Gilkin, 2005). This view is echoed by 
Sandler et al. (2002) with their statement "considering the burden to the patients due 
to the sometimes disabling symptoms and the burden to society due to the economic 
impact, the reward to accomplish these goals [providing effective treatments for IBS] 
is enormous". Although these are evocative statements and may initially appear to be 
over emotive, it can be seen throughout the literature and correspondence on this area 
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that much support is shown for these statements (e. g. Talley et al., 1995; Gralnek, 
2000; Bellini et al., 2005; Quigley et al., 2006; WHO, 1992; Silk, 2001; Stam et al., 
1999; Heymann-Mönnikes et al., 2002; Bertram et al., 2001; Munir et al., 2005). 
In this thesis the main area where the need for treatments is demonstrated is in the 
impact on individual sufferers, the term used to describe this impact is Health 
Related Quality of Life (HRQOL). The concept of HRQOL is a necessarily 
subjective one, as it aims to assess patients' perceptions of the aspects of their lives 
that are affected by their having a chronic illness. It is most coherently described by 
Frank et al. (2002) as a multidimensional concept "comprising physical, social and 
psychological functioning and well being". People without an understanding of IBS 
often comment that it is not a serious disorder which does not affect quality of life. 
Whilst this may be true for a small proportion of sufferers for many this statement is 
both inaccurate and insulting. As the studies by Bertram et al. (2001) and Dalton et 
al. (2004) demonstrate this is particularly problematic when it is the medical 
professional that does not consider HRQOL to be affected. The article by McCarthy 
(2002) in the context of the Alosetron debate is littered with evocative statements 
which clearly shows sufferers' HRQOL being affected. In addition lBS Network's 
quarterly publication and internet message boards are filled with comments from 
sufferers complaining about the impact IBS has on their quality of life. 
A recent paper by Simren et al (2006) investigating HRQOL compared organic and 
functional bowel disorders (including IBS). Their study used a large sample of 
patients (n=399) as they attended a GI outpatient clinic. Participants completed both 
the SF-36 and the Psychological General Well Being Index to assess quality of life, 
and also a gastrointestinal symptom rating scale. Although the analyses only 
compared functional (n=112) to organic (n=287) GI disorders and not lBS 
specifically the finding that patients with FGIDs report a lower HRQOL is of 
importance and the conclusion reached by the authors that the impact is `profound' 
cannot be overlooked. This study is also important as it shows that just because an 
illness does not have an identified organic cause does not mean impairment is any 
less real. 
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Gralnek et al. (2000) performed a large study utilizing IBS patients (n=877) and 
compared their HRQOL scores (on SF-36) with data from the American normal 
population, and with sufferers of a number of other chronic illnesses. The findings 
revealed that on all eight of the SF-36 scales IBS sufferers reported significantly 
worse quality of life than the general population (p < 0.001). When comparing the 
IBS group to the other illnesses similar levels of HRQOL were found. The only 
significant differences were for diabetes gastroesophageal reflux disease (GERD), 
where lower HRQOL was reported for IBS sufferers on selected scales, p<0.001. 
The overall conclusions drawn from this research suggest that HRQOL is indeed 
impaired in IBS sufferers and that beyond the basic symptoms, "what matters most is 
how they are able to function in their day to day lives". This research clearly 
suggests that the goal for research into treatments should focus on improving 
HRQOL rather than just symptoms, although they are inherently interrelated. This is 
a useful study as it compares lBS to the general population and also to other 
illnesses; type 2 errors are avoided by the use of large samples and adjustments for 
multiple comparisons. In addition strict inclusion criteria for the IBS participants of 
Rome II plus 3 Manning criteria ensured that the HRQOL reported here is likely to 
be generalisable to sufferers outside of the United States. The results of this study are 
supported by Frank et al. (2002). 
Taking the concept of HRQOL one stage further Miller (2004) investigated suicidal 
ideation in patients with IBS, one hundred tertiary care patients were compared with 
100 secondary care and 100 primary care. Patients were asked if they had either 
seriously contemplated or attempted suicide as a result specifically of their bowel 
problems. The results were recorded using the Hospital Anxiety and Depression 
Scale (HADS) and other clinical details were collected by the researchers. It was 
discovered that a proportion of patients in all groups had seriously considered suicide 
but this was statistically much higher in those patients who were in tertiary care (p = 
0.002 compared to secondary, p=0.00 1 compared to primary). Of the 100 tertiary 
care patients 5% had actually attempted suicide. This figure may appear quite low 
but is of importance as it shows the negative impact suffering from IBS can have, 
and interestingly that it seems to be much higher in those sufferers who are not 
getting as much medical attention. It is also important to note that this study cannot 
account for people who were actually successful in their suicide attempts, and 
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therefore it is possible that actual suicidal ideation may be higher. A closer 
interpretation of the reasons for this suicidal ideation revealed the main causes were 
feelings of hopelessness due to symptom severity, the interference suffering from 
IBS caused with general life, and perhaps unsurprisingly as the highest ideation was 
seen in the tertiary group, inadequacy of treatment were highlighted as crucial issues 
for all IBS patients. The authors concluded that IBS has the potential for a fatal 
outcome from suicide, and that despite previous claims, general depression does not 
account for all the variance in this relationship. This research therefore emphasises 
the level of hopelessness felt by some sufferers of IBS and the need for improvement 
in services. 
THE NEED FOR BIOPSYCHOSOCIAL BASED TREATMENTS 
IN IBS 
The research therefore strongly suggests that treatments are needed in IBS and that 
an integrated model is the way forward in designing effective management 
techniques for sufferers. As Camilleri (2001) suggests "understanding the brain-gut 
axis is the key to the development of effective therapies for IBS". This stance is 
logical as the section on aetiology demonstrated. In addition if IBS is truly a 
functional illness, or at least has a psychological component which many researchers 
agree is the case (e. g. Dancy et al., 1995; Drossman et al., 1999), then interventions 
from a psychological stance are highly suited. 
THE BIOPSYCHOSOCIAL MODEL 
It is clear that one reason why standard interventions meet with limited success is 
that the biomedical model underpinning their design is theoretically weak in 
comparison with the biopsychosocial model. Although there may be some reluctance 
to this theoretical shift amongst the medical community, there is clearly a need to 
explain and treat illnesses that do not seem to conform to traditional expectations of 
illnesses. The biopsychosocial approach, although rooted in the philosophical 
concept of dualism (e. g. Plato) has since its re-emergence in the late 1970s proved 
itself to be a highly scientific approach. The re-emergence of this model (table 5) is 
largely credited to Engel (1977). His contention that "health, illness and disease are 
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an interaction of biologic, psychological and social subsystems operating at multiple 
levels" has had a profound effect on medical advancement over the last thirty years. 
Table 2- The Biopsychosocial view of health and illness 
BIO PSYCHO SOCIAL 
Viruses Behaviour Class 
Bacteria Beliefs Employment 
Lesions Coping Ethnicity 
Stress 
Pain 
The key consideration with this model is, unlike some other alternative theories, it 
does not negate the success of the biomedical approach, it merely suggests that it is 
too rigid. Although different illnesses may vary in the degree to which psychological 
and social factors affect onset and progression it would be very naive to suggest they 
do not play a role as issues such as social inequalities in health (e. g. Hernändez- 
Quevedo, 2006), personality traits (e. g. Grant & Langham-Fox, 2006), pre- 
disposition (e. g. Shore & Johnson, 2006) and many other factors (e. g. Maguire, 
1999) have all been shown to play a role not just in health and illness, but in the 
specific nature of the illness developed. It is perhaps somewhat unsurprising that the 
biomedical approach is too rigid for IBS as this seems to be a general finding across 
all chronic illnesses (Munir et al., 2005). The complexity of the psychological, social 
and physiological factors in IBS makes this illness highly exemplary of the 
superiority of this approach in explaining its progression (Camilleri, 2001). 
BIOPSYCHOSOCIAL CONCEPTUALISATIONS OF IBS 
There are a number of justifications for the suitability of the biopsychosocial model 
for IBS (and indeed other FGIDS) which will be described below. Firstly there is a 
general reluctance for doctors to treat chronic conditions, especially functional ones. 
This is partly because functional illnesses may not be considered to be legitimate 
medical problems, and partly due to a general feeling of insecurity when 
pharmacological approaches to treatment fail (e. g. Bertram et al, 2001; Talley, 2001; 
Tougas, 2001). The biopsychosocial model therefore legitimises IBS as an illness by 
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suggesting a model to explain its aetiology, prognosis, and by increasing scientific 
research. 
The next justification for the suitability for the biopsychosocial model for this illness, 
is that it is far less rigid than the biomedical model allowing for both aetiology and 
symptom progression to be understood as multifaceted and multi-determined. 
Previously symptoms were considered to be purely physiological but this model 
allows for psychological, biological and social factors to contribute to symptom 
experience. 
Research into co-morbidity suggests interplay with psychology and physiology 
through hormones, neurotransmitters and perception. The two main areas supported 
by research are enhanced perception of pain amongst IBS sufferers (Verne et al., 
2003; Lembo et al., 2000) and the role of serotonin in the enhancement of bowel 
motility, the peristaltic reflex and facilitating intraluminal secretions (Crowell, 2001). 
This has important implications for the co-morbidity of depression, as this suggests 
that depressive state will necessarily increase abdominal pain, and tendency towards 
diarrhoea, creating a vicious cycle making it difficult for the person it elevate their 
current mood. It should be noted that the relationship between psychological factors 
and symptoms exists even when the psychological factors are not severe enough to 
meet DSM classification. Indeed the change in explanation from co-morbidity to bi- 
directionality also means that treatment programmes can be implemented which 
combine approaches rather than taking them as separate entities. 
The biopsychosocial approach therefore legitimises the so-called brain-gut axis, and 
the role of the central nervous system (CNS) in the aetiology of this illness 
(Drossman et al., 2000). This approach can therefore explain vast differences in 
aetiological suggestions from gastroenteritis to sexual abuse, and furthermore it also 
explains why IBS can, but does not necessarily result from these life events. 
In a similar vein the model can explain the illness prognosis, for instance the 
idiosyncrasies that exist between different sufferers, and also why symptom 
presentation is varied in the same person at different times. This is because the model 
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allows for psychological factors such as daily stresses, personality traits, and coping 
styles. 
In summary therefore chapter 1 has introduced the background to IBS. The 
information presented shows that IBS is a chronic, functional, gastrointestinal illness. 
Its aetiology and prognosis involve a complex interaction of physiological, 
psychological and social factors. It is therefore clear that in order to further 
understanding of IBS and to develop effective treatments for sufferers a 
biopsychosocial approach should be adopted. This is not merely a justifiable 
alternative approach to the study and treatment of IBS but is, as the previous chapter 
has shown highly suited to IBS. This has the potential to explain the main areas of 
previously unanswered questions, including brain-gut axis relationships, illness 
representations, illness behaviour, and coping styles. It should be noted that 
biopsychosocial approaches cover a broad spectrum of many theoretical models and 
it is therefore important to establish which specific biopsychosocial model is the 
most efficacious for IBS research. The aim of the systematic review (presented in the 
following chapter, chapter 2) was to investigate whether a successful model already 
existed or if an alternative model was in need of exploration. The systematic review 
revealed that whilst psychologically based approaches are no doubt efficacious in 
IBS treatment there is no model which dominates. Therefore an alternative model 
which was felt to have a number of useful components was used for this thesis, this is 
Leventhal et al's (1980; 1984) common sense model of illness representations 
(CSM). The description of the model and its justification are presented in chapter 3 
(following the systematic review in chapter 2). The three empirical chapters in this 
thesis, commencing with chapter 4, present a number of results based around the 
exploration of the different features of the CSM. 
Chapter 4 reports the results of study 1. This was an exploratory study which 
investigated the role of doctor-patient communication in irritable bowel syndrome. 
There were a number of different research questions but they grouped into three main 
areas of interest. The first area was a comparison of patients' and doctors' 
perceptions of doctor-patient communication. The second area was an assessment of 
the potential impact of patients' perceptions of doctor-patient communication on 
their illness representations and their illness outcomes (perceived health related 
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quality of life and symptom frequency). The third and final area of investigation was 
an exploration of the relationship between illness representations and illness 
outcomes independently from perceptions of doctor-patient communication. The 
rationale for this study is based on the need to identify which factors impact on the 
illness representations sufferers develop as without a clear understanding of these 
factors it will not be possible to devise effective interventions. 
Chapter 5 reports the results of study 2. This was an exploratory study which 
investigated the role of perceived social support in irritable bowel syndrome. There 
were a number of different research questions but they are grouped into four main 
areas of interest. The first area was an investigation of the attitudes that the general 
population held towards sufferers of IBS (in comparison with other illnesses). The 
second was a comparison of the general populations' attitudes towards IBS sufferers, 
with IBS sufferers' perceptions of the general populations' attitudes towards them. 
The third area of investigation was an assessment of the potential impact of IBS 
sufferers' perceptions of the general populations' attitudes, on their illness 
representations and illness outcomes. The fourth and final area of investigation was 
an exploration of the relationship of illness representations and illness outcomes 
independently from perceived attitudes to IBS. The rationale for this study stems 
from reports by sufferers of perceived lack of social support, as social support may 
be an important moderating factor in illness outcomes it is important to ascertain 
whether this perception is justified as this will affect the design of interventions for 
sufferers of IBS. 
Chapter 6 reports the results of study 3 the final study in this thesis. This study is 
entitled "a self-help booklet intervention study for irritable bowel syndrome (IBS) 
based on the common sense model (CSM)". This study is the culmination of the 
research preceding it, which serves to identify those factors which impact on the 
illness representations sufferers hold, and where appropriate to ascertain its impact 
on illness outcomes. Through the previous research conducted in this thesis, and the 
available literature this evidence-based intervention was designed. The rationale for 
this study was to produce an intervention which would improve both symptom 
frequency and quality of life for sufferers of IBS. Importantly the intervention should 
be superior to previous research on key dimensions, such as cost effectiveness (in 
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time and money), adaptive to the idiosyncratic nature of IBS and easily administrated 
to sufferers. 
Chapter 7 is the final chapter in the thesis. This provides a general discussion of the 
results found in the thesis, implications for treatment of IBS and any methodological 
issues raised. 
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CHAPTER 2 
PSYCHOLOGICALLY BASED ILLNESS INTERVENTIONS IN 
IRRITABLE BOWEL SYNDROME (IBS): A SYSTEMATIC 
REVIEW 
Aim 
The current review summarises interventions in IBS (conducted since the 1980s) that 
include a psychological component. The aims of the review were to gain an overview 
of a) the viability of a psychologically based intervention in IBS and b) to assess if 
any of the theoretical models used in the interventions are dominant in the field. In 
order to assess the efficacy of psychologically based treatments both psychological 
correlates of IBS and gastrointestinal symptoms were to be evaluated. The review 
therefore provides an overview of research in this area; clearly showing how the 
research presented in this thesis is 'contextualised with previous research, and also 
will provide a summary of the weaknesses in previous research which will serve to 
justify the need for alternative styles of intervention research. As Mulrow (1994) 
states: 
"The hundreds of hours spent conducting a scientific study ultimately contribute only 
a piece of an enormous puzzle. The value of any single study is derived from how it 
fits with and expands previous wort; as well as from the study's intrinsic properties. 
Through systematic review the puzzle's intricacies may be disentangled". 
The systematic review is therefore considered to provide essential background 
information to the development of IBS interventions. The assessment of the literature 
in a systematic way allows for a clear depiction of current states of knowledge and 
allows for an assessment of how future research should be directed. 
INTRODUCTION 
All available research that included a psychological component to the intervention 
was included, as this was a qualitative systematic review (as opposed to a meta- 
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analysis) it was not considered justifiable to restrict the literature to randomised 
control trials (RCTs). If a large number of studies had been conducted such as to 
render total inclusion unmanageable this would have been considered, but as less 
than 50 studies have been produced to date restricting the review to RCTs would 
have undoubtedly led to biased results due to the small number of studies eligible for 
inclusion. The review therefore covered all types of studies. The primary inclusion 
criterion was that the intervention itself had to include a psychological component 
and therefore studies, which measured psychological factors as an outcome variable 
but not as a factor in the intervention, were excluded. Full details of the inclusion 
criteria are given below. The efficacy of these interventions for both IBS symptoms 
and psychological outcomes (e. g. stress, depression, anxiety) was examined. 
A systematic search of the literature was performed on Medline, Embase, Science 
direct, Psych lit, Psych info and the Cochrane library. Reference lists and paper 
journals were also screened for studies that met inclusion / exclusion criteria. Studies 
were classified by their primary intervention stance and the different components of 
the intervention were determined. A total of 42 papers met the inclusion criteria. 
METHOD 
SEARCH TERMS 
Studies to be included in the review were identified using the following search terms: 
1. IBS / irritable bowel syndrome review 
2. IBS / Irritable bowel syndrome intervention 
3. IBS / Irritable bowel syndrome psychological 
4. IBS / Irritable bowel syndrome treatment 
5. IBS / Irritable bowel treatment trial 
6. IBS / Irritable bowel syndrome RCT 
7. IBS / Irritable bowel syndrome prospective 
8. IBS / Irritable bowel syndrome hypnotherapy 
9. IBS / Irritable bowel syndrome CBT 
10. IBS / Irritable bowel syndrome cognitive therapy 
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The internet search covered years 1980-2006 inclusive. In addition studies were 
identified by manually searching reference lists of reviews and retrieved papers. The 
studies listed in the review are from 1983 (when the first IBS intervention study was 
published) to studies published until July 2006. 
INCLUSION CRITERIA 
Inclusion criteria were: studies with (i) a psychological component to the 
intervention (as previously stated). In addition studies to be included were those that 
(ii) investigated an adult (> 18 years of age) IBS population (all subtypes), (iii) 
assessed a dependent measure of either physical (symptoms) or psychosocial 
outcomes, e. g. quality of life, stress, depression and anxiety, (iv) were published in 
peer reviewed English language journals. (The decision was taken not to include 
studies which had not been translated into English as resources were limited and the 
internet ensured that a majority of high quality research is available in English). In 
addition unpublished studies were also not included as their scientific validity is 
weaker and therefore their inclusion was unjustified in a review of this type, (v) were 
published from 1980 onwards (there are no published studies before this point). 
Intervention studies that did not involve a psychological intervention component 
were not included, as this was not felt to have any relevance to the devising of 
psychologically based interventions. In addition a number of recent reviews have 
focussed on medical management of IBS (e. g. Brandt et al., 2002). 
INTERVENTION TYPES 
Intervention type varied across studies, and as the majority contained a number of 
different intervention components each component was coded separately and listed 
accordingly. This was felt to be superior to simply including a small number of 
global categories, which would have overshadowed the multifaceted nature of the 
interventions. The coding of the intervention components is presented in table 3. 
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Table 3- Coding of intervention components 
Code Component description 
BF Bowel sound biofeedback: by learning to control bowel sounds through 
increasing and decreasing the amount of activity with the aim of learning to 
re ulate bowel activity and thus get symptom relief. 
BT Behaviour therapy: use of behavioural techniques such as goal setting, 
reinforcement, modelling, reward systems, alteration of environmental cues. 
CBT Cognitive behaviour therapy: use of both behavioural and cognitive 
techniques. 
CT Cognitive therapy: teaching or use of cognitive techniques to influence 
cognitions, e. g. challenging beliefs, considering role of thought and 
emotions, counselling and psychotherapy. When the term coping skills was 
used and did not adhere to the definition of problem solving it was coded as 
co nitive erapy. 
D Diet: participants prescribed a specific nutrition plan as part of the 
intervention. 
E Exercise: specific exercise sessions as part of the intervention. 
GISM Gastro intestinal symptom monitoring. 
HT Hypnotherapy: use of hypnotic techniques. 
IE Illness education: basic provision of information, commonly using didactic 
techniques, can include clarification of misconceptions. 
P Placebo 
PS Problem solving: identification of problems or barriers to behaviour and 
strategies to overcome them. Includes both practical and psychosocial 
problems. Focus should be on patient problem solving rather than by health 
care professionals. 
R Relaxation: actual practice of relaxation may include imagery or distraction 
techniques. 
SM Stress management: techniques for identifying and dealing with stressors. 
SMT Use / continuation of standard medical treatment. 
SS Social support: teaching techniques to specifically help participants to 
improve social support, e. g. where to go for extra support, communication 
skills. 
ST Skills trainin : teaching of practical aspects, such as meal planning. 
STUDY CATEGORISATION 
There were four categories of study design: Randomised controlled trial (RCT); 
Prospective longitudinal design (PLD); Case Study and Meta-analysis. 
RESULTS 
Table 4 presents the summary of the 42 studies which satisfied the inclusion criteria 
and were therefore included in the review. The mean number of participants in the 
studies was 76 (s. d. 102), and participant numbers ranged from Ito 431. It is worth 
noting that the mean number may not be the most representative average to take as 
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the standard deviation demonstrates, in fact only 10 (out of 42) studies had over 75 
participants, therefore although a handful of studies involved large samples the 
majority did not. The median number of participants in the studies was therefore 
calculated, and at 35 is considered to be a more representative average. 
Further detail on participant numbers is given in table 9, following the systematic 
review summary (table 4) and the coding for measures table (table 5). The `coding 
for measures' table explains the abbreviations given to the questionnaires in the 
systematic review (table 4). 
As this was a systematic review a number of key criteria were used to assess the 
quality of each of the studies. The assessment of study quality was based on the areas 
of importance proposed by Mulrow (1994). There are five criteria upon which each 
study was assessed. For each criterion the study received a `grade' of poor, fair, good 
or very good. There was not felt to be any justification for weighting any of the 
criteria more heavily than others, as all were felt to be important components to 
overall study quality. Therefore each category is equally weighted and the final grade 
reflects the overall quality of the study. The five areas are as follows: 
1) Study design: This assessment criterion is based on the quality of the study. In 
most cases it would be expected that an RCT would achieve the highest grading, 
however in determining the quality of the overall studies the appropriateness of the 
design is also considered. Therefore in order to receive a `grading' of very good the 
RCT would be expected to be double-blind and with an appropriate placebo control 
group. 
2) Number of participants: `grading' in this category primarily refers to the total 
number of participants in the study (as the name suggests). However, it was felt that 
limiting this category to total number would not be sufficient to take into account the 
number of participants in each group. This is important as although two studies may 
have 50 participants a study which has two conditions (n=25 per condition) would 
score more highly that a study with five conditions (n=10 per condition). This is a 
legitimate distinction as the two main reasons for securing a large cohort are sample 
distribution and power to detect significant findings. 
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3) Generalisability of participants: In addition to the amount of participants the 
generalisability is also important. In this category a study which includes all subtypes 
of IBS would receive a higher grading than a study which only used diarrhoea 
predominant sufferers. Another example would be a study with a large sample size, 
but one that only used female participants would be graded lower than a study with 
both males and females. This category also allows for an assessment where group 
may be highly selected (either by the researchers or self-selected), an example of this 
would be hypnosis. 
4) Adherence to the theoretical model: This is an important category as simply 
stating that research is based on a theoretical model does not mean that this was 
actualised in the methodology. In this respect two studies using the same theoretical 
model (for example CBT) might appear to show inconsistent findings. However, if a 
close appraisal reveals that one study actually used a methodology closer to cognitive 
therapy then it would be clear that the two studies were not congruent and this needs 
to be taken into consideration. As the name suggests studies that adhere strictly to 
their defined model will be graded higher than those that do not. 
5) Likelihood that the observed finding is a true finding: This category is of 
importance because it is not sufficient for a study merely to report a significant 
finding there needs to be an assessment as to whether the significant finding can be 
attributed to the success of the intervention as claimed. This category takes into 
account the possibility of placebo effects and other factors which may have been 
responsible for the finding. This category also takes into account possible reasons for 
when a good study does not yield a significant result, for example insufficient power. 
A summary of the quality of each of the areas (poor, fair, good and very good) is 
provided following each study listed in the systematic review table (table 4). In 
addition the overall quality of the study is reiterated in table 7. 
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Table 5- Coding for measures used in the systematic review 
ATQ-N Automatic thoughts questionnaire - negative (Holland & Kendall, 1980, 
cited in Blanchard et at., 2006) 
ATQ-P Automatic thoughts questionnaire - positive (Ingram & Wisnicki, 1988, 
cited in Blanchard et at., 2006) 
ASI Anxiety sensitivity index (Peterson & Reis 1993, cited in Lackner et at 
2006) 
BDI Beck depression inventory (Beck et al., 1961, cited in Blanchard et al 
1987) 
BDQ Bowel Disease Questionnaire (Tally et at., 1989, cited in Colwell et at 
1998) 
BSI Brief stom inventory (Derogatis 1993, cited in Lackner et at., 2006) 
BSSS Bowel symptom severity scale (Boyce et at., 2000) 
CAS Clinical anxiety scale (Snaith et at., 1982, cited in Guthrie et al., 1991) 
CI / Clinical improvement or composite primary symptom reduction score 
CPSR (Blanchard et at, 1988), essentially refers to a 50% reduction in 
symptom scores post treatment 
CIS Clinical Interview Schedule (DSM III criteria, cited in Comey et at., 
1991) 
CSFBDS The cognitive scale for functional bowel disorders (Toner et al., 1998, 
cited in Gonsalkorale et at., 2004) 
CPRS Comprehensive Psychopathological Rating Scale (Asberg et at., 1978, 
cited in Payne & Blanchard, 1995) 
DAS Dysfunction Attitudes Scale (Weissman & Beck 1978, cited in 
Blanchard et at, 1988) 
DSD Daily symptom diaries designed for individual studies 
EPS Eysenck Personality Inventory (Eysenck & Eysenck 1968, cited in 
Lynch and Zamble, 1989) 
GHQ General health questionnaire (Goldberg, 1972, cited in Comey et at, 
1991) 
GSI General severity index of the SCL-90R (Rosen et at., 2000, cited in 
Saito et at., 2002) 
GSRS Gastrointestinal symptom rating scale (Svetlund et al., 1988, cited in 
Bengtsson et at., 2005) 
HRSD Hamilton's rating scale for depression (Hamilton 1960, cited in Guthrie 
et al., 1991 
IIADS Hospital anxiety and depression scale (Zigmond & Snaith 1993, cited in 
Gonsalkorale et al., 2004) 
HPLP Health Promoting Lifestyle Profile (Walker et at., 1987, cited in 
Colwell et al., 1998) 
HRLCQ Health and illness related locus of control questionnaire (Lohan & 
Schmidt, cited in He an-Mönnikes et al., 2000) 
FBDSI Functional bowel disorder severity index (Drossman et al., 2003, cited 
in Drossman et al., 2003) 
IBSQ IBS questionnaire, a self rating symptoms scale, Bennet & Wilkinson, 
1985) 
IBS- OL IBS quality of life (Patrick et at., 1889, cited in Drossman et at., 2003 
IB Irrational beliefs questionnaire (Ma ges, 1989, cited in Heyman- 
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Mönnikes et al., 2000) 
LES Life events survey (Sarason et al 1978, cited in Lynch and Zamble, 
1989) 
MMPI Minnesota multiphasic personality inventory (Stark et al., 1942, cited in 
Blanchard et al., 1988) 
MOSSF Medical outcomes study short form (Ware & Sherbourne, 1992, cited in 
Boyce et al., 2000) 
PDQ Psychological distress questionnaire (Zersen, 1976, cited in Heyman- 
Mönnikes et al., 2000) 
PET Positron emission topology - assessment of gamma rays after 
'ingestion' of a biological substance such as food. 
PGWB Psychological general well being index (Dupy, 1984, cited in 
index Bengtssom et al., 1985) 
PSC Psychosomatic symptom checklist (Attanasio et al., 1984, cited in 
Blanchard et al., 1988) 
PSQW Penn State worry questionnaire (Meyer et al., cited in Lackner et al., 
2006) 
QSI Queens stress inventory (Malton, 1982, cited in Lynch and Zamble, 
1989) 
RAS Rathus Assertiveness Scale (Rathus, 1973, cited in Blanchard et al., 
1988) 
RQ Relatives questionnaire for recording the daily number of IBS related 
behaviours (Hellawell et al., 1984, cited in Bennet and Wilkinson, 
1985) 
SCID Structured clinical interview for DSM-IV (First et al., 1996 cited in 
Keefer and Blanchard, 2001 
SF-36 SF-36 Health Survey (Ware, 1993, cited in Blanchard et al., 2006) 
SRRS Social Readjustment Rating Scale (Holmes and Rahe, 1967, cited in 
Blanchard et al., 1988) 
STAI Stait - trait anxiety inventory (Spielberger et al., 1970, cited in 
Blanchard et al., 1988 
WSAS Work and social adjustment scale (Marks, 1986, cited in Kennedy et al., 
2005 
Table 6- Further details on participant numbers 
Number of IBS participants Number of studies Case numbers 
n=1-10 4 9,16,26,33 
n=11-20 8 3,4,7,15,17,25,28,36 
n=21-30 5 2,22,29,30,41 
n=31-40 7 1,6 a, 21,31,34,37,40 
n =41=50 5 5,12,23,39,42 
n= 51-60 1 11 
n= 61-70 1 24 
n= 71-100 2 6 b), 19 
n =100+ 10 10,13,14,18,20,27,32, 
35,38 
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Table 7- Assessment of retrieved papers 
Study 
number 
and 
design 
Significant 
improvement in 
IBS symptoms 
Significant 
improvement in 
psychosocial 
factors 
Theoretical 
model used 
Overall 
quality 
1 (RCT) No Yes PT Fair 
2 (PLD) Yes Yes IE Poor 
3 (RCT) Yes No CBT Good 
4 (RCT) Yes No CBT Good 
5 (Meta) Yes Yes CBT Ve ood 
6 (RCT) Yes Yes CBT Good 
7 (RCT) Yes No R Fair 
8 (PLD) Yes No CT Poor 
9 (PLD) No Yes CBT Poor 
10 (RCT) Yes Yes CBT Good 
11 (PLD) Yes Yes HP Fair 
12 (RCT) Yes Yes PT Good 
13 (RCT) Yes No PT Very good 
14 (RCT) Yes Yes CBT Very good 
15 (RCT) Yes Yes HT Good 
16 (Case) Yes Yes HT Fair 
17 (RCT) Yes Yes CT Fair 
18 (PLD) Yes Yes HT Good 
19 (PLD) Yes Yes HT Good 
20 (RCT) Yes No HT Very good 
21 (PLD) Yes No HT Good 
22 (RCT) Yes No CBT Very good 
23 (RCT) Yes No HT Very good 
24 (PLD) No No MC Poor 
25 (RCT) Yes No R Fair 
26 (RCT) Yes No R Poor 
27 (RCT) Yes No CBT Very good 
28 (RCT) Yes No CT Fair 
29 (RCT) Yes No CBT Good 
30 (RCT) Yes No CBT Fair 
31 (RCT) Yes Yes CT Fair 
32 (RCT) No No IE Poor 
33 (PLD) Yes No BF Good 
34 (RCT) Yes Yes CBT Good 
35 (PLD) Yes No IE Poor 
36 (RCT) Yes No CBT Good 
37 (RCT) Yes Yes SM Good 
38 (RCT) Yes Yes PT Very good 
39 (RCT) Yes Yes CBT Very good 
40 (RCT) Yes No CBT Good 
41 (RCT) Yes No HT Good 
42 (PLD) Yes No HT Fair 
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As can be seen in table 7 some of the studies report significant results, whereas 
others do not. In addition the quality of papers is not consistent. A summary of the 
main findings for both symptom reductions and psychological factors are presented 
in table 8. 
Table 8- Summary of main findings for symptoms and psychosocial 
factors 
Number of studies 
reporting significant 
reductions in IBS 
symptoms 
38 Number of studies 
reporting significant 
reductions in 
psychological 
symptoms 
19 
Number of studies where 25 Number of studies 12 
symptom reduction is not where psychological 
attributed to the placebo reduction is not 
effect attributed to the 
placebo effect 
Number of studies where 9 Number of studies 4 
symptom reduction is not where psychological 
attributed to the placebo reduction is not 
effect, that are rated as attributed to the 
reliable placebo effect, that 
are rated as reliable 
The first aim of this review was to assess the overall efficacy of psychologically 
based interventions in IBS. As table 8 demonstrates of the 42 studies only 25 
provided reasonable support for the efficacy of psychologically based interventions 
for symptom reduction. An even smaller number of studies, 12, provide support for 
the efficacy of psychologically based interventions for an improvement in 
psychological factors. As is also seen in table 8 when considering the assessment of 
the overall quality of the studies the number of studies which reliably report 
symptom reductions reduces to 9, and only 4 provide reliable support for 
psychological improvements. Further information and a consideration of the 
implications of these findings is given in the discussion. 
The second aim of this review was to assess which psychological models have been 
used in previous research and to establish the relative efficacy of each of the models. 
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A total of ten different theoretical models were identified, these were: psychotherapy 
(PT), illness education (IE), cognitive behavioural therapy (CBT), relaxation (R), 
cognitive therapy (CT), health promotion (HP), Hypnotherapy (HT), medical 
consultation (MC), bowel sound feedback (BF) and stress management (SM). A 
summary of this is provided in table 9. 
Table 9- Summary of psychological models identified from the review 
Model Number Case Scientific quality of 
of studies numbers identified papers 
PT 4 18,12*e, 1= fair, 12 = good, 13 = 
13*, 38*8 reliable, 38 = reliable 
IE 3 2*8,32,35* 2= weak, 32 = fair, 35 = 
good 
CBT 15 3*, 4*, 5*°, 3= good, 4= good, 5= 
6*e, 98,10*°, reliable, 6= good, 9= 
14*3,22*, weak, 10 = good, 14 = 
27*, 29*, reliable, 22 = reliable, 27 = 
30*, 34*e, reliable, 29 = good, 30 = 
36*, 39*°, fair, 34 = good, 36 = good, 
40* 40 =good. 
R 3 7*, 25*, 26* 7= fair, 25 = fair, 26 = 
weak 
CT 4 8*, 17*3, 8= weak, 17 = fair, 28 = 
28*, 31*' fair, 31 = fair 
HP 1 11 *8 11 =fair 
HT 9 15*e, 16*°, 15 = good, 16 = fair, 18 = 
18*a, 19*°, good, 19 = good, 20 = 
20*, 21 reliable, 21 = good, 23 = 
23 *, 41 reliable, 41 = good, 42 = 
42* fair 
MC 1 24 24 = weak 
BF 1 33* 33 = good 
SM 1 37*° 37 = good 
* indicates a significant decrease in symptoms, ° indicates a significant improvement 
in psychological factors. 
As table 12 demonstrates although there are ten theoretical models, only six have 
multiple papers. Of the six models with multiple papers the majority of research has 
been conducted using CBT (15 studies), with PT coming second (9 studies). For each 
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of the other theoretical models less than five studies have been published. Further 
information and a consideration of the implications of these findings is given in the 
discussion. 
DISCUSSION 
As detailed in the introduction there were two aims for this systematic review. The 
first aim was to gain an overview of the viability of psychologically based 
interventions for research into IBS. The second aim was to assess if any of the 
theoretical models emerged as dominant. For both of these several areas of the 
results need to be considered, the findings relating to the first aim, will be discussed 
now. 
As table 4 demonstrates a total of 42 published studies were identified. Although this 
is a relatively small number of papers, it should be noted research of this type in IBS 
has only been conducted since the 1980s. In the last few years interest in conducting 
intervention research in IBS has increased, with some specialised groups, such as the 
IBS Research Foundation, and the IBS Network emerging in the UK. It is therefore 
likely that future research will clarify the efficacy of psychologically based 
interventions, and provide detail on those specific interventions which yield the 
greatest successes. However, the aim of this review was simply to assess the viability 
of psychologically based interventions, and in this respect, the review demonstrates 
that psychological interventions are definitely efficacious. Although there is a 
possibility of a publication bias, it should be noted that the vast majority of studies 
showed significant results for either or both symptom reductions and psychological 
improvements, and importantly that no study showed the opposite effect. Although 
as tables 7 and 8 show in many cases there are methodological issues with the studies 
conducted so far, there are still a sufficient number of studies that beyond simply 
suggesting the viability of psychologically based interventions, actually show a 
superiority over standard medical care. This obviously has important implications for 
the future of IBS treatment, as has previously been addressed in chapter 1. 
The second aim of the review was to assess if any of the psychological models 
emerged as dominant. This is arguably more important than simply assessing the 
viability of psychological models. Firstly if one model is dominant to the extent to 
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which its results are largely consistent and conclusive, then the justification for 
conducting research on one of the alternative models is weaker. Secondly, if all 
psychological models are shown to be highly successful regardless to the theoretical 
model used, then there is a likelihood of an underlying factor (such as the placebo 
effect), and as such trying to design a complex model may prove an unnecessary 
waste of resources. Finally and most importantly by assessing the strengths and 
weaknesses of the models and study designs it will be possible to design an 
intervention that complements and extends the research already conducted, which is 
undoubtedly the aim of a systematic review (Mulrow, 1994). 
The first theoretical model is psychotherapy (PT). Four studies were identified, and 
all report significant findings. Two of these studies yielded significant results for 
both symptom reductions and psychological improvements. The other two studies 
both showed significant findings but only for either symptoms or psychological 
factors. Overall the quality of this research was high, and there would therefore 
appear to be preliminary support for psychotherapy in the treatment if IBS. There 
would therefore be justification for conducting research based on PT principles, 
however, the specific components of PT that bring about change should be easier to 
identify. 
The second theoretical model is that of illness education (IE). Here three studies 
were identified, of which two report significant findings. One study yielded 
significant results for both symptom reductions and psychological improvements, 
whilst the other one only reported significant reduction in symptoms. Unfortunately 
only one of these papers was regarded as of suitable scientific quality. It would 
therefore appear that there is preliminary evidence for illness education, but that 
further research is needed to identify the specific components of illness education 
that elicit change. There are two issues that need to be addressed in future research 
using illness education. The first aspect is to ensure that the education is given in a 
psychological way. Although these pieces of research claim to address these by 
actually ensuring both understanding, and cognitive alterations based on the new 
information, care should be taken to ensure this is actually the case for all 
participants. Secondly, and partially related is to ensure that the cohort selected is 
matched in both their levels of understanding and length of time suffering from IBS, 
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as the potential benefit of illness education may be somewhat minimised if the 
participants already were aware of the information being provided. In none of these 
papers was an assessment of current levels of understanding given. Therefore in 
summary, although illness education has the potential to have a tremendous impact in 
terms of reducing anxiety, and encouraging sufferers to make informed self 
management choices there is a need to ensure that the interventions are implemented 
in a structured way which will actually alter patient's cognitions. Therefore future 
research using illness education should ensure that sufferers actively assimilate the 
information, and that this actually changes their illness cognitions. In addition whilst 
further research is needed to clarify this issue, at the moment it would appear that 
illness education is best as part of a multi-component intervention. 
The third psychologically based intervention is cognitive behavioural therapy (CBT), 
which with fifteen studies identified' is by far the largest category of research. In 
addition to the number of papers with the exception of two studies they were deemed 
to be of good quality. Together they provide a high level of support for the efficacy 
of this model as all papers report significant findings. 6 studies yielded significant 
results for both symptom reductions and psychological improvements, a further 8 
only reported significant reduction in symptoms, and a further 1 reported significant 
improvement in psychological factors. It would therefore appear that there is a large 
amount of support for CBT in irritable bowel syndrome; this is consistent with CBT 
being the primary therapy offered in IBS clinics (such as the Cardinal Clinic in 
Windsor which hosted a conference in 2004 to inform general practitioners about 
their use of CBT in IBS). However, although there is a disproportionate amount of 
papers compared to the other models, it is not fair to say that the efficacy of CBT has 
been established beyond doubt, as several biases may have affected the results. 
Firstly, it is possible that a publication bias exists, and therefore studies showing no 
support for the model may have been produced but are not available to include in the 
review. Secondly, there is a dominant research group (Albany multi-component 
CBT), and it could be case that this specific type of CBT, which includes additional 
components might be the crucial element, and in this respect it could be a factor 
other than CBT which is responsible for the underlying change, or for that matter a 
location bias. As none of the studies provide a way of assessing the specific elements 
of the intervention which bring about change it is difficult to conclude that the 
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efficacy of CBT has been established beyond reasonable doubt. On balance however, 
CBT does appear to be an effective treatment option, and with a number of 
researchers championing its cause, one that does not seem necessary to research in 
this thesis. However, a model which shares similar principles of challenging 
maladaptive thoughts and altering behaviour would seem likely to meet with success. 
The fourth theoretical model is relaxation (R), interestingly whilst all three papers 
identified showed a significant reduction in symptoms, none showed a reduction in 
psychological factors. As none of the studies are of high quality it is difficult to 
assess if it is the model that is flawed, or if the methodological issues obscure this 
relationship. Despite the observed symptom reduction, there is currently no evidence 
for the superiority of relaxation over placebo effects, and in two of the three studies 
this is clearly the case. It is possible that relaxation is of benefit to sufferers, as 
research into stress strongly suggests an increase in symptoms following stressful 
events. (e. g. Dancey et al., 1995). However, in order to assess the potential benefits 
of relaxation high quality research is needed, and it is likely that achieving true 
relaxation in patients is going to be difficult with a short, group based intervention. It 
does not appear therefore that there is much justification for conducting simple 
relaxation research, however, if research is conducted measures must be included to 
assess if relaxation has occurred, and if so which how this affects illness outcomes. 
Simply showing a correlation will not be sufficient. 
The fifth theoretical model is cognitive therapy (CT). Of the four studies identified 
all show reductions in symptoms, and two additionally show an improvement in 
psychological factors. It would therefore seem that there is preliminary support for 
CT, however, all of the papers are of poor quality, and with this in mind there is no 
firm evidence. Therefore although this model seems plausible its efficacy has not 
been currently established. It would however, be interesting to compare its efficacy 
directly with CBT, as it may be the case that although some improvements are 
observed with CT greater changes may be found by adding the behavioural 
component. 
The sixth theoretical model is health promotion (HP). Although there is only one 
study, and it is not of particularly high quality, it did yield significant results for both 
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psychological and symptom factors. Although more research is clearly needed it is 
possible that this approach could be potentially useful to sufferers, and its initial 
support certainly suggests there may be some benefit (and at the very least no 
disbenefit) for incorporating general health promotion issues, such as exercise, and 
other positive health behaviours into an intervention. 
The seventh theoretical model is hypnotherapy (HP), which along with CBT is the 
second area where a majority of research has been conducted, and is again consistent 
with the use of hypnotherapy in clinical IBS populations, or through self-help tapes. 
Of the nine studies identified, only two are of poor quality, and therefore the results 
yielded can be considered to be largely reliable. The research suggests that HT is an 
effective treatment with all studies showing a significant reduction in symptoms, and 
four additionally showing an improvement in psychological factors. In addition in 
eight of these studies it seems highly unlikely that results are due to placebo effects. 
It would therefore appear that HT is an efficacious treatment. However, there are 
many people who would not be prepared to visit a hypnotherapist, and others who 
are not susceptible to hypnosis. With this in mind although the therapy was 
undoubtedly effective in these studies, it is possible that the samples used were 
specifically selected for these trials, and it may therefore not be a therapy that is 
suitable for many sufferers. It is also expensive, and may therefore not be a viable 
option for some sufferers. In addition although self-help hypnosis materials are 
available none of these papers investigate their efficacy, and until this is established 
the widespread utility of HT is unclear. 
The eighth theoretical model is a medical consultation (MC). Although this was 
designed to assess if the consultation itself provided a positive psychological 
environment and was therefore included in the review, it is'perhaps unsurprising that 
it was found to be unsuccessful. Although Illyckyj et al's., (2003) aim was to alter 
the standard medically consultation in a psychologically beneficial way is an 
interesting idea, it is one that is difficult to put into practice and is one which is 
unlikely to be revealed by a short intervention study. It is however, possible that 
doctor-patient communication does contribute to IBS illness outcomes, and as every 
RCT uses SMT as a comparison group it is important to assess that relative impact of 
the consultation itself as differential consultation styles may skew the results in the 
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supposed control group. This therefore represents an important area of research and 
one that is worthy of future research. However, at present it does not appear to be the 
case that an intervention based on medical consultations will be useful, as even for 
those studies where psychologically based interventions are not superior to SMT, 
they have so far never been found to produce worse results. 
The ninth theoretical model is bowel sound feedback (BF). There is only one study 
specifically investigating this, and this study did provide significant reductions in 
symptoms, but not for psychological aspects, and therefore its usefulness appears to 
be rather limited. There are no real conclusions that can be drawn at this point. 
The tenth and final theoretical model is stress management (SM). Although only one 
study was identified it did provide significant results for both symptoms and 
psychological factors. Therefore stress management techniques may be beneficial. 
Although more research is needed in this area, the rationale for stress management 
research is supported by previous research on the relationship between stress and 
symptom severity in IBS (e. g. Dancey et al., 1995). It therefore seems likely that 
stress management programmes will be beneficial and that future research will 
support the findings of this study. On this basis providing advice for stress reductions 
would appear sensible; this is consistent with the research on general health 
promotion previously mentioned. 
Overall the previous summary provides evidence for the efficacy of psychologically 
based interventions in IBS research; however, there is currently no conclusive 
evidence for any of the models. Although some models meet with success neither the 
level of improvement nor the consistency justifies a cessation of the search for 
alternative models in this area. One of the useful features of a systematic review is 
that it allows for an assessment of the `active' components of the interventions. 
Based on the review it is clear that the theoretical models that are particularly weak 
are those where the psychological component is limited, e. g. MC and HP, and 
conversely those that tend to produce significant results are those where the 
psychological components are clearly defined, such as CBT and HT. Based on these 
characteristics it seems likely that a model that may meet with success in 
psychologically based IBS interventions is the common sense model (Leventhal et al, 
1980; 1984). Although this model has not previously been considered in IBS 
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interventions research is emerging that suggests it to be a viable model for use in IBS 
research (e. g. Rutter and Rutter, 2002) and it therefore worthy of study. A full 
description and justification for this model will be provided in the following chapter. 
In terms of the development of interventions for IBS this systematic review also 
points to the necessity to assess not just that changes have occurred, but why this is 
the case. The difficulty is establishing the active components of the intervention is 
something that is particularly noticeable for less clearly defined interventions such as 
stress management. Therefore a measure should be used to establish if particular 
dimensions of the model are altered by the intervention, until this is assessed it is 
difficult to conclude with any degree of certainty that it is the specific nature of the 
intervention, rather than a `halo' or `placebo' effect that is responsible for the results. 
Although using a control group does minimise the likelihood of the placebo effect it 
should be noted that with the possible exception of SMT control groups used are not 
appropriate. This is due to their potential to inflate symptoms of IBS prior to study 
commencement, in particular in the case of waitlist controls, especially those in 
which SMT is suspended, and in the case of symptom monitoring, where participants 
may be resentful that they have to focus on their illness without being in the active 
intervention part of the trial. In addition it is important to ensure that the measures 
used for assessing change are accurate as this may explain the discrepancy of some 
of the research findings reported here. 
One final point is regarding the limitations of this review, although care was taken to 
search all the databases, and reference lists in order to compile the studies in this 
review it should be noted that there was no dual searching of references from an 
independent collaborator, therefore it is possible, although unlikely that references 
may have been omitted. If this is the case, I do not feel that this would in any way 
alter the results presented here. In conclusion, based on the findings elicited from the 
systematic review, chapter 3 considers the common sense model as a useful theory in 
the design of future interventions in IBS research. 
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CHAPTER 3 
THE COMMON SENSE MODEL OF ILLNESS 
REPRESENTATIONS (CSM) AND ITS APPLICATION TO 
IRRITABLE BOWEL SYNDROME (IBS) 
Aim 
The thesis so far has demonstrated that psychologically based approaches to studying 
IBS are not only appropriate based on the characteristics of the illness (chapter 1), 
but that interventions based on psychological principles may prove efficacious in the 
advancement of treatments in this area (chapter 2). However, as yet it is unclear 
which theoretical model these psychologically based treatments should adhere to. 
Based on the results of the systematic review in the previous chapter the information 
presented clearly shows that no one treatment dominates (Kennedy et al., 2005). 
However, as was proposed at the end of the review a theoretical model which takes 
account of the `active' components of the other models is likely to meet with success. 
As such Leventhal et al. 's (1980; 1984) common sense model of illness 
representations was proposed (CSM). This chapter seeks to explain this model, 
justify its choice for the studies conducted in this thesis, and briefly discuss why it 
was considered to be superior to other dominant models in this field. 
COMMON SENSE MODEL OF ILLNESS 
REPRESENTATIONS - OVERVIEW 
The common sense model of illness representations (CSM) was designed by 
Leventhal et al., (1980; 1984). It is a social cognitive model which proposes that 
health and illness behaviour are directed by two interrelated aspects regarding beliefs 
about a disease. The CSM states that people learn to think and feel about somatic and 
illness sensations from prior symptom episodes and ongoing visceral experiences. 
The CSM states that illness beliefs are structured and that coping reactions are 
dependent on the outcome of initial processing. Unlike other models the CSM posits 
the influence of emotional variables (such as stress, depression, anxiety) on health 
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and illness behaviours and incorporates a symptomatology component, defining its 
outcomes in terms of reactions to a health threat. It is worth noting that although it 
was recommended in personal communication that the CSM / common sense model 
of illness representations was chosen as the name for the model in this thesis 
(Leventhal, 2006) it is also commonly referred to as the common sense model of 
illness perceptions and the self regulatory model (SRM). Although the CSM will be 
the name used throughout this thesis it should be noted that the measure used to 
obtain scores on the illness representation dimensions is termed the illness perception 
questionnaire (revised version, Moss-Morris et al., 2002). The self regulatory model 
(SRM) is a useful alternative name for this approach as it reinforces a key aspect of 
the model: that it is the goal of the sufferer to re-establish a health state, a process 
which is affected by the different factors in the model. The CSM consists of three 
stages, these are outlined below. 
The first stage is the interpretation stage, whereby cognitive and emotional 
representations of a health threat are used by the patient to identify the meaning of 
the threat, also known as illness perceptions / representations. Earlier studies have 
identified five domains; these are emotional representations, identity, time line, 
consequences, cause and control beliefs. 
The second stage of the model is the coping stage, this stage constitutes avoidance or 
approach techniques, such as "action plans". Action plans relate to both action 
intentions (the planning of a response) and "actions" (executing a response by 
implementation of actions into one's daily routines (such as adhering to medical 
prescriptions), also including perceived self-efficiency to act upon intentions. 
The third stage of the model is termed appraisal. This is where the patient reflects on 
the outcome of the action plan. Although the definition of the three stages appear 
linear it is important to note that according to Leventhal et al. (1980) interaction 
between stages occurs in both directions. This means that the CSM is a parallel 
processing model in which illness stimuli simultaneously trigger cognitive and 
emotional feedback loops comprising illness representations, coping strategies, 
appraisal and outcomes. A cognitive representation may result in a particular action 
plan, which may lead to certain appraisal, but equally the perceived outcome of the 
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action plan may feedback to influence illness representations. A pictorial 
representation of this model is given in figure 3. 
Figure 3- The common sense model of illness representations* 
APPRAISAL OF COPING 
Evaluation of impact of coping styles 
COGNITIVE COPING STRATEGIES / strategies adopted 
ILLNESS AND STYLES 
REPRESENTATION Avoidance / denial 
Cause Cognitive reappraisal 
Consequence Expressing emotions 
Control / cure Problem-focussed coping 
Identity Seekino socials sunnort. ILLNESS OUTCOMES 
Timeline Disease state 
Physical functioning 
Psychological distress 
Psychological well-being 
ILLNESS STIMULI Role functioning 
Pool of lay information Social functioning 
stored in memory. Vitality 
Information given by 
external sources, somatic 
and symptomatic 
information. 
EMOTIONAL OUTCOMES 
Emotional distress 
21- 1 COPING 
EMOTIONAL ILLNESS STRATEGIES USED 
REPRESENTATION TO DEAL WITII 
EMOTIONAL 
REACTION 
From Nagger & Orbell (2003) 
APPRAISAL OF COPING 
Evaluation of coping 
Strategies / styles adopted to cope 
with emotional reaction 
As the pictorial representation demonstrates the parallel processing nature of this 
model means that an illness intervention aiming at only one stage should influence 
the entire CSM. 
COMMON SENSE MODEL - STAGE 1 INTERPRETATION 
The first stage of the CSM (Leventhal et al., 1980), termed illness representations, 
refers to the combination of the cognitive and emotional perceptions of the illness. 
The information, which contributes to the illness representation, comes from a 
number of different areas, but these are broadly divided into symptom experiences 
and social messages (e. g. from doctors or general public). Current conceptualisations 
of illness representations have identified five factors, these are: 
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1) Illness identity 
2) Cause 
3) Timeline 
4) Consequences 
5) Cure / controllability 
Illness Identity refers to the meaning ascribed to the illness label, the knowledge that 
the sufferer possesses, and the specific feelings experienced. 
Cause does not refer to what actually caused the illness but rather to the beliefs the 
sufferer has about what they view to be possible for causing their illness. In addition 
to medical factors, such as gastroenteritis or food poisoning the cause component 
also incorporates the patient's beliefs about their personal responsibility in causing 
the illness. 
Timeline refers to the individual's belief about the course of their illness. Based once 
again on available medical and idiosyncratic information the sufferer makes a 
judgement as to whether the illness timeline is acute, chronic and or cyclical. 
Consequences refers to both the severity of the symptoms experienced and also to 
any illness related consequences such as reductions in quality of life and impact on 
psychological, social, physical, sexual and economic dimensions. 
Cure/ Control is the final component of this model. Broadly cure is considered an 
outcome for an acute illness and control in chronic illnesses, although theoretically a 
cure can be found for chronic illnesses too. A sufferer's belief about this component 
can have a profound impact on the illness progression, such as illness related loci of 
control and beliefs about the necessity of taking medications or upholding advised 
self-management behaviours. The first four components of this model are credited to 
Leventhal et al. (1980), and the fifth to Lau and Hartman (1983). 
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COMMON SENSE MODEL - STAGE 2 COPING / ACTION 
PLANS 
Stage two involves the development of coping strategies, broadly categorised into 
approach / avoidance strategies. Coping can refer to the individual's attempt to a) 
come to terms with the diagnosis itself, b) deal with the crisis of an illness, or c) 
adjust to the illness through a process of cognitive adaptation often termed action 
plans. Action plans provide a framework for the influence of the representation on 
illness behaviours and related outcomes. Action plans incorporate both `action 
intentions', such as the planning of a response to a particular aspect, and also to 
`actions' themselves, which is the direct implementation of the plan into daily 
behaviours. In this respect actions incorporate such aspects as adhering to 
medications or dietary interventions, which may be influenced by the perceived 
controllability part of the representations formed (e. g. Edwards et al., 2001). As this 
is a highly psychological model it is somewhat unsurprising that perceived efficacy 
at performing particular actions have an impact upon the operationalisation of action 
intentions into actions. This is part of the conceptualisation of the CSM as a dynamic 
parallel processing model whereby the stages are continually interacting with each 
other. Therefore a specific illness representation may result in the devising of a 
particular action plan, but the outcome of enacting the action (actual or appraised) 
may lead to a modification of the illness representation. Although actions can be 
clearly specified they are often influenced by subconscious or unstructured 
processes. The dynamic nature of the model is crucial in the context of designing 
illness intervention studies as it suggests that an intervention at any stage of the 
model will have an impact on the other stages. However, an intervention 
incorporating both illness representations and actions would arguably give sufferers a 
more structured way of maintaining self-management behaviours. 
COMMON SENSE MODEL - STAGE 3 APPRAISAL 
Stage three involves appraisal, the evaluation of the strategies utilized so far and the 
decision of whether to proceed in the same way or use an alternative course of 
action. As this is a dynamic parallel processing model this stage does not require 
87 
CSM in IBS 
much detail because the outcome of the appraisal process will necessarily link into 
other stages. 
COMMON SENSE MODEL - JUSTIFICATION FOR USE IN IBS 
RESEARCH 
Although there is limited research on the CSM in IBS specifically there is 
justification for the theoretical utility of this model from the other chronic illnesses 
that have been researched such as Addison's disease (Heijmans, 1999), epilepsy 
(Kemp et al., 1999) and chronic fatigue syndrome (CFS, Edwards et al., 2001). 
Importantly from the context of the idiosyncratic nature of IBS this model is suitable 
for heterogeneous illnesses. The recent meta-analysis by Nagger & Orbell (2003) 
suggests that the illness cognition dimensions are robust across illness types, and that 
the CSM is therefore a useful model for studying chronic illnesses. In addition the 
CSM with its focus on action planning and interaction of stages is a practical model, 
which allows for a degree of flexibility in the designing of interventions based on its 
principles. 
To date there is only one published paper investigating the CSM in IBS (Rutter & 
Rutter, 2002). Although a conference paper by Boddington et al. (2001, cited in 
Hagger & Orbell, 2003) is considered to be of sufficient quality to be included in the 
aforementioned meta-analysis, this only offers weak support and therefore will not 
be described here. 
The justification for the theoretical utility of the CSM in IBS is therefore largely 
based on one paper. Although it is generally considered weak evidence to provide 
justification on one paper, in this case an exception should be made. There are a 
number of reasons for this exception. Firstly the application of the CSM to other 
illnesses, particularly those with similar illness components, such as chronic fatigue 
syndrome (Edwards et al., 2001) suggest that its application to irritable bowel 
syndrome will meet with similar success. Secondly as evidenced by the systematic 
review, even from a purely exploratory stance it is of importance to understand the 
theoretical constructs behind IBS symptoms if effective scientific interventions are 
going to be designed. Thirdly the current definition of IBS as a functional illness, 
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coupled with its embarrassing symptoms and the mixed messages patients receive 
(e. g. Bertram et al., 2001) strongly suggest the illness representations play a role in 
illness outcomes. Finally it is arguably the case that one good quality research paper 
is worth a great deal more than a large number of poor pieces of research, and with 
this in mind the study elicited is useful as it not only suggests the application of the 
CSM to the study of irritable bowel syndrome but suggests and implies a number of 
suggestions for further research based on this model. As this is the only published 
paper specifically addressing the role of the CSM in IBS it will be described in some 
detail here. 
The research by Rutter & Rutter (2002) investigated the relationship between illness 
representations, coping and symptom based outcome. Their research was conducted 
on 209 members of the IBS NETWORK (a common cohort for research in this area). 
As the systematic review demonstrated this is an uncharacteristically large number of 
participants for IBS research, and is therefore likely to be more representative of IBS 
sufferers than some other studies. A number of psychometric instruments were used, 
including the illness perception questionnaire (IPQ, Weinman et al., 1996), the 
COPE (Carver et al., 1999) and the Hospital Anxiety and Depression Scale (HADS, 
Zigmond & Snaith, 1983). Participants rated their self perceived quality of life and 
their satisfaction with their health. Symptoms were measured using a questionnaire 
devised by the authors, it comprised ten frequently experienced symptoms on a five 
point Likert scale, ranging from "no experience of this symptom" to "experience the 
symptom once a week", the Cronbach's alpha coefficient for this scale was 0.61. 
Finally in order to assess patients' perceived quality of life two items were taken 
from the WHOQOL-BREF (WHOQOL Group, 1998). These items were "how 
would you rate your quality of life" (1. very poor - 5. very good); and "How satisfied 
are you with your health" (1. very dissatisfied - 5. very satisfied). 
The results from the study show the reporting of serious perceived consequences of 
IBS were associated with lower scores on both of the quality of life scales, but only 
the satisfaction with health scale correlated with reported symptoms. Weaker control 
beliefs showed this same pattern (but was not associated to symptoms) but was also 
found to be associated with higher depression scores. Finally psychological causal 
attribution was positively correlated with both anxiety and depression. In summary 
89 
CSM in IBS 
the reporting of serious consequences independently predicted symptoms and quality 
of life, coping strategies independently predicted depression, and finally coping 
mediated between representation and outcome. 
It is clear therefore that there are a number of key outcomes of this study, and in 
particular the relationship of illness representations to illness outcomes is of 
importance because it shows that it should be possible to alter symptom frequency 
and associated psychological factors by encouraging positive representations of 
illness and their related productive coping strategies. This ability to change physical 
symptoms based on psychological factors is essential to the core of health 
psychology and is especially relevant in the context of IBS due to the ineffectiveness 
of pharmacological `solutions'. 
Although this research does not provide a conclusive account of the role of the CSM 
in IBS, it clearly provides justification of the utility of this model for IBS 
specifically, which adds to the justification for its utility in general illness research. 
In addition there are a number of methodological aspects of the study, which 
suggests ways in which this area of research should be conducted. 
The first methodological aspect is the use of psychometric instruments. Symptom- 
based questionnaires are often criticised as validity of retrospective recall of 
symptoms can be affected by poor memory, or perceptual biases. However, they are 
also essential in some areas of research where a formal assessment of symptoms is 
not viable. For IBS research specifically this poses a special problem. In some 
medical research analysis of stool samples is used, but in a psychological study this 
would be considered invasive, and indeed the likely anxiety it would cause to 
participants would ensure that the results were not accurate. Equally open ended 
questions about general symptoms are not going to yield usable data. In this research 
although a symptom questionnaire is used care is obviously taken to ensure its 
validity by the use of clearly defined Likert scale questions. The questionnaire 
designed is therefore a cohesive scientific instrument with an alpha coefficient of 
0.61, which considering the considerable heterogeneity of IBS symptoms does 
appear to be fairly reliable. By using questionnaires to assess all areas of this 
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research the authors were able to yield a large sample size, this is of considerable 
importance for generalisation of results. 
It is clear therefore that use of questionnaires is acceptable for CSM based IBS 
research. Building from the Rutter and Rutter (2002) study it could be suggested that 
with a number of modifications accuracy of results and strength of findings could be 
increased. Possible suggestions include extending the symptom scale to allow for 
experience of each symptom more than once a day (to account for the multiple and 
fluctuating symptoms, which may yield increased variance at the top end of the 
scale), and by comparing symptom reports with a daily-diary will enhance the results 
(Meissner et al., 1977). In addition an IBS specific longer scale for assessing quality 
of life (QOL) may also be beneficial, as although significant findings were yielded 
here, individual item scales are still not used in a majority of papers. 
CONSIDERATION OF OTHER THEORETICAL 
MODELS 
A full justification of the model chosen for this research would be incomplete 
without brief mention of the superiority of the CSM over alternative models. It has 
already been justified why a specific model was felt to be superior to a basic 
biopsychosocial approach, and the suitability of the CSM has been detailed, however 
there were two other models considered in the initial design of this thesis. These 
were rejected because they were not found to be suitable. 
HEALTH BELIEF MODEL 
The first theory considered as the theoretical background to this thesis was the Health 
Belief Model (Hochbaum, 1958; Rosenstock, 1966, cited in Taylor, 1999). The 
Health Belief Model (HBM) was initially considered due to its focus on the 
relationship between attitudes and health behaviours. Briefly the model states that 
there are two factors which influence whether a person engages in a particular `health 
behaviour'. The first of these factors is the degree to which the health threat is 
perceived as personal' and the second of these is the `belief in the ability of a 
particular health practice to reduce that threat'. In the initial stages of literature 
searching it appeared that the three issues most related to experience of symptoms in 
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IBS were stress, depression (e. g. Dancey et al., 1995; 1998) and eating habits (e. g. 
Simren et al., 2001). Based on these assumed symptom triggers this model seemed a 
highly suitable theoretical basis for conducting a series of studies assessing sufferers' 
perception of these three factors as health threats and then designing an intervention 
based upon changing these risk behaviours. However, a more detailed assessment of 
the literature revealed that these were not the primary factors, and as chapter 2 
demonstrated the aetiology of IBS symptoms is not easy to determine. As such, 
although this model has proved efficacious in diabetes prevention and management 
(Pinto et al., 2006), heart disease (Mirotznik et al., 1995) and a variety of other 
illnesses, it was not felt to be suitable for use in an IBS population. 
TRANSTHEORETICAL MODEL OF BEHAVIOUR CHANGE 
The second theory considered as the theoretical background for this thesis was the 
transtheoretical model of behaviour change (TTM). This model was proposed by 
Prochaska and collegues (Prochaska, 1994; Prochaska et al., 1992). Although it 
shares some of the background principles with the health belief model, this model 
was initially considered to be more useful due to its focus on the stages in which 
people change behaviours. The concept of stages of change seemed highly suitable to 
an IBS population as the model is robust enough to account for the considerable 
heterogeneity in this population. It also does not necessitate an understanding of how 
the symptoms occurred initially, and can therefore be adapted to each sufferer 
regardless to their individual illness and lifestyle factors. Briefly the model describes 
the stages that people work through in order to bring about a behavioural change. 
There are five stages to these model, precontemplation, contemplation, preparation, 
action and maintenance, these will be briefly described. 
Precontemplation. This stage occurs when the person has no intention to alter their 
behaviour, in fact in this stage many individuals are not even aware that there is a 
necessity to alter their behaviour. This is highly typical for example in smoking and 
other addictive behaviours, such as alcoholism. In this stage treatment may be 
sought, but this is generally under coercion from family members or authority 
figures, and unsurprisingly people attempting change at this stage meet with limited 
success. 
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Contemplation. This can really be seen as the stage where conscious desires to alter 
risk behaviours emerge, but it is a reflective stage where there is a general 
consideration to alter the behaviour in the future but no sense of urgency and no 
attempt to set goals for attaining the behaviour change. Due to the lack of urgency it 
is possible to remain in this stage for years, and a process of weighing up the costs 
and benefits of altering risk behaviours may fluctuate between the precontemplation 
and the preparation stage. 
Preparation. This is the first stage where a clear intention to change behaviour is 
seen, but this has not been actualised at this stage. There may be a slight modification 
to behaviour, such as reduction of amount of cigarettes smoked, or there may be real 
or assumed reasons for delay. The key issue at this stage is that no firm cognitive 
commitment has been made to altering the behaviour. 
Action. This is the stage where the behaviour is actually modified, and requires 
emotional and behavioural commitment. 
Maintenance. It is not sufficient to simply change a behaviour the behaviour must 
continue to be maintained, in this respect it is not just about cessation it is a cognitive 
commitment for the person to alter their self perception, e. g. from a smoker to a non- 
smoker. 
In should be noted that although the stages are described separately here, this is to 
aid clarity but the model itself in generally considered to be a spiral where relapse is 
common and fluctuation between the stages either side of the current stage generally 
occurs. It may be that the cycle is enacted a number of times before the behaviour is 
successfully eliminated. 
In some ways this model is appealing, as like any stage theory, it sets about clearly 
defining areas for research, and suggests a series of studies assessing current stages, 
concluding in an intervention to move participants to a further stage and an 
assessment of the impact on symptoms and quality of life. However, the TTM has 
also been widely criticised, and is even considered by Sutton (2001) to be `logically 
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flawed'. In addition, albeit not to the same extent, the criticisms of the HBM are still 
prevalent here. The problem is that there is no clear behaviour for IBS sufferers to 
alter, at best there is a series of lifestyle factors, but as the TTM works best when it is 
focussed on setting about one (e. g. addictive behaviours, Prochaska et at, 1992) or if 
necessary a small number of clearly defined changes (e. g. eating habits, Povey et al, 
1999), it is unlikely to prove useful for sufferers. Moreover, a majority of sufferers 
are already engaging in behaviour changes regarding diet (Niec, 1998), stress 
reduction (Dancey et at., 1995) and medications (Talley, 2001) and yet are meeting 
with limited success. It was therefore felt that unless clearly defined `risk' behaviour 
could be identified designing an intervention based around this model would not be 
successful. 
It is therefore clear from the exploration of the alternative theories that a model 
focussed on perceptions rather than specific behaviours is the most likely to achieve 
successful results for IBS sufferers, and as the systematic review (Chapter 2) and the 
justification for the CSM here shows it is felt that the most efficacious model was 
chosen. 
This marks the end of the literature review portion of the thesis. It should be clear 
from this chapter and from the preceding chapters that psychologically based 
approaches are suitable for IBS research and that indeed there is justification for 
investigating the role of the CSM specifically. As such the next three chapters will 
detail the empirical studies that were designed around this model. Each study was 
designed to test a specific component of the model. The first two studies are 
exploratory in nature with both studies investigating potential contributory factors to 
the assessment of current illness representations and also looking independently at 
illness representations and outcomes. This was felt to be imperative as this is an 
extremely under-researched model in IBS and it was therefore felt that prior to the 
devising on an intervention a thorough background investigation of the model needed 
to be conducted. The final empirical chapter presents the intervention study that was 
designed around the CSM. 
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CHAPTER 4 
STUDY 1 
DOCTOR-PATIENT COMMUNICATION, ILLNESS 
REPRESENTATIONS AND OUTCOMES IN IRRITABLE 
BOWEL SYNDROME (IBS) 
Aim 
Chapter 4 reports the results of study 1. This was an exploratory study which 
investigated the role of doctor-patient communication in irritable bowel syndrome. 
The role of the doctor comes under the category of social messages in the 
interpretation part of the model. It is therefore the model's inclusion of the doctor as 
the primary external informational source in the development and maintenance of 
illness representations which attests to its suitability. Theoretically doctor-patient 
communications can impact on each of the five cognitive representations of. identity, 
cause, timeline, consequences and cure/control (e. g. Frostholm et al., 2005). To date 
there has been no research directly addressing the role of doctor-patient 
communication in the illness representations of IBS sufferers. Therefore this is an 
important area of study that needs to be explored, both for its own merits and also in 
so far as it will further understanding of the specific nature of the intervention. 
There were a number of different research questions but they grouped into three main 
areas of interest. The first area was a comparison of patients' and doctors' 
perceptions of doctor-patient communication. The second area was an assessment of 
the potential impact of patients' perceptions of doctor-patient communication on 
their illness representations and their illness outcomes (perceived health related 
quality of life and symptom frequency). The third and final area of investigation was 
an exploration of the relationship between illness representations and illness 
outcomes independently from perceptions of doctor-patient communication. 
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INTRODUCTION 
The original impetus for this study was driven by reports from sufferers at IBS 
Network meetings. At the meetings sufferers complained that medical professionals 
(doctors and gastroenterologists) did not show any sympathy for their condition, that 
medical professionals did not view IBS as a legitimate illness, and that medical 
professionals did not believe their quality of life was affected. Many sufferers 
reported feeling frustrated and disappointed following consultations. Following these 
reports from sufferers a search of relevant literature was initiated. Although there is 
only a handful of studies investigating IBS patients' perceptions of medical 
consultations, the research identified, both on doctor-patient communication in 
general and in IBS, does support the views expressed at the self help groups and 
therefore legitimises this as an area of study. 
Over the past three decades research interest in the area of doctor-patient 
communication has begun to emerge. The complexity of this interaction means that 
there is currently only a limited amount of research available, but that which does 
exist serves to show the importance of this as an area of study, and defines the key 
components of this relationship. The clearest depiction to date of the area of doctor- 
patient communication provided by a review of the literature by Ong et al. (1995). In 
their review they use Cancer as an example; this is unsurprising as the majority of 
research conducted has been in this area. Although the potentially life threatening 
nature of Cancer makes direct comparisons to IBS difficult the two main conclusions 
drawn from the review persist across illness types. 
The first conclusion is that there are three main areas of importance in doctor-patient 
communication, these are: 1) the rapport between the doctor and the patient, 
including creating a comfortable atmosphere. 2) The need to effectively 
communicate information about the specific nature of the illness, and to alleviate any 
unnecessary distress on the part of the patient and 3) the need for the doctor to work 
with the patient to make informed decisions regarding treatment. 
The second conclusion is about the methods used to assess consultation efficacy. The 
review suggests that patients' perceptions should be considered the gold standard. In 
96 
Doctor-patient communication in IBS 
fact they suggest that this is due to doctors' underestimating the level of information 
patients desire, and the potential impact that doctor-patient communication may 
have. They therefore suggest that although interaction analysis systems (IAS) are 
often used to code the components of consultations, this is not an accurate measure 
for evaluating the potential impact of the consultation on the patients. 
The review concludes by suggesting that although there is limited research available 
there is evidence that patients' health outcomes for sufferers of chronic illness might 
be affected by doctor-patient communication. The main study cited is by Kaplan et 
al. (1989), they conclude that positive doctor-patient communication which serves to 
reinforce patients "self confidence, motivation and positive view of their health 
status", will have a direct impact on their perception of their health related quality of 
life, and will cause an indirect improvement to their illness symptoms. The results of 
this study are supported by recent research by Ong et al. (2000), with cancer patients. 
Ong et al. (2000) used content analysis to code the themes from 96 consultations, and 
multiple regression analyses were used to predict patient outcomes at one week and 
three months post consultation. The results indicated that the `affective quality of the 
consultation' predicted the patients' quality of life, and their satisfaction with the 
medical consultation. 
It can therefore be seen that the impact of doctor-patient communication is a 
theoretically viable, important and under researched area of study. Although research 
specifically investigating patients' perceptions of doctor-patient communication in 
IBS is limited, of the available research there are three studies (Coulson & Semper., 
2004; Bertram et al., 2001; Kennedy et al., 2004) that provide useful evidence to 
support the anecdotal accounts of poor perceptions of doctor-patient communication. 
The research by Coulson & Semper (2004) will be detailed first. 
In a novel approach to gaining information about patients' opinions this research 
collated and analysed the information posted by sufferers of IBS on internet message 
boards. This is a unique style of research which allows for the assessment of genuine 
opinions, rather than by asking questions which may bias or prime patient responses. 
The research assessed the messages (n=414) posted between February and July 2003, 
and coded the emerging themes. There were four main themes to emerge from this 
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research, interestingly all of them relate to doctor-patient communication to some 
degree. 
The first theme was `symptom understanding and experience'. The two sub themes 
were a) uncertainty over the multiple and mixed symptoms people were 
experiencing, with an implication that informational support given by medical 
professionals was insufficient, and b) discussions regarding the impact of symptoms 
on quality of life. The second theme was 'diagnosis'. In this theme the two main 
postings were a) "anger and despair over the lack of a formal diagnosis", and b) "the 
lengthy process.... before a confirmed IBS diagnosis can be made". The third theme 
was `interaction with health care professionals'. In this theme the main postings 
were descriptions of experiences where health care professionals appeared to show a 
lack of sympathy towards both their symptoms, and the impact of their symptoms on 
their quality of life. The overall result of this theme was an often reported 
dissatisfaction with the consultation. The fourth theme was `treatment options', 
specifically confusion over which treatment options were available and which were 
likely to yield success. Once again there is an implication that medical treatment is 
insufficient and that informational resources on alternative forms of treatment are not 
readily available from medical professionals. Overall this research provides clear 
evidence of patients' dissatisfaction with their medical consultations. Although all 
patients were members of the IBS Network, and may therefore represent a group 
who have a higher level of dissatisfaction than is observed in a more general cohort 
of IBS sufferers these concerns should nevertheless be addressed. Coulson & Semper 
(2004) recommend that further research in this area investigates whether these 
perceptions of poor communication actually impact on the progression of IBS. 
However, in order to assess this quantitative research, which takes into account 
doctors' perceptions alongside the sufferers' perception needs to be conducted. 
The second study, by Bertram et al. (2001) also has a qualitative design. Using focus 
groups they investigated patients' perceptions of their interactions with medical 
professionals. The two main themes to emerge were that `interaction with the 
medical community seldom clarified understanding of IBS', and sufferers felt 
`frustration due to lack of medical validation'. The authors concluded that these two 
factors support the notion of lack of understanding and sympathy within the medical 
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profession, and moreover that many IBS sufferers are considered to be 
hypochondriacs. 
The third study of Kennedy et al. (2003) is similar to the Bertram et al. (2001) study. 
Five focus groups were conducted, involving a total of 23 IBS sufferers who were 
asked to describe their experiences of the health care system (along with other 
variables). Although the study supports the results of this previous research it does 
not in itself extend the literature on this area. Therefore as its use is limited to 
showing consistency of perceptions of sufferers across cohorts no further detail will 
be provided here. Overall the results of these three studies match the themes derived 
by Coulson & Semper (2004), and together these pieces of research suggest that 
negative perceptions of doctor-patient communication amongst IBS sufferers have 
validity. 
An additional study that investigates doctor-patient communication in IBS is by Van 
Dulmen et al. (1994). The study used 120 outpatients with functional abdominal 
complaints, including IBS. In the research participants completed a questionnaire 
about their illness and also any illness related cognitions, behaviour and anxiety, 
prior to an initial consultation with an internal medicine specialist. Following this 
consultation, doctors completed a parallel version of the questionnaire to record what 
they assumed to be the perceptions of their previous patient. The results showed that 
there was a discrepancy in the accuracy of doctors' perceptions of physical and non- 
physical complaints. Interestingly although there was a discrepancy of both physical 
and non-physical symptoms, the doctors' perceptions of the physical symptoms were 
more closely matched to patient's perceptions, than their perceptions of non-physical 
symptoms were. In addition the research found that doctors underestimated patients' 
expectations and secondary complaints, and overestimated their pain related 
attributions, catastrophising and self efficacy cognitions. This research therefore 
suggests that patient's and doctors' perceptions of communication may be 
incongruent. It is a useful piece of work and supports the qualitative studies reported 
earlier. The results are also in line with findings reported by Forshaw & Langley 
(2004) that doctors overestimate the amount of knowledge patients have. However, 
the evidence from this study is by no means conclusive. For example, it does not 
address IBS sufferers as an independent group, does not directly measure the main 
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elements of doctor-patient communication in a structured form, and does not suggest 
if there is an impact of perceptions of communication on illness outcomes. Therefore 
more research is clearly needed in this area. 
From the above evidence it seems likely that there is a difference between patients' 
and doctors' perceptions of communication in medical consultations. However, as 
was seen with the research in other chronic illnesses, and specifically cancer it is not 
sufficient to merely show that there is a discrepancy in the views of doctors and 
patients, it is important to assess if there is an impact on quality of life and 
symptoms. Research by Letson & Dancey (1996) suggests that it is vital to assess the 
potential impact of negative attitudes held by medical professionals as negative 
attitudes may be widespread. Their research with a cohort of nurses suggests that 
"the majority of nurses hold negative attitudes towards IBS sufferers, which can only 
be detrimental to the treatment of patients with IBS". Although there is a danger 
generalising conclusions from nurses to doctors, this study is inline with the opinions 
of Maguire (1999), who opens his review of doctor-patient communication in cancer 
research with the didactic statement "how doctors and nurses communicate can 
profoundly affect the psychological adjustment and quality of life". The potential 
impact of doctor-patient communication is also demonstrated by Harrington et al. 's 
(2004) observation that the curriculum for training the medical profession has been 
revised to ensure that communication is an integral part of most courses. 
It therefore appears likely that poor-doctor patient communication may have a real 
impact on IBS sufferers' subsequent health. However there is only one piece of 
research which directly and quantitatively investigates the potential long term-effects 
of doctor-patient communication in IBS. It was conducted by Owens et al. (1995) 
and is a prospective study whereby 112 patients were monitored (using medical 
records) from diagnosis for an average of 29 years (range 1-32 years). The findings 
from this study revealed that the number of return visits (specifically related to IBS) 
were lower in those patients that reported higher levels of doctor-patient 
communication. Significant aspects of doctor-patient communication were whether 
the doctor assessed the patient's psychosocial history, whether the doctor seemed 
interested in why the patient had booked the appointment, and discussing the illness 
with the patient. In addition a rapport with the patient was approaching significance. 
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It therefore seems likely that positive doctor-patient communication impacts on the 
long term prognosis of IBS, as evidenced by fewer return visits in patients reporting 
higher degrees of satisfaction. However, the claim that the outcome variable, 
`amount of consultations for IBS symptoms equates to a genuinely lower mean 
frequency of symptoms (in patients who report a positive initial consultation)' is 
unsubstantiated. Whilst this may be the case, the research does not record any 
objective symptom measures and therefore this conclusion can at best be implied. 
However, the prospective nature of this study does suggest that there is a reduction in 
physician visits in those patients who report positive doctor-patient communication. 
This is a step forward in IBS research in this area, and supports the view that doctor- 
patient communication may impact on illness outcomes. 
Overall the previous review of the literature suggests that doctors and patients 
perceive the communications differently, and that perceptions of poor 
communication may affect illness prognosis. Although more research is clearly 
needed before either of these conclusions can be drawn with any degree of certainty 
it does seem likely that the impact on symptom frequency will be an indirect 
consequence of health related quality of life (HRQOL). This is an idea that was 
originally suggested by Kaplan et al. (1989, cited in Ong et al., 1995). Although there 
is undoubtedly a reciprocal relationship between symptoms and quality of life the 
dominant directionality appears to be exacerbation of symptoms by perception of 
poor quality of life. This is consistent with the literature on other psychological 
variables, such as stress (Dancey et al., 1998), and the role of abuse in IBS aetiology 
(Drossman et al., 1999). Recent research by Brennan et al. (2004) supports this 
notion, and agrees that although symptoms (subdivided into seven independent 
predictors) do contribute to HRQOL, there are eight other quality of life components 
which independently predict illness prognosis. There are two main conclusions 
which can be drawn from this study. The first is that where symptoms and HRQOL 
are both included as outcomes, it is likely the two variables will be correlated. 
However, the predictive relationship between the two should use HRQOL as the 
predictor and symptoms as the dependent variable. The second conclusion, and of 
importance for the area of doctor-patient communication is that in addition to 
assessing symptom severity doctors should aim to improve patients' perceptions of 
HRQOL. This is an interesting implication as it suggests that doctor-patient 
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communication could influence the perceived HRQOL of patients. Although this 
supports the research of Van Dulmen et al. (1994) and therefore is a theoretically 
viable suggestion, as this research does not measure perception of doctor-patient 
communication as a conclusion it should be treated with caution. 
One final paper which supports the conclusions drawn by Brennan et al. (2004) is by 
Salmon (2000) who suggests illnesses which show physical symptoms, but do not 
appear to have an underlying physical pathology (of which IBS conforms) are ones 
which are most likely to be influenced by doctor-patient communication. Although 
this is a descriptive article, rather that a study specifically investigating IBS 
consultations, there are a number of points raised that are worthy of mention. Firstly, 
supporting the views of Ong et al. (1995), Salmon (2000) agrees that the traditional 
approach to videotaped interaction analysis system (IAS) for recording consultation 
components, is unsuitable for use in an IBS population. He states that this approach 
is unsuitable because it is not the components of the interaction itself that impact on 
illness progression but on the patients' interpretation of these components. He goes 
on to suggest that whilst the view of the doctor as the `expert' may be suited to 
physical illnesses where pharmacological solutions can be given, it is not suited to 
IBS. In fact he described the `expert' approach as `invalid', and explains, that the 
mere fact that patients continue to seek treatment despite being told that their 
pathology is untreatable by traditional solutions, means that the patients require 
something different from the consultation. Salmon (2000) suggests this to be 
`sensitivity to the condition'. Judging by the findings from the Bertram et al. (2001), 
Coulson & Semper (2004) and Kennedy et al. (2004) this certainly appears to be a 
fair conclusion. 
Overall the research points to the need to measure HRQOL and symptoms in the 
context of doctor-patient communication. However, it is sparse and the findings 
limited. One of the problems with the current research as evidenced by the Owens et 
al. (1995) study is that even when there appears to be a relationship between doctor- 
patient communication and illness outcomes this relationship is not adequately 
explained. This points to the need to base research on established theories, as without 
the inclusion of a theoretical model it is not possible to conclude with any degree of 
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certainty that the differences in symptoms (either within or between subjects) are 
actually related to doctor-patient communication. 
A theoretical model which might explain the route from communication to illness 
outcomes is the common sense model of illness representations (CSM) (Leventhal et 
al., 1980; 1984). As this was described and justified in detail in chapter 4 this will not 
be reiterated here. However, it is important to emphasise that the role of the doctor 
comes under the category of social messages in the interpretation part of the model. 
It is therefore the model's inclusion of the doctor as the primary external 
informational source in the development and maintenance of illness representations 
which attests to its suitability. Theoretically doctor-patient communications can 
impact on each of the five cognitive representations of: identity, cause, timeline, 
consequences and cure/control. A recent study by Frostholm et al. (2005) exemplifies 
the suitability of the CSM to the study of doctor-patient communication, with an 
extremely large scale research involving one thousand seven hundred and eighty five 
participants recruited from twenty eight different GP practices. They found that poor 
perceptions of doctor-patient communication impacted on both the illness identity 
and the emotional representations components. 
To date there has been no research directly addressing the role of doctor-patient 
communication in the illness representations of IBS sufferers. Therefore this is an 
important area of study that needs to be explored. 
There is one component of the model which is worthy of more detailed 
consideration, this is the perceived cure / control dimension. There is some debate as 
to whether this dimension added by Lau and Hartman, (1983) is a true component of 
the illness representation model, or whether it will exert a direct effect. The role of 
perceived cure / controllability was considered by Leventhal et al. (1984), as the 
following statement demonstrates. They state: 
"Although this factor clearly belongs within common sense models, it is debateable 
whether it should be defined as an attribute of illness representations or a summary 
of expectations with respect to coping" 
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Possibly because of the controversy surrounding its role the questionnaire used to 
assess the illness representation components only contains limited questions for 
assessing this component, therefore an additional, dedicated measure will be 
included. Although theoretically some research may choose not to include this 
component, in the literature on illness representations (e. g. Hagger & Orbell, 2003) 
its inclusion is shown to be widespread. The factor of cure/control is often researched 
outside the context of the CSM, as a large body of research attests to. This research 
serves to confirm the likelihood of a relationship between perceptions of control and 
illness outcomes across a number of different chronic illness groups. Examples of the 
range of illnesses include diabetes (Kohlmann et al., 1993), brain injuries (Moore et 
al., 1991) and epilepsy (Krakow et al., 1999). Although there has been no dedicated 
research directly investigating the relationship between health related locus of 
control (HRLOC) and IBS, this does not negate the likelihood of the same 
relationship being observed as is seen for other illnesses. It is therefore an important 
area of study. Two papers provide limited support for the role of control beliefs and 
quality of life. The first is a paper by Rutter and Rutter (2002). As part of their 
investigation of illness representations they report that `weaker control styles' are 
associated with worse HRQOL and depression. However, this research does not 
include a dedicated locus of control measure, and there were no significant 
relationships between locus of control styles and symptoms. One other paper, Hobbis 
et al. (2003) investigated locus of control, alongside abnormal illness behaviour in 
IBS. They found that IBS sufferers were more prone to external locus of control 
styles than non FBD patients, but they did not investigate whether this affected 
illness outcomes. Despite the limited empirical support, the theoretical justification is 
clear. 
The route by which locus of control is said to affect perceived quality of life and 
illness outcomes is related to coping strategies. It has been suggested by Wallston et 
al. 1994) that an internal locus of control might encourage more productive self- 
management behaviours and a greater sense of an ability to improve the condition. 
This is based on the rationale that people with an internal locus of control tend to 
assume both more personal responsibility for their own health, and more belief in 
their ability to influence their illness progression. External locus of control is actually 
two constructs, one type of external control focuses on fatalistic views, such as God, 
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luck or chance. The other is the belief in powerful others. Although both external 
views are considered less protective of health, the people with a fatalistic locus of 
control are theoretically more likely to be at least accepting of their illness state. The 
other type of externality is considered to be the most detrimental to health, this is the 
belief in powerful others. A high score on this dimension represents an individual 
who expects medical professionals (and other authority figures) to be responsible for 
their health. This locus of control is likely to be problematic for IBS sufferers as its 
chronic trajectory coupled with the ineffectiveness of medical treatments means that 
people with a powerful others external locus of control are unlikely to engage in self- 
management behaviours and as a consequence have worse symptoms and poorer 
health related quality of life (HRQOL) (Wallston et al., 1994). 
It is theoretically viable therefore that the locus of control a person holds may be 
related to doctor-patient communication. The theoretical viability is derived both 
from the stance of the CSM as originally stated, and also from the locus of control 
construct itself. Although there is limited literature addressing the role of locus of 
control specifically within the context of doctor-patient communication, that which 
does exist suggests that illness outcomes are more severe for patients with external 
locus of control styles both for general illness (e. g. Burgoon et al., 1990) and 
epilepsy (Gopinath et al., 2000). There is no research which explores the relationship 
between doctor-patient communication and locus of control in IBS, and therefore this 
is a novel area of study. 
The aims of this research are therefore to support and extend the literature in this 
area. Its broad aims are: 
1) To compare patients' and doctors' perceptions of doctor-patient communication. 
2) To assess if there is a real impact of perceived communication on illness 
representations (including locus of control) and on illness outcomes (HRQOL and 
symptom frequency). 
3) To explore the role of illness representations (including locus of control) and 
illness outcomes, independently of doctor-patient communication. 
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METHOD 
PARTICIPANTS 
DOCTORS 
Doctors were recruited via opportunity sampling, by sending request letters to their 
surgeries. 245 packs were distributed to doctors and 58 completed packs were 
returned (response rate 23.7%). The doctors group comprised both GPs (n=44) and 
consultant gastroenterologists (n= 12, n=2 unspecified). Independent samples t-tests 
conducted for each of the communication dimensions showed that there were no 
significant differences between these groups on any of dimensions and therefore the 
data from the GPs and the gastroenterologists were combined to form one doctors 
group (n=58), which was used in the analysis. Further demographic information is 
given in table 10. 
Table 10 - Additional demographic information (doctors) 
Variable Mean S. D. Range 
Doctor participants age (years) 49.6 9.3 31-82 
Amount of time worked as a doctor 
(years) 
23.7 10.4 3-60 
Number of IBS consultations doctors 
have per week 
5.9 5.9 1-30 
IBS PARTICIPANTS 
IBS participants were recruited via opportunity and snowball sampling from a 
number of sources including universities, work places, self-help groups or by 
responding to advertisements placed in the IBS Network's quarterly publication and 
their website. The IBS Network is an independent national organisation set up to 
give advice, information, and support to sufferers of IBS. It is an important cohort for 
research in this area but it only represents just over half of the sample here. 139 
packs were distributed to IBS sufferers and 58 completed packs were returned by use 
of free-post (response rate 41.7%). Participants had to be over the age of 18, able to 
read English, and have a confirmed diagnosis of IBS from a medical professional. 
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The vast majority of participants were female (86%). This is unsurprising as a gender 
bias in IBS populations has been reported by many researchers (e. g. Dancey et al., 
1995; Drossman et al., 1999). It is currently unclear whether this bias is due to 
females actually being more likely to suffer from IBS, differential treatment seeking, 
or differential reporting in research. The important consideration here is that this 
sampling bias is congruent with that from previous research (e. g. Rutter and Rutter, 
2002; Lackner et al., 2004). Participants' ages ranged from 19-78 years, with a mean 
age of 47.1 (SD 17). 
The average time since diagnosis of IBS was 11.1 years (SD 9.4), with a range from 
less than a year to 37 years. The average time from first experiencing symptoms to 
being diagnosed was 4.4 years (SD 6.7), with a range from less than a year to 30 
years. With the exception of one American all participants were resident in the UK. 
Just over half of the sample was highly educated with 58.6% achieving `A' levels or 
higher, 19% of the sample reported having no academic qualification. Almost half 
(47%) of the sample reported having another illness. The most often reported 
illnesses were hypertension (8.6%) and asthma (8.6%), the only specified 
psychological illness was depression at 6.9% of the sample. 
MEASURES 
A disease specific version of the IPQ-R (Moss-Morris et al., 2002, appendix 1) was 
used to measure the illness representation components. This disease specific version 
was modified in accordance with standard procedures for its use with an IBS 
population. The items on the scale used as predictors in the multiple regression 
analyses in this research are identity (sum of symptoms believed to be related to 
IBS), perceived personal control (IP12-IP17), perceived treatment control (IP19- 
IP23), timeline acute/chronic (IPI-1P5, + IP18), perceived consequences (IP6-IP11), 
illness coherence (IP24-IP28) and emotional representations (IP33-IP38). The items 
in these scales are counterbalanced, and are rated on five point Likert scales from (1) 
strongly disagree to (5) strongly agree. The total score is averaged for each scale. All 
of the subscales have good internal consistency, with alpha values ranging from 0.79 
to 0.89 (Moss-Morris et al., 2002). 
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The IBS-36 (Groll et al., 2002, appendix2) was used to measure Heath Related 
Quality of Life of sufferers. This is a disease specific questionnaire, consisting of 36 
questions scored on a 7-point Likert scale; it addresses all areas of quality of life. The 
score used in the analysis is the `total IBS related quality of life score, this is 
calculated by summing the responses to the 36 questions. Higher scores represent a 
lower perceived quality of life. It has a very high internal consistency (Cronbach's 
alpha = 0.95) and a high test-retest reliability (Spearman's r=0.92, Groll et al., 
2002). It is highly suitable for this study, and is considered by its authors to be 
superior to measures used in previous research. 
The 7-day symptom diary (appendix 3) was designed for this study, as there is 
nothing suitable in the literature; however, it is based on traditional designs, and is 
considered to be a suitable measure based on Meissner et al. 's (1997) contention that 
a symptom diary should be the gold standard for measuring symptoms. 
Medical Interview Satisfaction Scale MISS-21 (Meakin & Weinman, 2002) was used 
to measure doctor-patient communication; it is a revised version of the MISS, which 
has been used extensively. The internal consistency of the MISS-21 is satisfactory 
(alpha coefficient's range 0.67-0.92, Meakin & Weinman, 2002). It was used to 
assess four dimensions of doctor-patient communication: `rapport', `distress relief', 
`consultation comfort', and `compliance to treatment'. For the purposes of this study 
two modified versions of this measure were produced. The first was an IBS specific 
version for the IBS participants (appendix 4). The alpha coefficient for this IBS 
specific version was 0.94. The second version of this questionnaire modified for this 
study was an IBS consultation specific version for the doctors (appendix S). The 
alpha coefficient for this version was 0.90. As the alpha coefficients demonstrate, 
despite the modifications to this measure the two versions created for this study can 
be considered to be highly suitable. 
The Multidimensional Health Locus of Control Scale (MHLC, appendix 6) (Wallston 
et al., 1994) was used to provide additional data on locus of control. Although the 
IPQ-R does include scales for perceived personal control, and perceived treatment 
control, it was considered useful to add this additional measure for this specific 
study. This is because the cure / controllability dimension was not part of Leventhal 
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et al's. (1980) original design, and therefore the scale is rather limited. The inclusion 
of an additional (specific locus of control) measure was to increase the likelihood of 
revealing a relationship (if one exists) between perceived doctor-patient 
communication and locus of control The MHLC scale was used because it has been 
extensively validated and across hundreds of studies it Cronbach's alphas are 
satisfactory (range 0.60-0.75), the test-retest stability coefficients range from 0.60 - 
0.70. This study utilized form C of the MHLC; this is an illness specific version, 
which in this case was modified for use in an IBS population. Responses were on a 
six point Likert scale from (1) strongly disagree to (6) strongly agree. It consists of 
18 questions, which comprise the three locus of control dimensions (internal, 
external -fate, and external - powerful others). 
Demographic Questionnaire There were two demographic questionnaires used in 
this study, one version was administered to the IBS participants (appendix 7), and an 
alternative version was used for doctors (appendix 8). 
PROCEDURE 
This was a postal based study; therefore both the doctors and the IBS participants 
received a research pack. The doctors' packs were posted to their surgery addresses, 
and the IBS participants' to their homes. 
The doctors' pack contained an information sheet along with a letter inviting them to 
take part in the research (appendix 9), consent forms and confirmation of ethics 
approval (appendix 10), a demographic questionnaire (appendix 8), the doctors' 
version of the MISS-21 (appendix 5) and a free post envelope for return of 
completed research packs. 
The IBS participants' pack contained an information sheet along with a letter inviting 
them to take part in the research (appendix 11), consent forms (appendix 12), a 
demographic questionnaire (appendix 7), the IBS patients' version of the MISS-21 
(appendix 4), a disease specific version of the IPQ-R (Moss-Morris et al., 2002, 
appendix 1), the IBS-36 (Groll et al., 2002, appendix 2), the 7-day symptom diary 
(appendix 3) and a free post envelope for return of completed research packs. 
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DATA TREATMENT 
Raw data was entered into SPSS (version 14). There was fortunately very little 
missing data, the small quantity was dealt with by using mean substitution. As the 
variables were normally distributed and mean substitution only affects the variance 
this was felt to be the best method. In the raw data set many questions on each of the 
measures are reversed, these were transformed and using guidelines in the 
questionnaire manuals the variables to be used in the analysis were computed. 
RESULTS 
COMPARISON OF DOCTORS' AND PATIENTS' 
PERCEPTIONS OF DOCTOR-PATIENT COMMUNICATION 
As is shown in figure 4, the mean scores for three out of the four dimensions of 
doctor-patient communication are higher in the doctors' group than the IBS patients' 
group. The largest difference is observed in perceived `distress relief. As figure 4 
shows the dimension which appears to have identical means is perceived treatment 
compliance. 
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Figure 4- Doctors' and IBS sufferers' perceived efficacy of communication 
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MISS-21 Components 
A series of one-way analyses of variance revealed that doctors reported significantly 
greater perceived efficacy of their communication than did IBS sufferers on all 
dimensions except treatment compliance. The significant differences were therefore 
between `consultation comfort' (F(1,114) = 8.87, p<0.005), `distress relief 
(F(1,114) = 70.02, p<0.0001) and `rapport' (F(1,114) = 21.29, p<0.0001). 
As the IBS sample was largely female biased it was not possible to split the data by 
gender. Although splitting the data by age was considered this was felt to be 
inappropriate as there may be interaction effects between age and length of time 
suffering from IBS. It was felt that with a data set of this size controlling for this 
would have left insufficient power to detect accurate effects, and as there was not felt 
be a legitimate reason why age might affect perception of communication this was 
not assessed. 
There were however three grouping variables that were explored. The first of these 
was whether participants were members of the IBS Network. This was conducted in 
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order to assess if perceptions differed between these two groups. This is a legitimate 
variable to explore as it was the members of the IBS Network's self-help groups who 
first suggested this research was conducted, and it was members of the IBS Network 
that Coulson & Semper (2004) used in their research. Therefore it is possible that this 
represents a group who hold worse perceptions of medical consultations than the 
general IBS population; therefore in order to ensure the generalisability of results this 
needs to be explored. Of the 58 IBS participants who took part in this study 37 were 
members of the IBS Network and n=21 were not. A series of ANOVAs revealed no 
significant differences between Network and non-Network members on any of the 
dimensions of doctor-patient communication. 
The second grouping variable was whether or not participants reported suffering 
from any other illness. Although participants were asked to only consider 
consultations relating to their IBS directly it may have been difficult for this to be 
actually achieved, especially if consultations had frequently covered the other 
illnesses too. As was discussed in chapter 2 prevalence of additional illnesses is 
common, and it was therefore felt that restricting the sample to only those 
participants who did not suffer from another illness would not have given an accurate 
representation of the IBS population as a whole. Therefore the decision was taken to 
include participants with additional illnesses, however, as a large proportion of the 
sample reported suffering from another illness (n=33) it was felt necessary to assess 
if there were differences in perceived communication between these groups. A series 
of ANOVAs revealed no significant differences between people with or without 
another illness on any of the dimensions. 
The third and final grouping variable was between subgroups of IBS. Considering 
that IBS has been shown by factor analysis to group into the three distinct, and 
potentially opposite illness groups, it seems logical to explore the relationship 
between these groups and perceived communication. However, aa majority of 
studies only investigate effects on IBS sufferers as a homogeneous group (as can be 
observed in the systematic literature review). In order to gain a full understanding of 
the differences between doctors' and patients' perceptions of doctor-patient 
communication it is therefore essential to assess if there are differences across the 
IBS subgroups. In this study there were n=19 IBS-D sufferers, n=19 IBS-A sufferers, 
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and n=15 IBS-C sufferers. Although these categories were self defined by the 
sufferers, it is likely that these categories are correct as the proportion in each group 
is similar to that reported in previous research (e. g. Lackner et al., 2004). A series of 
ANOVAs revealed that there were no significant differences between the subgroups 
of IBS on any of the dimensions. Therefore for this study the investigation of IBS 
sufferers as one group appears to be legitimate. 
PATIENTS' PERCEPTIONS OF DOCTOR-PATIENT 
COMMUNICATION AND ILLNESS REPRESENTATIONS 
A series of multiple regression analyses were conducted to explore potential 
relationships between patients' perceptions of doctor-patient communication 
(predictors being the four dimensions of. consultation comfort, distress relief, rapport 
and treatment compliance) and illness representations. It should be noted that 
perceived cause is a categorical variable; therefore this was not included in the 
analyses. 
The analysis revealed only one significant relationship between perceived doctor- 
patient communication and illness representations. This includes the additional 
measure to assess the cure / control component. This was that as perceived 
compliance to treatment increased perceived consequences of having IBS decreased 
(table 11). 
Table 11 - Multiple Regression Predicting Illness Representation: Perceived 
Consequences of Having IBS (R2 adi. 0.083) 
Doctor-patient communication ß 
Communication comfort -0.10 
Distress relief 0.01 
Rapport -0.22 
Compliance intent - 0.32* 
< 0.05 level 
As table 11 demonstrates the only dimension of doctor-patient communication that 
was predictive of illness representation dimensions was the one area which was 
shown not to differ between doctors and patients, namely compliance intent. It is 
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therefore possible that there is an independent theoretical construct underlying this 
relationship. 
PATIENTS' PERCEPTIONS OF DOCTOR-PATIENT 
COMMUNICATION AND HRQOL 
A multiple regression was carried out to assess if patients' perceptions of doctor- 
patient communication were predictive of their perceived HRQOL. None of the 
factors were found to be significant. It therefore does not appear that HRQOL is 
predicted by patients' perceptions of doctor-patient communication. 
PATIENTS' PERCEPTIONS OF DOCTOR-PATIENT 
COMMUNICATION AND SYMPTOM FREQUENCY 
A series of multiple regression analyses were undertaken to ascertain whether 
patients' perceptions of their doctor-patient communication were predictive of their 
symptom frequency. This was assessed for both total symptoms, and for each of the 
primary IBS symptom categories. There were no significant findings indicating that 
patients' perceptions of doctor-patient communication were not predictive of their 
symptom frequency. 
Taken together the lack of significant findings relating to HRQOL and symptom 
frequency suggest that although their may be differences in perceptions of 
communication between patients' and doctors' these do not have an affect on their 
illness outcomes. However, the lack of significance observed for perceptions of 
doctor-communication as a predictor of illness representations, does not negate the 
possibility that illness representations may be predictive of illness outcomes 
independently of perceived communication. Consequently this was also included in 
the analysis. 
ILLNESS PERCEPTIONS AND HRQOL 
Two of the illness representation components were found to be predictive of 
HRQOL, these were illness identity, and emotional representations, as table 12 
demonstrates. The results show that a greater illness identity (i. e. more symptoms 
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associated with IBS) results in increased quality of life (the score is negative because 
increased quality of life is measured by lower scores on the IBS-36). The results also 
show that the more emotional representations about the illness a sufferer holds the 
worse perceived quality of life is. 
Table 12 - Multiple regression of illness representations predicting health 
related quality of life (IBS-36): (R2 adi. 0.52) 
Illness representation dimensions ß 
Perceived personal control -0.14 
Perceived treatment control -0.07 
Identity -0.36** 
Time line 0.01 
Consequences 0.11 
Emotional representations 0.41 
Illness Coherence 0.07 
*p < 0.05 level, * *p < 0.001 level. 
To supplement the data elicited from the IPQ-R, the data from the MHLC was also 
used to further investigate the relationship between perceived HRLOC and HRQOL. 
Having an internal locus of control was found to be predictive of increased HRQOL, 
as table 13 shows. 
Table 13 - Multiple regression of MHLC predicting Health Related Quality of 
Life (IBS-36): (R2 ad i. 0.23) 
Health Related Locus of Control ß 
Internal locus of control -0.53*** 
External powerful others 0.00 
External fate / chance 0.17 
***p <0.0001 level 
An internal locus of control is highly correlated with the IPQ-R dimension of 
perceived personal control (r = 0.61, p<0.0001). This is expected as both variables 
are supposed to be measuring the same construct (using different measures). 
Therefore although perceived personal control was not predictive of HRQOL this is 
most probably a reflection of insufficient power in the IPQ-R to detect this 
relationship. This is understandable as the IPQ-R only contains a handful of 
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questions relating to this variable, where as the MHLC is a dedicated measure of 
locus of control. 
ILLNESS PERCEPTIONS AND SYMPTOMS 
None of the illness representation components (from the IPQ-R) were found to be 
predictive of either total symptom frequency, or any of the primary IBS symptoms. 
Emotional representations were however approaching significance, and this is in the 
same direction as was noted for quality of life (Table 14). 
Table 14 - Multiple regression of illness representation predicting symptoms: 
(R2 adj. 0.12) 
Illness representation dimensions ß 
Perceived personal control -0.23 
Perceived treatment control 0.10 
Identity -0.26' 
Time line 0.13 
Consequences -0.12 
Emotional representations 0.30' 
Illness Coherence 0.03 
'p < 0.07 
There was however, a significant relationship between internal locus of control and 
total symptom scores (Table 15). This reveals that having an internal locus of control 
is predictive of decreased total symptoms. 
Table 15 - Multiple regression of locus of control predicting total symptoms: (R2 
adi. 0.09) 
Health Related Locus of Control P 
Internal locus of control -0.40* 
External powerful others -0.21 
External fate / chance 0.16 
< 0.05 level 
There was also a significant relationship between internal locus of control and 
abdominal pain (table 16). This indicates that an internal locus of control is 
predictive of decreased abdominal pain. 
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Table 16 - Multiple regression of locus of control predicting abdominal pain: (R2 
adi. 0.10) 
Health Related Locus of Control P 
Internal locus of control -0.38* 
External powerful others 0.22 
External fate / chance -0.31 
*p < 0.05 level 
The final significant relationships between locus of control and individual symptoms 
were for diarrhoea. There were two significant findings, the first inline with variables 
was that having an internal locus of control was predictive of deceased frequency of 
diarrhoea. The second significant finding was that chance / fate was predictive of 
increased diarrhoea (table 17). 
Table 17 - Multiple regression of locus of control predicting diarrhoea: (R2 adj. 
0.11) 
Health Related Locus of Control P 
Internal locus of control -0.46* 
External powerful others -0.16 
External fate / chance 0.38* 
*p < 0.05 level 
RELATIONSHIP BETWEEN HRQOL AND SYMPTOMS 
According to Brennan et al. (2004) (as detailed earlier) it is likely that HRQOL and 
total symptoms will be correlated, therefore a Pearson's correlation was calculated to 
assess if this was the case. The results indicate that the two variables are correlated (r 
= 0.46, p<0.0001), as figure 5 demonstrates. 
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Figure 5 HROOL and total symptoms 
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Based on Brennan et al. 's (2004) suggestion that the directionality of the prediction 
was from HRQOL to symptom outcomes, rather than the other way around a linear 
regression analysis was conducted to see if HRQOL was in fact predictive of 
symptom frequency. The linear regression indicated that positive HRQOL was 
predictive of decreased total symptom frequency, R2 adj. 0.19, ß 0.46, p<0.05. As 
HRQOL was found to be predictive of total symptom frequency it is feasible that this 
an important implication for the relationships between variables reported earlier. 
EXPLORATION OF THE RELATIONSHIP BETWEEN LOCUS 
OF CONTROL AND ILLNESS OUTCOMES 
The implication of the prediction of symptoms by HRQOL is that when locus of 
control was found to be predictive of HRQOL and symptoms, the prediction of 
symptoms is actually not a direct consequence of locus of control. Instead the 
relationship between locus of control and symptoms maybe mediated by HRQOL. 
This suggestion would also explain why for the illness representation dimensions 
there was insufficient power to detect the relationship between illness representations 
and symptoms. This is represented pictorially in figure 6. 
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Figure 6 Potential relationships between illness representations, HRLOC and 
illness outcomes 
In order to assess the validity of this theory a stepwise regression was conducted 
where internal locus of control was the first step and HRQOL was the second step. In 
line with Brennan et at. (2004) HRQOL was found to fully mediate the effect of 
HRLOC on symptoms with HRLOC no longer a significant predictor of symptoms in 
this second step (table 21). 
Table 21 - Stepwise Multiple Regression HRLOC Predicting Symptoms 
mediated by HRQOL 
Steps R2 A R2 F change Df 1 Df 2 Sig. F 
change 
Final ß 
Step 1- 0.09 0.09 5.65 1 56 0.02* -0.10 
internal 
locus of 
control 
Step2- 0.22 0.13 8.70 1 55 0.005*** 0.41* 
IBS-36 
+p < 0.05 level ** *p < 0.005 level 
DISCUSSION 
The results revealed that there were significant differences between perceptions of 
consultations by patients and doctors. Specifically there were significant differences 
observed for three of the four communication dimensions, namely `distress relief, 
`consultation comfort', and `rapport'. In all cases IBS participants scored lower on 
these dimensions than the doctors' group. Overall the findings of significant 
differences between groups is in line with the research by Van Dulmen et al. (1995), 
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and extends the ideas raised in the research by Coulson & Semper (2004) and the 
findings reported by Bertram et al. (2001). 
It is interesting to consider why only three out of the four dimensions were 
significant, a closer look at the components for each of them may provide 
suggestions as to why this might be the case. The one which was not found to be 
significant was compliance intent. This is the extent to which both doctors and 
patients perceive that the patients will adhere to the advice given in the consultation. 
Although there was no difference in the mean scores for each group it is interesting 
to note that the mean score was only 11.5, the lowest score of any of the dimensions. 
As there were three questions which contributed to this factor this meant that the 
average score per question was 3.8, which fell between disagree and uncertain (the 
questionnaire comprised a seven point scale, where 1 was `very strongly disagree' 
and 7 was `very strongly agree'), indicating perhaps rather worryingly that neither 
the doctors or the patients have much faith that the advice is going to be followed. 
The first of the three dimensions that were found to be significant is `consultation 
comfort'. Doctors report a mean score of 21, whereas IBS patients report a mean 
score of 19. As there are four questions for this category, this represents the doctors' 
score of 5.25, referring to the agreement section of the scale, whereas IBS 
participants score of 4.75 falls between uncertain and agree, and is closer to agree. 
Although the doctors are significantly overestimating the level of comfort the IBS 
patients feel, on the whole it does not appear to be the case that either groups 
perceive the level of comfort derived from the consultation to be particularly poor. 
The second of the three dimensions that was found to be significant is `distress 
relief'. Doctors report a mean score of 31.5, whereas IBS patients report a mean 
score of 22.2. As there are six questions for this category, this represents the doctors' 
score of 5.25 referring to the agreement section of the scale, where as IBS 
participants score of 3.7 falling between disagree and uncertain. This shows that the 
doctors are significantly overestimating the level of comfort the IBS patients feel, 
and that in fact that their responses are on the opposite arm of the scale to the IBS 
sufferers. It is worrying that doctors perceive they alleviate sufferers' distress, 
whereas in actual fact this is something that is not achieved. Of all the dimensions of 
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doctor-patient communication this is the area that provides the greatest support for 
the ideas raised in the studies by Bertram et al. (2001) and Coulson & Semper 
(2004). An interesting implication of this study is that although sufferers' perceptions 
of poor levels of support from doctors at alleviating distress does appear to be valid it 
may be the case that this is accidental and therefore doctors' should be given more 
advice on providing adequate distress relief (e. g. Kennedy et al., 2003). From a 
social psychology perspective it makes sense that the patient seen by the doctor is 
only one of a number of people seen in any hour, whereas for the patient the 
significance of the interaction is much higher (Salmon, 2000). 
The final of the three dimensions that was found to be significant is `rapport'. 
Doctors report a mean score of 42.7, whereas IBS patients report a mean score of 
35.3. As there are eight questions for this category, this represents the doctors' score 
(averaged as 5.34) referring to the agreement section of the scale, whereas IBS 
participants (averaged as 4.41) are uncertain. This shows that the doctors are 
significantly overestimating the level of rapport they develop with their IBS patients. 
There were no significant differences between members of the IBS Network and 
non-members on any of the dimensions of doctor-patient communication. It therefore 
seems likely that the IBS Network is a representative group of IBS sufferers. In this 
respect this is useful for the future of IBS research as it provides a way of accessing a 
cohort of people suffering from the illness, but one that appears to still allow for 
generalisability of the results. 
There were no significant differences between those patients who reported suffering 
from no additional illnesses, and those that reported suffering from additional 
illnesses. It therefore seems likely that the perceptions reported were not related to 
differences in general illness state, and therefore there can be greater confidence that 
these patient's perceptions can be attributed specifically to their IBS consultations. 
Although none of the participants were screened to ensure that they actually suffered 
from IBS, inclusion into the study required participants to have a confirmed 
diagnosis of IBS from a genuine medical professional. As this was a cross sectional 
study, with no immediate perceived benefits to participants (as may be the case with 
an intervention) it seems highly unlikely that any of the participants would have 
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chosen to take part in the study unless they actually suffered from IBS. It can 
therefore be assumed that all the participants actually suffered from IBS, and 
moreover that suffering from additional illnesses does not appear to alter the results. 
There were no significant differences between subgroups of IBS; this suggests that 
despite the heterogeneous nature of the illness the same concerns are observed 
throughout the illness groups. This is likely to be a reflection of a general 
dissatisfaction with medical professionals, partly as a result of the lack of a clear 
understanding of symptoms or an established treatment regime. This supports the 
findings of Coulson & Semper (2004). But as this was a qualitative study, and there 
is no equivalent quantitative literature the comparison should be made with caution. 
This is especially relevant as although the observed results seem logical the overall 
sample size meant that there were not many cases in each group for comparison. 
Therefore more research exploring grouping variables is clearly needed before any 
clear conclusions can be drawn. 
There was only one significant relationship between patients' perceptions of doctor- 
patient communication and their illness representations, which is as perceived 
compliance to treatment increased perceived consequences of having IBS decreased. 
This finding makes intuitive sense and is consistent with Markoul et al. 's (1995) 
research on adherence to medications. However, compliance to medical treatment is 
the only dimension of doctor-patient communication that does not differ between 
groups. In may therefore be the case that there is an underlying theoretical construct 
responsible for this observed relationship. Feasibly patients' could hold this prior to 
and independently of the medical consultations they experience. On the basis of this 
these results should be interpreted with caution. 
There were no significant relationships between doctor-patient communication and 
either HRQOL or symptoms frequency. As there is no research directly investigating 
this hypothesis in IBS it is not possible to ascertain if this is a true finding, or the 
result of a limitation of the study. However, the closest comparative study of Owens 
et al. (1995) implies illness outcomes decrease, as a correlate of reduced use of 
health care services. The finding of no impact of perceived communication on illness 
outcomes is also in opposition to the findings in the Cancer literature (e. g. Ong et al., 
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2000). It is essential that further research, in particular of a prospective nature is 
undertaken to establish if perception of doctor-patient communication affects illness 
progression. 
Two of the illness representation components were found to be predictive of 
HRQOL, namely illness identity and emotional representations. It should be noted, 
however, that despite its significance illness identity was in the opposite direction to 
that suggested by previous research (e. g. Frostholm et al., 2005). The relationship 
between emotional representations and HRQOL, however match Frostholm et al. 
(2005). As the Frostholm study involved a vast sample size of almost two thousand 
patients, it seems likely that these results can be accepted with a high degree of 
certainty. It also strongly suggests that despite the heterogeneous nature of IBS its 
relationship to the CSM is similar to that of other illnesses. This is an important step 
forward for both research into IBS, and the CSM. However, as Leventhal et al. 
(1984) explain the model was specifically designed for heterogeneous illnesses, and 
therefore perhaps this robustness is unsurprising. Using the MHLC questionnaire to 
provide additional data on the locus of control component it was also discovered that 
an internal locus of control was predictive of increased quality of life, consistent with 
the theory of Wallston et al. (1994) and the research into other chronic illnesses (e. g. 
Moore et al., 1991). 
Although none of the illness representation components were predictive of symptoms 
emotional representations were approaching significance. It therefore seems likely 
that the true finding is one of significance, but that study limitations did not reveal 
this using this data set. However, it is likely as Brennan et al. (2004) suggest that the 
relationship between illness representations and symptoms is indirect and is mediated 
by HRQOL. Although it is not possible to assess this as the relationship is not 
significant it does suggest why there was sufficient power to detect the relationship 
between illness representations and HRQOL, but not for symptoms. It is also logical 
as HRQOL and symptoms were shown to be correlated. Using the MHLC 
questionnaire it was shown that an internal locus of control was predictive of 
symptoms. Significance was observed for total symptom frequency, diarrhoea and 
abdominal pain. Having an external locus of control (the chance / fate dimension) 
was also significantly related to having a higher frequency of diarrhoea. In order to 
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fully assess the relationship between the variables as Brennan et al. (2004) suggest a 
step wise multiple regression with total symptoms as the dependent variable, 
HRLOC as step one, and HRQOL as step two was conducted. This revealed as 
suspected that the relationship between HRLOC and symptoms was fully mediated 
by HRQOL. 
Overall the results show some significant relationships, but leave other areas in need 
of further research. One of the reasons for this is the lack of additional research to 
support the claims made here. Another reason is the limitations of this study. 
Although these do not negate the importance of these findings they should still be 
taken into account when conclusions are drawn. 
STUDY LIMITATIONS AND SUGGESTED MODIFICATIONS 
PARTICIPANTS 
Although the significant findings suggest that participant numbers were not too low, 
it is still likely that insufficient participant numbers meant that there were less 
significant findings than might other wise have been found. This is because with only 
58 participants, the statistics would have only detected a large effect size. Power 
analyses indicate that to detect medium effects with a multiple regression with the 
predictors used in this study a sample size of in excess of one hundred would have 
been necessary. Concerns over sample size are particularly worth noting for the 
analyses where further grouping variables were used. In order to establish therefore if 
small sample size was a contributory factor to the lack of a significant finding here it 
is advisable for further research to use larger sample sizes. Related to the amount of 
participants the second methodological issue is low response rates, with the implied 
potential for a volunteer bias in each of the participant groups. The doctors' group 
will be dealt with first. 
Although it is not possible to know if a bias did occur it is theoretically possible that 
those doctors who agreed to participate in the study were those who had a higher 
perception of their efficacy at communication or showed more compassion to their 
patients in general, or to their IBS patients specifically than those who did not 
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respond. As the questionnaire only comprised twenty one questions and would have 
taken under ten minutes to complete the excuse of not having enough time seems 
highly unlikely, and therefore response rates are likely to reflect a greater interest in 
the specific research. It is not possible to establish if a more representative sample 
would increase or decrease the disparity in perceptions of communication and 
therefore again more research with a larger sample, is necessary before the results are 
generalized with certainty. An additional concern is that the questionnaire responses 
provided by the doctors might have been influenced by social desirability biases, and 
therefore perhaps a peer review of consultations maybe useful to ensure the 
responses are accurate. 
For the participants, although the response rate was not as low, and the comparison 
between IBS Network and non network members suggests this is quite a 
representative group, it is still a possibility that participants were those who were 
more likely to have an interest in the field of doctor-patient communication. As no 
payment was offered to participants, there is a slight question over motivation for 
participation that should be taken into account in the reading of the results. In order 
to address these concerns in future, payment might be useful to alter the motivation 
for taking part in the research. 
MEASURES 
As this study was interested in participants' perceptions the use of questionnaires 
was highly suitable, the use of established measures (such as the IPQ-R and the 
MHLC) and IBS specific measures (such as the IBS-36) increases the suitability of 
these methodological choices. However, methodological concerns with the MISS-21 
and the diary need to be considered. 
The first methodological issue is the suitability of the MISS-21 to assess doctors' 
perceptions of the consultation. It was used as there was no superior questionnaire 
based method for eliciting perceived communications available, but it was originally 
intended as a measure of an individual consultancy. In this respect its psychometric 
properties were established over both immediate perceptions and with individual 
patients. It is therefore possible that doctors found it hard to think about their 
dealings with IBS patients as a whole, and indeed the personality of the patient may 
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be far more indicative of communication styles than the type of illness they possess. 
In addition for the purposes of this study a parallel version was created for patients to 
record their perceptions. It is therefore possible that although the measure was 
suitable for the use of ANOVA where only the mean scores were used, that the 
measure was not sensitive enough for use in the regression analyses where a range of 
responses is important. It should be noted in the defence of these concerns that the 
alpha coefficients elicited for the two versions used in this study were very high, and 
therefore although these limitations may be more theoretical than actual. 
Although the diary methodology for recording symptoms is less prone to recall bias 
then retrospective questionnaires one problem with this methodology is that without 
financial incentives participants are reluctant to complete diaries over long periods of 
time (Patten et al., 2003). This may be problematic in IBS research as symptoms are 
cyclic and indeed may vary on a daily basis. To minimise daily fluctuations in 
symptoms the mean score over the week was taken to assess the impact of perceived 
communication on Illness representations, HRQOL and symptoms. However, in 
order to gain a full assessment of the relationships it is necessary to take diary 
recordings at a number of times, preferably for a couple of weeks before and after 
consultations on different occasions. 
DESIGN 
There is a possibility that the assessment of symptoms and the quality of life referred 
to a different time period than the perception questionnaire. For the perception 
questionnaire participants were asked to think about their experiences in previous 
consultations, but the symptoms measured one week only and quality of life 
questionnaire measured perceptions over the previous two months. Therefore in 
order to fully assess whether doctor-patient communication does indeed impact on 
illness outcomes it is necessary to have a longitudinal study design where assessment 
of symptoms is taken at baseline, and following a consultation. 
Another potential concern is the use of unrelated doctor-patient dyads. In the initial 
design of the study it was thought suitable to compare a general doctors' group with 
an IBS patients' group as a way of assessing if scores between the two groups were 
different. Whilst this does show a lower mean score for the IBS group the results also 
126 
Doctor-patient communication in IBS 
report a 'greater degree of variance in the IBS sufferers group, particularly for distress 
relief and rapport. Although the variables are normally distributed, it does suggest 
that the relationship between individual patients and their specific doctors may prove 
to be a more worthwhile comparison. However, it would still be perceived 
communication not actual communication which would be the important independent 
variable. It should be noted that the use of unrelated doctor-patient dyads does not 
negate the findings, but it does mean that it is potentially harder to find a difference 
between groups. It may therefore be the case that the significant difference between 
doctors' and patients' observed here actually demonstrates that the underlying theory 
is strong. 
CONCLUSIONS AND FURTHER RESEARCH 
This chapter has demonstrated that the CSM is a model which should be investigated 
in IBS research. However, the constraints of the study mean that the specific 
relationships between doctor-patient communication and illness representations are 
currently unclear. However, the results of this study offer an important insight to the 
development of intervention research in IBS as they do not provide any firm 
justification for focussing on the therapeutic relationship in the intervention. This 
conclusion echoes the results of a study by Ilyckyj et al. (2003) who found that an 
intervention to improve the `therapeutic value' of a GP visit had no impact on 
subsequent IBS symptoms. 
The next stage of this thesis is to examine the other proposed external contributing 
factor to illness representations, social support. Accordingly the next chapter (chapter 
5) will report the results of a study investigating the role of perceived social support 
and attitudes to IBS. In addition to this being an important component of the model 
and therefore as worthy of investigation as the potential role of doctor-patient 
communication further justification is provided by the results to the current study. 
This justification comes from the results relating to HRQOL. This research strongly 
suggests that illness representations impact on perceived HRQOL, and on symptoms 
(at least indirectly). It therefore appears that an intervention that includes a 
component addressing HRQOL will be efficacious. It is therefore essential that the 
role of social support in illness representations be investigated. The results of this 
study are presented in chapter 5. 
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CHAPTER 5 
STUDY 2 
ATTITUDES TO IRRITABLE BOWEL SYNDROME (IBS), 
ILLNESS REPRESENTATIONS AND OUTCOMES 
Aim 
Chapter 5 reports the results of study 2. This was an exploratory study which 
investigated the role of perceived social support in irritable bowel syndrome. This 
study complements the research on doctor-patient communication as it investigates 
the other external contributing factor to illness representations. The aim of this 
chapter is to assess the importance of perceived social support in current illness 
representations. As with the previous study it is important to investigate the factors 
that impact on the illness representations sufferers hold in order to identify those 
areas that need to be challenged in order to alter illness representations. 
There were a number of different research questions but they are grouped into four 
main areas of interest. The first area was an investigation of the attitudes that the 
general population held towards sufferers of IBS (in comparison with other 
illnesses). The second was a comparison of the general populations' attitudes 
towards IBS sufferers, with IBS sufferers' perceptions of the general populations' 
attitudes towards them. The third area of investigation was an assessment of the 
potential impact of IBS sufferers' perceptions of the general populations' attitudes, 
on their illness representations and illness outcomes. The fourth and final area of 
investigation was an exploration of the relationship of illness representations and 
illness outcomes independently from perceived attitudes to IBS. 
INTRODUCTION 
As with the previous study (doctor-patient communication) the original impetus for 
this study was driven by reports from sufferers at IBS Network meetings. At the 
meetings sufferers expressed concern over the attitudes that non-sufferers held 
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towards their illness. Many sufferers reported that people held negative opinions 
towards them. In some cases sufferers reported these negative attitudes, in particular 
amongst friends and family, as resulting in a perceived lack of social support. The 
emotion expressed by many sufferers shows their strength in their belief of the 
perceived lack of social support. In order to assess the validity of the claims of the 
IBS sufferers a literature search was initiated. This was divided into two main areas. 
The first area is literature relating to the attitudes of the general population. The 
second area is literature relating to IBS sufferer's perceptions of other people's 
attitudes towards them. Although both the IBS Network and the Chicago division of 
gastroenterology are currently conducting research into attitudes of the general 
population to IBS there is no literature to date investigating perceptions of the 
general population. This is because the literature on attitudes to IBS is either from the 
patient's perspective (dealt with in the next section) or from the medical profession 
(as was described in chapter 5). As the present study compares perceptions of IBS 
with asthma and epilepsy the example of epilepsy will be given here. Epilepsy was 
chosen because there is a wealth of literature available investigating attitudes towards 
epilepsy amongst many different population groups and cultures. Although direct 
comparisons between IBS and epilepsy are not possible it is hoped that this example 
with place the results of this study in the context of the current literature as attitudes 
towards IBS reported here, can be compared to the attitudes towards epilepsy. 
Although there is also a large literature on other chronic illnesses, it was not felt 
worthwhile to include additional examples as their results may not be generalisable 
to IBS. 
ATTITUDES OF THE GENERAL POPULATION 
The literature relating to the attitudes of the general population towards sufferers of 
chronic illness falls into a number of different terms. Some studies specify attitude as 
a continuum from a positive to negative (e. g. Young et al., 2003), other studies 
investigate negative attitudes in the context of stigma (e. g. Snadden & Brown, 1992), 
and others consider attitudes to be inherently linked to social support (Hogan et al., 
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2002). Whilst arguably these terms have distinct meanings', in the literature the 
boundaries are often blurred. However, each of these pieces of research shares a 
commonality, in that they aim to elucidate the views of society in the context of 
chronic illness. 
ATTITUDES TOWARDS EPILEPSY 
One of the most researched areas in the context of attitudes to chronic illness (aside 
from mental illnesses, and HIV/AIDS) is epilepsy. The literature on attitudes to 
epilepsy covers a wide range of different groups and cultures. Although not directly 
relevant here there are a number of studies investigating attitudes towards children 
with epilepsy, and in particular teachers' perceptions of epileptic students (e. g. Sanya 
et al., 2005; Sharkawy et al., 2006; Birbeck et al., 2006). In addition a large number 
of studies have been conducted cross culturally, showing a large discrepancy in the 
attitudes held (Doughty et al., 2003). Two examples of countries that report 
particularly negative attitudes are Vietnam (Le et al., 2006) and India 
(Radhakrishnan et al., 2000). 
Le et al. (2006) conducted a large scale population survey of one thousand randomly 
selected people in Vietnam. The findings revealed a large degree of stigma towards 
epileptics with 56% reporting that they would not allow one of their children to 
marry someone with epilepsy, and 42% believing that epileptics should not be 
employed in mainstream employment. It is suggested that these negative attitudes 
result from a lack of understanding of epilepsy and indeed this does appear to be the 
1 Stigma - There are a number of different definitions of stigma, but essentially it is considered to be 
a social construction whereby there is recognition of a difference based on some distinguishing factor. 
This can either be visible, such as in the case of a physical deformity, or race, or can be less obviously 
visible, such as homosexuality, or chronic illness. In the less obviously visible illnesses disclosure 
(either full or partial is more relevant). The essential component of stigma is that the knowledge of the 
`distinguishing factor' results in a devaluation of the person. 
Social Support - There are a number of different conceptualisations of social support, but essentially 
it comprises four main components. Firstly the structural aspects of a social network e. g. size of social 
network and the resources available. Secondly functional aspects of social support, this involves 
emotional support and a sense of acceptance (this can be related to stigma). Thirdly the actual 
enacting of the support, that is it is not just the availability of the resources, but the provision of these 
when they are needed. Finally the subjective perception of whether support will, or has been given. 
Attitudes - Attitudes are the opinions people hold on topics and issues. Attitudes are complex 
differing in degrees of negativity, and in strength. It is also possible for conflicting attitudes to be 
held, such as in the form of cognitive dissonance. The attitudes a person / group have can in an 
extreme form be considered a stigma, and will necessarily affect the social support they will provide. 
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case with 24% of participants reporting epilepsy to be a form of dementia. The 
results of the study by Radhakrishnan et al. (2000) suggest that a large degree of 
stigma is also observed in south India. Their exceptionally large study was based on 
238,102 people, all of which were from households without an epileptic. Their 
results showed that 27% of the sample thought that epilepsy was a form of insanity, 
and 40% did not think that epileptics should be employed in mainstream 
employment. They do not report opinions regarding marriage of offspring to 
epileptics, but their results do report that 11% of parents would object to their 
children being friends with a child who has epilepsy. These results are consistent 
with Le et al. (2006) and suggest that even the most recent research shows some 
countries hold negative attitudes towards epileptics. Although there have been many 
studies conducted in a variety of countries the ones most relevant to the attitude 
study presented here is that of western countries. In contrast to the negative attitudes 
seen in some cultures the western research suggests that attitudes towards epilepsy 
have improved since the 1940s (the first study was conducted in 1947). It would 
appear that the most marked changes have occurred from late 80s. It should be noted 
that despite the negative attitudes in some cultures there is still a general trend 
towards improvement since the 80s, as research in the Czech Republic demonstrates 
(e. g. Novotna & Rektor, 2002). A study by LaMartina (1989) in the USA revealed 
that one in three Americans held negative attitudes towards epileptics and their 
families, and one in six believed that epilepsy is a form of mental illness. Although 
recent research suggests that some groups, e. g. adolescents may perceive stigma in 
relation to their epilepsy (MacLeod & Austin, 2003), research investigating the 
perceptions of the general population towards epileptics suggests that negative 
attitudes are not generally the norm, although they still stress people should be better 
educated about epilepsy (Kobau & Price, 2003) 
A recent study by Young et al. (2002) gives a clear indication of the current research 
findings regarding attitudes towards epilepsy. This was a questionnaire based study 
of Canadian college students (n=191). The questionnaire comprised three sections, 
demographic information, knowledge and attitudes. Although the study design could 
be criticised for its limited sample and use of closed questions to assess attitudes, the 
results yielded are extremely strong and clear. They show that attitudes to epilepsy 
are `uniformly favourable' with more than 80% of students answering each of the 
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attitude items favourably, these were: 1) children associating with persons with 
epilepsy 95%, 2) relative marrying someone with epilepsy 95%, 3) whether 
epileptics should have children 84%, 4) whether epileptics should be employed in the 
same jobs as other people 84%. In addition for attitudes towards the work place it is 
likely that the slightly lower positive rating was related to concerns over safety rather 
than stigma relating to abilities. 
The results of the previous study are supported but studies conducted in other 
countries, such as the research of Jacoby et al. (2004) in the UK, which found that on 
the whole people's attitudes towards epileptics were positive, but a fifth of the 
sample (total sample size n= 1600) agreed with the statement that `people with 
epilepsy have more personality problems, than people without epilepsy'. Research by 
Spalt et al. (2005) in Austria reported that only ten percent of the sample (total 
sample size n= 2128) reported having negative attitudes to epileptics. Further support 
is provided by Hills & MacKenzie (2002) in New Zealand. Their study, conducted 
on 400 participants showed that `attitudes towards epilepsy were favourable', with 
only five percent of the sample reporting negative attitudes. 
In the Young et al. (2002) study it was suggested that negative attitudes towards 
epileptics in mainstream employment may be one area of negativity that is still 
observed in western cultures. Although they suggest that this is due to `concern' 
rather than `stigma', it is still a cause for concern. Therefore two final papers 
investigating attitudes towards epilepsy specifically within the context of the 
workplace will be discussed. The first study is by Harden et al. (2004). This is in a 
slightly different style from the standard questionnaire based research as it used 
vignettes. 200 employees (in two companies in New York) were given three 
vignettes describing a co-worker. One had depression, one multiple sclerosis (MS) 
and the other one had epilepsy. It should be noted that the epilepsy vignette did not 
describe a seizure. Of the 74 returned study packs it was discovered that participants 
reported more anxiety with regards to potentially working with an epileptic, although 
this was not significantly different from the other groups. There were however 
significant differences between groups with worry about `sudden, unpredictable 
behaviour' scoring significantly higher for epilepsy than for MS. Interestingly the 
finding of significantly less comfort providing first aid for epileptics compared with 
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both other groups, suggests that negative attitudes towards epileptics in the work 
place are perceived by those that hold them to be as a result of health concerns, rather 
than stigma. However, it could be argued that the uninformed opinion of the working 
abilities of epileptics as a whole, as opposed to individual's abilities and level of 
expertise is still discrimination, and is based on a lack of understanding about the 
condition. Whilst it may be the case that some environments are unsuitable for 
epileptics, due to seizure triggers, such as strobe lighting in a night club, this 
certainly does not mean that negative attitudes towards general employment are 
acceptable. A recent study by Jacoby et al. (2005) provides useful information 
relating to the employment of epileptics and shows that although there is an overall 
improvement of attitudes towards epilepsy within the general population, this is not 
held when employment is specifically referenced. Their cohort comprised 204 
employers who were sent a survey asking about employment opportunities for 
epileptics. The results revealed that 16% said that there company did not offer any 
jobs suitable for epileptics, 21% thought that employment of an epileptic would be a 
"major issue", and rather worryingly around 50% of the sample reported that the 
thought of working with an epileptic person caused them to feel "major concern". 
Although only a small selection of research is reviewed here there are three findings 
which can clearly be taken from the previous review. Firstly that attitudes to epilepsy 
differ as a function of culture with western cultures generally reporting more positive 
findings. Secondly that attitudes towards epilepsy in all cultures have become more 
positive in the last couple of decades, and lastly that attitudes towards epileptics in 
the work place are more negative than attitudes towards epileptics in general. The 
literature on epilepsy is useful as it provides a clear report on people's attitudes to 
this chronic illness, by comparing IBS to epilepsy it will be possible to gain some 
idea of the strength of people's attitudes to IBS specifically. 
POTENTIAL IMPACT OF IBS SUFFERERS' PERCEPTIONS OF 
OTHER PEOPLE'S ATTITUDES TOWARDS THEM 
Although it is not ideal to draw too many implications from the research on epilepsy 
it should be noted that within the context of the common sense model (CSM 
Leventhal et al., 1980; 1984) it is not the actual attitudes held by the general 
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population, but the perceived attitudes held by the IBS sufferers that are of 
importance. As the CSM was described in detail in chapter 4 this will not be repeated 
here, however, the rationale behind the investigation of perceived attitudes will be 
briefly described below. The relationship between perceived attitudes and illness 
outcomes is considered to act on similar processes as perceived doctor-patient 
communication. That is the perception of attitudes forms part of the social messages 
component in the interpretation part of the model, however, as was explained earlier 
each stage of this model impacts on the other stages. It is possible that the attitudes of 
significant others will show a stronger relationship with the illness representation 
components, than doctor-patient communication. This is because, of the three 
primary sources of information, 1) social communication and cultural knowledge, 2) 
external social environment and significant and authoritative others, 3) current 
(including previous) symptom experience (Leventhal et al., 1980; 1984) doctor- 
patient communication only relates to category 2, whereas the attitudes of the general 
population encompass both category 1, and also (specifically within the context of 
social support) category 2. This is therefore a much broader category than the unique 
relationship between the doctor and the patient, and one that is much more integral to 
the daily experience of the patient. 
The suggestion of a relationship between perceived attitudes and health outcomes is 
not unique to the CSM. It is integral to the underlying theory of biopsychosocial 
approaches to health. A review by Gaynes & Drossman (1999) reports a clear and 
protective relationship of social support to health. They state: 
"The degree to which individuals maintain close personal relationships with others 
can promote health status and help protect against the various stressors on ones 
health" 
Numerous pieces of research confirm this relationship across a range of illnesses, as 
the review by Hogan et al. (2002) demonstrates. Echoing the views of Gaynes & 
Drossman (1999) they comment that research repeatedly provides evidence of the 
protective nature of social support for long term health outcomes. This is stated to be 
primarily a function of the two interconnected aspects of better immune function and 
lower blood pressure. In fact the article goes on to say that the beneficial relationship 
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of social support is so strong that interventions based on improving social support are 
efficacious at improving health outcomes across a range of illnesses. It should be 
noted however, that the active components of these interventions are not currently 
established. Although there were no intervention studies investigating the role of 
social support in IBS at the time of this review, the range of illnesses included (e. g. 
cancer, obesity, cardiovascular disease etc. ) suggest that the results should be 
generalisable. This is a view that is shared by Gaynes & Drossman (1999) who in 
fact considered the relationship between social support and illness outcomes to be so 
well established, that they made two key recommendations specifically relating to 
social support in IBS. The recommendations they made were 1) that the way the 
family interact with the IBS sufferer has an impact of their illness outcomes, and 2) 
that the patients' overall social network is vital to their illness outcomes. It is 
therefore important to conduct research to assess the validity of these claims, and it is 
therefore important not just to assess the actual attitudes held by the general 
population, but the patients' perceptions of these attitudes. 
There is only a handful of papers that investigate `perceived attitudes' in IBS 
specifically, but what does exist suggest that this is both an important and under 
researched area of study. These papers will briefly be described here. 
Dancey & Backhouse (1993) conducted a cross-sectional questionnaire based study 
which asked 148 IBS sufferers (IBS Network members) a number of questions about 
the perceived impact of their illness across a range of different dimensions. Their 
results showed that IBS affects all aspects of sufferers' lives and only one of these 
aspects was their relationships with other people, of which perceived attitudes was a 
contributing factor. Although this research is useful as it provides preliminary 
evidence for the potential impact of the perception of negative attitudes of the 
general population, and of those people who make up the sufferer's social network, 
there are clearly a number of limitations to this study. The first limitation is the 
questionnaire based design, which may have elicited more negative responses, than 
an interview or a focus group. Secondly although there are over one hundred 
respondents it is possible that there is a sampling bias towards people with more 
negative attitudes taking part in the studies. The third and main limitation of this 
study is that the variable of perceived attitudes is very limited, and therefore research 
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which is specifically focussed on this aspect is clearly needed before any firm 
conclusions can be drawn. 
In a further study Dancey et al. (2002) investigated the factors which contribute to 
illness intrusiveness and quality of life in IBS sufferers. This study is similar in 
design and aim to the Dancey & Backhouse (1993) study, but differs in that it 
directly investigates perceived stigma as an independent construct. This cross 
sectional questionnaire based research used a different cohort of IBS Network 
members, but participant numbers (n=117) and potential concerns regarding biases 
are similar. The results indicated that perceived stigma negatively correlated with 
quality of life; that is as perceived stigma increased reported quality of life reduced. 
In addition an interesting finding was that although perceived stigma was negatively 
correlated with quality of life for the sample as a whole, significantly worse effects 
were noted for men. This suggests that studies investigating the impact of perceived 
attitudes on IBS outcomes should compare the effects on males and females, as there 
may be some differences between these two groups. 
The previous studies are useful because together they provide preliminary evidence 
both for IBS sufferers holding negative perceptions of the attitudes of the general 
population towards them, and also for the potential impact of these perceptions on 
quality of life. Certainly the Dancey et al. (2002) study is consistent with the views 
proposed by the CSM, although the relationship between attitudes and symptom 
outcomes was not found to be significant. Clearly more research is needed to fully 
explore these relationships. 
In a different style of research Munir et al. (2005) investigated predictors of 
disclosure of chronic illness at work. They looked at a range of chronic illnesses, 
including IBS, with a large sample of 610 participants. Partial disclosure (informing 
line managers about the presence of a chronic illness) and full disclosure (informing 
line managers how that chronic illness affected them at work) were predicted by 
discrete management factors. The study showed that for partial disclosure greater 
experience of illness was predictive, and this was said to be related to the need to 
receive practical support at work. However, when considering the context of full 
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disclosure although illness experience was still found to be predictive, social support 
factors were additionally found to be independent predictors of disclosure. Therefore 
full disclosure was significantly more likely if colleagues had already been 
supportive to illness disclosure, and if the sufferer perceived their line managers as 
supporting their disclosure. An interesting finding was that academics were less 
likely to disclose their illness, but whether this is a function of a perceived lack of 
social support or whether the flexibility of working practices meant that it is not 
essential for a majority of sufferers is unclear. One of the most useful findings to 
emerge from this research is homogeneity of disclosure across illness groups, with 
only diabetes sufferers reporting significantly more partial disclosure to their line 
managers. The authors suggest that this may be due to the specific management 
strategy employed in diabetes, but more research is needed to clarify this distinction. 
The results relating to the other illness groups suggest that prediction of disclosure 
for IBS is therefore not distinct from other medical illnesses. This is interesting as in 
their introduction the authors suggest that IBS is a more `stigmatising health 
condition' than established organic illnesses, but this was not shown by the study 
itself. There are a number of possible reasons why this difference was not observed. 
1) There is no difference between stigmatising and non-stigmatising illnesses, 2) IBS 
is not stigmatised, 3) a measure of stigma was not actually included in the study, 4) a 
response bias meant that highly stigmatised individuals / very severe sufferers were 
not included in the sample, 5) that conducting the study in one UK university 
(despite the range of professions within the environment) may not be truly 
generalisable. 
Although the lack of research in this area makes it difficult to fully establish the role 
of perceived attitudes in IBS health outcomes (Jones et al., 2006; Koloski et al., 
2001) the growth in the research effort in this area over the next few years by Dancey 
and the Chicago division of gastroenterology, means that many unresolved questions 
may be answered. To date the most informative research, as it places IBS within the 
context of both other functional illnesses, and illnesses with an established organic 
cause it that of Looper & Kirmayer (2004). The aim of their research was to 
compare levels of perceived stigma between illness groups. It was a cross-sectional 
questionnaire based design that compared three functional somatic symptom illnesses 
(FSS), with three matched organic illnesses. There were a total of 238 participants 
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divided between six different illnesses, these were chronic fatigue syndrome (CFS - 
n=42) paired with multiple sclerosis (MS - n=33), fibromyalgia (FM - n=35) paired 
with rheumatoid arthritis (RA - n=39) and IBS (n=38) paired with inflammatory 
bowel disease (IBS - n=5 1). The results showed that there were greater levels of 
perceived stigma overall when comparing the combined FSS group with the organic 
illness group. However, for IBS specifically there was no difference with the 
matched illness of IBD. The authors suggest that this is due to the symptoms of IBS 
being a universal experience, albeit in a less intense form. However, this is 
speculation rather than evidenced and is inconsistent with the research by Dancey et 
al. (2002). Therefore further research is clearly needed to clarify these issues. The 
only pair where the FSS illness was reported to have higher levels of perceived 
stigma was for CFS, the authors suggest that this may be due to the ambiguity of its 
status as a medical condition. Whilst this claim is logical the difference observed 
may also be a function of the pair, which was MS, which may not be as `matched' as 
the researchers suggest. Overall this is a very useful piece of research, its only major 
limitation is that it does not address whether perceived stigma impacts on sufferers' 
HRQOL or symptoms. These are obviously important areas that warrant further 
study. 
One study which implies attitudes of others and the need to obtain social support 
impacts on sufferers' illness outcomes is that of Coulson (2005). In a novel style of 
research, which he has been utilising across illness types Coulson (2005) investigated 
the use of IBS specific internet message boards as a means of gaining social support 
from other sufferers and sympathisers. He used deductive thematic analysis on the 
572 messages posted during an eight month study period in 2004. He found that the 
primary function of the internet message group was the provision of social support, 
both informational support (symptom interpretation, illness management and 
interaction with health care professionals) and also in the other forms of social 
support most closely related to attitudes (emotional support and self-esteem). 
It is therefore clear that this is an under researched area, and one where there is 
justification for conducting further research. The aims of this research are therefore 
to support and extend the literature in this area. Its broad aims are: 
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1) To investigate the attitudes that the general population hold towards sufferers of 
IBS (in comparison with epilepsy and asthma). 
2) To compare the general populations' attitudes towards IBS sufferers, with IBS 
sufferers' perceptions of the general populations' attitudes towards them. 
3) To assess the potential impact of IBS sufferers' perceptions of the general 
populations' attitudes, on their illness representations and illness outcomes. 
4) To explore the role of illness representations and illness outcomes independently 
of perceived attitudes to IBS. 
METHODS 
PARTICIPANTS 
GENERAL POPULATION 
Opportunity and snowball sampling was used to recruit from the general population. 
Questionnaires were administered by hand, through the post or via e-mail. A total of 
350 questionnaires were administered, of which 252 were returned (response rate 
72%). Of the 252 questionnaires returned 13 were excluded from the analysis due to 
missing data. Therefore there were 239 participants included in the analysis. Of the 
239 participants there were 83 men and 155 females (one unspecified), the mean age 
of participants was 36.4 (SD 15), and ages ranged from 18-8 1. The majority of 
participants were British (87%). 
IBS PARTICIPANTS 
Although this was a different cohort of IBS participants than was used for study I the 
methods for recruiting were the same (opportunity and snowball sampling - for 
details see chapter 5). 130 packs were distributed to IBS sufferers (same inclusion 
and exclusion criteria as for study 1) and 62 packs were returned (response rate 
48%). This is an almost identical response rate to study 1. Of the participants there 
were 53 females, and 6 males (3 unspecified). This means the percentage of females 
was between 85% and 90%, this is again similar to the reported percentage of 
females in study 1 (86%) and in other studies (e. g. Dancey et al., 1995; Lackner et 
al., 2004). Participants' ages ranged from 19-71 years, with a mean age of 43 (SD 
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14). This is slightly lower, but again similar to study 1 (19-78 years, mean 47.1 SD 
17). 51 % of the sample were members of the IBS Network. 
The average time since diagnosis of IBS was 10.5 years (SD 9.6), with a range from 
less than a year to 33 years. The average time from first experiencing symptoms to 
being diagnosed was 5.5 years (SD 8.3), with a range from less than a year to 33 
years. Within the main IBS group the numbers of participants in the three IBS 
subgroups were as follows, IBS-D (n=26), IBS-C (n=15), IBS-A (n=18), NB three 
participants did not specify their subgroup. With the exception of two Americans all 
participants were resident in the UK. Just over half of the sample was highly 
educated with 53% achieving `A' levels or higher and only 10% of the sample 
reported having no academic qualification. Exactly 50% of the sample reported 
having another illness. The most often reported illnesses were arthritis (8%) and 
asthma (5%), the only specified psychological illness was depression at 15 % of the 
sample. All of these participant characteristics are very similar to the sample for 
study one, the two main differences are that the percentage of the sample that have 
no qualifications is approximately half in this cohort, and that hypertension was not 
reported as a frequent additional illness. 
MEASURES 
A number of the measures used are the same as in study 1, so these will not be 
detailed here. The measures which are the same are: 
A disease specific version of the IPQ-R (Moss-Morris et al., 2002, appendix 1) 
The IBS-36 (Groll et al., 2002, appendix 2) 
The 7-day symptom diary (appendix 3) 
There were two versions of the `Attitudes to Chronic Illness Questionnaire' designed 
for the purposes of this study. There was one version for the general population 
(appendix 13), and one for the IBS participants (termed PSSS, appendix 14). The 
general population version will be detailed first. 
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General population version of the attitudes to chronic illness questionnaire. An 
important feature of the general population version of the questionnaire is that it did 
not only ask questions relating to IBS. The questionnaire also contained parallel 
questions for asthma and epilepsy. There were two main reasons for the inclusion of 
these additional illnesses. Firstly including the other illnesses minimises the potential 
for bias within the questionnaire as it allowed for the individual symptoms to be 
listed, rather than asking direct questions about IBS. This means that the participants 
were not aware that the direct aim of the study was to assess attitudes towards IBS, 
and therefore it is hoped that the responses are more accurate. Secondly, rather than 
simply reporting in a qualitative manner the percentages of people reporting positive 
/ negative attitudes, the inclusion of other illnesses allows for an assessment of 
attitudes to IBS in comparison with other illnesses, in particular those which have 
been more extensively studied, such as epilepsy. Care was taken in the illness 
selection to choose illnesses with some similar components to IBS, the main 
components were: 
" Variety of symptoms 
" Differing levels of severity 
" Chronic but characterised by periods of symptoms and remissions 
" Unpredictability of symptoms 
" Perceived embarrassment of symptoms 
" Restrictions to social activities 
Despite the desire to have similar illnesses the decision was chosen to include 
illnesses with an established organic component in order to provide comparative data 
in the same style as Looper & Kirmayer (2004). 
The questionnaire was divided into five sections. 
Section 1 
This section asked participants about the level of comfort they felt discussing illness 
symptoms. It consisted of an eight point Likert scale which ran from (1) extremely 
comfortable to (8) not prepared to discuss this symptom. It contained a list of the 28 
symptoms most commonly associated with each of the illnesses. Of these 28 
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symptoms eight refer to IBS (numbered 7,10,20,18,26,12,15,2), twelve refer to 
epilepsy (1,22,16,21,17,8,27,24,5,14,11,4) and the remaining eight refer to asthma 
(6,9,13,28,19,25,23,3). It is important to note that as there are unequal numbers of 
symptoms in each group the scores reported in the analysis are the mean scores (i. e. 
total IBS / 8, total epilepsy / 12) rather than the total scores which would have 
necessarily resulted in epilepsy scoring higher. 
Section 2 
This section asked participants about the level of comfort they felt witnessing illness 
symptoms. In all other characteristics (other than now saying witnessing) this section 
was identical to section 1. 
Section 3 
This was a parallel version to the perceived consequences scale of the IPQ-R. There 
are six sub scales within this section (although the questions are counterbalanced to 
that they appear as one scale of 30 questions). The first scale relates to perceptions of 
the physical consequences of having each of the illnesses, the second scale relates to 
perceptions of the social support impact of having each of the illnesses. Although the 
questions in the two scales were different they contained the same amount of 
questions and were scored the same. For each illness there were five questions per 
scale. The responses were scored on a5 point Likert scale from (1) strongly disagree 
to (5) strongly agree. An example of one of the questions on the perceived physical 
consequences scale is, "IBS is a serious condition". An example of one of the 
questions on the social support impact scale is, "if a person had epilepsy it would 
strongly affect the way I viewed them". With the exception of the asthma physical 
consequences sub scale where the alpha coefficient was quite low at 0.39, the alpha 
coefficients of the other scales were reasonable. The coefficient for the IBS physical 
consequences sub scale was 0.60 and it was 0.72 for the social support impact sub 
scale. The coefficient for the epilepsy physical consequences sub scale was 0.63, and 
it was 0.75 for the social support impact sub scale. The coefficient for the asthma 
social support impact sub scale was 0.70. 
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Section 4 
This scale asked participants to imagine that they had a friend who suffered from 
each of the illnesses, and to report the concessions and favours that they would be 
prepared to undertake for a friend. This is referred to in the results section as the 
social support concessions scale. In total this scale comprises eighteen questions, 
scored on a7 point Likert scale from (0) never, to (6) always. There are three sub 
scales (one per illness) of 6 questions each. An example of a question in this section 
is "I would be happy to avoid travelling on public transport if my friend did not want 
to due to worry about having an IBS attack". This section is scored by summing the 6 
questions in each section (note questions 5,13 and 18 are reversed and therefore 
need to be recoded prior to computation of the total score). The alpha coefficients for 
the three illness subscales were fair at IBS 0.79, epilepsy 0.77, and asthma 0.82. 
Section 5 
This was a simple scale which listed fourteen common social activities that are either 
not possible or difficult for sufferers of one or more of the illnesses to be involved in. 
This is a6 point Likert scale scored from (0) never, to (6) always. It includes going 
out to dinner, night clubs and the cinema. Participants are asked to indicate how 
often, on average they would be prepared to avoid each of the activities when 
planning a social event, in order to allow their friend with the illness to be included. 
These can either be taken as individual activities or summed to provide a total `social 
activity' score. 
IBS version of the attitudes to chronic illness questionnaire termed the perceived 
social support scale (PSSS). The IBS version of the Attitudes to Chronic Illness 
Questionnaire is similar to the general population's version. It differs in three main 
ways. 
The first difference is that this version only asks questions relating to IBS, this means 
that for sections 1 and 2 there are 8 symptoms per section, and for section 4 there are 
six questions. The section 5 social activity section is identical, and the Likert scale 
and scoring for each of these sections are the same. An example of one of the 
questions in section 4, which is the perceived social concessions and favours section 
would be, "on average my friends and family would be happy to avoid travelling on 
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public transport if I did not want to due to worry about having an IBS attack'. The 
alpha coefficient elicited for this scale is 0.84. 
The second difference is that it does not ask sufferers to record their own attitudes to 
their illness; instead they have to record the attitudes that they think other people 
have towards their illness. This will be referred to as perceived attitudes, because it 
related to the IBS sufferer's perceptions of the attitudes of others. Because the 
general population questionnaire specifically asks participants to respond to the 
questionnaire on the basis of the person with the illness being a friend or family 
member, the IBS version replicates this by asking participants to consider the 
attitudes of their friends and family towards their illness. 
The third and final way in which this version differs is that it does not include the 
perceived physical and social consequences subscales (section 3). These are excluded 
they would be an exact replica of the IPQ-R. As the participants already have to 
complete the IPQ-R the responses to this scale of the IPQ-R will be used in the 
analysis. 
Demographic Questionnaire There were two demographic questionnaires used in the 
study, one version was administered to the IBS participants (appendix 7), and an 
alternative version for the general population (appendix 15). 
PROCEDURE 
The procedure was slightly different for the general population and for the IBS 
participants. For the general population the research pack was administered either by 
hand or by post (77%), or via the internet (33%). For the IBS participants a research 
pack was sent to their home addresses. 
For the general population the research pack contained an information sheet along 
with a letter inviting them to take part in the research (appendix 16), consent forms 
(appendix 17), a demographic questionnaire (appendix 15), and the attitudes to 
chronic illness questionnaire (appendix 13). The postal participants were also given a 
free post envelope for the return of completed research packs. 
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For the IBS participants the research pack contained an information sheet along with 
a letter inviting them to take part in the research (appendix 18), consent forms and 
ethics approval (appendix 19), a demographic questionnaire (appendix 7), the IBS 
participants version of the attitudes to chronic illness questionnaire (appendix 14), a 
disease specific version of the IPQ-R (Moss-Morris et al., 2002, appendix 1), the 
IBS 36 (Groll et al., 2002, appendix 2), the 7-day symptom diary (appendix 3) and a 
free post envelope for the return of completed research packs. 
DATA TREATMENT 
Raw data was entered into SPSS (version 14). As there was a large amount of 
returned questionnaires the ones with a large quantity of missing data were excluded 
from the analysis. With the data that remained, as with the previous research there 
was very little missing data, and again as the variables were normally distributed 
mean substitution was used. As with the previous research the functions of 
transformation and compute was used to produce the variables that were used in the 
analysis. In addition, in accordance with normal statistical procedures where multiple 
t-tests were used a Bonferoni correction was employed, whereby statistics were only 
recorded as significant if the p value exceeded that required after applying the 
correction. 
RESULTS 
ATTITUDES OF THE GENERAL POPULATION TOWARDS 
DISCUSSING ILLNESS SYMPTOMS 
Descriptive statistics (figure 7) reveal that people do not hold negative views towards 
discussing any of the illness symptoms. The original scale ranged from of (1) 
extremely comfortable to (8) not prepared to discuss this symptom. In the responses 
given by the population no mean responses were above 5 (slightly uncomfortable), 
this shows that the majority of the responses were on the `comfortable' side of the 
scale. 
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Figure 7 -Attitudes of the general population towards discussing illness 
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As figure 7 demonstrates there are only three symptoms leaning towards slightly 
uncomfortable. These are a) discussing loss of bowel control whilst conscious, b) 
discussing fainting spells where bowel control was lost, and c) discussing fainting 
spells where bladder control was lost. The first of these is an IBS symptom, although 
it is less commonly experienced (and closely related to an urgent need to defecate as 
opposed to general incontinence). The other two are related to epilepsy. 
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ATTITUDES OF THE GENERAL POPULATION TOWARDS 
WITNESSING ILLNESS SYMPTOMS 
Descriptive statistics (figure 8) reveal that people do not hold negative views towards 
witnessing any of the illness symptoms. Although the mean scores were higher than 
for discussing the symptoms, the highest reported mean was still below 6 indicating 
that at most people felt (5) slightly to (6) moderately uncomfortable. 
Figure 8 -Attitudes of the general population towards witnessing illness 
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As figure 8 demonstrates the three least comfortable symptoms are in the same rank 
order as for discussing. 
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ATTITUDES OF THE GENERAL POPULATION TOWARDS 
DISCUSSING IBS, ASTHMA AND EPILEPSY 
Although it is interesting to report the responses to the individual symptoms, in order 
for meaningful comparisons to be drawn it is necessary to transform the individual 
symptoms into the three illness variables. The overall responses to the three illnesses 
revealed that people were least comfortable discussing epilepsy, followed by IBS and 
asthma (figure 9). It is however, important to note that the poorest recorded mean 
was `slightly comfortable'. Paired samples t-tests revealed no significant differences 
between discussing IBS and epilepsy, but that people were significantly more 
comfortable discussing asthma than either IBS or epilepsy: asthma and IBS t(239) _ 
15.03, p<0.0001, asthma and epilepsy t(239) = 17.20, p<0.0001. 
ATTITUDES OF THE GENERAL POPULATION TOWARDS 
WITNESSING IBS, ASTHMA AND EPILEPSY 
Overall responses to witnessing the three illnesses revealed the same order as 
discussing. Paired samples t-tests revealed significant differences between all three 
variables: asthma and IBS t(239) = 15.94, p<0.0001, asthma and epilepsy t(239) _ 
23.97, p<0.0001, IBS and epilepsy t(239) = 6.89, p<0.0001. 
COMPARISON OF THE GENERAL POPULATION ATTITUDES 
TOWARDS DISCUSSING AND WITNESSING IBS, ASTHMA 
AND EPILEPSY 
Overall differences for discussing and witnessing symptoms showed that for all three 
illnesses people felt more comfortable discussing the illnesses than they did 
witnessing them (figure 9). 
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Figure 9- Comparison of discussing and witnessing symptoms 
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ATTITUDES OF THE GENERAL POPULATION REGARDING 
THE PERCEIVED PHYSICAL CONSEQUENCES OF IBS, 
ASTHMA AND EPILEPSY 
For the perceived physical consequences of having the illnesses the same pattern was 
observed as for the discussing and witnessing variables, i. e. epilepsy being 
considered the most serious, with IBS and asthma following. It is important to note 
that for each of the illnesses the mean scores were between 3 and 4 indicating that 
the scores were between (3) `neither agree nor disagree' and (4) `agree'. This 
indicates that none of the illnesses were judged to have serious physical 
consequences. 
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Figure 10 - Means of physical consequences scale 
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As figure 10 demonstrates there was a main effect of group. Scheffe post hoc tests 
found significant differences between all groups, differences between IBS and 
asthma, p<0.005, between IBS and epilepsy, p<0.0001 and finally between 
epilepsy and asthma, p<0.0001. 
ATTITUDES OF THE GENERAL POPULATION REGARDING 
THE PERCEIVED SOCIAL CONSEQUENCES OF IBS, ASTHMA 
AND EPILEPSY 
For the perceived social consequences data the same pattern was observed. The mean 
scores were under 2, which is disagree, with asthma being closer to 1, which is 
strongly disagree. This indicates that people do not hold negative feelings to 
providing social support to sufferers of any of these illnesses. 
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Figure 11-Means of social support consequences scale 
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As figure 11 demonstrates there was a main effect of group. Scheffe post hoc tests 
found significant differences between all groups, differences between IBS and 
asthma, p<0.0001, between IBS and epilepsy, p<0.05 and finally between epilepsy 
and asthma, p<0.0001. 
SOCIAL SUPPORT CONCESSIONS SCALE 
For the social support concessions scale, the mean responses were approximately 5. 
As the scale was from 0 to 6, where 0 indicated never prepared to make the 
concession, and 6 indicating always prepared to make the concession a score of five 
is very pleasing. This indicates that the majority of the time people are prepared to 
make concessions when planning social activities to allow a friend with a chronic 
illness to be included. Once again significant differences were observed between 
groups with epilepsy eliciting the greatest amount of concessions. 
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Figure 12 - Means of social support concessions scale 
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Scheffe post hoc tests found significant differences between two of the three groups. 
There were no differences observed between IBS and asthma, but there were 
significant differences between IBS and epilepsy, p<0.001 and between epilepsy 
and asthma, p<0.005. 
SOCIAL ACTIVITY SCALE 
Supplementing the social concession scale, the social activity scale (also scored from 
0 never -6 always) shows that for a large range of different activities people are on 
average prepared to avoid activities to allow their friends to be involved (figure 13). 
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Figure 13 - Means of social activity scale 
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Within subjects ANOVA revealed significant differences between activities F(13, 
3303) = 18.64, p<0.0001. Tukeys' HSD revealed that these significant differences 
lie between a vast number of different activities, as was expected from the p value. 
The most meaningful differences from the perspective of IBS sufferers are that the 
two activities people are least happy to avoid are going abroad and going out to 
dinner. However, despite these being the two activities people are least happy to 
avoid the mean figures indicate that for all activities at least half of the time people 
are prepared to come up with alternative activities. 
KNOWLEDGE OF IBS FROM THE GENERAL POPULATION 
The attitude scale was specifically designed to elicit responses to symptoms, and 
therefore did not require the participants to have knowledge of the three illnesses. 
However, the final part of the questionnaire comprised a qualitative section asking 
participants to describe what they considered to be each of the three illnesses. These 
responses were coded to produce a frequency table (table 22) to show the amount of 
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knowledge participants had. For the purposes of this thesis it is only the knowledge 
of IBS that is relevant (as the other illnesses were included for comparison) and 
therefore only the data relating to IBS will be described here. Of the 239 participants 
in this study data is available for 228 participants. The categories which are correct 
are indicated by the use of bold type font. 
Table 19 - Knowledge of IBS symptoms 
Category Frequency of reported category % 
Food Sensitivity 26 
Diarrhoea 41 
Pain 37 
Bowel movement problems 43 
Constipation 30 
Digestion problems 9 
Flatulence 11 
Abdominal discomfort 10 
Frequency of defecation 3 
Urgent need to defecate 15 
Bloating 14 
Loss of bowel control 13 
Episodic 6 
Vomiting 3 
Affects quality of life 5 
Different degrees of severity 4 
Triggered by stress 16 
As table 19 demonstrates the vast majority of the categories were correct, but that in 
no case was the reporting of a particular category above half of the sample. 
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COMPARISON OF IBS SUFFERERS PERCEIVED ATTITUDES 
WITH THE GENERAL POPULATIONS REPORTED 
ATTITUDES 
Table 20 - Significant differences between groups on attitude variables 
VARIABLE IBS MEAN POP. MEAN SIGNIFICANCE 
Discussing 3.61 3.16 t(298) = 2.881, p< 
symptoms 0.005 
Witnessing 4.26 3.76 t(298) = 2.637, p< 
symptoms 0.005 
Social support 4.21 4.94 t(78) = 5.178, p< 
concessions 0.001 
Social activity 3.61 4.06 t(78) = 3.052, p< 
concessions 0.005 
As demonstrated in table 20 independent t-tests reveal that all four variables IBS 
sufferers perceive attitudes of the general population to be worse than the general 
population report them to be. Specifically the table demonstrates that higher means 
were observed for the IBS participants for discussing and witnessing symptoms 
(higher scores indicate more negative views), and lower means were observed for the 
social support and social activity concession scales (lower scores indicate more 
negative views). In addition to the data reported in the table a paired samples t-test 
was also conducted to compare the means of IBS participant's perceptions between 
discussing and witnessing symptoms. It was found that the mean score for witnessing 
symptoms is significantly higher t(60) = 6.048, p<0.0001. One final point regarding 
the data here is that for the social support concessions and the social activity scales 
the Levene's test for equality of variance revealed the groups were non- 
homogeneous, therefore the statistic reported is for `equal variance not assumed', 
which is why the degrees of freedom are 78. 
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THE RELATIONSHIP BETWEEN IBS SUFFERERS 
PERCEPTIONS OF THE GENERAL POPULATIONS 
ATTITUDES AND ILLNESS REPRESENTATIONS, HRQOL 
AND SYMPTOM FREQUENCY 
A series of linear regressions were conducted to explore the relationships between 
IBS sufferers' perceived attitudes towards the four independent variables of 
discussing symptoms, witnessing symptoms, social support concessions and social 
activities, with the dependent variables of illness representations, HRQOL, total 
symptom frequency, and individual symptom frequency. The only significant 
relationship was between witnessing IBS symptoms and HRQOL R2 adj. 0.056, ß 
0.27, p<0.05. This shows that negative attitudes were predictive of a worse 
perceived HRQOL. It should however be noted that there were in excess of 60 linear 
regressions conducted, and chance would suggest that at least three of the 
relationships should emerge as significant. 
ILLNESS PERCEPTIONS AND HRQOL 
The analysis conducted in study 1 investigating the relationship between illness 
representations and illness outcomes is repeated here, as this is a different cohort. 
Only emotional representations were found to be predictive of HRQOL, R2 adj. 
0.370, ß 0.543, p<0.005. Whereby the more emotional representations about the 
illness the suffer holds the worse perceived quality of life is. Emotional 
representations were also found to be predictive of HRQOL in study 1, R2 adj. 0.52, 
ß0.41, p<0.05. 
ILLNESS PERCEPTIONS AND SYMPTOMS 
None of the illness representation components were predictive of total symptoms; 
this was the same as the finding observed for study 1. In contrast to study 1, 
however, some significant findings were observed for the individual symptoms. Both 
chronic timeline (R2 adj. 0.128, ß -0.378, p<0.05) and illness identity (R2 adj. 0.128, 
ß 0.490, p<0.01) were predictive of diarrhoea. The results indicate that a view that 
the IBS was likely to be chronic (rather than acute) was predictive of a decreased 
frequency of diarrhoea, and that a greater illness identity (i. e. more symptoms 
associated with IBS) was predictive of increased diarrhoea. Finally illness identity 
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was also predictive of an increased frequency of the urgent need to defecate (R2 adj. 
0.017,0 0.414, p<0.05). 
A final analysis was conducted between HRQOL and symptom frequency (both total 
and individual). In this cohort of IBS sufferers' HRQOL was neither predictive, nor 
correlated with frequency of IBS symptoms. This is in contrast to study 1 where 
HRQOL was found to predict symptom frequency. 
DISCUSSION 
RESEARCH AIM 1- TO INVESTIGATE THE ATTITUDES 
THAT THE GENERAL POPULATION HOLD TOWARDS 
SUFFERERS OF IBS (IN COMPARISON WITH OTHER 
ILLNESSES) 
The results for the first aim are highly significant and very clear. Essentially the 
results show that: 
1) People do not hold negative attitudes towards any of the variables associated 
with IBS or the other two illnesses (discussing, witnessing, physical 
consequences, social consequences, social support and social activities) 
2) Of the three illnesses for all variables epilepsy was perceived as worse than 
IBS, followed by asthma (discussing, witnessing, physical consequences, 
social consequences, social support and social activities) 
3) Attitudes to witnessing IBS, epilepsy and asthma were significantly worse 
than for discussing 
4) Knowledge of IBS was largely accurate. 
Overall these results suggest that attitudes towards IBS are not associated with the 
stigma that has been suggested by Dancey et al. (2002), and are more consistent with 
the results of Looper & Kirmayer (2004). This research may therefore provide some 
validation to Looper & Kirmayer's (2004) suggestion that IBS symptoms are not 
perceived badly due to the general population having personal experience of them. 
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The finding that epilepsy was perceived as worse than the other illnesses is consistent 
with the views of LaMartina (1989), who attests that epilepsy is more stigmatised 
because it is less well understood. However, despite epilepsy being significantly 
more negatively perceived relative to the other illnesses, it was still perceived on the 
positive end of the scale for each of the dimensions. Therefore the findings are also 
consistent with the more recent research of MacLeod & Austin (2003) and Young et 
al. (2002) who report that negative attitudes are not generally the norm. The observed 
finding that people perceive epilepsy to be associated with more serious physical 
consequences than IBS or asthma is also consistent with research suggesting that 
negative attitudes towards epileptics in the working environment are due to concerns 
over the perceived severity of epilepsy (Young et al., 2002). 
The interpretation of the finding that witnessing illness symptoms is significantly 
worse than discussing symptoms is difficult to interpret. In the original design of the 
study it was assumed that if witnessing scored more highly than discussing 
symptoms then this meant that IBS sufferers' concerns over the embarrassing nature 
of their symptoms had validity, however, this may not be necessarily the case. Part of 
the reason for the difficulty in interpreting this finding is that the scale asked people 
to rate on a scale on `comfort' rather than `embarrassment'. A number of people gave 
feedback on the questionnaire and reported that their scores on the witnessing scale 
were related to not knowing how to help the person, rather than a problem with 
witnessing the symptom per se. This is a logical explanation; it is consistent with the 
scoring of epilepsy being consistently higher across all variables, and with the 
conclusions drawn by Harden et al. (2004). Further research is needed to clarify this 
issue. 
Knowledge of IBS is largely accurate, although this is only a descriptive statistic the 
results still show that there were only three reported misconceptions, and with the 
exception of food sensitivity (which is contentious amongst researchers) the 
percentages were very low: food sensitivity 26%, loss of bowel control 13%, and 
vomiting 3%. It should be noted that whilst vomiting is not generally considered a 
symptom of IBS and loss of bowel control is very rare (and related to urgency), these 
are not particularly strong misconceptions. In addition considering the section on 
knowledge was open, asking participants to write a brief paragraph to show their 
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understanding the lack of misconceptions is more revealing than the percentages in 
each category. These findings are pleasing and again provide support for the results 
of Looper & Kirmayer (2004) that knowledge of IBS in the general population is 
fairly high. One slight concern however is that knowledge of IBS may have been 
biased by the earlier questions and therefore future research that asks people to show 
their understanding prior to filling in the questionnaire is advisable. 
RESEARCH AIM 2- TO COMPARE THE GENERAL 
POPULATIONS' ATTITUDES TOWARDS IBS SUFFERERS, 
WITH IBS SUFFERERS' PERCEPTIONS OF THE GENERAL 
POPULATIONS' ATTITUDES TOWARDS THEM 
The research findings for this aim show a clear distinction between the two groups 
on all variables, these are as follows: 
1) IBS sufferers perceive the attitudes of the general population towards 
discussing IBS symptoms to be worse that the attitudes reported by the 
general population. 
2) IBS sufferers perceive the attitudes of the general population towards 
witnessing IBS symptoms to be worse that the attitudes reported by the 
general population. 
3) IBS sufferers perceive the attitudes of the general population towards 
providing social support concessions to be worse that the attitudes reported 
by the general population. 
4) IBS sufferers perceive the attitudes of the general population towards 
providing social activity concessions to be worse that the attitudes reported 
by the general population. 
The findings for this aim clearly show a discrepancy in the reported attitudes of the 
general population and the perceptions of the IBS sufferers. Although there have not 
been any studies conducted so far that compare perceptions of the general population 
with sufferers of IBS these findings are in line with the combination of research 
papers detailed in the introduction. That is, it is consistent with the studies that report 
perceived stigma amongst sufferers, such as the studies by Dancey et al. (2002) and 
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Coulson (2005), but it is also in line with the studies that report no actual stigma 
from the general population, such as the Munir et al. (2005) study and the Looper & 
Kirmayer (2004) study. It is clear however, that more research is needed to explain 
why these differences exist, as a number of hypotheses are equally viable. It could be 
the case that IBS sufferers perceive levels of social support to be lower than they 
actually are, or it may be the case that respondents from the general population 
overestimated their level of positive attitudes. An overestimation could emerge 
through either a social desirability bias, or a simple miscalculation of an idealised 
view of reactions, rather than how they would actually respond in a given situation. 
Therefore future research investigating social interactions may be useful to clarify 
the reasons for these consistent distinctions between groups. However, as the issue of 
primary concern is not specifically the differences between perceptions but whether 
the perceptions of IBS sufferers impact on their illness outcomes, it is the next 
section of results that are of most interest. 
RESEARCH AIM 3- TO ASSESS THE POTENTIAL IMPACT OF 
IBS SUFFERERS' PERCEPTIONS OF THE GENERAL 
POPULATIONS' ATTITUDES, ON THEIR ILLNESS 
REPRESENTATIONS AND ILLNESS OUTCOMES 
Unfortunately the majority of results of this aim are not significant and due to the 
lack of previous research are therefore less easy to interpret; the results are therefore 
divided into non-significant and significant. 
SIGNIFICANT FINDINGS 
There was only one significant finding that is perceived attitudes to witnessing IBS 
symptoms predicted HRQOL of sufferers, i. e. the worse the attitudes were perceived 
the worse the quality of life was reported to be. 
NON SIGNIFICANT FINDINGS 
1) Perceived attitudes towards discussing IBS symptoms were not predictive of 
illness representations. 
2) Perceived attitudes towards discussing IBS symptoms were not predictive of 
HRQOL. 
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3) Perceived attitudes towards discussing IBS symptoms were not predictive of 
symptom frequency. 
4) Perceived attitudes towards witnessing IBS symptoms were not predictive of 
illness representations. 
5) Perceived attitudes towards witnessing IBS symptoms were not predictive of 
symptom frequency. 
6) Perceived attitudes towards the social support concessions scale were not 
predictive of illness representations. 
7) Perceived attitudes towards the social support concessions scale were not 
predictive of symptom frequency 
8) Perceived attitudes towards the social activity scale were not predictive of 
illness representations. 
The finding that none of the variables are predictive of the illness representation 
dimensions is difficult to interpret. It is not possible to say whether the findings are 
true or due to methodological artefacts as there has been no previous research for 
comparison. They do however, contradict the closest research, that by Dancey et al. 
(2002) on contributors to illness intrusiveness. More research is clearly needed 
before any conclusions can be drawn. 
The lack of a relationship between attitudes and HRQOL is rather more worrying, as 
this is a relationship that has been established across illness types (e. g. Gaynes & 
Drossman., 1999; Hogan et al., 2002) and suggests that maybe the measure is not 
sensitive enough to elicit the true findings. This suggestion is made more likely by 
the fact that the only significant finding that emerged for this research aim is that 
perceived attitudes to witnessing IBS symptoms predicted HRQOL of sufferers. 
Although it is possible that this finding is a function of running a number of 
regressions, it is consistent with the primary outcome of the Dancey et al. (2002) 
study. In addition the lack of significant findings regarding symptoms is also 
consistent with the Dancey et al. (2002) study, but it is unclear whether this means 
that the observed finding of no relationship is a true finding or a reflection of 
methodological artefacts with both studies. 
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Overall the results for this aim are disappointing and no real conclusions can be 
drawn without further research. 
RESEARCH AIM 4- TO EXPLORE THE ROLE OF ILLNESS 
REPRESENTATIONS AND ILLNESS OUTCOMES 
INDEPENDENTLY OF PERCEIVED ATTITUDES TO IBS 
Using the same rationale as for study 1 the role of illness representations and illness 
outcomes was assessed independently. There were three significant findings which 
were as follows: 
1) Emotional representations were predictive of HRQOL 
2) Chronic time line was predictive of decreased symptom frequency 
3) Illness identity was predictive of diarrhoea 
Although it is disappointing that the results with this cohort did not exactly replicate 
those of study 1, as HRQOL is not predictive of symptom frequency, they do provide 
partial support for the previous findings. The role of emotional representations was 
predictive of HRQOL in both studies and therefore it seems likely that this represents 
a true finding. This is strengthened further by the same results in the Frostholm et al. 
(2005) study. A further point to note is that that in study 1 illness identity was found 
to be predictive of HRQOL, however as this relationship was in the opposite 
direction to that expected the finding was hypothesized to be spurious. The lack of a 
replication of this relationship here supports the notion that the relationship observed 
in study 1 was not a true finding. This is further strengthened by the finding that in 
this study high illness identity was predictive of diarrhoea, which is in line with the 
expectations of the CSM. 
The finding that belief in a chronic time line of IBS is predictive of a reduced 
frequency of diarrhoea is difficult to interpret, as this has not be reported in previous 
research and is intuitively in the wrong direction, it is therefore possible that this 
finding is spurious. Further research is clearly needed to clarify this issue. 
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One final non significant finding that is worthy of note is that HRQOL was not found 
to be predictive or even correlated with symptom outcome. This is in contradiction to 
study 1 and also with the research by Brennan et al. (2004). It is therefore unclear 
why this finding was not replicated here. 
Overall this research reports many significant findings. This study therefore makes a 
valuable contribution both to the aims of this thesis as a whole, and to research into 
attitudes to IBS. The main findings are that people do not report negative attitudes 
towards IBS, that perceptions of attitudes differ between IBS sufferers and the 
general population, that the illness representations appear to be important predictors 
of illness outcomes, in IBS, but that overall perceived attitudes do not appear to 
contribute to illness interpretation as suggested. It is of course possible that features 
of this study are responsible for this observed lack of significance, and that the theory 
itself is accurate. Although this is speculative study limitations which may have 
resulted in the observed findings will now be detailed. 
STUDY LIMITATIONS AND SUGGESTED MODIFICATIONS 
PARTICIPANTS 
As there were two groups of participants the general population group will be 
discussed first. This was a large and diverse group, and therefore despite the response 
rate of 48% the generalisability of these results can be accepted with a high degree of 
certainty, certainly within the UK. As far as the IBS group is concerned low 
participant numbers may be partially responsible for the lack of reported 
significance. This is a concern that could be easily addressed by conducting further 
research using the same design, but recruiting more people. In addition further 
research using large sample sizes is desirable to assess if there are any gender or IBS 
sub-group effects, neither of which were practical to investigate here due to the 
sample size and the largely female bias. However, despite the sample size this may 
be taken as a representative sample as participants were recruited from a number of 
different sources, and appear similar to that reported in previous research (e. g. 
Dancey et al., 1995; Lackner et al., 2004). Therefore it is likely that the comparative 
data of the attitudes are accurate and generalisable to other IBS sufferers. It should be 
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noted, as was mentioned earlier, that this assumes that people report their true 
feelings. Overall whilst IBS participant numbers may have resulted in less significant 
findings, there are no major problems with either participant group and in this respect 
participants should not be considered a major limitation. 
MEASURES 
As this study was concerned with participants' perceptions the use of questionnaires 
was highly suitable. The use of established measures (such as the IPQ-R) and IBS 
specific measures (such as the IBS-36) increases the suitability of these 
methodological choices. However, the two versions of the Attitudes to Chronic 
illness questionnaires were not established measures, and therefore may have 
contributed to the lack of significant findings relating to illness perceptions. 
However, this may be a slightly pessimistic view as the questionnaires were based on 
the scales of the IPQ-R, and the IBS-36 as well as literature searching about the main 
components of the illnesses. In addition, with the exception of the asthma version of 
the perceived physical consequences scale the alpha coefficients elicited for each of 
the scales on both versions of the questionnaire suggest it to be a legitimate tool. It 
would however, be useful to conduct further research with additional measures of 
attitude perceptions, such as that currently being designed at the University of East 
London, and The Chicago Illinois division of gastroenterology. It is therefore likely 
that future research will clarify these relationships. 
One final methodological consideration concerns the use of diaries to report 
symptoms, this is particularly of note as HRQOL and symptom frequency were not 
correlated in this cohort. Concerns over the reliability of a one week diary were 
raised in study 1, but the findings here strongly suggest the need to include a 
questionnaire based measure of symptoms for comparison in future research. 
DESIGN 
Although the design was highly suitable for this study, it is clear that to fully 
establish the impact of perceived attitudes on illness outcomes in IBS longitudinal 
and intervention based research is needed. 
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FURTHER RESEARCH 
This is an area where research is still in its infancy and therefore there are many 
future research directions. Suggestions include: 
1) The recording of physiological measure to assess whether reported levels of 
comfort discussing symptoms are accurate. 
2) The use of the implicit association test (IAT, Greenwald et al., 1998) as an 
additional means of increasing a finding relating to true attitudes, rather than 
reported (explicit) attitudes. 
3) To use quota sampling to investigate perceptions of different groups of 
society. 
4) Cross cultural research is also important as the literature on epilepsy strongly 
suggests these findings are unlikely to be generalisable across different 
cultural groups. 
CONCLUSIONS 
The perceptions held by IBS sufferers that people hold negative views towards them 
are inaccurate. This is an important finding in the context of both intervention 
research and general counselling as it strongly suggests that challenging patients' 
perceptions concerning social support are both legitimate and potentially beneficial 
in improving representations of IBS and related illness outcomes. Taken together 
with study 1 (chapter 4) these two exploratory chapters provide strong justification 
for the utility of the CSM in IBS. In addition to supporting the use of the CSM as a 
theoretical model these exploratory chapters provide insight into components which 
should or should not be emphasised in an intervention. Essentially they have shown 
that in addition to challenging every part of a person's illness representations there 
should be explicit advice to seek out social support. 
Based on the results of these two empirical chapters and copious literature reviewing 
an intervention was designed based around the CSM. The intervention took the form 
of an evidence based self-help book. The description and results of this study are 
described in the next chapter (chapter 6) 
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CHAPTER 6 
STUDY 3 
A SELF-HELP BOOKLET INTERVENTION STUDY FOR 
IRRITABLE BOWEL SYNDROME (IBS) BASED ON THE 
COMMON SENSE MODEL (CSM) 
Aim 
Chapter 6 reports the results of study 3, the final study in this thesis. 
The overall aim for this study was to design an informed evidence based intervention 
for IBS sufferers, based on the principles of the CSM (Leventhal et al., 1980; 1984). 
As expected of intervention research the aim of this study was to improve sufferers' 
illness outcomes, post the intervention. Illness outcomes comprised a number of 
different areas, the primary ones were illness perceptions, health related quality of 
life (HRQOL) and symptom frequency. The design of this study (as was suggested at 
the end of the previous chapter) is heavily influenced by the preceding chapters in 
this thesis. The contribution of each of the previous chapters to this study is briefly 
described in the following section. 
INTRODUCTION 
It was not felt necessary to provide the standard literature based introduction to this 
study, as the introduction to this intervention is the culmination of the previous 
chapters, all of which are aimed at justifying both the need and the design specifics 
of the study presented here. Therefore the background to this study will be in the 
form of a summary of the preceding chapters. 
Chapter 1- This chapter is important as it provides an overview to IBS and by doing 
so demonstrates the suitability of psychologically based perspectives to studying this 
illness. Chapter 1 also demonstrates the gaps in current knowledge relating to IBS 
and therefore justifies the continued need for research in this area. By the end of 
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chapter 1 it can be seen that there is a clear need for research into this area and that 
the approach taken by this thesis is highly suitable. 
Chapter 1 clearly shows that there is a need for effective illness management 
techniques for sufferers of IBS. Firstly it shows that the current management options 
(both medical and alternatives) are lacking in efficacy. In fact in Talley's (2001) 
consideration of the main medical options available to sufferers of IBS (medical, 
complementary and life style based) he concludes that none of the current 
management options are effective at curing, or even controlling the multiple and 
fluctuating symptoms that characterise IBS. There is therefore clearly a need to 
devise alternative methods of treatment for sufferers of IBS. The need to provide 
effective treatments is strengthened by the percentage of people who suffer from 
IBS, with prevalence rates as high as 20% reported (e. g. Dancey et al., 1999). 
However, it is not just the prevalence of IBS that makes it important to find a way of 
treating, or at last controlling its symptoms, it is the degree to which sufferers' lives 
are affected. In fact, as chapter 1 details research of this type in IBS specifically is 
essential because of the burden IBS places not just on sufferers, but on `health care 
systems' and `society as a whole' (Gilkin, 2005). In addition to identifying a clear 
need for effective intervention research to be conducted chapter 1 also provides the 
general background regarding the form this intervention should take. There is a clear 
need for future treatment research to adopt a holistic approach, whereby the IBS 
sufferer is considered, not just the symptoms. This will therefore enable a treatment 
that can encompass the idiosyncratic elements to IBS. Therefore an integrated model 
to the treatment of IBS is clearly the way forward in the design of effective 
management techniques. Chapter 1 justifies the use of a biopsychosocial model, and 
the brain-gut axis (Drossman et al., 1999). Further support for this model is provided 
by Camilleri (2001) who states that "the brain-gut axis is the key to the development 
of effective therapies in IBS". 
Chapter 2 is one of the most influential chapters in terms of providing a background 
to the design of this study. This is because it is a systematic literature review 
specifically addressing the efficacy of psychologically based interventions in IBS. 
The review strongly suggests that conducting psychologically based research into 
IBS is both viable and justifiable, with the majority of studies showing significant 
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improvements of psychologically based interventions. In addition no study reported 
illness outcomes to worsen as a result of the intervention, admittedly there is a 
possibility that this could be due to a publication bias. An important outcome of the 
review was the finding that not only were psychologically based interventions 
successful, in many cases they were significantly more efficacious than medical care, 
for both psychological and symptom based illness outcomes (e. g. Guthrie et al., 
1991; Kennedy et al., 2005). Although psychologically based interventions in general 
are justified by the review, there is no one model that emerges as dominant. This is 
important as it strongly suggests that further research into alternative models is 
necessary. In addition to justifying the design of psychologically based interventions 
for IBS in general, the review also provides useful information regarding the 
specifications the intervention should take, these will be briefly detailed. 
The first design feature is the clear need for the treatments, and intervention studies 
to be based on established psychological models, as those studies where the 
psychological component was limited (e. g. Colwell et al., 1998: illness education) 
were the ones least likely to find conclusive results. In contrast the studies based on 
established models, such as cognitive behavioural theory (e. g. Lynch & Zamble, 
1989; Schwarz et at., 1990) were most likely to show significant and conclusive 
results, and are therefore clearly superior to any of the other, less well defined 
theories. In addition to the general need to include a psychological model, the 
superiority of cognitive behavioural (CBT) based approaches strongly suggests that 
any intervention that shares similar principles, in particular the need to challenge 
maladaptive thoughts, feelings and behaviours, is likely to meet with success. One of 
the most informative features of the systematic review as, Mulrow (1994) suggests is 
that it allows for a clear assessment of the intervention components which are most 
likely to improve IBS, and allow for the improvement to be measured effectively. 
These are as follows: 
1) There needs to be a measure included to assess whether the components of the 
model used have altered, e. g. in the context of a relaxation intervention a measure to 
assess self-reported relaxation could be included. 
2) The intervention should encourage participation by being as short as possible, 
without affecting the ability to effect change. 
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3) Unless essential any alterations to standard medical care should be avoided. 
4) Waitlist control groups, are not appropriate and can result in elevated symptoms 
prior to the intervention. 
5) Measures used need to be sensitive enough to detect subtle changes. 
6) It is not sufficient to include a psychological model as a general background, its 
principles must be rigorously adhered to in the design of the intervention. 
7) The intervention must be practical for the participants to continue the behaviours 
after the intervention period, and therefore increase the likelihood of maintenance of 
changes, or ideally continued improvement. It therefore needs to teach self 
management behaviours (e. g. Keefer & Blanchard, 2002). 
As the systematic review of chapter 2 provided a strong argument for the necessity of 
an established model in IBS, and moreover one that was not included in the review, 
chapter 4 assessed the viability of the common sense model (CSM) of Leventhal et 
al. (1980; 1984). Although it is not necessary to repeat the detail of this model here it 
should be noted that this model is highly suitable for the specific characteristics of 
IBS, in particular its heterogeneous nature. As chapter 3 reveals the CSM is superior 
to other similar models, such as health belief models (HBM) and the transtheoretical 
model (TTM, Prochaska et al., 1992). Justification for the viability of the CSM in 
IBS research comes from its application to illnesses with similar unknown 
aetiological features, such as chronic fatigue syndrome (Edwards et al., 2001), and 
from research investigating the relationship between illness representations and 
coping in IBS specifically (Rutter & Rutter, 2002). The key features of the CSM 
which are therefore necessary to take into consideration when designing treatments 
based on its principles are: 
1) That illness beliefs are structured and management behaviours are dependent on 
the beliefs held. 
2) That emotional factors can influence both illness beliefs and illness features. 
3) That self-regulation (management) is an important feature of suffering from an 
illness, and therefore the sufferer will aim to re-establish a health state. 
4) There are three interlinking components to the CSM, these are illness 
interpretation, coping and appraisal. Although their interconnected nature means that 
an intervention targeted to one component will necessarily impact on the other two, 
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in order for maximum efficacy an intervention should aim to incorporate all three 
components. 
Although chapter 3 clearly detailed the components of the model necessary for the 
design of an intervention there were two aspects of the illness interpretation stage 
where it was felt that current literature was not sufficient for firm conclusions to be 
drawn. These two aspects were the role of perceived doctor-patient communication 
and the role of perceived social support. Therefore studies I (chapter 4) and two 
(chapter 5) were designed to gain an understanding of these two factors and the 
results of these studies were taken into consideration in the design of this 
intervention. 
The overall conclusion drawn from study 1 is that perception of doctor-patient 
communication differed between patients and doctors, although it was not possible to 
establish which groups (or potentially both) perceptions are inaccurate. In addition 
the conclusion that perceived communication does not appear to affect IBS sufferers' 
illness outcomes suggests that it is not necessary to include a section of the 
intervention specifically targeted at improving patients' communication with doctors. 
In contrast the conclusion drawn from study 2 strongly suggests that sufferers' 
perceptions that other people hold negative attitudes towards them and their 
condition are inaccurate. Therefore an intervention should include a section which 
informs participants that poor social support is not a necessary consequence of IBS 
and therefore encouraging them to alter this perception and actively seek social 
support. 
Overall based on the results of the literature reviews and the exploratory studies it 
was decided to design an intervention based on the principles of the CSM. To ensure 
that the intervention was inline with the suggestions raised by the systematic review 
a self-help booklet based intervention was designed. A self-help booklet was felt to 
be an improvement on previous study designs since its flexibility allowed sufferers to 
complete the intervention in their own homes. Allowing for completion of the study 
in the sufferers' homes was an important design feature as it would not restrict the 
study to only those sufferers' whose symptoms were mild enough to travel, a 
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consideration which is often overlooked in intervention research. Secondly it was 
hoped that by the initial intervention taking place within the participants' home it 
would be easier for them to continue with the practices suggested after the 
intervention was over. Although an IBS self-help booklet was recently designed by 
Kennedy et al. (2003) it is in no way sensitive to either the intelligence, or 
differences in illness knowledge of sufferers, the idiosyncratic nature of the illness, 
treatment options or to the concept of empowering sufferers. The principles behind 
the booklet are that it is: 
1) Evidence based 
2) Allows the sufferer to appraise their current behaviour and to think of changes 
3) Has the aim of empowering patients to take responsibility for their own health 
4) Encouraging them to adopt productive coping strategies 
The ultimate goal of this research is to improve patient's illness representations and 
related illness outcomes (symptom frequency and HRQOL). Although use of a self- 
help booklet is not in itself unique the specific design of this study, in particular the 
use of the CSM and the detailed consideration of the limitations of previous research, 
means that this study is both unique and highly evidence based. 
Aims 
The aim of this research was therefore to design an effective, theory based, self-help 
booklet style, intervention for sufferers of irritable bowel syndrome (IBS). The 
primary research question is therefore to assess the efficacy of this intervention. The 
efficacy of the intervention will be assessed on a number of dimensions, these are 
illness representation, symptom frequency and HRQOL. 
Based on the previous literature in this thesis there was felt to be sufficient evidence 
to make three one tailed hypotheses: 
HI: There will be a significant reduction in total symptom frequency from pre 
intervention to immediately post the intervention 
H2: There will be a significant reduction in total symptom frequency from pre 
intervention to two moths post the intervention. 
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113: There will be a significant improvement in health related quality of life 
(HRQOL) from pre intervention to two months post the intervention (NB, it is not 
suitable to assess changes in HRQOL immediately post the intervention). 
In addition to the hypotheses there were a number of research questions that were 
also addressed. These were: 
1) To investigate whether there are reductions in any of the individual symptoms. 
2) To explore the relationship between HRQOL and symptom frequency. 
3) To investigate whether any there are any changes in medication post intervention. 
4) To assess whether any changes have occurred in the different scales of perceived 
social support immediately following the intervention and at two month follow up. 
5) To investigate if there are any changes in the illness representation components 
post intervention. 
6) To assess if any observed improvements post intervention are a result of the 
changes in the illness representation components. 
METHOD 
PARTICIPANTS 
There was only one group of participants used in this study, this was IBS sufferers. 
However as this was a longitudinal design consisting of 4 phases, there were 
participant dropouts over the course of the study. Therefore the participant 
characteristics at each phase will be detailed. 
PHASE 1- PRE INTERVENTION PHASE 
The participants in this research were the same cohort who participated in the 
attitudes to chronic illness research (study 2, Chapter 5). It should be noted that 
participation in the attitudes to chronic illness research was prior to the 
commencement of this study, and therefore the results of study 2 were not affected 
by the intervention. As the cohort is the same as was used in the previous study it 
will only be briefly described here. There were a total of 130 pre intervention 
research packs distributed to participants (phase 1). A total of 62 completed packs 
were returned (response rate 48%). Of the participants there were 53 females, and 6 
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males (3 unspecified). Participants' ages ranged from 19-71 years, with a mean age 
of 43 (SD 14). 51 % of the sample were members of the IBS Network. The average 
time since diagnosis of IBS was 10.5 years (SD 9.6), with a range from less than a 
year to 33 years. The average time from first experiencing symptoms to being 
diagnosed was 5.5 years (SD 8.3), with a range from less than a year to 33 years. 
Within the main IBS group the numbers of participants in the three IBS subgroups 
were as follows, IBS-D (n=26), IBS-C (n=15), IBS-A (n=18) (NB three participants 
did not specify their subgroup). With the exception of two Americans all participants 
were resident in the UK. Just over half of the sample was highly educated with 53% 
achieving `A' levels or higher, only 10% of the sample reported having no academic 
qualification. Exactly 50% of the sample reported having another illness. The most 
often reported illnesses were arthritis (8%) and asthma (5%), the only specified 
psychological illness was depression at 15 % of the sample. As stated previously all 
of these participant characteristics are very similar study 1 and to previous research 
(e. g. Dancey et al., 1995; Lackner et al., 2004). 
Because the response rate was fairly low at 48%, the 68 participants who did not 
return completed research packs were sent a short questionnaire (appendix 20) asking 
them to indicate their reasons why they did not return their pack. In addition they 
were asked to fill in the demographic questionnaire so that the characteristics of 
those who participated and those who did not could be compared so as to gain an 
indication of how generalisable the cohort was. A total of 28 (41%) people returned 
their questionnaires. The reasons for not participating in the intervention study, along 
with the number of people who reported the same reason are shown in table 21 
Table 21 - Reasons why people did not return completed research packs 
REASON NUMBER 
It was discovered that the diagnosis of IBS was inaccurate 5 
I am too unwell to have the time to participate 2 
Did not like the fact that it was a psychological study, do not think 
the mind plays a role in IBS 
2 
No reason specified just did not wish to take part 3 
Do not have time to participate 14 
Sudden improvement in IBS symptoms I 
Objected to the quantitative nature of the study, stated "I would have 
been more interested in just writing down my experiences rather than 
ticking boxes which makes me feel like a statistic" 
1 
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As expected the most commonly reported reason for not returning the research packs 
was not having time to participate (50%). The second most commonly reported 
reason was inaccuracy of diagnosis (18%). Demographic data was available for 15 
people, due to eight people not completing the questionnaires, and the data from the 
five people who did not actually suffer from IBS being excluded. Of the 15 people 
who completed the demographic questionnaires there were 12 females, and 3 males. 
Participants' ages ranged from 17-60 years, with a mean age of 42 (SD 14). 33 % 
members of the IBS Network. The average time since diagnosis of IBS was 7.6 years 
(SD 5), with a range from less than a year to 18 years. The average time from first 
experiencing symptoms to being diagnosed was 7.6 years (SD 5), with a range from 
less than a year to 20 years. Within the main IBS group the numbers of participants 
in the three IBS subgroups were as follows, IBS-D (n=2), IBS-C (n=6), IBS-A (n=7). 
All participants were resident in the UK. One third of the sample were highly 
educated with 33% achieving `A' levels or higher, and no one 0% reported having no 
academic qualification. 47% of the sample reported having another illness. The most 
often reported illnesses was asthma (14%), the only specified psychological illness 
was depression at 7% of the sample. These characteristics are similar to those who 
did not return their research packs; the only difference is that there were 
proportionally less IBS-D sufferers. It is therefore the case that sample biases 
towards IBS-D reported in previous research may reflect a bias towards IBS-D 
sufferers being more likely to participate in research, rather than a bias in actual 
symptom clustering amongst IBS sufferers. 
PHASE 2- INTERVENTION PHASE 
At the end of the pre intervention stage (the day after filling in the last day of the 
diary / the day after filling in the questionnaires if no diary was completed) the 
intervention booklet was completed. 
PHASE 3- POST INTERVENTION PHASE 
15 participants did not return the post intervention packs, and therefore only 47 
participants took part in this stage of the study. Of the participants there were 39 
females, and 5 males (3 unspecified). Participants' ages ranged from 19-68 years, 
with a mean age of 45 (SD 14). 57% of the sample were members of the IBS 
Network. The average time since diagnosis of IBS was 11.4 years (SD 10.3), with a 
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range from less than a year to 41 years. The average time from first experiencing 
symptoms to being diagnosed was 6.4 years (SD 9.2), with a range from less than a 
year to 33 years. Within the main IBS group the numbers of participants in the three 
IBS subgroups were as follows, IBS-D (n=21), IBS-C (n=11), IBS-A (n=12) (NB 
three participants did not specify their subgroup). All participants were resident in 
the UK. Just over half of the sample were highly educated with 52% achieving `A' 
levels or higher, only 11 % of the sample reported having no academic qualification. 
52% of the sample reported having another illness. The most often reported illnesses 
were arthritis (9%) and asthma (6%), the only specified psychological illness was 
depression at 14 % of the sample. Although the participant numbers are lower in this 
phase the participant's characteristics are largely the same. 
PHASE 4- TWO MONTH POST INTERVENTION PHASE 
Unfortunately there were more participant drop outs between the post intervention 
stage and the two months post intervention stage, and therefore only 36 participants 
took part in this stage of the study. It should be noted however, that the two month 
post intervention pack was sent to all participants; therefore some of the people who 
did not complete the post intervention pack still returned their two month post 
intervention pack. Of the participants at this stage there were 30 females, and 4 males 
(2 unspecified). Participants' ages ranged from 19-71 years, with a mean age of 47 
(SD 15). 59% of the sample were members of the IBS Network. The average time 
since diagnosis of IBS was 13.2 years (SD 10.7), with a range from less than a year 
to 41 years. The average time from first experiencing symptoms to being diagnosed 
was 5.8 years (SD 8.5), with a range from less than a year to 33 years. Within the 
main IBS group the numbers of participants in the three IBS subgroups were as 
follows, IBS-D (n=15), IBS-C (n=10), IBS-A (n=9) (NB two participants did not 
specify their subgroup). All participants were resident in the UK. Just over half of the 
sample were highly educated with 54% achieving `A' levels or higher, only 15% of 
the sample reported having no academic qualification. 59% of the sample reported 
having another illness. The most often reported illnesses were arthritis (11%) and 
asthma (9%), the only specified psychological illness was depression at 14 % of the 
sample. Although the participant numbers are lower in this phase the participant's 
characteristics are largely the same as in the other two phases. 
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DESIGN 
This is quantitative postal based research. It has a within subjects longitudinal 
design, comprising four phases. Phase 1 is a pre intervention phase where 
participants' baseline characteristics are measured prior to commencement of the 
intervention. Phase 2 is the intervention stage where participants fill in the 
intervention booklet. The booklet is completed in one sitting on the day following the 
completion of the 7 day diary (or upon completion of the questionnaires if no diary is 
being used). Phase 3 is a post intervention phase, where measures suitable for 
immediate test-retest assessment are re-administered immediately post the 
intervention to assess if any changes have occurred. The final phase, phase 3 is 
included to assess the short term effects of the intervention, and therefore the 
measures are re administered at two months post the intervention. There are three 
main independent variables these are participants' illness representations (number of 
dimensions), perceived health related quality of life (HRQOL), and symptom 
frequency (total symptoms and individual symptoms). The dependent variables are 
the changes in these variables at phase 2 and phase 3. 
MEASURES 
A number of the measures used in this study are the same as in the previous two 
studies, so these will not be detailed here. The measures which are the same are: 
A disease specific version of the IPQ-R (Moss-Morris et al., 2002, appendix 1) 
The IBS-36 (Groll et al., 2002, appendix 2) 
The 7-day symptom diary (appendix 3) 
IBS participant's version of the Attitudes to Chronic Illness Questionnaire (termed 
PSSS, appendix 14) 
Demographic Questionnaire (appendix 7) 
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In addition there are two questionnaires and an intervention booklet designed for this 
study. 
The first questionnaire is termed the IBS symptom scale (ISS, appendix 21). This is a 
supplementary measure to the 7-day symptom diary. It was included for two reasons. 
The first reason is that relationships between the independent variables and symptom 
frequency in the previous two studies were either weak or not significant. It is 
currently unclear whether this represents a true finding or a methodological factor. 
As it is important to assess the efficacy of the intervention in terms of symptom 
changes it was felt useful to include an additional symptom measure for comparison. 
The second reason for its inclusion was due to worries over low participant numbers 
for diary based research. This worry is based on the time commitment required for 
diary based studies. In this case each diary takes a week to complete, and as this is a 
three phase study means that three weeks worth of diaries would need to be 
completed over a two month period. In contrast each questionnaire takes under half 
an hour, and its therefore more appealing to some participants. Although participants 
were obviously encouraged to complete both the diaries and the ISS throughout the 
study, where people specified that they would only take part without the diaries (as 
happened in a few cases) the ISS questionnaire provided a useful way of still 
including a symptom outcome variable. The design of the ISS was informed by 
previous literature in this area. A review article by Naliboff et al. (1999) provides 
detailed assessment measures used to record symptom frequency, and the 
suggestions raised provided the framework for the questionnaire designed. The ISS is 
similar to the questionnaire designed by Dancey et al. (1998). 
The ISS asks participants to retrospectively recall their symptoms over the previous 
week and indicate the frequency of their symptoms on a Likert scale from 0 (not 
experienced this symptom) to 6 (experienced this symptom constantly). There are a 
total of nineteen symptoms listed, this includes the primary IBS symptoms and also a 
number of extra-intestinal symptoms that have been suggested to be experienced by 
sufferers of IBS, e. g. joint pain and nausea and the psychological variables of 
perceived stress and depression levels. This is considered to be superior to the 
questionnaire used by Dancey et al. (1998) as their questionnaire only included the 
seven dominant IBS symptoms, whereas this questionnaire allows for a more global 
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assessment of symptoms. In addition the ISS included a category of `not applicable', 
this was only to be circled if the symptom had never been experienced since being 
diagnosed with IBS. The `not applicable' category is distinct from the category of 
not experienced this symptom, which refers to symptoms which had been 
experienced in the past but had not been experienced in the preceding week. The ISS 
is scored, in the same manner as the IBS-36 by summing the responses to each of the 
symptoms. However, in order to provide comparable data to the symptom diary the 
total score only includes the primary IBS symptoms. As with the diary frequency of 
the individual symptoms will also be investigated, this is where potential changes in 
the non-IBS symptoms can be determined. As this questionnaire was administered 
twice in this study, one pre intervention, and again at two months post intervention 
internal reliability analysis was performed twice. The alpha coefficients show the 
questionnaire to be highly reliable, with the pre intervention administration being 
0.763, and the two month post intervention administration being 0.868. 
The final questionnaire is a short post-intervention questionnaire (appendix, 22), 
which is to be completed at two months post the intervention, it contains an open 
ended question asking sufferers if they have made any changes since the 
intervention. As this is a qualitative section the responses will be shown using a 
frequency table. 
MATERIALS 
A self-help booklet was designed for the purposes of the intervention (appendix 23). 
As stated earlier although the recent research by Kennedy et al. (2003) provides a 
useful justification of the viability of self-help booklets in IBS intervention research 
there are a number of flaws in its design that make it unsuitable as a measure. 
Therefore prior to the detailed, section based description, of the self-help booklet the 
main features will be described. As the design of this self-help booklet was largely 
based on addressing the flaws in the Kennedy et al. (2003) research these will be 
described along with the modifications made. 
1) Firstly Kennedy et al. (2003) entitle their paper an `evidence based' self-help 
booklet, however, this `evidence' comes from qualitative reports, from only 25 IBS 
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sufferers at focus groups. It could therefore be argued that rather than evidence based 
as they suggest the Kennedy et al. (2003) research is actually opinion based. This is 
particularly worrying in light of the results of study 2 which show a marked 
discrepancy in the attitudes of IBS sufferers and the general population. In order for a 
booklet to be truly evidence based there has to be a considerable effort extended in 
reviewing the literature, and ensuring that all the information provided to sufferers is 
accurate according to current knowledge. This is particularly important in irritable 
bowel syndrome as the information available to sufferers is often unclear, conflicting 
or completely inappropriate for an individual's symptom presentation (e. g. Dancey et 
al., 1999; Stenner et al., 2000). Therefore the only information included in this self- 
help booklet was for areas where reliable references could be given. In addition next 
to each piece of information about IBS was a number which corresponded to the 
reference section. This way participants could be assured of the reliability of the 
information, and should they desire, obtain the original reference for further detail. 
The need to include only evidence based information means that any areas of 
uncertainty, for example over some nutritional aspects were excluded from the 
booklet. 
2) There is no model underlying the Kennedy et al. (2003) booklet, therefore even if 
its efficacy was established by research (no research has currently been published 
assessing its efficacy) there would be no way of identifying why improvements were 
observed. As shown by the systematic review it is not sufficient to conduct general 
psychologically based interventions in IBS, the greatest success both theoretically 
and practically is for those studies that are driven by theory. Therefore the design of 
this self-help booklet adhered rigidly to the principles of the CSM (Leventhal et al., 
1980; 1984), as detailed in Chapter 4. 
3) The information in the self-help booklet by Kennedy et al. (2003) is provided in a 
passive manner. It is therefore largely descriptive providing opinions from other 
sufferers with an assumption that this will help sufferers by showing that other 
people have encountered similar experiences. Whilst this is undoubtedly the case as 
Coulson (2005) shows with his research, it still assumes that the information 
provided will be relevant. However, it is possible that some people (especially those 
who have suffered for a long time) will feel it patronising to simply read about the 
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experiences of other people, when they were expecting useful information 
concerning their specific symptoms. On the basis of this criticism, and in line with 
the CSM it was felt important to design a booklet that would enable people to answer 
the questions in a manner that was relevant to them, by providing as much or as little 
detail as they wanted and by providing sections which asked about current 
knowledge levels rather than assuming all participants would have the same level of 
knowledge. It also asks people to actively think about and list changes relevant to 
them. In this respect, although not tailored in its truest sense the booklet is designed 
in a manner that will result in it being completed in a different way by each person. 
The result of this is that whilst the Kennedy et al. (2003) booklet is limited to one 
reading with this booklet a sufferer can fill it in as many times as they wish over the 
course of their illness. In addition as it is divided into clearly defined sections, on 
subsequent completions it is possible for a particular section, such as the knowledge 
section, to be used without the need to read the entire booklet again. 
4) As a final point of consideration Kennedy et al. (2003) report that their cohort 
were not good at suggesting coping strategies, this strongly suggest that the booklet 
must not be limited to merely providing information. Sufferers require and therefore 
must be given suggestions to aid them in their self management. Therefore in this 
booklet a variety of suggestions will be provided, again taking into consideration 
what is practical and desirable to one person will not be to another. 
Despite the criticisms of the Kennedy et al. (2003) booklet the overall aim of both 
booklets is to help sufferers adjust to their illness identity as an IBS sufferer. 
However, in addition to this aim the ultimate goal of the booklet designed for this 
study is to empower sufferers to make positive changes which help their illness 
representations, HRQOL and symptom frequency throughout their illness. 
THE IBS INTERVENTION BOOKLET 
In line with the CSM there were three main components to the booklet. Sufferers 
were asked to a) consider their current illness interpretations (on each illness 
perception dimension) b) encourage positive representations and c) produce action 
plans for the future. These components are inherent throughout the booklet, which 
comprises 6 sections, which are as follows: 
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Section 1 
Following an instruction page section one starts with the illness representation 
dimensions of illness identity. The first part of this section is a) to consider current 
illness representations. This section asks participants to write down how they feel 
about being `labelled' an IBS sufferer. In line with the CSM they are instructed that 
it is their current views that they are required to report, and therefore it does not 
matter how they have felt in the past. This is important as it takes into account that 
all experiences contribute to the illness identity a person has, and with this in mind 
the responses may differ, if not from day to day, certainly throughout other periods 
of time. This is important as it enables the booklet to be as relevant to both newly 
diagnosed sufferers as to those who have suffered for a long time. Sufferers are asked 
to list as many (or as few) feelings as they feel helpful, and are provided an example 
of both a positive and a negative feeling. Sufferers are assured that there are no right 
or wrong answers. This is important as research, e. g. Bertram et al. (2001) has shown 
that people are frustrated by unhelpful advice in particular from medical 
professionals whom many perceived as having no understanding of their condition. 
Therefore from the start this booklet allows the sufferer to be in control. An example 
of the kinds of responses a sufferer may include in this section are, "I feel slightly 
embarrassed and don't want to advertise the fact I have IBS", or "IBS is being 
recognised by more people, which makes it easier to talk about and share 
experiences". Following on from this section is section b) encouraging positive 
illness representations. In this section participants are asked to concentrate only on 
the positive aspects of having IBS. Initially participants are asked to look back over 
their list of feelings, and to re-write any that are positive. Next they are asked to 
think of anything positive relating to their being an IBS sufferer. It is noted in the 
instructions that some people may initially find this hard but to take the time to 
reflect. An example of the responses in this section include "having IBS has 
encouraged me to have more empathy for other people", and "I am happy that it is a 
genuine medical condition". The final part of this section, part c) to produce action 
plans for the future asks sufferers which action(s) they could take that would help 
them to feel more positive about their illness in the future. An example of a response 
in this section is "sharing personal experiences with others who also suffer from 
IBS". Participants are also asked to rate on a scale from very easy to very hard how 
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easy it would be for them to act on the changes they had suggested. By making 
people think about the procedures involved in actually undertaking the action step 
this takes it from an abstract idea to something which is directly considered. 
Section 2 
Section 2 relates to the illness representation dimension of illness coherence, the first 
part of this section a) to consider current illness representations, provides a list of 8 
IBS `key facts', and asks participants to indicate (with a tick or a cross) which ones 
they were aware of. For example "IBS affects one in five people", and "there are 
three main subtypes of IBS". Detail is provided for the 8 key facts (along with 
references). This is important as research, e. g. Dancey et al. (1999) suggests that IBS 
sufferers hold many misconceptions about their illness. In the second part of this 
section b) encouraging positive illness representations sufferers are asked if there are 
any changes they would like to make on the basis of the new information they have 
gained about IBS. Participants are asked to indicate whether these changes are in 
feelings or behaviour, e. g. behaviour change would be "to go to the doctor if I found 
blood in my stool". Section c) to produce action plans for the future asks people to 
rate how easy it would be for them to act on these changes, using the same scale as 
with section 1. 
Section 3 
Section 3 relates to the illness representation dimension of cause. The first part of 
this section a) to consider current illness representations asks participants to list what 
they believe caused their IBS. Following this they are asked to write the cause / 
causes under common subheadings, such as `caused by an illness'. Following on 
from this section is a list of the current knowledge regarding causes of IBS. This is as 
important as the IBS `key facts' section as it aims to clear up any misconceptions 
people have regarding causes of their illness. By learning which causes are evidence 
based and which are not participants are able to b) alter their illness representations 
concerning any maladaptive causes, such as a food allergy. Again participants are 
asked to reflect on the information given, to specify if their opinion regarding the 
cause of their symptoms has changed and to c) to produce action plans for the future 
asking people to rate how easy it would be for them to act on these changes, using 
the same scale as with section 1. 
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Section 4 
Section 4 relates to the illness representation dimension of timeline (both chronic and 
cyclical). The first part of this section a) to consider current illness representations 
provides participants with a list of potential beliefs relating to the timeline of IBS, 
and asks participants to circle which category they feel best describes their 
symptoms. An example is `chronic but controllable'. The second part of this section 
b) to alter illness representations lists any categories which are inaccurate, e. g. `IBS 
is terminal', and tells participants who have circled an incorrect category to think 
about their IBS and indicate which of the accurate categories their IBS most relates 
to. Consistent with the semi-tailored nature of this booklet section c) producing 
action plans for the future is only relevant for those people who have to change their 
perceptions of their timeline. For those people who are unsure they are recommended 
to monitor their IBS for a few weeks until they have a better understanding of their 
illness. 
Section 5 
Section 5 relates to the illness representation dimension of perceived consequences. 
The first part of this section a) to consider current illness representations asks people 
to list any consequences to their life as a result of having IBS, these can be either 
negative or positive. An example of a negative consequence is "scared to travel too 
far from home". An example of a positive consequence is "found enjoyment in going 
for short walks". In a similar style to section 1, part b) to alter illness representations 
reminds participants that focusing on negative outcomes is not productive and asks 
them to think of more positive consequences of having IBS. Participants are told that 
as one of their action plans for the future (c) they should keep the list of positive 
thoughts and whenever they feel negative they should look over the list. In addition 
they are instructed that whenever they think of an additional positive consequence 
that they should add it to the list. In addition a list of misconceptions about 
consequences, such as `poor social support is not a necessary consequence of IBS' is 
included to help people rethink some of their inaccurate perceptions. Finally in 
addition to encouraging positive views on consequences sufferers are also asked to 
think about how any of the negative consequences can be minimised. An example of 
this is the negative consequence of 'feeling that quality of life has reduced' can be 
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minimised by thinking of new hobbies that are compatible with IBS, such as a book 
club. Again people are asked to rate how easy it would be for them to act on these 
changes, using the same scale as with section 1. 
Section 6 
Section 6 relates to the illness representation dimension of cure / control. The first 
part of this section a) to consider current illness representations asks people to list 
any actions that they currently undertake as a way of controlling their symptoms. An 
example is `take long baths'. The second part of this section, b) to alter illness 
representations lists a number of suggestions that may help people to control their 
IBS, this is divided into `general help' and `symptom specific help'. It provides a 
number of different evidence based suggestions, such as thinking positively, 
increasing exercise or having cognitive behavioural therapy. This section aims to 
alter peoples' illness representations concerning controlling, and potentially curing 
their IBS by suggesting things that they may not have been aware of as potentially 
beneficial. The final section of the booklet c) action plan for the future, asks 
participants to list up to three suggestions for improving their IBS that they would 
like to try, again along with the scale to indicate how easy this is to achieve. 
As the previous sections demonstrate the booklet strictly adheres to the principles of 
the CSM, it incorporates all the illness representation dimensions, and each of the 
stages of the model. 
PROCEDURE 
PRE INTERVENTION STAGE, INTERVENTION, IMMEDIATE POST 
INTERVENTION STAGE 
Participants received the research pack which contained two envelopes and the 
intervention booklet. The first envelope was marked pre intervention pack and 
contained an information sheet along with a letter inviting them to take part in the 
research (appendix 24) consent forms and ethics approval (appendix 19), a 
demographic questionnaire (appendix 7), a disease specific version of the IPQ-R 
(Moss-Morris et al., 2002, appendix 1), the IBS-36 (Groll et al., 2002, appendix 2), 
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IBS participant's version of the Attitudes to Chronic Illness Questionnaire (termed 
PSSS, appendix 14), the ISS, (appendix 21), the 7-day symptom diary (appendix 3) 
and a free post envelope. The second envelope was marked post intervention pack 
and contained some of the same materials as the pre-intervention pack. It contained a 
disease specific version of the IPQ-R (Moss-Morris et al., 2002, appendix 1), IBS 
participant's version of the Attitudes to Chronic Illness Questionnaire (termed PSSS, 
appendix 14), the 7-day symptom diary (appendix 3) and a free post envelope. 
Participants are instructed to complete the pre intervention pack, then to seal it and 
post it back. Immediately following the pre intervention pack (i. e. within a day or 
two of completing the pre intervention measures) they are to complete the 
intervention booklet, and following this (again within a day or two of completing the 
intervention to complete the post intervention pack and post it back. 
TWO MONTH POST INTERVENTION STAGE 
Two months after the completion of the post intervention pack, participants received 
the two month post intervention pack. This pack was identical to the pre intervention 
pack, however it also included the short post intervention questionnaire (appendix, 
22) and a letter reminding people that they are participating in the study and ask them 
to fill in the pack if they still wish to take part (appendix 25). 
DATA TREATMENT 
Raw data was entered into SPSS (version 14). As with the previous research where a 
questionnaire was completed there was very little missing data, therefore as the 
variables were normally distributed mean substitution was used. However, in a 
number of cases a particular measure, such as the daily diary was not completed by a 
number of participants therefore case wise deletion was used (using the select cases 
function) for those variables where there was too much missing data for meaningful 
results to be derived. This is visible in the results section where the degrees of 
freedom differ for each variable. As with the previous research the functions of 
transformation and compute was used to produce the variables that were used in the 
analysis. In addition, in accordance with normal statistical procedures where multiple 
t-tests were used a Bonferoni correction was employed, whereby statistics were only 
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recorded as significant if the p value exceeded that required after applying the 
correction. 
RESULTS 
DESCRIPTIVE STATISTICS 
As statistical analysis is focussed primarily on average responses it was felt to be 
useful to provide some descriptive information on the pattern of symptoms and 
changes experienced over the study. Table 21 therefore provides detailed 
information for each patient's symptoms at all three time points. The data presented 
are for the total symptoms and for the individual symptoms. The table shows both the 
7-day diary and the ISS (symptom questionnaire). It should be noted that the ISS was 
not administered at immediate follow up. There appears to be a large quantity of 
missing data in the table; this refers to participants not completing the measures 
either due to drop outs or not wishing to complete the diaries. The amount of 
participants used in each stage of the analysis can clearly be seen by the degrees of 
freedom presented later on. 
Table 21 - Descriptive statistics of IBS symptom frequency at pre-intervention, 
immediately post intervention and at two months post intervention. 
Case 
Number 
Pre intervention Post intervention 2m Post intervention 
Total sm toms using the 7-day diary 
1 25.00 22.00 Missing data 
2 57.00 59.00 21.00 
3 51.00 47.00 46.00 
4 15.00 4.00 11.00 
5 17.00 5.00 4.00 
6 25.00 22.00 Missing data 
7 19.00 8.00 22.00 
8 25.00 34.00 23.00 
9 20.00 14.00 10.00 
10 18.00 4.00 2.00 
11 48.00 34.00 Missing data 
12 50.00 43.00 10.00 
13 Missing data Missing data . 00 
14 13.00 3.00 26.00 
15 62.00 32.00 39.00 
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16 Missing data Missing data 34.00 
17 10.00 11.00 Missing data 
18 29.00 24.00 Missing data 
19 17.00 15.00 15.00 
20 3.00 11.00 10.00 
21 Missing data Missing data Missing data 
22 Missing data Missing data Missing data 
23 57.00 32.00 Missing data 
24 Missing data Missing data Missing data 
25 Missing data Missing data Missing data 
26 Missing data Missing data Missing data 
27 Missing data Missing data 30.00 
28 Missing data Missing data 8.00 
29 6.00 8.00 10.00 
30 52.00 37.00 Missing data 
31 28.00 2.00 Missing data 
32 Kissing data Missing data 11.00 
33 80.00 4.00 36.00 
34 22.00 17.00 Missing data 
35 19.00 13.00 7.00 
36 22.00 39.00 9.00 
37 4.00 2.00 3.00 
38 Missing data Missing data Missing data 
39 Missing data Missing data Missing data 
40 Missing data Missing data Missing data 
41 39.00 41.00 25.00 
42 26.00 18.00 Missing data 
43 Missing data Missing data Missing data 
44 Missing data Missing data Missing data 
45 6.00 10.00 17.00 
46 26.00 40.00 20.00 
47 Missing data Missing data Missing data 
48 Missing data Missing data Missing data 
49 33.00 15.00 8.00 
50 44.00 8.00 Missing data 
51 Missing data Missing data Missing data 
52 91.00 112.00 Missing data 
53 Missing data Missing data Missing data 
54 66.00 45.00 39.00 
55 Missing data Missing data Missing data 
56 Missing data Missing data Missin data 
57 Missing data Missing data 46.00 
58 Missing data Missing data Missing data 
59 6.00 9.00 Missin data 
60 13.00 4.00 Missing data 
61 23.00 14.00 Missing data 
62 Missing data Missing data Missing data 
Total sympt oms using the ISS quest ionnaire 
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1 24.00 Missing data 
2 38.00 40.00 
3 26.00 25.00 
4 31.00 10.00 
5 9.00 5.00 
6 24.00 Missing data 
7 25.00 14.00 
8 Missing data 22.00 
9 29.00 15.00 
10 28.00 10.00 
11 24.00 18.00 
12 31.00 20.00 
13 29.00 17.00 
14 19.00 15.00 
15 23.00 25.00 
16 28.00 31.00 
17 19.00 Missing data 
18 30.00 35.00 
19 17.00 12.00 
20 18.00 28.00 
21 20.00 Missing data 
22 21.00 Missing data 
23 36.00 38.00 
24 24.00 32.00 
25 19.00 Missing data 
26 28.00 Missing data 
27 13.00 9.00 
28 28.00 20.00 
29 17.00 15.00 
30 21.00 Missing data 
31 8.00 Missing data 
32 32.00 17.00 
33 
34 
28.00 
31.00 
31.00 
Missing data 
35 18.00 9.00 
36 
37 
38 
. 39 
20.00 
Missin data 
26.00 
22.00 
29.00 
19.00 
Missing data 
Missing data 
40 22.00 Missing data 
41 
42 
43 
32.00 
28.00 
20.00 
36.00 
Missing data 
Missing data 
44 22.00 Missing data 
45 28.00 29.00 
46 
47 
21.00 
Missing data 
18.00 
Missing data 
48 22.00 Missing data 
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49 29.00 20.00 
50 13.00 Missing data 
51 31.00 27.00 
52 17.00 20.00 
53 13.00 Missing data 
54 27.00 Missing data 
55 23.00 24.00 
56 36.00 Missing data 
57 21.00 21.00 
58 Missing data Missing data 
59 27.00 Missing data 
60 14.00 Missing data 
61 23.00 Missing data 
62 31.00 Missing data 
Diarrhoea assessed using the 7-da diary 
1 . 00 3.00 
Missing data 
2 3.00 6.00 . 00 
3 6.00 . 00 . 00 
4 4.00 3.00 1.00 
5 . 00 . 
00 . 00 
6 . 00 3.00 
Missing data 
7 . 00 . 
00 . 00 
8 3.00 4.00 3.00 
9 . 00 . 00 . 
00 
10 3.00 1.00 . 00 
11 . 00 . 
00 Missing data 
12 . 00 
4.00 . 00 
13 Missing data 2.00 . 00 
14 . 00 . 
00 . 00 
15 . 00 
3.00 . 00 
16 4.00 13.00 1.00 
17 . 00 
1.00 Missing data 
18 . 00 
1.00 . 00 
19 . 00 . 
00 . 00 
20 1.00 5.00 2.00 
21 3.00 Missing data Missing data 
22 . 00 
Missing data Missing data 
23 1.00 . 00 . 
00 
24 Missing data Missing data Missing data 
25 Missing data Missing data Missing data 
26 1.00 Missing data Missing data 
27 2.00 Missing data 1.00 
28 . 00 
2.00 2.00 
29 5.00 7.00 . 00 
30 . 00 . 
00 Missing data 
31 1.00 . 00 Missing data 
32 . 00 Missing 
data . 00 
33 3.00 . 00 . 00 
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34 4.00 1.00 Missing data 
35 . 00 . 00 . 00 36 1.00 2.00 . 00 37 4.00 2.00 3.00 
38 2.00 Missing data Missing data 
39 2.00 Missing data Missing data 
40 1.00 . 00 Missing data 41 . 00 . 00 1.00 42 3.00 1.00 Missing data 
43 Missing data Missing data Missing data 
44 Missing data Missing data Missing data 
45 . 00 . 00 . 00 46 
. 00 . 00 . 00 47 . 00 Missing data Missing data 48 Missing data Missing data Missing data 
49 . 00 . 00 1.00 50 1.00 . 00 Missing data 51 Missing data Missing data Missing data 
52 45.00 Missing data 46.00 
53 Missing data Missing data Missing data 
54 3.00 4.00 4.00 
55 Missing data Missing data Missing data 
56 2.00 Missing data Missing data 
57 . 00 . 00 . 00 58 Missing data Missing data Missing data 
59 2.00 4.00 Missing data 
60 5.00 . 00 Missing data 61 7.00 2.00 Missing data 
62 Missing data Missing data Missing data 
Diarrhoea assessed using the ISS uestionnaire 
1 3.00 Missing data 
2 2.00 5.00 
3 4.00 3.00 
4 5.00 1.00 
5 . 00 . 00 6 3.00 Missing data 
7 2.00 . 00 
8 
9 
4.00 
2.00 
4.00 
. 00 
10 6.00 3.00 
11 . 00 . 
00 
12 5.00 1.00 
13 
14 
15 
4.00 
. 00 
. 00 
1.00 
. 00 
. 00 
16 
17 
4.00 
. 00 
5.00 
Missin data 
18 2.00 4.00 
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19 . 00 
4.00 
20 3.00 5.00 
21 . 00 
Missing data 
22 . 00 
Missing data 
23 6.00 6.00 
24 2.00 4.00 
25 . 00 
Missing data 
26 4.00 Missing data 
27 3.00 1.00 
28 5.00 3.00 
29 5.00 4.00 
30 . 00 
Missing data 
31 2.00 Missing data 
32 . 00 . 
00 
33 . 00 
5.00 
34 4.00 Missing data 
35 4.00 . 00 
36 1.00 1.00 
37 Missing data 6.00 
38 3.00 Missing data 
39 3.00 Missing data 
40 3.00 Missing data 
41 . 00 
5.00 
42 . 00 
Missing data 
43 2.00 Missing data 
44 . 00 
Missing data 
45 . 00 
6.00 
46 1.00 . 00 
47 . 00 
Missing data 
48 4.00 Missing data 
49 3.00 3.00 
50 1.00 Missing data 
51 1.00 2.00 
52 6.00 5.00 
53 . 00 
Missing data 
54 4.00 999.00 
55 3.00 4.00 
56 6.00 Missing data 
57 . 00 . 
00 
58 Missing data Missing data 
59 5.00 Missing data 
60 4.00 Missing data 
61 6.00 Missing data 
62 6.00 Missing data 
Constip atio n assessed using the 7-day diary 
1 3.00 5.00 Missing data 
2 11.00 11.00 3.00 
3 1.00 10.00 1.00 
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4 . 00 . 00 1.00 5 
. 00 . 00 . 00 6 3.00 5.00 Missing data 
7 . 00 . 00 . 00 8 . 00 . 00 . 00 9 2.00 4.00 2.00 
10 3.00 . 00 . 00 11 4.00 . 00 Missing data 12 2.00 5.00 1.00 
13 Missing data . 00 . 00 14 . 00 . 00 . 00 15 9.00 3.00 3.00 
16 . 00 . 00 . 00 17 1.00 . 00 Missing data 18 . 00 . 00 . 00 19 3.00 3.00 1.00 
20 . 00 . 00 . 
00 
21 1.00 Missing data Missin data 
22 2.00 Missing data Missing data 
23 . 00 1.00 . 
00 
24 Missing data Missing data Missing data 
25 Missing data Missing data Missing data 
26 . 00 Missing 
data Missing data 
27 . 00 Missing 
data . 00 
28 Missing data 3.00 . 00 
29 . 00 . 00 . 00 30 2.00 1.00 Missing data 
31 2.00 . 00 Missing data 
32 1.00 Missing data 4.00 
33 . 00 . 00 1.00 34 . 00 2.00 
Missing data 
35 
. 00 . 
00 . 00 
36 3.00 . 00 . 00 
37 . 00 . 00 . 
00 
38 2.00 Missing data Missing data 
39 5.00 Missing data Missing data 
40 4.00 1.00 Missing data 
41 2.00 2.00 2.00 
42 2.00 2.00 Missing data 
43 Missing data Missing data Missing data 
44 Missin data Missing data Missing data 
45 . 00 . 
00 . 00 
46 2.00 4.00 2.00 
47 . 00 
Missing data Missing data 
48 Missing data Missing data Missing data 
49 12.00 5.00 . 00 
50 6.00 1.00 Missing data 
51 Missing data Missing data Missing data 
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52 . 00 . 00 . 00 53 Missing data Missing data Missing data 
54 . 00 . 
00 . 00 
55 Missing data Missing data Missing data 
56 . 00 Missing data Missing data 57 1.00 5.00 4.00 
58 Missing data Missing data Missing data 
59 . 00 . 00 
Missing data 
60 . 00 . 00 
Missing data 
61 . 00 . 
00 Missing data 
62 Missing data Missing data Missing data 
Constip ation assessed usin the ISS uestionnaire 
1 . 00 
Missing data 
2 6.00 6.00 
3 . 00 
1.00 
4 4.00 1.00 
5 . 00 . 
00 
6 . 00 
Missing data 
7 
8 
9 
10 
11 
2.00 
Missing 
5.00 
1.00 
3.00 
data 
1.00 
. 00 
2.00 
1.00 
3.00 
12 . 00 . 
00 
13 
14 
. 00 
. 00 
2.00 
. 00 
15 6.00 6.00 
16 . 00 . 
00 
17 5.00 Missing data 
18 
19 
. 00 4.00 
1.00 
3.00 
20 
21 . 
00 
3.00 
1.00 
Missing data 
22 4.00 Missing data 
23 . 00 
2.00 
24 4.00 4.00 
25 . 00 
Missing data 
26 2.00 Missing data 
27 1.00 . 00 
28 
29 
1.00 
. 00 
3.00 
. 00 
30 2.00 Missing data 
31 . 00 
Missing data 
32 6.00 5.00 
33 6.00 5.00 
34 
35 
2.00 
. 00 
Missing 
. 00 
data 
36 3.00 1.00 
193 
CSM self-help booklet intervention 
37 Missing data . 00 38 5.00 Missing data 
39 4.00 Missing data 
40 4.00 Missing data 
41 4.00 5.00 
42 3.00 Missing data 
43 . 00 Missin data 44 6.00 Missing data 
45 4.00 . 00 46 4.00 3.00 
47 1.00 Missing data 
48 2.00 Missing data 
49 3.00 3.00 
50 4.00 Missing data 
51 4.00 2.00 
52 . 00 . 
00 
53 4.00 Missing data 
54 . 00 
Missing data 
55 3.00 5.00 
56 . 00 
Missing data 
57 5.00 5.00 
58 Missing data Missing data 
59 2.00 Missing data 
60 . 00 
Missing data 
61 . 00 
Missing data 
62 . 00 
Missing data 
Bloating assessed using the 7-day dia 
1 7.00 7.00 Missing data 
2 6.00 6.00 6.00 
3 4.00 4.00 14.00 
4 1.00 . 00 1.00 
5 . 00 . 
00 . 00 
6 7.00 7.00 Missing data 
7 3.00 1.00 7.00 
8 1.00 3.00 1.00 
9 2.00 1.00 . 00 
10 2.00 . 00 . 00 
11 8.00 1.00 Missing data 
12 2.00 . 00 
5.00 
13 Missing data 1.00 . 00 
14 3.00 . 00 
4.00 
15 14.00 2.00 6.00 
16 6.00 6.00 6.00 
17 2.00 2.00 Missing data 
18 2.00 . 00 18.00 
19 5.00 3.00 7.00 
20 2.00 1.00 4.00 
21 18.00 Missing data Missing data 
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22 9.00 Missing data Missing data 
23 9.00 4.00 16.00 
24 Missing data Missing data Missing data 
25 Missing data Missing data Missing data 
26 2.00 Missing data Missing data 
27 3.00 Missing data 8.00 
28 Missing data . 00 6.00 29 . 00 . 00 . 00 30 9.00 11.00 Missing data 
31 4.00 . 00 Missing data 32 3.00 Missing data 5.00 
33 42.00 . 00 10.00 34 4.00 2.00 Missing data 
35 4.00 3.00 . 00 36 . 00 5.00 2.00 37 
. 00 . 00 . 
00 
38 5.00 Missing data Missing data 
39 1.00 Missing data Missing data 
40 1.00 15.00 Missing data 
41 8.00 14.00 12.00 
42 4.00 2.00 Missing data 
43 Missing data Missing data Missing data 
44 Missing data Missing data Missing data 
45 2.00 4.00 4.00 
46 7.00 14.00 4.00 
47 1.00 Missing data Missing data 
48 Missing data Missin data Missin data 
49 6.00 . 00 . 00 
50 19.00 6.00 Missing data 
51 Missing data Missin data Missing data 
52 . 00 2.00 . 
00 
53 Missing data Missing data Missing data 
54 5.00 . 00 . 00 55 Missing data Missing data Missing data 
56 6.00 Missin data Missing data 
57 30.00 36.00 27.00 
58 Missing data Missing data Missing data 
59 . 00 . 
00 Missing data 
60 2.00 1.00 Missing data 
61 
. 00 . 
00 Missing data 
62 Missing data Missing data Missing data 
Bloating assessed using the ISS uestionnaire 
1 6.00 Missing data 
2 6.00 6.00 
3 
4 
5 
5.00 
5.00 
5.00 
5.00 
1.00 
. 00 
6 6.00 Missing data 
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7 6.00 4.00 
8 3.00 4.00 
9 4.00 1.00 
10 4.00 1.00 
11 5.00 3.00 
12 5.00 5.00 
13 3.00 2.00 
14 3.00 2.00 
15 5.00 5.00 
16 5.00 5.00 
17 3.00 Missing data 
18 6.00 6.00 
19 3.00 . 00 
20 3.00 5.00 
21 6.00 Missing data 
22 5.00 Missing data 
23 6.00 6.00 
24 3.00 4.00 
25 5.00 Missing data 
26 4.00 Missing data 
27 2.00 2.00 
28 6.00 2.00 
29 . 00 . 
00 
30 4.00 Missing data 
31 1.00 Missing data 
32 6.00 3.00 
33 6.00 3.00 
34 4.00 Missing data 
35 4.00 2.00 
36 3.00 6.00 
37 Missin data . 00 
38 4.00 Missing data 
39 . 00 
Missing data 
40 . 00 
Missing data 
41 6.00 6.00 
42 5.00 Missing data 
43 3.00 Missing data 
44 6.00 Missing data 
45 6.00 5.00 
46 6.00 6.00 
47 1.00 Missing data 
48 3.00 Missing data 
49 5.00 3.00 
50 6.00 Missing data 
51 5.00 5.00 
52 2.00 2.00 
53 . 00 
Missin data 
54 5.00 ssing data 
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55 3.00 5.00 
56 6.00 Missing data 
57 6.00 5.00 
58 Missing data Missing data 
59 4.00 Missing data 
60 1.00 Missing data 
61 . 00 Missing 
data 
62 4.00 Missing data 
Abdominal pain assessed using the 7-day dairy 
1 . 00 . 00 Missing 
data 
2 22.00 19.00 7.00 
3 2.00 2.00 . 00 
4 3.00 . 00 . 00 
5 10.00 2.00 1.00 
6 . 00 . 
00 Missing data 
7 6.00 1.00 5.00 
8 6.00 5.00 9.00 
9 10.00 7.00 4.00 
10 1.00 1.00 . 00 
11 2.00 . 00 Missing 
data 
12 22.00 18.00 1.00 
13 Missing data 2.00 . 00 
14 6.00 2.00 16.00 
15 21.00 17.00 25.00 
16 8.00 13.00 1.00 
17 2.00 2.00 Missing data 
18 1.00 1.00 . 00 
19 1.00 1.00 2.00 
20 . 00 
3.00 . 00 
21 1.00 Missing data Missing data 
22 2.00 Missing data Missing data 
23 15.00 1.00 21.00 
24 Missing data Missing data Missing data 
25 Missing data Missing data Missing data 
26 2.00 Missing data Missing data 
27 20.00 Missing data 19.00 
28 Missing data . 00 . 
00 
29 . 00 . 
00 . 00 
30 14.00 7.00 Missing data 
31 13.00 1.00 Missing data 
32 3.00 Missing data . 00 
33 23.00 . 00 
3.00 
34 7.00 5.00 Missing data 
35 2.00 1.00 . 00 
36 7.00 2.00 5.00 
37 . 00 . 
00 . 00 
38 3.00 Missing data Missing data 
39 3.00 Missing data Missing data 
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40 2.00 4.00 Missing data 
41 8.00 5.00 . 00 42 10.00 6.00 Missing data 
43 Missing data Missin data Missing data 
44 Missing data Missing data Missing data 
45 1.00 2.00 5.00 
46 2.00 1.00 . 00 47 . 00 Missing data Missing data 48 Missing data Missing data Missing data 
49 . 00 2.00 1.00 50 1.00 . 00 Missing data 51 Missing data Missing data Missing data 
52 1.00 1.00 . 00 
53 Missing data Missing data Missing data 
54 3.00 15.00 11.00 
55 Missing data Missing data Missing data 
56 7.00 Missing data Missing data 
57 3.00 8.00 3.00 
58 Missing data Missing data Missing data 
59 2.00 3.00 Missing data 
60 2.00 . 00 Missing data 
61 7.00 3.00 Missing data 
62 Missing data Missing data Missing data 
Abdominal pain assessed usin the ISS uestionnaire 
1 4.00 Missing data 
2 6.00 5.00 
3 2.00 3.00 
4 4.00 . 00 
5 3.00 2.00 
6 
7 
4.00 
3.00 
Missing data 
1.00 
8 3.00 3.00 
9 
10 
5.00 
3.00 
3.00 
. 00 
11 2.00 1.00 
12 6.00 3.00 
13 
14 
5.00 
5.00 
1.00 
4.00 
15 5.00 5.00 
16 
17 
18 
4.00 
3.00 
4.00 
5.00 
Missing data 
6.00 
19 3.00 . 00 
20 5.00 4.00 
21 2.00 Missing data 
22 5.00 Missing data 
23 6.00 6.00 
24 2.00 5.00 
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25 4.00 Missin g data 
26 5.00 Missing data 
27 3.00 3.00 
28 1.00 . 00 
29 4.00 1.00 
30 5.00 Missing data 
31 1.00 Missing data 
32 4.00 2.00 
33 4.00 1.00 
34 6.00 Missing data 
35 2.00 1.00 
36 3.00 5.00 
37 Missing data 2.00 
38 3.00 Missing data 
39 4.00 Missing data 
40 4.00 Missing data 
41 6.00 4.00 
42 5.00 Missing data 
43 6.00 Missing data 
44 1.00 Missing data 
45 6.00 2.00 
46 1.00 . 00 
47 Missing data Missing data 
48 5.00 Missing data 
49 4.00 3.00 
50 . 00 
Missing data 
51 5.00 4.00 
52 . 00 
2.00 
53 6.00 Missing data 
54 
55 
1.00 
1.00 
Missing 
1.00 
data 
56 6.00 Missing data 
57 2.00 1.00 
58 Missing data Missing data 
59 5.00 Missing data 
60 1.00 Missing data 
61 
62 
4.00 
6.00 
Missing 
Missing 
data 
data 
Urgent nee d to defecate assessed u sing the 7-da diary 
1 5.00 5.00 Missing data 
2 4.00 4.00 1.00 
3 5.00 5.00 11.00 
4 1.00 1.00 4.00 
5 1.00 1.00 1.00 
6 5.00 5.00 Missing data 
7 . 00 . 
00 . 00 
8 9.00 9.00 4.00 
9 . 00 . 
00 1.00 
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10 2.00 2.00 1.00 
11 6.00 6.00 Missing data 
12 2.00 9.00 2.00 
13 Missing data 2.00 . 00 14 1.00 1.00 4.00 
15 1.00 1.00 . 00 16 10.00 10.00 12.00 
17 . 00 . 00 Missing data 18 6.00 6.00 2.00 
19 2.00 2.00 1.00 
20 . 00 . 00 2.00 21 2.00 Missing data 999.00 
22 1.00 Missing data Missing data 
23 4.00 4.00 11.00 
24 Missing data Missing data Missing data 
25 Missing data Missing data Missing data 
26 5.00 Missing data Missing data 
27 2.00 Missing data . 00 28 Missing data . 00 . 00 29 1.00 1.00 10.00 
30 . 00 . 00 Missing data 31 1.00 1.00 Missing data 
32 . 00 Missing data 1.00 33 . 00 . 00 . 00 34 3.00 3.00 Missing data 
35 1.00 1.00 3.00 
36 1.00 1.00 1.00 
37 . 00 . 00 . 00 38 . 00 Missing data Missing data 39 2.00 Missing data Missing data 
40 . 00 . 00 Missing data 41 1.00 1.00 . 00 
42 2.00 2.00 Missing data 
43 Missing data Missing data Missing data 
44 Missing data Missing data Missing data 
45 . 00 . 00 2.00 46 2.00 2.00 . 00 
47 5.00 Missing data Missing data 
48 Missing data Missing data Missing data 
49 4.00 4.00 6.00 
50 . 00 . 
00 Missin data 
51 Missing data Missing data Missing data 
52 19.00 19.00 17.00 
53 Missing data Missing data Missing data 
54 5.00 5.00 5.00 
55 Missing data Missing data Missin data 
56 . 00 Missing 
data Missing data 
57 4.00 4.00 3.00 
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58 Missing data Missing data Missin g data 
59 2.00 2.00 Missin g data 
60 1.00 1.00 Missin g data 
61 6.00 6.00 Missin g data 
62 Missing data Missing data Missin g data 
Urgent need to defecate assessed usin the ISS uestionnaire 
1 2.00 Missin g data 
2 6.00 6.00 
3 5.00 4.00 
4 5.00 4.00 
5 . 00 . 00 6 2.00 Missin g data 
7 2.00 2.00 
8 6.00 6.00 
9 4.00 3.00 
10 5.00 3.00 
11 3.00 2.00 
12 5.00 3.00 
13 5.00 3.00 
14 4.00 4.00 
15 . 00 
1.00 
16 5.00 5.00 
17 2.00 Missing data 
18 6.00 6.00 
19 2.00 4.00 
20 3.00 5.00 
21 . 00 
Missing data 
22 3.00 Missing data 
23 6.00 6.00 
24 
25 
4.00 
4.00 
5.00 
Missing data 
26 5.00 Missing data 
27 
28 
29 
2.00 
5.00 
4.00 
1.00 
5.00 
5.00 
30 
31 
. 00 
. 00 
Missing 
Missing 
data 
data 
32 5.00 . 00 
33 2.00 5.00 
34 5.00 Missing data 
35 2.00 2.00 
36 
37 
38 
39 
2.00 
Missing data 
1.00 
5.00 
4.00 
4.00 
Missing 
Missing 
data 
data 
40 
41 
5.00 
4.00 
Missing 
5.00 
data 
42 4.00 Missing data 
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43 2.00 Missin g data 
44 . 00 
Missin g data 
45 4.00 6.00 
46 . 00 . 
00 
47 3.00 Missing data 
48 3.00 Missing data 
49 5.00 4.00 
50 . 00 
Missing data 
51 5.00 4.00 
52 4.00 4.00 
53 1.00 Missing data 
54 5.00 Missing data 
55 
56 
1.00 
6.00 
1.00 
Missing data 
57 . 00 
2.00 
58 Missing data Missing data 
59 4.00 Missing data 
60 
61 
62 
1.00 
6.00 
4.00 
Missing 
Missing 
Missing 
data 
data 
data 
Feelin gs of incomplete evacuation assessed using the 7-da diary 
1 5.00 1.00 Missing data 
2 2.00 3.00 . 00 
3 8.00 5.00 . 00 
4 4.00 . 00 
1.00 
5 . 00 . 
00 . 00 
6 5.00 1.00 Missing data 
7 . 00 . 
00 . 00 
8 . 00 
1.00 . 00 
9 2.00 1.00 . 00 
10 6.00 . 00 . 
00 
11 7.00 18.00 Missing data 
12 13.00 2.00 . 00 
13 Missing data 1.00 . 00 
14 3.00 . 00 1.00 
15 6.00 1.00 . 00 
16 8.00 23.00 8.00 
17 1.00 1.00 Missing data 
18 5.00 6.00 2.00 
19 4.00 3.00 1.00 
20 . 00 . 
00 . 00 
21 . 00 
Missing data Missing data 
22 2.00 Missing data Missing data 
23 16.00 1.00 20.00 
24 Missing data Missing data Missin data 
25 Missing data Missing data Missing data 
26 3.00 Missing data Missing data 
27 . 00 
Missing data . 00 
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28 Missing data . 00 . 00 
29 . 00 . 00 . 00 30 13.00 10.00 Missing data 
31 1.00 . 00 Missing data 32 . 00 Missing data . 00 33 2.00 . 00 1.00 34 2.00 2.00 Missing data 
35 4.00 2.00 . 00 36 3.00 6.00 1.00 
37 . 00 . 00 . 00 38 3.00 999.00 999.00 
39 1.00 999.00 Missing data 
40 1.00 3.00 Missing data 
41 9.00 3.00 1.00 
42 1.00 1.00 Missing data 
43 Missing data Missing data Missing data 
44 Missing data Missing data Missing data 
45 1.00 1.00 1.00 
46 4.00 4.00 5.00 
47 2.00 Missing data Missing data 
48 Missing data Missing data Missing data 
49 2.00 3.00 . 00 
50 . 00 . 
00 Missing data 
51 Missing data Missing data Missin data 
52 14.00 27.00 28.00 
53 Missing data Missing data Missing data 
54 2.00 4.00 . 00 
55 Missing data Missing data Missing data 
56 1.00 Missing data Missing data 
57 11.00 10.00 3.00 
58 Missing data Missing data Missing data 
59 . 00 . 00 
Missing data 
60 2.00 . 00 
Missing data 
61 2.00 3.00 Missing data 
62 Missing data Missing data Missing data 
Feelings of incomplete evacuation assessed usin the ISS uestionnaire 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
4.00 
6.00 
5.00 
4.00 
. 00 4.00 
4.00 
1.00 
4.00 
4.00 
5.00 
6.00 
Missing data 
6.00 
4.00 
. 00 
. 00 
Missing data 
. 00 
. 00 2.00 
1.00 
4.00 
4.00 
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13 6.00 2.00 
14 5.00 4.00 
15 4.00 4.00 
16 5.00 6.00 
17 1.00 Missing data 
18 6.00 6.00 
19 3.00 . 00 
20 2.00 4.00 
21 4.00 Missing data 
22 3.00 Missing data 
23 6.00 6.00 
24 4.00 5.00 
25 3.00 Missing data 
26 3.00 Missing data 
27 1.00 1.00 
28 5.00 5.00 
29 4.00 4.00 
30 5.00 Missing data 
31 . 00 
Missing data 
32 5.00 2.00 
33 6.00 6.00 
34 5.00 Missing data 
35 2.00 1.00 
36 3.00 6.00 
37 Missin data 4.00 
38 4.00 Missin data 
39 1.00 Missing data 
40 1.00 Missing data 
41 6.00 5.00 
42 5.00 Missing data 
43 3.00 Missing data 
44 4.00 Missing data 
45 5.00 6.00 
46 3.00 3.00 
47 3.00 Missing data 
48 2.00 Missing data 
49 4.00 2.00 
50 . 00 
Missing data 
51 5.00 5.00 
52 2.00 4.00 
53 1.00 Missing data 
54 6.00 Missin data 
55 6.00 4.00 
56 6.00 Missing data 
57 3.00 4.00 
58 Missing data Missing data 
59 4.00 Missing data 
60 3.00 Missing data 
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61 4.00 Missin data 
62 6.00 issing data 
Flatulence assessed using the 7-da diary 
1 5.00 1.00 Missing data 
2 9.00 10.00 4.00 
3 25.00 21.00 20.00 
4 2.00 . 00 3.00 5 6.00 2.00 2.00 
6 5.00 1.00 Missing data 
7 10.00 6.00 10.00 
8 6.00 12.00 6.00 
9 4.00 1.00 3.00 
10 1.00 . 00 1.00 
11 21.00 9.00 Missing data 
12 9.00 5.00 1.00 
13 Missing data 1.00 . 00 
14 . 00 . 
00 1.00 
15 11.00 5.00 5.00 
16 5.00 6.00 6.00 
17 4.00 5.00 Missing data 
18 15.00 10.00 33.00 
19 2.00 3.00 3.00 
20 . 00 2.00 
2.00 
21 13.00 Missing data Missing data 
22 4.00 Missing data Missing data 
23 12.00 21.00 3.00 
24 Missing data Missing data Missing data 
25 Missing data Missing data Missing data 
26 10.00 Missing data Missing data 
27 1.00 Missing data 2.00 
28 Missing data 3.00 . 00 
29 . 00 . 
00 . 00 
30 14.00 8.00 Missing data 
31 6.00 . 00 Missing data 
32 1.00 Missing data 1.00 
33 10.00 4.00 21.00 
34 2.00 2.00 Missin data 
35 8.00 6.00 4.00 
36 7.00 23.00 . 00 
37 . 00 . 
00 . 00 
38 4.00 Missing data Missing data 
39 1.00 Missing data Missing data 
40 2.00 15.00 Missing data 
41 11.00 16.00 9.00 
42 4.00 4.00 Missing data 
43 Missing data Missing data Missing data 
44 Missing data Missing data Missing data 
45 2.00 3.00 5.00 
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46 9.00 15.00 9.00 
47 . 00 
Missing data Missing data 
48 Missing data Missing data Missing data 
49 9.00 1.00 . 00 
50 17.00 1.00 Missing data 
51 Missing data Missing data Missing data 
52 12.00 13.00 27.00 
53 Missing data Missing data Missing data 
54 48.00 17.00 19.00 
55 Missing data Missing data Missing data 
56 5.00 Missing data Missing data 
57 19.00 19.00 6.00 
58 Missing data Missing data Missing data 
59 . 00 . 
00 Missing data 
60 1.00 2.00 Missing data 
61 1.00 . 00 Missing 
data 
62 Missing data Miss in data Missing data 
Flatulence assessed using the ISS uestionnaire 
1 5.00 Missing data 
2 6.00 6.00 
3 5.00 5.00 
4 4.00 3.00 
5 
6 
1.00 
5.00 
3.00 
Missing data 
7 
8 
9 
10 
11 
6.00 
3.00 
5.00 
5.00 
6.00 
6.00 
5.00 
4.00 
1.00 
5.00 
12 4.00 4.00 
13 
14 
6.00 
2.00 
6.00 
1.00 
15 
16 
3.00 
5.00 
4.00 
5.00 
17 
18 
19 
20 
21 
22 
23 
24 
25 
5.00 
6.00 
2.00 
2.00 
5.00 
1.00 
6.00 
5.00 
3.00 
Missing data 
6.00 
1.00 
4.00 
Missing data 
Missing data 
6.00 
5.00 
Missing data 
26 
27 
28 
5.00 
1.00 
5.00 
Missing data 
1.00 
2.00 
29 . 00 
1.00 
30 5.00 Missin data 
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31 4.00 Missin g data 
32 6.00 5.00 
33 4.00 6.00 
34 5.00 Missin g data 
35 4.00 3.00 
36 5.00 6.00 
37 Missin data 3.00 
38 6.00 Missin g data 
39 5.00 Missing data 
40 5.00 Missing data 
41 6.00 6.00 
42 6.00 Missing data 
43 4.00 Missing data 
44 5.00 Missing data 
45 3.00 4.00 
46 6.00 6.00 
47 
. 00 Missing data 48 3.00 Missing data 
49 5.00 2.00 
50 2.00 Missing data 
51 6.00 5.00 
52 3.00 3.00 
53 1.00 Missing data 
54 6.00 Missing data 
55 6.00 4.00 
56 6.00 Missing data 
57 5.00 4.00 
58 Missing data Missing data 
59 3.00 Missing data 
60 4.00 Missing data 
61 3.00 Missing data 
62 5.00 Missing data 
SYMPTOM FREQUENCY 
TOTAL SYMPTOMS -7 DAY DIARY 
There was a reduction in total symptom frequency from pre intervention (30.71, SD 
21.7) to immediately post the intervention (22.68, SD 21.4). A paired samples t-test 
revealed that this reduction was significant t(37) = 2.974, p<0.005. Therefore the 
first hypothesis was supported. 
There was a reduction in total symptom frequency from pre intervention (28.65, SD 
21) to two months post the intervention (18.77, SD 12.5). A paired samples t-test 
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revealed that this reduction was significant t(25) = 3.332, p<0.005. Therefore the 
second hypothesis was supported. 
Although there was a reduction in total symptom frequency from immediately post 
intervention (22.88, SD 21) to two months post the intervention (17.96, SD 13.7) this 
was not found to be significant. However, as there was no significant increase in 
symptoms it does show that symptom improvements at phase 2 (immediately post 
the intervention) were maintained at phase 3 (two months after the intervention) 
INDIVIDUAL SYMPTOMS -7 DAY DIARY 
The only significant changes observed for individual symptoms were for constipation 
and diarrhoea. However reductions in feelings of incomplete evacuation and 
abdominal pain were approaching significance (were significant prior to the 
application of the Bonferroni correction). The change in diarrhoea was between 
immediate post intervention (2.03, SD 2.9) and at two months post intervention 
(0.62, SD 1.1). A paired samples t-test revealed that this reduction was significant 
t(28) = 2.698, p<0.05. Reductions between pre intervention and two months post 
intervention were approaching significance (were significant prior to the application 
of the Bonferroni correction). The change in constipation was also between 
immediate post intervention (1.73, SD 3.2) and at two months post intervention 
(0.83, SD 1.3). A paired samples t-test revealed that this reduction was significant 
t(29) = 2.638, p<0.05. 
TOTAL SYMPTOMS - ISS QUESTIONNAIRE 
The ISS was not included in the immediate post intervention pack, but there was a 
reduction in total symptom frequency from pre intervention (24.93 SD 6.6) to two 
months post the intervention (21.66, SD 9.2). A paired samples t-test revealed that 
this reduction was significant t(33) = 2.433, p<0.05. This provides additional 
support for hypothesis 2, that total symptom frequency was reduced at two months 
post intervention. The ISS and the symptom diary were correlated r= . 398, p<0.05. 
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INDIVIDUAL SYMPTOMS - ISS QUESTIONNAIRE 
Three of the individual symptoms were found to reduce from pre intervention to two 
months post intervention. This was for abdominal pain (pre intervention 3.58, SD 1.7 
- two months post intervention 2.56, SD 1.8) t(33) = 3.334, p<0.005, bloating (pre 
intervention 4.44, SD 1.5 - two months post intervention 3.53, SD 2) t(33) = 2.876, 
p<0.005, and feelings of incomplete evacuation (pre intervention 4.12, SD 1.6 - 
two months post intervention 3.41, SD 2.1) t(33) = 2.352, p<0.05. 
HRQOL 
There was a significant reduction in scores on the IBS-36 post intervention (pre 
intervention, 115.83, SD 36.9 - two months post intervention, 99.17, SD 36.5). This 
reduction was found to be significant t(34) = 4.667, p<0.0001. As a reduction in 
score indicates an improvement in HRQOL, this finding provides support for 
hypothesis three. 
THE RELATIONSHIP BETWEEN HRQOL AND SYMPTOMS 
HRQOL at two months post intervention was neither predictive nor correlated with 
total symptoms measured by the symptom diary. However, HRQOL at two months 
post intervention was predictive of total symptoms at two months post intervention 
when measured by the questionnaire R2 adj. 0.364, p<0.001. 
MEDICATION 
The improvements in HRQOL and symptoms post intervention were not as a result 
of increases in medication. In fact medication intake in the week immediately post 
the intervention (5.76, SD 8) was less than medication intake in the week preceding 
the intervention (7.24, SD 9.4). A paired samples t-test revealed that this reduction 
was significant t(36) = 2.537, p<0.05. 
CHANGES IN PERCEIVED SOCIAL SUPPORT (PSS) 
PERCEIVED ATTITUDES TO DISCUSSING SYMPTOMS 
There were significant reductions in scores on the perceived attitudes to discussing 
symptoms scale from pre intervention (35.15, SD 11.5) to post intervention (29.75, 
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SD 9.3). A paired samples t-test revealed that this reduction was significant t(51) _ 
3.267 
,p<0.005. It should be noted that lower scores on this scale indicate more 
positive perceptions, which is the IBS sufferers perceived people as being more 
prepared to discuss their symptoms after the intervention. There were no significant 
reductions from pre intervention to two months post intervention or for immediately 
post intervention to two months post intervention. Whilst there were no significant 
reductions in scores as there was no significant increase it does show that 
improvements in perceived attitudes to discussing symptoms is maintained at phase 3 
(two months after the intervention). 
PERCEIVED ATTITUDES TO WITNESSING SYMPTOMS 
There were significant reductions in scores on the perceived attitudes to witnessing 
symptoms scale from pre intervention (35, SD 10.6) to post intervention (30.2, SD 
9.1). A paired samples t-test revealed that this reduction was significant t(39) = 
13.961 ,p<0.0001. It should be noted that 
lower scores on this scale indicate more 
positive perceptions, which is the IBS sufferers perceived people as being more 
prepared to witness their symptoms after the intervention. There were no significant 
reductions from pre intervention to two months post intervention or for immediately 
post intervention to two months post intervention. Whilst there were no significant 
reductions in scores as there was no significant increase it does show that 
improvements in perceived attitudes to discussing symptoms is maintained at phase 3 
(two months after the intervention). 
PERCEIVED SOCIAL SUPPORT CONCESSION SCALE AND PERCEIVED 
SOCIAL ACTIVITY SCALE 
There were no significant improvements in the responses to the social support 
concessions scale or the social activity scale at either immediately post intervention 
or at two months post intervention. 
PERCEIVED SOCIAL SUPPORT (PSS) AND ILLNESS 
OUTCOMES 
A series out multiple regressions were conducted (with attitudes towards discussing 
and witnessing symptoms as predictors) to explore the relationship between 
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perceived attitudes and illness outcomes. Neither attitudes towards discussing or 
witnessing symptoms were predictive of symptom outcomes (on either the ISS or 
daily diary) immediately post intervention. Attitudes towards discussing symptoms 
were also not predictive of any of the illness outcomes at two months post 
intervention. However, attitudes towards witnessing symptoms at two months post 
the intervention were predictive of HRQOL, that is quality of life increased as 
attitudes towards witnessing symptoms were perceived as being more positive, R2 
adj. 0.273, p<0.05. Attitudes towards witnessing symptoms at two months post the 
intervention were also predictive of total symptoms, on both the diary, R2 adj. 0.277, 
0 0.673, p<0.05, and the ISS, R2 adj. 0.185,0 0.581, p<0.05. 
CHANGES IN THE ILLNESS REPRESENTATION 
COMPONENTS 
Paired samples t-tests revealed a number of significant changes between pre 
intervention, immediately post intervention and two month post the intervention on 
several of the illness representation dimensions. All of these significant changes were 
in the direction anticipated, that is where lower scores were associated with more 
positive representations lower scores were found post intervention, and when higher 
scores were associated with more positive representations higher scores were found 
post intervention. The significant illness representation components, means and 
significance levels are shown in tables 22 and 23. 
Table 22 - Illness representation components pre intervention and significant 
changes immediately post intervention 
ILLNESS PRE POST t df p 
REPRESENTATIONS INTERVENTION INTERVENTION 
MEAN MEAN 
CHRONIC 25.96 SD 3.1 24.71 SD 3.7 4.547 44 0.0001 
TIMELINE 
PERCEIVED 17.98 SD 3.6 19.85 SD 3.2 3.850 46 0.0001 
PERSONAL 
CONTROL 
EMOTIONAL 21.58 SD 4.8 19.82 SD 5.4 2.854 45 0.01 
REPRESENTATIONS 
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As table 22 demonstrates there were three significant improvements in illness 
representations immediately post the intervention, these were in chronic time line, 
perceived personal control and emotional representations. Illness coherence was also 
approaching significance (was significant prior to the Bonferoni correction). 
Table 23 - Illness representation components pre intervention and significant 
changes at two months post intervention 
ILLNESS PRE 2 MONTHS t df p 
REPRESENTATIONS INTERVENTION POST 
MEAN INTERVENTION 
MEAN 
CHRONIC 26.37 SD 3.2 24.66 SD 3.8 2.908 31 0.01 
TIMELINE 
PERCEIVED 18.47 SD 3.7 19.85 SD 3 2.638 33 0.05 
PERSONAL 
CONTROL 
EMOTIONAL 21.58 SD 5.8 19.73 SD 4.6 3.295 32 0.005 
REPRESENTATIONS 
ILLNESS 16.23 SD 4.2 13.31 SD 4 5.166 34 0.0001 
COHERENCE 
ILLNESS IDENTITY 22.97 SD 2.5 21.3 SD 2.1 3.169 32 0.005 
As table 23 demonstrates five illness representations showed significant 
improvements from pre intervention to immediately post the intervention, these were 
in chronic time line, perceived personal control, illness coherence, emotional 
representations and illness identity. The only components of illness representations 
which did not alter were cyclical timeline, perceived consequences and perceived 
treatment control. 
The only significant change from immediately post intervention (mean 23.39, SD 
2.3) to two months post intervention (mean 21.33, SD 2.1) was illness identity, t(32) 
= 6.338, p<0.0001. However, there were no significant decreases in any of the 
illness representations either, therefore the changes immediately post intervention 
were maintained at two month follow up. 
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REPORTED CHANGES AT TWO MONTHS POST 
INTERVENTION 
The short post intervention questionnaire asked people to report if they had made any 
changes as a result of taking part in the intervention. Data was available for 23 
participants. Of these three did not report any changes, of the other twenty 
participants some reported only one, whereas others reported more than one. As no 
meaningful information can be derived from this questionnaire in a statistical sense, 
the responses are just listed in the frequency table, table 24. 
Table 24 - Reported changes at two months post intervention 
Change made Number Psychological change 
of or practical change 
people 
Dietary alterations 5 practical 
Feeling empowered to make changes to 1 psychological 
effect IBS 
Making a conscious effort to use 2 psychological & 
relaxation techniques practical 
Trying to have less anxiety about 3 psychological 
symptoms 
Concentrating on the positive aspects 5 psychological 
about having IBS 
Making efforts to deal with stress 3 psychological 
Removing key stressors 2 practical & 
psychological 
Trying alternative therapies 2 practical 
Taking time for myself 1 psychological 
Improved communication with GP 1 practical & 
psychological 
Not letting IBS affect my [perceived] 2 psychological 
quality of life 
Undergoing further medical tests 2 practical 
Cognitive Behavioural Treatment 2 psychological & 
practical 
Exercise 2 practical 
Obtain information from IBS Network 1 practical 
about IBS 
Hypnosis 1 practical & 
s cholo ical 
Acceptance of past experiences, and 1 psychological 
trying to let go 
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As table 24 demonstrates the varied nature of the booklet means that different 
sources of advice appeal to different participants. Some of these changes are 
practical, some psychological and some a combination. Where there is a combination 
the dominant feature is listed first. The two changes which are tied for most 
frequently mentioned are dietary changes and positive thinking. 
THE RELATIONSHIPS BETWEEN ILLNESS 
REPRESENTATIONS AND ILLNESS OUTCOMES 
Based on the original rationale for this research the final stage of the analysis was to 
assess if the increase in positive illness representations was predictive of the 
improvement in symptoms and HRQOL following the intervention. Therefore a 
series of hierarchical multiple regressions were conducted to assess the relationships 
between variables both immediately following the intervention and at two months 
post the intervention. As there is insufficient power in this sample to include all of 
the predictor variables in the analysis the regression only used a handful. The 
decision as to which variables were used was based on the analysis presented earlier 
in this chapter showing which representations change from pre to post intervention. 
Accordingly the predictors used to assess change from pre to immediately post the 
intervention were: chronic timeline, personal control and emotional representations. 
For this hierarchical multiple regression the dependent variable was change in illness 
perceptions from time 1 (pre intervention) to time 2 (immediately post intervention). 
Accordingly the predictor variables at time one were entered in block one and the 
time two variables in block two. The predictors used to assess change from pre to 
two months post the intervention were chronic timeline, personal control, emotional 
representations, illness coherence and illness identity. For this hierarchical multiple 
regression the dependent variable was change in illness perceptions from time I (pre 
intervention) to time 3 (immediately post intervention). Accordingly the predictor 
variables at time one were entered in block one and the time three variables in block 
two. 
The multiple regressions that were conducted were as follows: 
1) Illness representations and total symptoms using the daily diary (pre to 
immediately post the intervention) 
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2) Illness representations and individual symptoms using the daily diary (pre to 
immediately post the intervention) 
3) Illness representations and total symptoms using the daily diary (pre to two 
months post the intervention) 
4) Illness representations and individual symptoms using the daily diary (pre to two 
months post the intervention) 
5) Illness representations and total symptoms using the ISS questionnaire (pre to two 
months post the intervention) 
6) Illness representations and individual symptoms using the ISS questionnaire (pre 
to two months post the intervention) 
7) Illness representations and HRQOL at two months post the intervention 
ILLNESS REPRESENTATIONS AND TOTAL SYMPTOMS 
There were no significant relationships between illness representations either 
immediately post the intervention or at two months. The finding of non significance 
was reported using both the diary and questionnaire measures. 
ILLNESS REPRESENTATIONS AND INDIVIDUAL SYMPTOMS 
There were no significant predictors of change in any of the individual symptoms 
between pre intervention and immediately post the intervention. There were also no 
significant predictors of change for pre and two months post the intervention. 
ILLNESS REPRESENTATIONS AND IIRQOL 
There were no significant predictors of HRQOL at two months, after pre intervention 
scores had been partialed out. 
NB the IBS-36 questionnaire (Groll et al., 2002, appendix 2) used to assess HRQOL 
asks participants to average their responses based on their experiences over the 
previous two months. This is therefore not suitable for assessment of change 
immediately post the intervention, as an average score of the previous two months 
will cover largely the same time period as the pre-intervention questionnaire. 
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INTER - ITEM CORRELATIONS BETWEEN ILLNESS 
REPRESENTATIONS COMPONENTS 
The final stage of the analysis was to explore the relationships between the illness 
representation components both immediately post intervention and at two months 
post intervention, in both cases Pearsons' revealed several variables were highly 
correlated. The inter-item correlations for immediately post the intervention are 
shown in table 25 and the inter-item correlations for two months post the intervention 
are shown in table 26. NB only the variables which have significant correlations are 
shown. 
Table 25 - Inter-item correlations between illness representation components 
immediately post intervention 
Perceived Perceived 
Perceived personal Timeline Emotional treatment Timeline 
consequences control (cyclical) reps. control (chronic) 
Perceived 
consequences 
Perceived 
personal -. 350 (*) 
control n=45 
Timeline 0.188 -. 090 
(cyclical) n=45 n=47 
Emotional . 583 (**) -. 115 . 
236 
reps. n=45 n=47 n=47 
Perceived 
treatment -. 349 . 578 (**) -. 168 -. 
122 
control n=29 n=30 n=30 n=30 
Timeline . 262 -. 
263 -. 067 . 145 -. 501 (**) 
(chronic) n=44 n=46 n=46 n=46 n=29 
Illness . 189 -. 147 . 327 (*) . 
187 -0.93 -. 183 
coherence n=44 n=46 n=46 n=46 n=29 n=45 
Correlation is significant at the 0.01 level (2 tailed) 
9 Correlation is significant at the 0.05 level (2 tailed) 
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Table 26 - Inter-item correlations between illness representation components at 
two months post intervention 
Perceived Perceived Timeline Emotional Perceived Timeline Illness 
consequences personal (cyclical) reps. treatment (chronic) identity 
control control 
Perceived 
consequences 
Perceived -. 143 
personal n=34 
control 
Timeline 
. 063 . 064 (cyclical) n=34 n=33 
Emotional 
. 494 (**) -. 249 0.163 
reps. n=33 n=33 n=33 
Perceived -. 081 . 737 (**) . 233 -. 176 treatment n=33 n=33 n=32 n=32 
control 
Timeline -. 105 -. 361 (*) . 096 -. 110 -. 365 (*) (chronic) n=32 n=32 n=31 n=31 n=31 
Illness -. 354 (*) . 164 -. 264 -. 443 (*) 0.87 -0.81 identity n=33 n=32 n=32 n=31 n=31 n=31 
** Correlation is significant at the 0.01 level (2 tailed) 
* Correlation is significant at the 0.05 level (2 tailed) 
The inter-item correlations reported here are consistent with previous research as 
they demonstrate that there are significant inter-item correlations between some of 
the illness representation dimensions (measured by the IPQ-R). Importantly they 
show that none of the inter-item correlations are of such magnitude that they indicate 
a conceptual overlap demonstrating the legitimacy of the multiple dimensions of 
illness representations, rather than a global representation of illness (Hagger & 
Orbell, 2003) 
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DISCUSSION 
SUMMARY OF FINDINGS 
As the results section details there are a number of significant research findings. The 
first findings relate to the change in symptoms post intervention. There were 
significant reductions in symptom frequency (assessed using the diary) from both pre 
intervention to immediately post intervention, and from pre intervention to two 
months post intervention. In addition there was also a significant reduction in 
symptom frequency from pre intervention to two months post intervention using the 
ISS (symptom questionnaire). Therefore hypothesis one, that there would be a 
reduction in symptom frequency immediately following the intervention was 
supported. Hypothesis two, that there would be a reduction in symptom frequency 
from pre the intervention to two months post the intervention, was also supported by 
both the diary and the perceived frequency of symptoms using the ISS. The ISS and 
the 7 day diary were found to be correlated, this is an important finding as 
theoretically the sufferers' perceptions of their symptom frequency may have 
differed from their actual symptoms. This suggests that the ISS is therefore a suitable 
measure for assessing symptom frequencies where using a diary based format is not 
practical. 
The exploratory research question as to whether there would be significant 
reductions between immediately post the intervention and two months post the 
intervention was not found to be significant. Although this was not found to be 
significant there was still a reduction in symptoms, this suggests that symptoms did 
continue to improve after the intervention. At the very least the lack of a significant 
difference in the opposite direction demonstrates that symptoms did not revert back 
to pre intervention frequencies after the intervention. These research findings have 
important implications for the future of treatment research in IBS as they strongly 
suggest that this intervention booklet is efficacious at reducing symptom frequency, 
at least in the short term, this is consistent with a number of other psychologically 
based research, such as Blanchard et al. (1993) and Heyman-MSnnikes et al. (2000). 
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Using the 7 day diary there were significant reductions in diarrhoea and constipation. 
The reductions in diarrhoea occurred between pre intervention and two months post 
intervention. The reductions in constipation occurred between immediately post 
intervention and two months post intervention. These were the only symptoms that 
were significant after the Bonferoni correction had been employed, and on this basis 
it can be suggested that the amount of symptoms suffered for each of the individual 
symptoms was too low for there to be sufficient power to detect changes. This is why 
Dancey et at. (1995; 1998) propose that computation of total symptom scores is the 
only meaningful measure of IBS symptoms. Using the ISS there were also significant 
changes in reported frequency of symptoms between pre intervention and two 
months post intervention. These were for abdominal pain, bloating and feelings of 
incomplete evacuation. Although none of these symptoms were significant using the 
diary, both abdominal pain and feelings of incomplete evacuation were approaching 
significance, this provides further support for the likelihood that there were 
significant changes in multiple symptoms, but there was insufficient power to detect 
it in this instance. 
There was a significant improvement in HRQOL from pre intervention to two 
months post intervention and therefore, hypothesis three was supported. The 
improvement in HRQOL is consistent with previous research, such as Gonsalkorale 
et al. (2002) and Boyce et al. (2000). 
The relationship between HRQOL and total symptom frequency at two months post 
the intervention differed as a function of the measure used to assess symptom 
frequency. Consistent with the findings of study 2, and of Brennan et al. (2004) but 
inconsistent with the findings in study 1 HRQOL was neither predictive nor 
correlated with symptoms when the diary was used as the outcome measure. In the 
limitations of study 2 it was suggested that this may have been a result of the 
measure rather than a relationship not existing. This idea is supported by the finding 
here that HRQOL significantly predicted symptom frequency when the ISS was 
used. However, it should be noted that the ISS technically measures perceived 
symptom frequency, and in this respect the predictive relationship could potentially 
be a result of perceived HRQOL being correlated with perceived symptom 
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frequency, rather than actual symptom frequency. This concern is however made less 
likely by the observed correlation of the diary and the ISS. 
The finding that medication use significantly decreased immediately post the 
intervention is important as it shows that the improvements in symptoms were purely 
as a result of the changes in the illness representation dimensions, and not due to 
increased symptom usage. Moreover it provides further support for the observed 
finding that symptoms decrease, because it logically follows that if symptoms are 
less that less medication will be taken. Although there were no further reductions in 
medication use from immediately post intervention to two months post intervention, 
there were no significant increases either. This means that medication decreases 
following the intervention were maintained up till at least two month follow up. This 
finding is again consistent with the maintenance of symptom improvements from 
immediately post to two months post intervention. 
There were changes in perceived social support in both the discussing and witnessing 
symptoms scale from pre intervention to immediately post intervention. Although 
there were no further changes from post intervention to two months post 
intervention, the improvements were maintained. In order to evaluate the impact on 
perceived social support on illness outcomes a series of multiple regressions were 
conducted. There were no significant relationships between perceptions of discussing 
symptoms and illness outcomes (HRQOL and symptoms). However perceived 
attitudes towards witnessing symptoms at two months post intervention were 
predictive of HRQOL and total symptom frequency (on both the diary and ISS). 
Although study 2 suggested that the only predictive relationship was between 
perceived attitudes towards witnessing symptoms and HRQOL, this study strongly 
suggests that perceived attitudes towards witnessing symptoms do affect symptoms 
too. This supports the notion that this relationship existed in study 2 but that this was 
not revealed due to insufficient power in the previous study. 
There were changes in the illness representation components at pre and post 
intervention, pre and two months post the intervention and post and two months post 
the intervention. All of the changes were denoted a positive improvement (although 
dimensions are counterbalanced so scores on some variables are negative). The only 
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illness representations that did not change at all were cyclical timeline, perceived 
consequences and perceived treatment control. The illness representations that 
changed between pre and immediately post the intervention were chronic timeline, 
perceived personal control and emotional representations. These same illness 
representations changed between pre and two month post and in addition illness 
coherence and illness identity also improved. These findings demonstrate that the 
intervention booklet did in fact adhere rigidly to the principles of the CSM, that 
improvements in illness representations occurred both immediately post the 
intervention and at two months post the intervention, and moreover that both illness 
coherence and illness identity were additionally significant at two months post 
intervention, suggesting that participants continued to gain a better understanding of 
their IBS following the intervention. Only illness identity significantly improved 
from immediately post intervention to two months post intervention, and illness 
coherence was significant prior to the Bonferoni correction. 
Participants were asked to list any changes they had made between the intervention 
and two months post the intervention. From the twenty three participants who 
returned the post intervention forms a total of seventeen different changes were 
reported. This is interesting as it shows that the booklet inspired different changes in 
different individuals. Of these changes the two changes that were most frequent were 
dietary alterations, and concentrating of the positive aspects of IBS. The decision to 
concentrate on the positive aspect of IBS is consistent with the aims of the CSM, and 
also with similar changes, such as having less anxiety over symptoms, and not letting 
IBS affect my quality of life. There were some dietary alterations suggested, 
although this was not the focus of the self-help booklet, however, this change is 
unsurprising as dietary alterations form a large part of IBS sufferers' self- 
management approaches (e. g. Atkinson et al., 2004). It is unfortunately not possible 
to tell whether these dietary changes were as a result of the advice in the booklet, or 
an alternative way of managing symptoms. Regardless to the reason however it does 
suggest a more positive self-management strategy and this is clearly related to the 
changes in illness representations. 
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There were no significant predictors of change between pre intervention and post 
intervention (either immediately post or at two months post intervention) for total 
symptoms or for individual symptomd (on both measures). There were no significant 
predictors of change between pre intervention and two months post intervention for 
HRQOL. More research is needed to ascertain if the lack of significance if a true 
finding or due to a methodological factor, such as a insufficient power. 
It was hoped that as so many of the illness representations changed from pre to post 
intervention that there would be predictors of both symptoms and HRQOL at both 
immediately post the intervention and at two months post the intervention. Although 
the lack of multiple predictors in might be partly explained by the number of illness 
representation dimensions that are correlated, it may also be the result of another 
variable mediating the relationship between illness representations and illness 
outcomes. Coping has been shown by previous research to mediate this relationship 
(Rutter & Rutter, 2002), and therefore its role should be addressed more thoroughly 
in subsequent research. 
STUDY LIMITATIONS 
The number of participants in this study could be considered a limitation, and indeed 
in the original design of the research it was intended that an approximate sample size 
of n=110 would be attempted as this is the number of participants recommended to 
detect medium sized effects (GPower, Erdfelder et al., 1996). However, as many 
significant findings were yielded it can be suggested both that low participant 
numbers are not as much of a limitation and moreover that the effect sizes found in 
this research were large. In addition participant numbers are not low compared to 
participant numbers reported in previous psychologically based intervention research 
in IBS specifically. In fact as the systematic review in chapter 3 showed only thirteen 
of the forty two papers included in the study involved more than 60 participants. The 
main weakness of the low participant numbers, with a highly female bias was that is 
was not possible to legitimately assess any grouping variables, in particular an 
investigation of differences in efficacy of the intervention between males and 
females, IBS-subgroups and length of time suffering from IBS would also be useful. 
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The participant drop outs could also be considered a potential limitation, but as the 
method section details the characteristics in phases two and three are almost identical 
to the participant characteristics in the phase one the drop outs should not be 
considered to be troublesome. However, although the analysis of the data from 
participants who did not return their research packs suggests that the demographic 
characteristics are the same as those who did the responses from sufferers detailing 
why they did not participate includes reasons such as `too ill', `not enough time' and 
`did not want to take part in psychologically based research'. These responses are 
concerning as they suggest that sufferers who experience more symptoms, who are 
not prepared to engage in self-management behaviours and those who do not accept a 
biopsychosocial approach to chronic illness as not going to participate in this 
research. Therefore although the characteristics of those who participated and those 
who did not appear to be the same it is possible that those sufferers with different 
characteristics were the ones who did not even fill in the `non-responder' 
questionnaire, therefore although the results of this study may be generalisable to 
IBS sufferers as a whole they should be treated with caution until further research 
can support these claims. It should also be noted that five out of the twenty eight 
`drop outs' reported `finding out that they had something other than IBS'. This is 
concerning as potentially participants used in the analysis may later discover that 
they did not in fact suffer from IBS, this is an idea discussed further in the general 
discussion. However, from the stance of this study the intervention does appear to be 
highly successful and if some of the participants discovered that their symptoms 
were not in fact IBS as a later date this only serves to justify the utility of the CSM 
model across a range of illnesses. In addition an interesting point that is raised by the 
participant dropouts is that the proportion of IBS-D sufferers that `dropped out' was 
much less, and therefore further exploration as to whether the bias towards IBS-D 
sufferers participating in research that is often observed (e. g. Rutter & Rutter, 2002) 
is worthy of further investigation. 
There are no major limitations to the IBS booklet itself, although in order to ensure 
that it remains relevant it does need to be updated as new research findings emerge. 
The main limitation of the booklet is in its use in this research specifically. The 
limitation is that except for a few cases the intervention booklets were not returned. It 
should be noted that this was a conscious decision whereby participants were 
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informed that the booklet would be confidential. It was felt that this was necessary in 
order for the intervention booklet to be completed honestly, as the success of the 
intervention relied on people realising and changing their illness representations. 
However, the few booklets that participants chose to return showed a marked 
difference in the detail of the responses, in one case where a participant was asked to 
list positive aspects of having IBS the response was "there are none". It is therefore a 
limitation not to have the intervention booklets returned as it is theoretically likely 
that the intervention would be more successful for sufferers who engaged with the 
booklet, unfortunately this could not be assessed here. 
In studies 1 and 2 it was discussed that the use of diaries to report symptom 
outcomes might be considered a limitation, because although it is an objective 
measure it is difficult to show improvements in symptom outcomes over a one week 
period. However, the improvements in total symptom frequency both immediately 
post the intervention and at two months post the intervention suggest that it in fact is 
a suitable measure. However, despite Meissner et at. (1997) contention that a 
symptom diary should be considered the gold standard for assessing symptoms, the 
significant reduction in symptoms observed when the ISS was used, coupled with its 
correlation with the diary suggest that this is an equally suitable measure. The 
limitation to the ISS in the context of this study, however, is that is was only 
administered at two months post intervention. Although it could have and should 
have been administered one week after the intervention (as it asked about symptoms 
over the previous week) it was not, and therefore although not detrimental here as the 
diary did show that significant symptom changes were obtained, this should still be 
considered a limitation. 
Although the efficacy of the self-help book is shown here this study is arguably not 
as scientific as a true randomized control trial (RCT) in terms of its scientific quality 
(Mulrow, 1994). From a purely theoretical stance the superiority of an RCT design is 
clear, however, a number of practical constraints for IBS specifically, demonstrate 
that control groups are largely unsuitable for research into IBS. As the systematic 
review shows both prospective longitudinal (PLD) and RCT designs are prevalent. 
Although it therefore appears that either a PLD or an RCT design could have been 
employed a close reading of the study characteristics demonstrates that none of the 
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potential options for a control group are suitable. Firstly a waitlist control group (e. g. 
Blanchard et al., 1998) is not a true control as `wait group' is not homogeneous as 
the experiences and treatment experienced by sufferers prior to the intervention will 
show a marked degree of variability depending on symptom fluctuations and self- 
medication practices. Secondly a waitlist control, where normal medical care is 
suspended (e. g. Bennet and Wilkinson, 1995) is unsuitable because, as the Bennet 
and Wilkinson (1995) study showed any improvements in symptoms post 
intervention are attributed to an increase in symptoms following suspension of 
medical care. Therefore in addition to not being a suitable control group this also has 
ethical considerations. Thirdly a symptom monitoring control, which was used in a 
majority of early research (e. g. Blanchard et al., 1987) has been shown in increase 
symptoms, and has suggested by Blanchard et al. (1987) to be due to increasing an 
awareness of being an IBS sufferer, coupled with the frustration of being in the 
control group. The only potential control group that has any possibility of providing 
legitimate comparisons is a matched control. However, taking into account the key 
features of the illness, such as sub group, length of time suffering, sex, co-morbid 
illnesses and many other factors, a vast sample size would be needed, and as the 
systematic review demonstrates large participant numbers are not usually achieved. 
However, the difficulty of achieving a matched control group in terms of the 
resources needed is secondary to the argument that a true between subjects control 
will never be possible as within these broad categories many idiosyncratic 
differences exist. It is therefore clear that an RCT is a highly unsuitable design and 
that for research of this type the most applicable control group is the participants 
themselves, therefore the PLD design used here is the most suitable. This is a view 
supported by many previous researchers, such as, Saito et al. (2002) and Colwell et 
al. (1998). Although the use of use of a PLD means it is not possible to guarantee 
with certainty that the results are not due to placebo effects (Bengtsson et al., 2005), 
the changes observed on the illness representation components from pre to post 
intervention suggest that the changes in illness outcomes can be attributed to the 
intervention. 
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MODIFICATIONS AND FURTHER RESEARCH 
1) Due to time constraints it was not possible to reassess the efficacy of the 
intervention beyond the two month period. It would therefore be useful to reassess 
whether there have been further improvements, or at least maintenance of illness 
outcomes at six months and a year post the intervention. This is of particular interest 
for HRQOL where it is expected that improvements will not be immediate. 
2) Although the philosophy of this self-help booklet is based on it being tailored to 
the needs of the individual sufferers, this is not truly possible with a paper based 
format. There would be clear benefits to this intervention being administered on a 
website with a detailed demographic and personality questionnaire which influenced 
which information was delivered to people. Since this research was conducted the 
IBS Network have launched their self-management programme on their website, this 
validates this as a mode of presentation, but does not negate the importance of this 
booklet being presented in this way as their programme is not based on the principles 
of the CSM, which as the results show is efficacious as an intervention. 
3) The limitations regarding the completion of the booklet suggest that a 
modification could be to have a therapist working through the booklet with the 
sufferer, this will allow for each area to be fully explored and enable the therapist to 
challenge the perceptions of sufferers who are reluctant to alter their perceptions. 
4) Future research with more people and in particular using cohort sampling to 
ensure that various grouping variables can be explored would be very useful, in 
terms of assessing the efficacy of the intervention in specific groups. 
CONCLUSIONS 
The self-help booklet appears to be effective at improving IBS sufferers' illness 
representations, perceived quality of life and at reducing both actual and perceived 
symptom frequency. This study therefore provides support for the theoretical utility 
of Leventhal et al's. (1980; 1984) common sense model in the devising of illness 
interventions. It also suggests that a short self-help booklet based intervention is a 
a cost effective and easily administered way of improving IBS sufferers' health and 
quality of life for at least two months post the intervention. Although the relationship 
between illness representations and illness outcomes is worthy of further exploration 
overall this intervention was very successful. 
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CHAPTER 7 
GENERAL DISCUSSION 
Aims 
The aim of this chapter is to bring together the implications and limitations of the 
studies reported in this thesis. The first part of this chapter will discuss the overall 
findings of the studies in the context of current research in this field, and show how 
this thesis has made a valid contribution of advancing knowledge in this area. The 
second part of this chapter will discuss the limitations of this thesis along with 
suggestions for future research in this field. There are three empirical chapters to this 
thesis, all of which individually and collectively make a valid contribution to 
advancing knowledge of the CSM, and of IBS specifically. 
OVERALL FINDINGS OF THE THESIS 
DOCTOR-PATIENT COMMUNICATION 
The area of doctor-patient communication was addressed in the first study of this 
thesis. There were two primary areas of doctor-patient communication that were of 
interest, these were whether differences existed in perceptions of communication 
between doctors and patients, and whether patients' perceptions of doctor-patient 
communication were predictive of their current illness representations and illness 
outcomes. The results relating to the question of differences between doctors and 
patients were highly significant. The results showed that patients perception of 
communication were less positive than doctors on three out of four dimensions of 
doctor-patient communication. The dimensions that differed between groups were 
`distress relief, `consultation comfort', and `rapport'. The only dimension that did 
not differ between groups was `compliance intent'. The results of this research are 
consistent with the current literature in this field, and also provide a novel 
contribution as IBS specific, quantitative research addressing perceived doctor- 
patient communication is lacking. The findings observed here therefore support and 
extend the qualitative studies of Coulson & Semper (2004) and Bertram et al. (2001), 
who showed that patients have negative perceptions of doctor-patient 
communication, but did not include doctors' perceptions as a comparison. The 
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findings also support the research on functional abdominal complaints by Van 
Dulmen et al. (1995). 
In the initial design of this study it was hoped to gain sufficient participant numbers 
to compare perceptions of both GPs and gastroenterologists, however due to low 
participant numbers these were merged to form one group. As a one way analysis of 
variance showed there were no significant differences between the two groups this 
merge was deemed statistically legitimate. Upon reflection it is interesting to 
consider possible reasons why no difference was observed between groups. It is 
possible that a difference does exist but low participant numbers meant that this 
relationship was not revealed. However, it is also possible that the observed finding 
is accurate, and that despite being specialists in their field gastroenterologists' 
perceptions are comparable with GPs. Although it is not possible to conclude which 
of these (or potentially an alternative explanation) is correct, the suggestion that both 
groups perceive the communication in a similar manner is congruent with previous 
research (e. g. Letson & Dancey, 1996; Maguire, 1999). 
Overall the results clearly demonstrate that there is a discrepancy in perceptions of 
doctor-patient communication between doctors and patients. Furthermore they 
suggest that this discrepancy may be observed for medical professionals in general, 
rather than an IBS specific interaction. Although more research is clearly needed to 
fully establish the differences between medical professionals and sufferers 
perceptions of communication, in IBS specifically, it is clear that this study makes a 
valuable contribution to the literautre on perceived doctor-patient communication in 
IBS. In addition the findings reported here are consistent with the literature on cancer 
(e. g. Ong et al., 2002) and therefore suggest that communication training for doctors 
would be a logical practical implication of these research findings. This suggestion is 
consistent with Harrington et al. 's (2004) observation that the medical curriculum 
has been revised to include doctor-patient communication. This research suggests 
that communication training should be mandatory to all medical professionals as part 
of continued professional development, this is in line with the focus groups 
conducted by Kennedy et al. (2003) and with Owens et al. (1995) who showed that 
repeat visits to the doctor were lower in patients who reported positive doctor-patient 
communication. 
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The results relating to the relationship between patients' perceptions of doctor- 
patient communication and their illness representations were less clear. Although it 
was hypothesised that perceived communication would relate to illness 
representations as Leventhal et al. (1980; 1984) suggest, this was not evidenced. 
Although the observed finding that `treatment compliance' was predictive of 
perceived consequences of IBS (as perceived compliance increased perceived 
consequences decreased) is in line with Markoul et al. 's (1995) research on 
adherence to medications, it does not appear to be related to perceived 
communication as expected. This is because `treatment compliance' did not differ 
between groups. It is therefore not possible to conclude with any degree of certainty 
whether perceived communication impacts on illness representations of IBS 
sufferers. However, Leventhal et al. (1980; 1894) suggest interaction with doctors to 
be integral to the interpretation stage of the CSM and both Frostholm et al. 's (2005) 
large scale study, and Hagger & Orbell's (2003) meta-alanysis show illness 
representations to be consistent amongst illness types. It does therefore seem more 
likely that the observed finding is inaccurate. Although there are a number of reasons 
why the observed finding may be inaccurate such as the questionnaire used, 
participant numbers, the length of time since diagnosis etc. these are little more than 
speculative. Further research is therefore necessary to clarify these issues. 
None of the dimensions of perceived communication were predictive of HRQOL or 
symptom frequency. Although this finding is clear it is inconclusive and is 
inconsistent with Owens et al. (1995). However, the lack of literature in this specific 
area means it is not possible to ascertain whether the observed finding is true or the 
result of a methodological artifact. This research is therefore useful as a springboard 
for future research into this relationship, and in order to ensure the best chance of 
yielding accurate results this should be a prospective longitudinal study. 
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ATTITUDES TOWARDS IBS SUFFERERS 
The investigation of attitudes towards IBS sufferers was addressed in the second 
study of this thesis. It complements the research on doctor-patient communication as 
perceived attitudes of the general population are also suggested by Leventhal et al. 
(1980; 1984) to contribute to the interpretation stage of the CSM. 
When comparing the perceptions of attitudes of the general population and IBS 
sufferers perceived attitudes of the general population there was a clear distinction 
between the two groups on all variables. Briefly the results showed that IBS sufferers 
perceive the attitudes of the general population towards discussing IBS symptoms, 
witnessing IBS symptoms, providing social support concessions, and providing 
social activity concessions to be worse than the attitudes reported by the general 
population. However, the results showed that people do not hold negative attitudes 
towards any of the variables associated with IBS. The results of this study are 
important as they suggest that the concerns IBS sufferers hold regarding negative 
attitudes of the general population (e. g. Dancey & Backhouse, 1993; Dancey et al., 
2002) are not valid. These results are consistent with the findings of Munir et al. 
(2005) and Looper & Kirmayer (2004) who suggest that IBS is not a stigmatised 
condition. The implication from this study is that these inaccurate perceptions should 
be challenged as part of a therapeutic approach for IBS sufferers. 
When attitudes towards IBS were compared to attitudes towards asthma and epilepsy 
the results showed that none the illnesses were perceived negatively, but that 
significant differences did exist between the illnesses in the degree to which 
perceptions were positive. In all cases more negative attitudes were reported towards 
epilepsy, followed by IBS, then asthma. This pattern of findings is in line with 
research that compares attitudes towards epilepsy to other illnesses, for example 
LaMartina (1989) and Young et al. (2002) who report attitudes towards epilepsy 
were more negative than other illnesses, but that they are still largely positive. The 
findings are also in line with Looper & Kirmayer (2004) who suggest that whilst 
functional illnesses as a whole appear to be perceived negatively, looking at IBS 
specifically this is not the case. Looper & Kirmayer (2004) suggest the reason for 
this is due to everybody experiencing bowel disruption at some point in their lives, 
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this suggestion does appear to be supported by the results of this study, as knowledge 
of IBS was largely accurate. Although further research is needed before attitudes 
towards IBS can be conclusively placed in the context of other illnesses the results of 
this study are promising. 
As was observed for doctor-patient communication perceived attitudes were not 
found to relate to illness representations. This is inconsistent with Leventhal et al. 
(1980; 1894) who suggest perception of social support to be integral to the 
interpretation stage of the CSM. Although the relationship between perceived social 
support and illness representations has not been specifically addressed in IBS, this 
observed finding is inconsistent with qualitative research showing the need for 
sufferers to obtain social support (e. g. Coulson, 2005) and with a vast literature 
relating to interaction between perceived social support and illness outcomes (e. g. 
Hogan et al., 2002; Gaynes & Drossman, 1999). It is therefore unclear why perceived 
attitudes were not found to be related to illness representations and more research 
would be desirable to explore this relationship. 
The only significant relationship between perceived attitudes and illness outcomes, 
was between witnessing IBS symptoms and HRQOL, i. e. the worse the attitudes 
were perceived the worse the quality of life was reported to be. Although this does 
not appear to be related to illness representations it is likely that this is a true research 
finding as this is supported by the previous research on HRQOL in IBS (e. g. Dancey 
& Backhouse, 1993), and the literature on perceived social support and illness 
outcomes (e. g. Hogan et al., 2002) in general. In addition this finding is supported 
and extended by study 3 which found that perceived attitudes towards witnessing 
symptoms at two months post intervention were predictive of both HRQOL and total 
symptom frequency (on both the diary and ISS) at two months post the intervention. 
This finding is of interest as it suggests that attitudes towards witnessing symptoms 
are predictive of both HRQOL and symptom frequency and suggests that the lack of 
significance for symptom frequency in study 2 is a result of low statistical power 
(Brennan et al., 2004). 
Although the relationship between perceived attitudes and illness representations are 
unclear this research clearly complements the existing literature and shows that 
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perception of poor social support negatively impacts on illness outcomes. However, 
as perceptions of negative social support have been shown to be inaccurate it is vital 
that these are challenged in order to improve illness outcomes for sufferers. 
ILLNESS REPRESENTATIONS AND ILLNESS OUTCOMES 
As the overall aim of this thesis was to assess the efficacy of the CSM in IBS 
research the exploration of illness representations is pervasive throughout the studies 
included in this thesis. In the all three studies the relationship between illness 
representations and illness outcomes was assessed independently of the other 
variables included in the research. Firstly the relationship between illness 
representations and HRQOL is clear and consistent across studies. In all three studies 
emotional representations were predictive of HRQOL. The replication of this finding 
across three studies strongly suggests that this relationship can be accepted with a 
high degree of certainty. Further support is offered from the literature (e. g. Frostholm 
et al., 2005). Frostholm et al. (2005) also reported illness identity to be a significant 
predictor of illness outcomes. Although illness identity was found to be predictive of 
HRQOL in study 1a close inspection of the results revealed that this was in the 
wrong direction (i. e. lower illness identity scores resulted in worse HRQOL). 
However, in study three illness identity was approaching significance in the correct 
direction. Therefore a more detailed assessment of this dimension is necessary to 
clarify the results. In addition support for the general concept of illness 
representations predicting HRQOL is provided by Rutter & Rutter (2002), although 
the specific variable of `perceived consequences' was not elicited as a predictor in 
this thesis. Although an additional measure to assess locus of control was only 
included in study 1 it was of note that an internal locus of control was predictive of 
increased quality of life. This is consistent with the theory of Wallston et al. (1994) 
and research into other chronic illnesses (e. g. Moore et al., 1991). 
The relationship between illness representations and symptoms across studies is less 
clear. For total symptom frequency there were no significant relationships in either 
study I or study 2, although emotional representations were approaching significance 
in study 1. In study 3 however there was a significant relationship between perceived 
treatment control and total symptoms at two months post the intervention. It is 
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difficult to interpret these findings although a number of alternative suggestions may 
be viable. Firstly it is possible that there is no relationship between illness 
representations and symptoms. This suggestion seems unlikely as significant findings 
for individual symptoms were found in studies 2 and 3 (specifically that chronic time 
line and illness identity predict diarrhoea and that illness identity predicted the urgent 
need to defecate). Secondly it is possible that the measures used to assess symptoms 
were not sensitive enough. This is a concern that was addressed in study 3 with the 
inclusion of an additional questionnaire to supplement the 7-day diary but this still 
did not reveal significant relationships between illness representations and 
symptoms. Connected to the sensitivity of the measures is the possibility that the 
timeframe for assessing symptoms was too brief. This is possible and therefore future 
research should assess symptoms over a longer period. The most likely suggestion is 
that the relationship between illness representations and symptoms is indirect and is 
mediated by another variable. This is a suggestion raised by Brennan et al. (2004) 
who suggests that HRQOL is predictive of symptom outcomes. In addition, Rutter 
and Rutter (2002) report `satisfaction with health' to be correlated with symptoms. 
Although not observed in study 2 both studies 1 and 3 show that HRQOL is 
predictive of total symptom frequency. It does therefore appear that there is a 
relationship between illness representations and outcomes, but that this is indirect. 
This would provide a plausible explanation why there was insufficient power to 
detect a relationship between illness representations and symptoms. Further support 
for the mediation of illness representations and symptoms is provided by the data on 
locus of control included in study 1. Although internal locus of control initially 
appeared to be predictive of symptoms, this relationship was fully mediated by 
HRQOL as Brennan et al. (2004) suggested. 
INTERVENTION 
One of the main aims of the first two studies was to assess the utility of the CSM as a 
model to explain illness outcomes in IBS. As studies 1 and 2 showed a clear 
relationship between illness representations and HRQOL and suggested an indirect 
relationship between illness representations and symptoms it was considered 
legitimate in study 3 to devise an intervention based on the principles of the CSM 
(Leventhal et al., 1980; 1984). The results showed that the intervention was 
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efficacious with significant reductions in symptom frequency (assessed using the 
diary) from both pre intervention to immediately post intervention, and from pre 
intervention to two months post intervention (on both the diary and symptom 
questionnaire). Using the 7 day diary there were significant reductions in diarrhoea 
and constipation. The reductions in diarrhoea occurred between pre intervention and 
two months post intervention. The reductions in constipation occurred between 
immediately post intervention and two months post intervention. Using the ISS there 
were also significant changes in reported frequency of abdominal pain, bloating and 
feelings of incomplete evacuation between pre intervention and two months post 
intervention. These research findings have important implications for the future of 
treatment research in IBS as they strongly suggest that this intervention booklet is 
efficacious at reducing symptom frequency, at least in the short term, this is 
consistent with a number of other psychologically based interventions, such as 
Blanchard et al. (1993) and Heyman-Mönnikes et al. (2000). 
There was a significant improvement in HRQOL from pre intervention to two 
months post intervention The improvement in HRQOL is consistent with previous 
research, such as Gonsalkorale et al. (2002) and Boyce et al. (2000). There were also 
changes in perceived social support in both the discussing and witnessing symptoms 
scale from pre intervention to immediately post intervention. It is interesting that 
medication use significantly decreased immediately post the intervention, suggesting 
that the findings can truly be attributed to the CSM based intervention rather than to 
increases in medication. 
The illness representations that changed between pre and immediately post the 
intervention were chronic timeline, perceived personal control and emotional 
representations. These same illness representations changed between pre and two 
month post and in addition illness coherence and illness identity also improved. 
These findings demonstrate that the intervention booklet did in fact adhere rigidly to 
the principles of the CSM, that improvements in illness representations occurred both 
immediately post the intervention and at two months post the intervention, and 
moreover that both illness coherence and illness identity were additionally significant 
at two months post intervention, suggesting that participants maintained their better 
understanding of their IBS following the intervention. In addition illness identity 
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significantly improved from immediately post intervention to two months post 
intervention. There were however no significant predictors of change in HRQOL or 
symptoms (total and individual) between pre intervention and immediately post the 
intervention There were also no significant predictors of change in symptoms (total 
and individual) between pre intervention and at two months post the intervention. As 
these findings may be due to insufficient power no conclusions can be drawn until 
more research has been conducted. 
The self-help booklet appears to be effective at improving IBS sufferers' illness 
representations, perceived quality of life and at reducing both actual and perceived 
symptom frequency. This study therefore provides support for the theoretical utility 
of Leventhal et al's. (1980; 1984) common sense model in the devising of illness 
interventions. It also suggests that a short self-help booklet based intervention is a 
cost effective and easily administered way of improving IBS sufferers' health and 
quality of life for at least two months post the intervention. Further support for the 
usefulness of self-help booklet based interventions in IBS comes from the recent 
study of Robinson et al. (2006). Although this booklet is not based on a specific 
model and its results are therefore inconclusive it does show that at one year post 
intervention there is a 60% reduction in medical consultations and a reduction in 
perceived symptom severity. 
STRENGTHS OF THE RESEARCH 
Although proponents of the qualitative approach may feel that the use of 
questionnaires and diary data may not provide as much detailed scope for exploring 
perceptions of individuals, it was felt that the use of quantitative measures was vital 
in order to assess the components of IBS in a meaningful and structured way. In the 
literature reviews, in particular for study 1 there was a bias towards qualitative 
research, which although providing a useful background does not go far enough in 
providing meaningful data. Research into the psychological aspects of IBS has only 
emerged relatively recently and therefore the qualitative studies are understandable 
and indeed provide a useful background. However, the ideas raised by earlier 
research (both qualitative and quantitative) have now reached a stage where more 
scientific quantitative research is needed. Although in some respects research in this 
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area is still exploratory this data is more useful then qualitative research which 
simply replicates previous findings. 
The use of questionnaires is prevalent in research, this is unsurprising as it is 
extremely convenient, both for the researcher (especially on restricted budgets) and 
for the participants. In particular it is highly suited to an IBS cohort who may be 
reluctant to leave the house, especially if long distances are involved. It is therefore a 
highly suitable method to have used in this thesis. In terms of the specific 
questionnaires used care was taken to use established measures where suitable ones 
were available, to modify measure where necessary, and to design measures where 
nothing suitable existed. As is detailed in the methods sections of the various studies 
the studies designed for the research are highly literature based, and all measures 
reported high degrees of internal consistency. Therefore the specific measures used 
are highly suited to the aims of the research. One final point regarding the specific 
use of the IBS-36 to measure quality of life is that whilst some researchers (e. g. 
Drossman et al., 2003; Heyman-Mönnikes et al., 2000) champion the use of the IBS- 
QOL (Patrick et al., 1998) the two month recall period of the IBS-36 (Groll et al., 
2002) was felt to be superior to the current day recall period of the IBS-QOL which 
was felt would not take into account the fluctuating nature of the IBS symptoms. 
A challenge for all researchers in this field is how to accurately record symptoms, as 
a truly objective way of measuring symptoms is both impractical and arguably 
unethical. It was therefore felt that a diary methodology was the most accurate way 
of recording the symptoms. Although there is no guarantee that participants will 
remember to record their symptoms immediately there is much less chance of the 
retrospective recall bias likely in a basic questionnaire design. The superiority of 
diary methodology is noted by Meissner et al. (1997) who are key researchers in this 
field and regard diary methodology as the `gold standard'. Therefore whilst the diary 
format in itself should not necessarily be a limitation, the difficulty of finding 
significant relationships using this measure suggests that one week was perhaps not 
an appropriate timeframe. Although one week initially appeared to be appropriate as 
in order to be classified as suffering from IBS symptoms must be experienced at least 
once a week, and this is the recommendation by Keefer & Blanchard (2002) in some 
cases very few symptoms were reported leading to little variance in total symptom 
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scores. Although a longer time for recording symptoms would not have been 
achievable here both due to time constraints and the potential for lower participant 
numbers (especially in phases 2 and 3 of the intervention) in future research it is 
clearly advisable to record symptoms for at least a two week period, and at a number 
of times throughout at least a six month period, to take into account the fluctuating 
and cyclic nature of symptoms. However, a strength of this thesis is that the 
difficulty in obtaining significant findings using the diary in studies I and 2 meant 
that an additional questionnaire measure of symptoms was included in study 3. The 
Likert scale questionnaire was similar to that used in previous research (e. g. Dancey 
et al., 1998) and based on the suggestions from the review by Naliboff et al. (1999). 
The questionnaire and the diary were found to be correlated as expected and 
therefore the addition of the questionnaire for study 3 shows the benefit of addressing 
potential weaknesses in previous research in the design of subsequent studies. 
LIMITATIONS OF THE RESEARCH 
Although the limitations regarding the participants are detailed in the individual 
studies, with varying degrees of limitations depending on participant group, it is 
worth noting that there is a general limitation to the participants recruited in these 
studies. Although care was taken to recruit as many, and as representative cohorts as 
possible the inability to offer financial incentives, coupled with the comparatively 
short time frame for data collection in PhD research means that it is notoriously 
difficult to entice people to take part in research. As the motivations for those who 
participated was not established there is still a concern that the results of these 
studies may not be truly generalisable. This concern is potentially more worrying for 
the doctors group (study 1) where participant numbers were so low (n = 58) that the 
original design of recruiting both gastroenterologists and doctors had to be altered to 
produce one single medical professional group. Although ANOVA suggested that it 
was legitimate to combine these two groups it would obviously have been superior to 
recruit sufficient numbers of participants to allow for detailed comparisons to be 
made. Although care was taken in the study design not to burden the doctors, and 
therefore only a 21 item Likert scale questionnaire was administered response rates 
were still very low (23.7%). The low response rate means that a volunteer bias is a 
genuine concern. Although this is not a concern which is valid for the general 
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population group in the attitudes research where the cohort was considerably higher 
(n =239) and the generalisability of these results can therefore be accepted with a 
high degree of certainty (certainly within the UK), this is a concern that is valid, 
albeit to a lesser extent, in the IBS sufferers group. Although the participant 
characteristics match those reported in other studies (e. g. Dancey et al., 1995; 
Lackner et al., 2004) it is possible that this represents a volunteer bias inherent in 
research in this area in general, rather than a truly representative group. This 
potential bias comes from approximately half of the participants in all studies being 
recruited from the IBS Network. This is a common cohort for research in this area, 
and the IBS Network warns that participants recruited from the Network may be 
"over researched". In addition, in particular for the intervention study there is likely 
to be a personal significance bias towards the recruiting of participants who consider 
IBS to have a psychological component, which is not true of all sufferers. These 
suggest that more research is needed in this under researched area in order to ensure 
the true generalisability of the results found in this thesis; however these limitations 
are relatively minor and in no way negate the significant results reported. 
In addition although the many significant results attest to the legitimacy of the theory 
behind each of the studies it is possible that there are additional significant 
relationships which were not revealed due to insufficient power, therefore 
replications with greater participant numbers are desirable. This is particularly 
relevant for the investigation of gender and IBS subgroups, both for main and 
interaction effects. The lack of data concerning IBS subgroups is something which is 
common to psychologically based research in IBS, as the systematic review 
demonstrates, but it is definitely an area that should be addressed in the future, in this 
respect recruiting using cohort sampling is advisable. One final minor limitation is 
that the results cannot be generalised cross culturally, however, as there is limited 
research investigating the concepts covered in this thesis, this not too problematic at 
this stage, and care was taken in the use of a postal based design to ensure that there 
was no specific local bias. Overall whilst there are undoubtedly limitations to the 
participants recruited in this thesis these are no worse than those seen in similar 
research and do not in any way invalidate the results of the thesis. 
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An additional concern is whether the IBS participants that participated in the study 
did in fact suffer from IBS. Although participants were only recruited in the studies if 
they reported confirmed diagnosis of IBS from a medical professional, there were no 
checks of medical records to ensure that this was the case. Although this was beyond 
the scope of this thesis in terms of securing ethics approval, it provides a limitation 
whereby a number of participants may not have in fact suffered from IBS. Although 
it is highly unlikely that this would have been deliberate, concerns over legitimacy of 
diagnosis detailed in chapter 2, coupled with the five participants who `dropped out' 
prior to the commencement of study 3, due to receiving a confirmed diagnosis of an 
organic cause of their symptoms means that it cannot be accepted without reservation 
that all of the participants did in fact suffer from IBS as anticipated. It should be 
noted that this is not a limitation specific to this research, it is indicative of the areas 
of overlap between IBS and other illnesses (both functional and organic). In fact a 
recent study by Babak et al. (2006) reported the same problem with 25 participants 
withdrawing from the research due to discovering an organic cause for their 
symptoms. Although in a larger funded study medical professionals could have been 
enlisted to confirm IBS using the Rome II criteria (e. g. Gralnek et al., 2000), this was 
simply beyond the scope of this thesis. Although ensuring accuracy of diagnosis in 
this way is obviously advisable, as the research by Babak et al. (2006) demonstrates 
reliance on patient reports in smaller studies is common (e. g. Rutter & Rutter, 2002) 
and should therefore not be considered a major flaw in this thesis. In addition 
concerns over legitimacy of diagnosis is somewhat reduced by the diary 
methodology, which allows for an assessment of the symptoms to be made, and 
therefore if, the symptoms reported did not appear to be representative of IBS the 
participant could have been removed from the analysis. As this was not observed 
here it can be assumed to some extent that although verification of IBS status would 
therefore have been desirable there is no reason to consider that the data collected 
does not reflect a sample of true IBS sufferers. 
One final potential limitation is the lack of a control group in study 3, however the 
justification for the lack of a control group was detailed in chapter 7 and therefore it 
is not necessary to reiterate this here. The conclusion reached however was that due 
to an inability to create a legitimate control group the PLD design was the most 
suitable for the intervention study. 
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THEORETICAL IMPLICATIONS 
Although detailed consideration of the justification for the use of the Leventhal et al. 
(1980; 1984) CSM was given in chapter 4 in light of the results of this thesis its 
utility must be evaluated. The direct relationship between illness representations and 
HRQOL, the indirect relationship between illness representations and symptoms 
observed in all three studies, coupled with efficacy of the CSM based intervention 
booklet strongly suggests that the CSM is a viable model for use in IBS. This is 
perhaps unsurprising as Hagger and Orbell (2003) have demonstrated that the CSM 
is robust over a wide range of chronic illnesses and Rutter and Rutter (2002) 
demonstrate its applicability for IBS specifically. In particular the efficacy of the 
intervention booklet which adheres rigidly to the components of the CSM marks an 
important step forward in establishing the CSM as a reliable model upon which to 
base illness interventions, in IBS. It has been commented by Saito (2002) that 
"because of the heterogeneity in symptoms and diagnostic findings patients with IBS 
remain a challenge to treat and to study". This thesis has demonstrated that the CSM 
is a sound theoretical model which as Leventhal et al. (1980; 1984) intended is 
highly suited to chronic illnesses of heterogeneous nature, and therefore if research 
investigating this model continues, based on the results observed here, it seems fair 
to conclude that the `challenge' may be met. 
Although the results of this thesis strongly support the role of the CSM in explaining 
sufferers representations of their illness and subsequent illness outcomes, it is likely 
that the observed findings do not fully represent the complexities of the relationship 
between illness representations and illness outcomes. Although there would need to 
be many further studies to fully assess the various aspects of this model there are two 
areas that should be addressed in all subsequent research. The first area is the ability 
of the IPQ-R (Moss-Morris et al., 2002) to accurately measure the illness 
representation dimensions. Although the revised version, used in this study, is 
suggested by Nagger & Orbell (2003) to be superior to the original version and 
highly accurate at the majority of illness representation dimensions across illness 
types, it is not a good measure of `cause'. Although low participant numbers meant 
that the `cause' variable could not be constructed and was therefore not included in 
this thesis the difficulty of analysing the `cause' component is noted by Nagger and 
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Orbell (2003) who `dropped' the cause component from their meta-analysis due to 
the difficulties in accurately coding it both within and between different studies. This 
is obviously problematic as 'cause' is one of the primary illness representation 
dimensions and therefore perhaps the IPQ should be modified a third time to address 
this factor. 
The second area that should be addressed in future research is the role of coping. 
Despite the success of the intervention in improving illness outcomes and in the 
changes observed on multiple illness representations the predictive ability of illness 
representations and illness outcome was weak in all studies. On reflection it seems 
highly likely that this is due to an additional variable mediating this relationship; this 
variable is likely to be coping. Support for coping mediating the relationship between 
illness representations and outcomes has been reported in IBS (Rutter & Rutter, 
2002), and was consistently found to mediate the relationship between illness 
representations and outcomes across illness types in a recent meta-analytic review of 
the CSM by Hagger & Orbell (2003). Although improving coping techniques were 
integral to the advice of the intervention booklet a measure to assess coping was not 
included. Upon reflection it was an oversight and a mistake not to include a measure 
to assess coping in this thesis, and if any of the studies presented here were to 
replicated this is without hesitation the fundamental change that should be made, and 
in this respect it is the largest limitation of this research. However, despite the lack of 
an investigation into coping as a mediating variable the results clearly show that 
illness representations, and changes in illness representations are related to illness 
outcomes, and therefore it is the role of future research to fully explore these 
relationships. 
One final theoretical consideration is the relationship between perceived attitudes, 
both of doctor-patient communication and of the general population and illness 
representations. Although studies 1 and 2 only provide weak evidence of these 
factors is unclear why this is. It is possible that this is due to a weakness in the 
methodology of the studies resulting in insufficient power to detect any thing below 
large effects. A further suggestion is that the impact of other people's attitudes is 
limited to the initial stages of illness diagnosis, not pervasive as the CSM suggests. 
However, the most likely explanation is that the CSM states that illness interpretation 
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is a complex process comprising multiple cues, therefore whilst perceived attitudes 
may play a role their predictive quality may be overshadowed by a stronger 
predictor. Further research is needed to clarify these issues. 
PRACTICAL IMPLICATIONS 
The practical implications of this thesis are clear as the overall aim was to devise a 
successful self-help booklet based intervention. Therefore as the intervention was 
successful the primary practical implication is to improve IBS sufferers' illness 
outcomes. Therefore it will obviously be productive to make the booklet available to 
IBS sufferers. This can be done in a number of formats: as a book, on a website or 
administered in a clinical setting. In addition the theoretical implications suggest that 
further intervention research based around the principles of the CSM, for example 
education classes should also prove efficacious. There is a potential benefit in 
improving the individualised nature of the intervention in order to make it a truly 
tailored intervention. Personality questionnaires, full case histories and a much 
longer symptom monitoring duration pre intervention should be employed. Although 
this would require considerable effort it is likely that this would yield positive 
results, and whilst the costs versus benefits of the current booklet compared with a 
more tailored approach would need to be assessed it is an important area of study in 
terms of both theoretical and practical applications. 
One important practical implication that comes out of this thesis is the possibility of 
assessing the illness representations of patients reporting acute bowel dysfunction 
with an aim to identify those factors which influence the development of IBS. If 
these factors can be identified then theoretically development of IBS can be 
prevented, which is clearly the ultimate goal for chronic illness research. 
FUTURE DIRECTIONS 
As this is an area that is relatively under researched there are numerous research 
directions suggested by the thesis. A selection of some of the most worthwhile 
further areas of interest are: 
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1) A detailed comparison of the attitudes of different medical professionals towards 
IBS, coupled with an intervention aimed at improving medical professionals 
communication and advice on how to help sufferers form and maintain positive 
illness representations. 
2) A detailed investigation of the attitudes of specific groups of society, such as 
employers, teachers, parents, and cross culturally. 
3) An assessment of the role of coping and other potential mediating variables in the 
relationships between illness representations and outcomes. 
4) An exploration of the role of personality factors and the CSM in IBS. 
5) A large scale prospective longitudinal study which investigates the development 
of illness representations in a cohort of newly diagnosed sufferers. 
6) A comparison of the efficacy of the intervention booklet in different 
administration styles, such as in a group setting or with a facilitator. 
7) An assessment of the long-term effects of the self-help booklet 
CONCLUSION 
The studies in this thesis clearly link together to investigate the role of the CSM in 
IBS. According to the findings it is clear that the CSM is a viable model to explain 
the interaction between illness representations and illness outcomes. This thesis 
therefore clearly demonstrates a novel and important contribution to knowledge of 
both IBS and the CSM. In addition it suggests the viability of a one time self-help 
booklet based intervention in improving illness outcomes in IBS. 
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APPENDICES 
APPENDIX I 
DISEASE SPECIFIC VERSION OF THE IPQ-R 
(MOSS-MORRIS ET AL., 2002) 
Version 1 07/04/2005 
ILLNESS PERCEPTION QUESTIONNAIRE (IPQ-R) 
Code 11'ord ........................... 
Date....................................... 
YOUR VIEWS ABOUT YOUR IRRITABLE BOWEL SYNDROME 
Listed below are a number of symptoms that you may or may not have experienced since your II3S. 
Please indicate by circling Yes or No, whether you have experienced any of these symptoms since 
your illness, and whether you believe that these symptoms are related to your II3S. 
I have experienced this This symptom is related to 
symptom since my IBS my IBS 
Pain Yes No Yes No 
Sore Throat Yes No Yes No 
Nausea Yes No Yes No 
Breathlessness Yes No Yes No 
Weight Loss Yes No Yes No 
Fatigue Yes No Yes No 
Stiff Joints Yes No Yes No 
Sore Eyes Yes No Yes No 
Wheeziness Yes No Yes No 
Headaches Yes No Yes No 
Upset Stomach Yes No Yes No 
Sleep Difficulties Yes No Yes No 
Dizziness Yes No Yes No 
Loss of Strength Yes No Yes No 
We are interested in your own personal views of how you now see your current lBS. 
Please indicate how much you agree or disagree with the following statements about your illness by 
ticking the appropriate box. 
" VIEWS ABOUT YOUR ILLNESS DISAGREE 
DISAGREE 
ANEITHER GREE NOR 
AGREE 
ASTRONGLY GREE 
DISAGREE 
Illy IBS will last a short time 
IP1 My I11S is likely to be permanent rather than 
temporary 
My IBS will last for a long time 
This IBS will pass quickly 
If's I expect to have this IBS for the rest of my life 
S1KO CLv DISAGREE NEITHER AGREE S1RONGLI VIEWS ABOUT YOUR ILLNESS DISAGREE ACREENOK AGREE 
6 
DISACRFE 
Aly I13S is a serious condition 
My IBS has major consequences on my life 
1 lv 1135 does not have much effect on my life 
Nl113S strongly affects the way others see me 
A13 , 113S has serious financial consequences 
A13 , 113S causes difficulties for those who are 
close to me 
There is a lot which I can do to control my 
symptoms 
What I do can determine whether my IBS gets 
better or worse 
The course of my I13S depends on nie 
Nothing I do will affect my IBS 
I have the power to influence lily 1ßS 
Aly actions will have no affect on the outcome 
of m IBS 
Aly IBS will improve in time 
There is very little that can be done to 
im rove illy IBS 
Ally treatment will be effective in curing my 
IBS 
The negative effects of my IBS can be 
prevented (avoided) by illy treatment 
My treatment can control my 113S 
There is nothing which can help my condition 
The symptoms of my condition are puzzling to 
me 
Aly 113S is a mystery to inc 
I don't understand my IBS 
lily HIS doesn't make any sense to me 
I have a clear picture or understanding of my 
condition 
The symptoms of my IBS change a great deal 
from da to day 
Aly symptoms come and go in cycles 
Aly HIS is very unpredictable 
I go through cycles in which my IBS gets 
better and worse 
I get depressed when I think about my 113S 
When I think about my IBS I get upset 
My I13S makes me feel angry 
My 113S does not worry inc 
(laving this IBS makes me feel anxious 
lily 1I3S makes me feel afraid 
CAUSES OF MY I13S 
We are interested in what ±ou consider may have been the cause of your IRS. As people are very different, 
there is no correct answer for this question. We are most interested in your own views about the factors that 
caused your IRS rather than what others including doctors or family may have suggested to you. Below is a list of possible causes for your IBS. Please indicate how much you agree or disagree that they were causes 
for you by ticking the appropriate box. 
SIRON POSSIBLE CAUSES DS 
IGN 
EE 
DISAGREE ÄGREENOR A`RLE 
AG EE411 
DISAGREE 
Stress or worry 
Hereditary - it runs in my family 
A germ or virus 
Diet or eating habits 
Chance or bad luck 
Poor medical care in my past 
Pollution in the environment 
My own behaviour 
AIy mental attitude e. g. thinking about life 
negatively 
Family problems or worries caused my 
illness 
Overwork 
My emotional state e. g. feeling down, lonely, 
anxious, empty 
Ageing 
Alcohol 
Smoking 
Accident or injury 
F 
My personality 
Altered immunity 
In the table below, please list in rank-order the three most important factors that you now believe caused 
W)UR IBS You may use any of the items from the box above, or you may have additional ideas of your 
01%. n. 
The most important causes for me: - 
I, 
z, 
3. 
Items for IPQ-R Subscales 
1. Identity (sum of yes-rated symptoms in column 2 on p. 1) 
2. Timeline (acute/chronic) items IP1 - 1P5 + IP18 
3. Consequences items IP6 - IP11 
4. Personal control items IP12 - 1P17 
5. Treatment control items IP19 - IP23 
6. Illness coherence items IP24 - IP28 
7. Timeline cyclical IP29 - IP32 
8. Emotional representations IP33 - IP38 
9. Causes Cl - C18 - do not use these as a scale. Start analysis with separate items 
- used as grouping variables (ie those who do/do not believe 
in a specific causal factor). With a sufficient sample size 
(n=85 or more), factor analysis can be used to identify 
groups of causal beliefs (eg lifestyle ; stress etc) which can 
then be used as sub-scales (e. g. see Weinman et al, in press). 
Reference 
Weinman, J, Petrie, KJ, Sharpe, N& Walker, S. Causal attributions in patients and spouses following 
first-time myocardial infarction and subsequent lifestyle changes. Br. J. Health Psychology, in press. 
APPENDIX 2 
IBS-36 (GROLL ET AL., 2002) 
The IBS - 36 Quality of Life Measure 
Please circle the number that explains how you have been IN THE PAST TWO AIONTIIS. 
Please say "In the Past two months" ahead of each question as you think about the answer. 
If the question does not apply to you, please circle not applicable. 
Example: /------------ /---------- /---------- /---------- /-------- --/----------- / Not applicable 
0! 23456 
Never Always 
IN TILE PAST TWO MONTHS 
1) Have you been afraid to eat out because of food causing bowel symptoms? 
/-----------/----------/----------/----------/----------/-----------/ Not applicable 
0123456 
Never Always 
2) Have you felt angry as a result of your bowel problem? 
/-----------/----------/---------/----------/--------/-----------/ Not applicable 
0123456 
Never Always 
3) Did you need to go suddenly when you had a bowel movement? 
/------------ /---------- /_--_----/---------- /--------- /----------/ Not applicable 
0123456 
Never Always 
4) Did your bowel symptoms interfere with your relationship with your children and/or partner? 
/----------/.. _------/-------- -/------ ----/------- -/---_-----. / Not applicable 
0123456 
Never Always 
5) Did you avoid foods that you like because you were afraid that they might cause bowel symptoms? 
/------------ /---------- /---------- /---------- Not applicable 
0123456 
Never Always 
6) Did your bowel symptoms interfere with being able to do well at work/school/usual daily activities? 
/------------/----------/----------/----------/--------/-----------/ Not applicable 
0123456 
Never Always 
7) Have you felt tearful or discouraged as a result of our bowel problem? 
/------------ /---------- /---------- /---------- /---------- %----------- / Not applicable 
0123456 
Never Always 
8) Did you feel that your family/friends thought your symptoms were not real? 
/----------/----------/---------/---------/---------/----------/ Not applicable 
0I23456 
Never Always 
9) How often, while participating in leisure or sport activities did you have to stop because of your bowel symptoms? 
/----- -----/---------- /---------- /------ ----/-------- -/----------- / Not applicable 
0123456 
Never Always 
10) Have you felt worried or anxious about never feeling any better? 
I -----------/----------/----------/----------/--------I"--------/ Not applicable 
0123456 
Never Always 
11) Did you miss work/school/usual daily activities because of your bowel problem? 
/---------/----------/----------/----------/----------/----------/ Not applicable 
0I23456 
Never Always 
12) Did your bowel symptoms interfere with being able to concentrate? 
------- --/--------- /-----»--/»--------/-----------/ Not applicable 
0123456 
Never Always 
13) Have you felt alone or isolated from your family because of bowel symptoms? 
/--------- ---/---------- /-_---_---/-. ------- /--------- /-----------/ Not applicable 
0123456 
Never Always 
14) Were you embarrassed because of your bowel symptoms? 
/--------- --/---- ------ /......... /......... /.......... /----------- / Not applicable 
0123456 
Never Always 
15) Were )ou troubled by pain in )our abdomen? 
/------------ /---------- /---------- /---------- /---------- /----------- / Not applicable 
0I23456 
Never Always 
16) Were you afraid that your bowel symptoms were getting worse? 
/---------/-------/---------/--------/---------/----------/ Not applicable 
0I23456 
Never Always 
17) Were you troubled by bowel movements that were hard/difficult to pass? 
/------------ /------ ----/---------- /---------- /---------- /----------- / Not applicable 
0123456 
Never Always 
18) Did you check your diet from the previous day trying to find foods that might cause bowel symptoms? 
/°------- ---/_. ------/---------- /---------- /--------- /----------- / Not applicable 
0123456 
Never Always 
19) Did you avoid traveling due to worry about bowel symptoms? 
/------------/----------/----------/----------/---------/-----------/ Not applicable 
0123456 
Never Always 
20) Did your bowel problems shorten the length of time you could work each day? 
I -----------/---------/---------/---------/--------/-----------/ Not applicable 
0123456 
Never Always 
21) Did your bowel symptoms keep you from sleeping soundly during the night? 
/----------/---------- /---------- /---------- /-------- -/----------- / Not applicable 
0123456 
Never Always 
22) Were you troubled by loose bowel movements? 
/------------/----------/----------/---------/---------/-----------/ Not applicable 
0123456 
Never Always 
23) Did )our bo\%el condition interfere %%ith having sexual relations? 
/------------! ----------/---------- ----------/----------/-----------f Not applicable 
0123456 
Never Always 
24) Has being bloated troubled you? 
/------------/---------/----------/---------/---------/----------/ Not applicable 
0123456 
Never Always 
25) Did your bowel symptoms interfere with your enjoyment of leisure or sport activities? 
/------------/----------/----------/----------/----------/----------/ Not applicable 
0123456 
Never Always 
26) Was passing large amount of gas a problem? 
/------------ /------ ----/---------- /---------- /---------- /----------- / Not applicable 
0123456 
Never Always 
27) Were you concerned that your symptoms may be due to cancer? 
/------------ /---------- /---------- /---------- /---------- /------- ----/ Not applicable 
0123456 
Never Always 
28) Have you had to delay or cancel going out socially because of your bowel problem? 
/----------- /---------/---------- /---------- /---- ----- /-----------/ Not applicable 
0123456 
Never Always 
29) Were you tired in the morning because of your bowel symptoms? 
/------------/----------/---------/----------/--------/---------/ Not applicable 
0123456 
Never Always 
30) Did your bowel symptoms interfere with your desire to have sexual relations with your partner? 
/------------ /---------- /---------- /--------- /--------- /------- _--/ Not applicable 
0123456 
Never Always 
31) 1 as feel in- that you need to go to the bathroom even though your ho els are empty troubled you? 
i------------! ----------! ----------/----------/----------/-----------! Not applicable 
0123456 
Never Always 
32) Did you feel that your doctor/health professionals did not believe that your bowel symptoms were real? 
/------------ /------ ---/---------- /------ _--/---°----/---_.. -__--/ Not applicable 
0123456 
Never Always 
33) }how often do you immediately need to find where washrooms are when you are in a new place? 
/------------ /---------- /---------- /---------/-------- -/---------- / Not applicable 
0123456 
Never Always 
34) Did you avoid planning activities ahead of time because you were unsure of how your bowel symptoms would be? 
/------------/----------/----------/----------/---------/----------/ Not applicable 
0I23456 
Never Always 
35) Lias accidental soiling ofyour underwear troubled you? 
/-----------/----------/----------/----------/----------/-----------/ Not applicable 
0I23456 
Never Always 
36) Were you late for or did you delay work/school/usual daily activities because of your bowel symptoms. 
/------------ /---------- /------ ----/------ ---/-------- -/-------- --/ Not applicable 
0123456 
Never Always 
APPENDIX 3 
7-DAY SYMPTOM DIARY 
(INSTRUCTIONS AND SAMPLE PAGES) 
Version 1 19105/2004 Instructions for Filling in the IRS daist, diary 
e j'l:, f' . 
fill 11: ! ii'. .: 1,: ý \ L', ', J_\ 
A',. !.,: - ýý1' . , \, . c) 
" One Page is allocated 1är rich da), but t)hrie are extra pages included it-ý ou 
require. Use as many pages as necessary per day, but please start each day 
with a new page. 
" Prior to starting the diaries please write the date, day of the week and the code 
word you specified on your consent form. 
" Please record every time you experience a symptom and every time you take 
medication. 
" The key at the top of the page is designed to aid you by minimising the 
amount of writing required, e. g. instead of diarrhoea, you may write in the 
letter A. If the key is confusing you are welcome to write everything in 
instead. 
" The first page of the Diary is a sample page, this should help to clarify what is 
required. Note that where mistakes have been made simply cross them out. 
" When a symptom lasts for longer than fifteen minutes please include the time 
taken, e. g. bloating for I hour. 
If you have any queries regarding the completion of the 
diary then please contact 
Carly Jacobs 
Psychology Department 
School of Human Sciences 
University of Surrey 
G112 7X11 
L; -mail -- c_jacc, ls rrýsun_eý_ýr.. ul. 
'Fckphonc. - 07931565$2O 
'i IOt1 i 1')'. 1$Ili i 
.1 Uj 
' 
ý, 'ý /,, ý , ýiýýi 
IFS (gaily- fly 
"1 
i 
B Constipation 
C. Abdominal Pain 
D. Flatualence 
E. Urgent Need to Defecate 
F. Feeling of Incomplete Evacuation 
G. Bloating 
H. Normal Stool 
I Thin Stool 
J. Loose Stool 
K. Hard (pellet like) Stools 
L. [Belching 
M. Other (please specify) 
fil,. l iI il ) Lt i 
ýi 1I! n. )titU; n 1 lu 
C Immodium Instants 
1) Other Anli-diarrhoeal (please specify) 
E Senacot 
F. Other Laaitives (please specify) 
G. Fibrogel 
H. Antidepressants (please specify) 
1. Antispasmodics (please specify) 
J. Herbal Supplements (please specify) 
K. Other (please specify) 
If you did not experience any symptoms today please tick this box 
If you did not take any medication today please tick this box 
APPENDIX 4 
IBS SPECIFIC VERSION OF THE MISS-21 
(MEAKIN & WEINMAN, 2002) 
Version 1 19/05/2004 Adapted I. 1JSS-21 For 113S Sufferers 
I aiu interested in }oursiews about the cons uI(ations you had is it h your doctor roucerning 
your IBS. Please think back to all of the consultations you have had regarding your IBS 
including your first informing your GP of your bowel complaints. 
Please think about all the consultations you have had and indicate overall the extent to 
which you agree or disagree with each of the following statements. 
Circle one numberfor each statement 
very very 
strongly strongly strongly strongly 
disagree disagree disagree uncertain agree agree agree 
1. My doctor told me exactly what 
IBS is. 1234567 
2. After talking with my doctor, I know 
whether IBS is serious. 1234567 
3. My doctor told me all I wanted to know 
about my JBS. 1234567 
4.1 am not really certain about how to 
follow my doctor's advice. 1234567 
5. After talking with my doctor, I have a 
good idea of my chance of recovery 
1234567 
6. My doctor seems interested in me as 
a person. 1234567 
7. My doctor seems wann and friendly 
tome. 1234567 
8. My doctor seems to take my IBS 
seriously. 1234567 
9.1 feel embarrassed while talking with my 
doctor. 1234567 
10.1 feel free to talk to my doctor about 
private matters. 1234567 
11. The doctor gives me a chance to say 
what was really on my mind. 1234567 
% crv 
. e"1 
sfrongl% unngh sýun; ly >twntk 
disagree disagree disagree uncertain agree agree agree 
12.1 really feel understood by my doctor. 1234567 
13. My doctor does not allow me to say 
everything I want about my 
problems. 1234567 
14. My doctor does not really understand 
my main reason for coming. 1234567 
15. Mine is a doctor I would trust with 
my life. 1234567 
16. My doctor seems to know what 
(s)he was doing. 1234567 
17. My doctor has relieved my worries 
about my illness. 1234567 
18. My doctor seems to know just 
what to do for my problem. 1234567 
19. It has been easy for 
me to follow my doctor's advice. 1234567 
20. It has been difficult for me to do exactly 
what my doctor told me to do. 1234567 
21. I'm not sure the doctor's treatment 
is worth the trouble it has taken. 1234567 
PLEASE CHECK THAT YOU HAVE GIVEN YOUR OPINION ON EACH 
STATEMENT. 
THANK YOU FOR YOUR TIME. 
APPENDIX 5 
DOCTOR SPECIFIC VERSION OF THE MISS-21 
(MEAKIN & WEINMAN, 2002) 
Version 1 19/05/2004 Adapted MISS-21 for Docloºs 
I am interested in your views about the consultations you had A ith your IBS patients, 
concerning their IBS. Please think back to all of the consultations you hal e given to people 
with IBS, including when they first informed you of experiencing bowel complaints. 
Please think about all the consultations you have given and indicate on average the extent to 
which you agree or disagree with each of the following statements. 
Circle one numberfor each statement 
very very 
strongly strongly strongly strongly 
disagree disagree disagree uncertain agree agree agree 
1.1 inform my patients exactly what 
IBS is. 1234567 
2. After talking with my patients, they 
know whether IBS is serious. 1234567 
3. I tell my patients all they want to know 
about their IBS. 1234567 
4. They are not really certain about how to 
follow my advice. 1234567 
5. After talking with my IBS patients, they have 
a good idea of their chance of recovery 
1234567 
6. I appear to be interested in my IBS 
patients as people. 1234567 
7. I appear warm and friendly 
to my IBS patients 1234567 
8.1 take patients with IBS 
seriously. 1234567 
9. My IBS. patients feel embarrassed 
when talking to me 1234567 
10. My IBS patients feel free to talk to 
me about private matters. 1234567 
11.1 give my IBS patients a chance to say 
what is really on their minds. 1234567 
%er 
strongly 
: er 
strongly strongly strongly 
disagree disagree disagree uncertain agree agree agree 
12. My IBS patients really feel 
understood by me 1 234567 
13.1 do not allow my IBS patients to say 
everything they want to about their 
problems. 1 234567 
14. I did not really understand 
their main reason for coming. 1 234567 
15.1 am a doctor my IBS patients 
would trust with their life. 1 234S67 
16.1 appear to my IBS patients to 1 234567 
know what I am doing 
17. I relieve my IBS patient's worries 
about their illness. 1 234567 
18.1 appear to my IBS patients to know 
just what to do for their problem. 1 234567 
19.1 expect that it is easy for my IBS 
patients to follow my advice. 1 234567 
20. It may be difficult for my IBS patients 
to do exactly what I told them to do. 1 234567 
21. I'm not sure the treatment I suggest 
will be worth the trouble it will take. 1 234567 
PLEASE CHECK THAT YOU HAVE GIVEN YOUR OPINION ON EACH 
STATEMENT. 
THANK YOU FOR YOUR TIME. 
APPENDIX 6 
MHLC (WALLSTON ET AL., 1994) 
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APPENDIX 7 
DEMOGRAPHIC QUESTIONNAIRE FOR IBS PARTICIPANTS 
Version 1 7/04/2005 - Demographic Questionnaire for I13S Sufferers 
Please answer the questions below prior to completing the questionnaires 
I. Date of birth ............................................. 
2. Age in years .............................................. 
3. Sex 
......................................................... 
4. Country of Residence ................................... 
5. Nationality 
................................................ 
6. Highest Qualification Obtained ...................... (e. g. 0 level, A level) 
7. Occupation 
............................................... (if unemployed go to q7) 
8. Is your unemployment due to you illness? ......................... 
9. Where did you hear about the research? ..................................... 
10. Do you smoke? ................................................... 
11. Which hand do you write with? ............................................. 
12. When were you diagnosed as having IBS? .................................. Please specify the 
year, and how many years ago, e. g. 1999 (4years ago) 
13. Were you diagnosed by a medical professional? ............................................ 
14. flow long was it from your first experience of symptoms before your 
diagnosis? 
............................................................ 
15. Please specify on average which sub-group of IBS most accurately describes your 
symptoms by circling below: 
predominately diarrhoea predominately constipation alternating 
It is really important that you are classified into one of these three groups, so please think 
carefully about your answers to this question, if you really feel that you do not fit into one of 
these categories, please provide an explanation of your primary symptoms 
below ......................................................................................................... 
Do you suffer from any other illnesses? (please specify) 
APPENDIX 8 
DEMOGRAPHIC QUESTIONNAIRE FOR DOCTORS 
Version 1 19/05/2004 - Demographic Questionnaire for Doctors 
Please answer the questions below prior to completing the questionnaire 
1. Date of birth ............................................. 
2. Age in years .............................................. 
3. Sex ........................................................ 
4. Nationality ................................................ 
5. Highest Qualification Obtained .................. (e. g. Medical degree, doctorate) 
6. Occupation / specialisation ......................... 
(e. g. GP or Gastroenterologist) 
7. How long have you worked as a Doctor for? ........................................ 
8. Where did you hear about the research? .............................................................. 
9. On average how many consultations per week involve sufferers of II3S........... 
APPENDIX 9 
LETTER TO DOCTORS AND INFORMATION SHEET 
Version 1 19/05/2004 
Carly Jacobs 
Bsc (Hons) MSc 
Dear Doctor (name), 
University of Surrey Department of 
Guildford Psychology 
Surrey GU2 5XH UK 
Tel: +44 (0)1483 686883 
Fax: +44 (0)1483 689553 
Email: c. jacobs@surrey. ac. uk 
20 December 2006 
I am studying for my PhD in Health Psychology at the University of Surrey. As part 
of my research I am investigating doctor-patient communication in irritable bowel syndrome. 
I would be grateful if you are willing to participate in my research. This involves completion 
of a short (21 item) questionnaire. All of the necessary information is contained on the 
information sheet provided. 
Thank you for your time 
Yours truly, 
Carly Jacobs 
Vcrsion 1-19/0 /04 PIS for IBS Doctors 
Carly Jacobs 
fit' Bsc (lions) tilSc 
University ot'Surrey 
Guildford 
Surrey GU2 7X11 UK 
Tel: +44 (0)1483 686883 
Fax: +44 (0)1483 689553 
Email: c. jacobs@surrey. ac. uk 
Department of 
Psycholog 
Patient Information Sheet For Doctors 
1. Study Title 
Doctor Patient Communication in IBS and Outcomes 
2. Invitation Paragraph 
23 August 2004 
You are being invited to take part in a research study. Before you decide if you would like to 
take part it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it with 
others if you wish. Contact me if there is anything that is unclear to you, or if you would like 
more information. Take time to decide whether or not you with to take part 
Thank you for reading this. 
3. What is the purpose of the study? 
Thank you for your interest in participating in this study. The purpose of the study, is to gain 
a better understanding of the factors that affect the severity of symptoms experienced, and the 
factors which affect how much sufferers feel their daily lives are affected by their IBS. It is 
necessary to gain a better understanding of these processes in order to provide a back ground 
for designing interventions to reduce symptoms and improve quality of life. It will take up to 
ten minutes of your time (the proposed duration if this study is a year). There are three main 
questions to be investigated there are as follows. The first question is whether quality of 
doctor-patient communication is related to IBS outcomes. Outcomes involve both quality of 
life, related to having IBS, and the frequency of symptoms you have. The second question is 
whether this relationship is affected by a theory in health psychology known as illness 
representations, focussing on one aspect of it called the `control component'. The final 
question is whether doctors' and patients' views of the quality of consultations for IBS 
patients are the same or different. 
4. Why have I been chosen? 
You have been chosen because you are a GP, or a consultant gastroenterologist, and therefore 
have experience of consultations involving sufferers of IBS. You are one of approximately 
150 medical professionals participating in this study 
5. Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you wwilI be 
given this information sheet to keep and he asked to sign a consent form. NOhich Nou still 
receive a copy of If you decide to take part you are still free to withdraw at any time and 
without giving a reason. A decision to withdraw at any time, or a decision not to take part, 
will not affect you ability to participate in future research. 
6. What will happen to me if I take part? 
Your involvement in this research will be for a period of ten minutes. All that is required is 
the fill out a short (21 item) questionnaire and return it using the pre-paid envelope provided. 
7. What do I have to do? 
The research is designed to involve minimal disruption to your routine, and can be completed 
at a location convenient to you. There are no lifestyle restrictions and you can therefore 
continue to undertake all normal activities. 
S. What are the possible disadvantages and risks of taking part? 
There are no disadvantages or risks for participating in this study 
9. What are the possible benefits of taking part? 
There are two main potential benefits for your participation in this study. The first is the 
necessity to isolate potential problem areas in order to improve practice. The second is that 
IBS sufferers constitute a large proportion of clinic appointments, which contributes to the 
pressures faced in managing to see all patients in the working day. This study investigates, 
which factors result in less repeat doctors appointments. Isolation of these factors will shape 
intervention programs potentially resulting in a reduction of the proportion of sufferers 
regularly visiting their GP. 
10. What if new information becomes available? 
This is unlikely to occur as the research is cross sectional and there is no treatment involved. 
However, in'the event of further contact being necessary, inclusion of your address on the 
consent form will allow for you to be contacted. 
11. What if something goes wrong? 
In the unlikely event you are harmed by taking part in this research, there are no special 
compensation arrangements, but standard university insurance cover is in place. If you are 
harmed due to someone's negligence, then you may have grounds for a legal action, but you 
may have to pay for it. Regardless of this if you wish to complain, or have any concerns 
about any aspect of the way you have been approached or treated during the course of this 
study, the standard university complaints mechanisms should be available to you. 
12. Will my taking part in this study be kept confidential? 
All personal data will be anonymous and processed in the strictest of confidence and in 
accordance with the Data Protection Act (1988). By consenting to participate in this studs' 
you are indicating your agreement not to restrict the results of the study on the understanding 
that your anonymity is preserved. It is necessary for you to sign the consent form to indicate 
your consent, but this is the only place where your name will appear, all other data will be 
identified by coding only. If you would like to be contacted in the event of any further 
information regarding this research becoming available, then please include a contact address 
on the consent form. 
13. What happens to the results of the research study? 
It is anticipated that the results of this study will be published. Participants should note that 
they will not be able to be identified in any publication. Publication may be in academic 
journals, in the journal of the IBS NETWORK, and on the IBS NETWORK's website. The 
findings may also be presented at academic conferences. The IBS NETWORK's website has 
no access restrictions and can therefore be accessed by the general public. Requests can also 
be made to myself the chief investigator for a summary of the research findings. 
14. Who is organising and funding the research? 
The research is funded by the University of Surrey. 
15. Who has reviewed the study? 
This study has been revieved by the Multi-centre Research Ethics Committee. 
16. Contact for further information 
If you have any questions regarding any aspects of the study, or would like further 
information and advice please do not hesitate to contact me prior to the commencement of the 
study. The signing of the consent form indicates that you fully understand the study, and 
therefore if this is not the case please contact me prior to indicating your consent. 
Carly Jacobs 
Psychology Department 
School of Human Sciences 
University of Surrey 
GU2 7XH 
E-mail - c. iacobsnsurrey. ac. uk 
Tel: (University) +44 (01438) 686883 (Mob) 07931 565820 
APPENDIX 10 
CONSENT FORM FOR DOCTORS AND ETHICS APPROVAL FOR 
THE STUDY 
West Midlands Multi-centre Research Ethics Committee 
04 August 2004 
Miss Carly Jacobs 
Department of Psychology 
Guilford 
GU2 7XH 
Dear Miss Jacobs, 
27 Highfield Road 
Edgbaston 
Birmingham 
815 3DP 
Tel: 0121 245 2544 
Fax: 0121 245 2519 
Full title of study: Role of doctor-patient communication in the control component of 
illness representations, and outcomes, for sufferers of irritable bowel syndrome (IBS) 
REC reference number: 041MRE07/29 
Protocol number: I 
Thank you for your letter of 19 July 2004, responding to the Committee's request for further 
information on the above research. 
The further information has been considered on behalf of the Committee by the Chairman. 
Confirmation of ethical opinion 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation. 
Conditions of approval 
The favourable opinion is given provided that you comply with the conditions set out in the 
attached document. You are advised to study the conditions carefully. 
Approved documents 
The final list of documents reviewed and approved by the Committee is as follows: 
Document Type: Application 
Version: 
Dated: 19/05/2004 
Date Received: 20/05/2004 
Document Type: Investigator CV 
Version: 
Dated: 19/05/2004 
Date Received: 20/05/2004 
Document Type: Protocol 
Version: 1 
Dated: 19/05/2004 
Date Received: 20/05/2004 
Document Type: Summary/Synopsis 
Version: 1 
Dated: 19/05/2004 
Date Received: 20/0512004 
1/... 
The Central Office for Research Ethics Committees is responsible for the 
operational management of Multi-centre Research Ethics Committees 
UniS 
Ethics Committee 
19 August 2004 
Ms Carly Jacobs 
Department of Psychology 
School of Human Sciences 
Dear Ms Jacobs 
Role of doctor-patient communication in the control component of illness 
representations, and outcomes, for sufferers of irritable bowel syndrome (IBS) 
(EC/2004/82/Psych - FAST TRACK 
I am writing to inform you that the University Ethics Committee has considered the above 
protocol under its 'Fast Track' procedure, and has approved it on the understanding that 
the Ethical Guidelines for Teaching and Research are observed and the following condition 
is met: 
" That the Information Sheet for Participants and the advertisement material include the 
University's telephone number in addition to your personal mobile number, as some 
participants may prefer to use this to contact you. 
For your information, and future reference, these Guidelines can be downloaded from the 
Committee's website at http: //www. surrey. ac. uk/Surrey/ACE/. 
This letter of approval relates only to the study specified in your research protocol 
(EC/2004/82/Psych - Fast Track. The Committee should be notified of any changes to the 
proposal, any adverse reactions and if the study is terminated earlier than expected, with 
reasons. 
I should be grateful if you would confirm in writing your acceptance of the condition above, 
forwarding a copy of the amended documents for the Committee's records. 
Date of approval by the Ethics Committee: 19 August 2004 
Date of expiry of approval by the Ethics Committee: 18 August 2009 
Please inform me when the research has been completed. 
Yours sincerely 
Catherine Ashbee (Mrs) 
Secretary, University Ethics Committee 
Registry 
cc: Professor T Desombre, Chairman, EC 
13 fC - lý 's lc ;a 
Version 2 15/07/04 Consent form for Doctors 
Carly Jacobs 
I3sc (Hons) MSc 
'i rý } 
University of Surrey 
Guildford 
Surrey GU 2 7N}1 UK 
7'el: 444 (0)1483 686883 
Fax: +44 (0)1483 689553 
Email: cjacobs@surrey. ac. uk 
I A19% 
ULIIS Department of 
Psycholog) 
10 August 2004 
CONSENT FORM 
Title of Project: Doctor-Patient Communication in Irritable Bowel Syndrome (IRS) 
Name of Researcher: Carly Jacobs 
Please initial box 
1. I confirm that I have read and understand the information sheet dated ... 19/05/04 
Q 
(version 1) for the above study and have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
Q 
without giving any reason, without my medical care or legal rights being affected. 
3. I agree to take part in the above study. 
Q 
Name of Volunteer Date Signature 
(Block Capitals) 
Address of Volunteer (optional) 
Researcher Date Signature 
APPENDIX 11 
LETTER TO IBS SUFFERERS AND INFORMATION SHEET 
Version 1 19/05/04 
Information for advertisement to appear in newspapers, magazines and on websites: 
Unis 
Department of Psychology 
Participants required for a research investigating doctor-patient communication in 
irritable bowel syndrome (IBS). The research is administered by post and can 
therefore be completed at your convenience. The total time required for participation 
is one hour. There is no payment for this research but postage costs are included by 
use of free post. 
There are two parts to this research. The first stage involves completion of four short 
questionnaires. The second stage involves completion of a symptom and medication 
diary for one week. 
All sufferers who have been diagnosed by a medical professional (e. g. GP or 
Gastroenterologist) are eligible to participate. 
For more information please contact Carly Jacobs 
Psychology Department 
School of Human Sciences 
University of Surrey 
GU2 7XH 
E-mail -c jacobsnsurrey. ac. uk Telephone - 07931565820 
Version 2- 19/07/04 I'IS for IRS Participants 
' 
Carly Jacobs 
I3sc (I Ions) MSc 
Unix ersity of Surre 
Guildford 
Surrey GU2 7X11 UK 
Tel: +44 (0)1483 686883 
Fax: +44 (0)1483 689553 
Emnail: c. jacobs@surrey. ac. uk 
Department of 
PS dit Jog\ 
Patient Information Sheet For IBS Participants 
1. Study Title 
Doctor-Patient Communication in Irritable Bowel Syndrome (IBS) 
2. Invitation Paragraph 
23 August 2004 
You are being invited to take part in a research study. Before you decide if you would like to 
take part it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it with 
others if you wish. Contact me if there is anything that is unclear to you, or if you would like 
more information. Take time to decide whether or not you wish to take part. 
Thank you for reading this. 
3. What is the purpose of the study? 
Thank you for your interest in participating in this study. This study will investigate whether 
doctor-patient communication is related to frequency of IBS symptoms and quality of life. 
Patients' views on doctor-patient communication and beliefs about IBS will be measured. 
In addition Doctors' views on the quality of their consultations are also being measured so 
that their views can be compared with the patients' views to see if they are the same. 
Research of this type is necessary to gain a better understanding of what affects IBS has in 
order to design interventions to reduce symptoms and improve quality of life. It will take up 
to one hour of your time spread over eight days (proposed duration of the study one year). 
4. Why have I been chosen? 
You have been chosen because you are a sufferer of IBS, with a confirmed diagnosis from a 
medical professional. You are one of approximately 150 patients participating in this study. 
5. Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form, which you will have 
a copy of If you decide to take part you are still free to withdraw at any time and without 
giving a reason. A decision to withdraw at any time, or a decision not to take part, will not 
affect the care you receive from the NHS. 
6. What will happen to nie if I take part? 
Your involvement in this research will be for a period of eight days. It is anticipated that the 
total duration of the study is no more than one hour. There are two parts to the research. The first stage involves filling in questionnaires, and the second stage filling in a symptom and 
medication diary for a one week period. The questionnaires are to be filled in first, and they 
are to be completed in the order they are presented to you. After filling in the questionnaires 
you are to return them, along with the consent form using one of the prepaid envelopes 
provided. Starting the next day you are required to fill in the symptom diary for a one week 
period, before returning it using the second prepaid envelope provided. 
7. What do I have to do? 
The research is designed to involve minimal disruption to your routine, and can be completed 
at a location convenient to you. There are no lifestyle restrictions and you can therefore 
continue to undertake all normal activities. 
S. What are the possible disadvantages and risks of taking part? 
There are no disadvantages or risks from participating in this study. 
9. What are the possible benefits of taking part? 
There are many potential benefits from your participation in this study. The first is that 
knowledge of IBS may be increased. This is important as many sufferers report frustration at 
the current lack of knowledge concerning this illness. No previous research has addressed the 
role of doctor-patient communication in IBS, this is necessary as the quality of doctor-patient 
communication must first be established to see if changes need to be made. Finally the 
potential effect of doctor-patient communication needs to be established as this will shape the 
designing of a future intervention programme. 
10. What if new information becomes available? 
This is unlikely to occur as the research takes place over a short time period. however, in the 
event of further contact being necessary, inclusion of your address on the consent form will 
allow for you to be contacted. 
11. What if something goes wrong? 
In the unlikely event you are harmed by taking part in this research, there are no special 
compensation arrangements, but standard university insurance cover is in place. If you are 
harmed due to someone's negligence, then you may have grounds for a legal action, but you 
may have to pay for it. Regardless of this if you wish to complain, or have any concerns 
about any aspect of the way you have been approached or treated during the course of this 
study, the standard university complaints mechanisms should be available to you. 
12. Will my taking part in this study be kept confidential? 
Your doctor Neill not he informed of your participation in this study. All personal data ww-iII he 
anonymous and processed in the strictest of confidence and in accoidance %\ ith the Data 
Protection Act (1988). By consenting to participate in this study you are indicating your 
agreement not to restrict the results of the study on the understanding that your anonymity is 
preserved. It is necessary for you to sign the consent form to indicate your consent, but this is 
the only place where your name will appear, all other data will be identified by coding only. 
It is essential that you include an identifying code word on the consent form, and the same 
word on the diary, this will allow for your questionnaire data to be matched to your diary. If 
you would like to be contacted in the event of any further information regarding this research 
becoming available, then please include a contact address on the consent form. 
13. What happens to the results of the research study? 
It is anticipated that the results of this study will be published. Participants should note that 
they will not be able to be identified in any publication. Publication may be in academic 
journals, in the journal of the IBS NETWORK, and on the IBS NETWORK's website. The 
findings may also be presented at academic conferences. The IBS NETWORK's website has 
no access restrictions and can therefore be accessed by the general public. Requests can also 
be made to myself the chief investigator for a summary of the research findings. 
14. Who is organising and funding the research? 
The research is funded by the University of Surrey. 
15. Who has reviewed the study? 
This study has been reviewed by the Multi-centre Research Ethics Committee. 
16. Contact for further information 
If you have any questions regarding any aspects of the study, or would like further 
information and advice please do not hesitate to contact me prior to the start of the study. The 
signing of the consent form indicates that you fully understand the study, and therefore if this 
is not the case please contact me prior to indicating your consent. 
Carly Jacobs 
Psychology Department 
School of Human Sciences 
University of Surrey 
GU2 7X11 
E-mail - c. jacosnsurrey. ac. uk 
Tel: (University) +44 (01438) 686883 (Mob) 07931 565820 
APPENDIX 12 
CONSENT FORM FOR IBS PARTICIPANTS 
Version 2 15/07/04 Consent form for LBS Participants 
Carly Jacobs 
ßsc (Boils) MSc 
University of Surrey 
Guildford 
Surrc, - (cl I" 7X11 ( ºK 
Tel: +44 (0) 1483 686583 
Fax: 444 (0)1483 689553 
Email: c. jacobs@surre),. ac. uk 
CONSENT FORM 
Uni$ Department of 
Psychology 
10 August 2004 
Title of Project: Doctor-Patient Communication in Irritable Bowel Syndrome (IRS) 
Name of Researcher: Carly Jacobs 
Please initial box 
1. I confirm that I have read and understand the information sheet dated ... 19/07/04 
(version 2) for the above study and have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
Q 
without giving any reason, without my medical care or legal rights being affected. 
3.1 agree to take part in the above study. 
Q 
Name of Volunteer 
(Block Capitals) 
Address of Volunteer (optional) 
Date Signature 
Researcher Date Signature 
Code word for identification 
APPENDIX 13 
GENERAL POPULATION VERSION OF 
ATTITUDES TO CHRONIC ILLNESS QUESTIONNAIRE 
Attitudes to Chronic Illness Questionnaire 
I am interested in your views concerning chronic illnesses, please answer 
the questions below honestly and in the order they are presented to you. 
There are no right or wrong answers, and you do not need to look up a 
definition of any of the illnesses, just answer the questions on the basis of 
how you feel, and based on your current knowledge. You may, however, 
use a dictionary or translator if you do not understand the symptoms 
listed in section one. 
Section 1 
All chronic illnesses have a number of symptoms associated with them. The 
symptoms listed below are either experienced by sufferers of Epilepsy, Astluna or 
Irritable Bowel Syndrome (IBS). A particular symptom might be related to one, or a 
number of these illnesses. Please indicate the number that best represents your 
feelings towards discussing the symptom described below. Imagine that you have a 
friend who has just disclosed to you that they suffer from these symptoms and rate 
your answers according to how comfortable / uncomfortable you would feel 
discussing them. Write the number that best indicates how you feel on the line next to 
the symptom. 
Discussing this symptom, I would feel... 
1= extremely comfortable 
2= moderately comfortable 
3= slightly comfortable 
4= neither 
5= slightly uncomfortable 
6= moderately uncomfortable 
7= extremely uncomfortable 
8= not be prepared to discuss this'symptom 
e. g. If the symptom was vomiting and discussing this made you moderately 
uncomfortable your response would look like this: 
Vomiting ........ 6........... 
1. A convulsion ........................................................ 
2. Belching ............................................................. 
3. Nasal flaring (nostril size increases with breathing).......... 
4. Muscle jerks of arms, legs or body .............................. 
5. Dazed behaviour (unable to communicate) ..................... 
6. Wheezing ............................................................ 
7. Diarrhoea ............................................................ 
8. Brief periods of no response to questions / instructions....... 
9. Coughing 
.............................................................. 
Discussing this symptom, I would feel... 
1= extremely comfortable 
2= moderately comfortable 
3= slightly comfortable 
4= neither 
5= slightly uncomfortable 
6= moderately uncomfortable 
7= extremely uncomfortable 
8= not be prepared to discuss this symptom 
10. Constipation 
..................................................... 11. Sudden fear, anger or panic for no reason ................... 
12. Bloating 
.......................................................... 13. Shortness of breath ............................................. 14. Repeated out of place / unnatural movements ............... 
15. Loss of bowel control whilst fully conscious ............... 16. "Fainting spells" where bladder control is lost ............. 
17. Episodes of blank staring ...................................... 
18. Flatulence ........................................................ 
19. Difficulty talking or concentrating ............................ 
20. Abdominal pain ................................................. 
21. "Fainting spells" where bowel control is lost ................ 
22. Short periods of blackout or confused memory .............. 
23. Hunched shoulders ............................................... 
24. Episodes of blinking / chewing at inappropriate times...... 
25. Shortness of breath when walking ............................... 
26. Urgent need to defecate .......................................... 
27. Sudden stiffening or falls for no apparent reason ............. 
28. Tightness in the chest .............................................. 
Please indicate the number that best represents your feelings towards witnessing the 
symptom described below. Imagine that you have a friend who suffers from these 
symptoms, and rate your answers according to how comfortable / uncomfortable you 
would feel witnessing them experiencing each symptom. Write the number that 
most indicates how you feel on the line next to the symptom. 
Witnessing this symptom, I would feel... 
1= extremely comfortable 
2= moderately comfortable 
3= slightly comfortable 
4= neither 
5= slightly uncomfortable 
6= moderately uncomfortable 
7= extremely uncomfortable 
S= not be prepared to witness this symptom 
e. g. If the symptom was vomiting and witnessing this made you 
moderately comfortable your response would look like this: 
Vomiting ......... 
2........... 
1. A convulsion ........................................................ 
2. Belching ............................................................. 
3. Nasal flaring (nostril size increases with breathing).......... 
4. Muscle jerks of arms, legs or body .............................. 
5. Dazed behaviour (unable to communicate) ..................... 
6. Wheezing ............................................................ 
7. Diarrhoea ............................................................ 
8. Brief periods of no response to questions / instructions....... 
9. Coughing ............................................................. 
10. Constipation ....................................................... 
11. Sudden fear, anger or panic for no reason ..................... 
12. Bloating ............................................................ 
13. Shortness of breath ................................................ 
14. Repeated out of place / unnatural movements.................. 
15. Loss of bowel control whilst fully conscious ................. 
16. "Fainting spells" where bladder control is lost ............... 
17. Episodes of blank staring ........................................ 
18. Flatulence .......................................................... 
19. Difficulty talking or concentrating ............................... 
20. Abdominal Pain ................................................... 
Witnessing this symptom, I would feel... 
1= extremely comfortable 
2= moderately, comfortable 
3= slightly comfortable 
4= neither 
5= slightly uncomfortable 
6= moderately uncomfortable 
7= extremely uncomfortable 
8= not be prepared to witness this symptom 
21. "Fainting spells" where bowel control is lost ................... 22. Short periods of blackout or confused memory ................. 23. Hunched shoulders .................................................. 
24. Episodes of blinking / chewing at inappropriate times......... 
25. Shortness of breath when walking ................................. 
26. Urgent need to defecate ............................................ 
27. Sudden stiffening or falls for no apparent reason ............... 
28. Tightness in the chest ............................................... 
Please mark the box which best represents your opinion. 
VIEWS ABOUT CITRON 
If a person had ASTHMA it would 
strop 1 affect the wa I viewed them 
2-" Having EPILEPSY has major 
consequences uences on a sufferers life 
3 ASTHMA is a serious condition 
4 If a person I was close to had EPILEPSY 
it would cause difficulties for me 
5 Having IBS does not have much effect on 
a sufferers life 
6 Having ASTHMA has serious financial 
consequences for sufferers 
person had EPILEPSY it would 
p 1wed them 
ving IBS has major consequences on a 
erers life 
person I was close to had ASTHMA 
ould cause difficulties for me 
person had IBS it would strongly 
ct the way I viewed them 
11 Having EPILEPSY has serious financial 
consequences for sufferers 
STRONGLY 
U SAGREE 
I DISAGREE I 
AGREE 
NEITHER I AGREE I 
ASTRON, G EE 
VIEWS ABOUT CHRONIC ILLNESS STRONGLY DISAGREE NEI IHER AGREE SIRONGLI 
DISAGREE AGREE AGREE 
NOR 
DISAGREE: 
12 If a person I was close to had HIS it 
would cause difficulties for me 
13 Having EPILEPSY does not have much 
effect on a sufferers life 
14 1 IBS is a serious condition 
is I EPILEPSY is a serious condition 
16 Having ASTHMA has major 
consequences on a sufferers life 
ý7 Having IBS has serious financial 
consequences for sufferers 
18 Having ASTII11MA does not have much 
effect on a sufferers life 
19 I would be embarrassed of a friend 
because of their EPILEPSY 
20 1 do not think that EPILEPSY 
sm toms are real 
:1 If my partner developed ASTHMA it 
would affect my relationship with them 
:2 I would choose not to be friends with 
someone if I knew they had EPILEPSY 
:3 1 would be embarrassed of a friend 
because of their IBS 
24 1 would choose not to be friends with 
someone if I knew they had ASTHMA 
25 I do not think IBS symptoms are real 
: 26 I would be embarrassed of a friend 
because of their ASTHMA 
2ý If my partner developed IBS it would 
affect my relationship with then 
ýg I would choose not to be friends with 
someone if I knew they had IBS 
. 29 I do not think ASTIIMA symptoms are 
- real 30 If my partner developed EPILEPSY it 
would affect my relationship with them 
Section 3 
Having a chronic illness limits the variety of activities a person is able to engage in. 
The types of activities that are limited obviously vary depending on the nature of the 
illness, but there are sonne features which are common to many illnesses. Imagine that 
you are friends with a person who suffers from each of the three illnesses described 
(IBS, epilepsy, asthma) and answer the questions below to indicate (by circling or 
highlighting) how often you would be prepared to make these concessions in planning 
social activities. 
1) I would be happy to avoid travelling on public transport if my friend 
did not want to due to worry about having an lBS attack 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
2) I would be happy to cancel going out socially because of my friend's 
Epilepsy 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
3) I would be happy to collect Epilepsy medication for my friend if they 
were too unwell to collect it themselves 
/------------/------------/----------/-------- -/----------/----------/ 
0123456 
Never Always 
4) I would be happy to cancel going out socially because of my friend's 
IBS 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
5) I would be happy to collect Asthma medication for my friend if they 
were too unwell to collect it themselves 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
6) I would be sympathetic if my friend was reluctant to plan activities 
ahead of time because of their Asthma symptoms 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
7) I would be happy to delay going out socially because of my friend's 
IBS 
/------------/------------/- 
012 
Never 
-----/----------/----------/----------/ 
3456 
Always 
8) I would be understanding if my friend was late because of their 
Epilepsy 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
9) I would be happy to cancel going out socially because of my friend's 
Asthma 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
10) I would be sympathetic if my friend was reluctant to plan activities 
ahead of time because of their IBS symptoms 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
11) I would be happy to avoid travelling on public transport if my friend 
did not want to due to worry about having an Epileptic attack 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
12) 1 would be understanding if my friend was late because of their IBS 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
13) I would be happy to delay going out socially because of my friend's 
Epilepsy 
/------------/------------/----------/----------/----------/----------/ 
0 1.2 3456 
Never Always 
14) I would be happy to avoid travelling on public transport if my friend 
did not want to due to worry about having an Asthma attack 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
15) I would be sympathetic if my friend was reluctant to plan activities 
ahead of time because of their Epileptic symptoms 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
16) I would be happy to delay going out socially because of my friend's 
Asthma 
/------------/------------/----------/----------/----------/----------/ 
023456 
Never Always 
17) I would be understanding if my friend was late because of their 
Asthma 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
18) I would be happy to collect IBS medication for my friend if they were 
too unwell to collect it themselves 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
Below is a list of common social activities that are restricted to sufferers of Epilepsy, 
Asthma or IBS. A particular activity may be restricted to one, or a number of these. 
illnesses. Please indicate the number which best represents how prepared you are to 
avoid these activities when planning group social activities to allow your friend to be 
involved. As with the previous section the items are scored on a scale from 0-6, where 
0 is never and 6 is always 
e. g. If the activity was bowling and you were always prepared to avoid this when 
planning group activities your response would look like this: 
0 Bowling ...... 
6....... 
" Swimming ........................... 
" Going to night clubs ................ 
" Lazer quest ........................... 
" Long drives .......................... 
" Theme Parks ........................ 
" Water Parks ......................... 
" Going out to dinner ................ 
" Going abroad ........................ 
" Going on train journeys............ 
" Going to the cinema ................ 
" Going for long walks ............... 
" Team sports ........................ 
" Aerobics classes ..................... 
" Playing computer games............ 
Section 4 
Please provide a short description of what you understand Epilepsy to be: 
........................................................................................ 
Do you know anybody Who suffers from Epilepsy?.................. Yes / No 
If yes: would you consider this person(s) to be a friend? ......... Yes / No 
If no: what is your relationship with them? .................................... 
If you consider this person to be a friend do you feel that there have been 
situations when their illness has had a negative impact on you or your 
relationship with them, if so please explain below: 
....................................................................................... 
....................................................................................... 
....................................................................................... 
....................................................................................... 
....................................................................................... 
........................................................................................ 
Please provide a short description of what you understand IBS to be: 
....................................................................................... 
....................................................................................... 
....................................................................................... 
....................................................................................... 
....................................................................................... 
........................................................................................ 
Do you know anybody who suffers from IBS? ........................ Yes / No 
If yes: would you consider this person(s) to be a friend?............ Yes / No 
If no: what is your relationship with them? .................................... 
If you consider this person to be a friend do you feel that there have been 
situations when their illness has had a negative impact on you or your 
relationship with them, if so please explain below: 
........................................................................................ 
Please provide a short description of what you understand Asthma to be: 
....................................................................................... 
....................................................................................... 
....................................................................................... 
....................................................................................... 
....................................................................................... 
........................................................................................ 
Do you know anybody who suffers from Asthma .................. Yes No 
If yes: would you consider this person(s) to be a friend? ........... Yes No 
If no: what is your relationship with them? ..................................... 
If you consider this person to be a friend do you feel that there have been 
situations when their illness has had a negative impact on you or your 
relationship with them, if so please explain below: 
Of the three illnesses described please rank which condition you think 
would most impact on your friendship with a person. 1= greatest impact, 
2= middle impact, 3=least impact. 
EPILEPSY .......................... 
IBS ................................... ASTHMA .................:......... 
Thank you very much for your time. 
Please check you have answered every question. If you have any 
additional comments please write them on the back page of the 
questionnaire. 
Carly Jacobs 
Chronic Illness Questionnaire Scoring: 
For section 1 scoring is computed in to different ways. 
1) Using descriptive stats, like a bar chart so see 1Nhich symptoms are 
scores the highest, and to see where abouts on the range the IBS 
symptoms are, and then using an ANOVA to compare the mean 
responses for each of the symptoms (for discussing and witnessing 
respectively), to see if the differences between symptoms are 
significantly different 
2) Summing and averaging each group of symptoms (IBS questions 
7,10,20,18,26,12,15,2, epilepsy 1,22,16,21,17,8,27,24,5,14,11,4, 
asthma 6,9,13,28,19,25,23,3) and comparing the means of the three 
groups, to look at the overall impact of the illness as compared 
with each other. 
For section 2 the parallel version of the IPQ-R consequences scale 
scoring would be done in the same way as on the original IPQ-R. This 
just involves summing the 6 questions in each section (except that 
questions 5,18 and 13 are inverted and needs to be recoded first). This 
will then allow for a comparison of the perceived consequences from the 
general population about each of the illnesses, which can then be 
compared to each other to see which illness scores the highest, and if the 
means are sig different. The IBS version can also be compared to the data 
from the IBS participants to see if the perceptions of people match the 
assumed perceptions the IBS people have, which will have implications 
for the intervention study. I have also added onto this for each illness the 
other perception questions I wanted to ask because I think they fit in this 
section, when I analyse the data I will also look at factor analysis of this 
section to see if it can be effectively added in, and if so I will also do that. 
For section three concession scale. To just be summed for each illness 
For section 41 have gone for a more qualitative style just to get some 
more info, I can then code the descriptions of the illnesses to give them a 
score to see accurate the definitions are. I can then as past of the data 
analysis include accuracy of knowledge as an interaction variable 
APPENDIX 14 
PERCEIVED SOCIAL SUPPORT SCALE (PSSS) 
Version 1 07/04/2005 
Perceived Social Support Scale (PSSS) 
I am interested in your views concerning the level of social support you 
think your friends and family provide with regards to your suffering from 
Irritable Bowel Syndrome (IBS). Please answer the questions below 
honestly and in the order they are presented to you. As different friends 
and family members may respond differently you are required to think 
about all of their likely responses and record the avera, 'e respofrse of how 
you think your friends and family are likely to respond. In the case of a 
particular symptom not being relevant to your experience of IBS please 
write N/A next to the question. DO NOT JUST LEAVE IT BLANK. 
Section 1 
Think about how your friends and family would feel discussing each of your 
symptoms of IBS with you. Please indicate the number that best represents the 
average response your friends and family would have towards discussing the 
symptom described below. Imagine that you have initiated a conversation with them 
about these symptoms and rate how comfortable / uncomfortable you think they 
would feel discussing them. Write the number that best indicates how you think they 
feel on the line next to the symptom. If a symptom is not relevant to your experience 
of IBS then write N/A next to the question, do not just leave it blank. 
Discussing this symptom, my friends / family would feel... 
1= extremely comfortable 
2= moderately comfortable 
3= slightly comfortable 
4= neither 
5= slightly uncomfortable 
6= moderately uncomfortable 
7= extremely uncomfortable 
8= not be prepared to discuss this symptom 
e. g. If the symptom was vomiting and you think discussing this with your friends 
and family would on average make them feel moderately uncomfortable your 
response would look like this: 
Vomiting ......... 6........... 
1. Belching ............................................................. 
2. Diarrhea ................. 
'........................................... 
3. Coughing .............................................................. 
4. Constipation 
..................................................... 5. Bloating 
.......................................................... 6. Flatulence 
........................................................ 7. Abdominal pain ................................................. 8. Urgent need to defecate .......................................... 
Section 2 
Think about how your friends and family would feel witnessing each of your 
symptoms of IBS. Please indicate the number that best represents the average 
response your friends and family would have towards witnessing the symptoms 
described below. Imagine that are experiencing this symptom in front of them and rate 
how comfortable / uncomfortable you think they would feel witnessing them. Write 
the number that best indicates how you think they feel on the line next to the 
symptom. If a symptom is not relevant to your experience of IBS then write N/A next 
to the question, do not just leave it blank. 
Witnessing this symptom, my friends and family would feel... 
1= extremely comfortable 
2= moderately comfortable 
3= slightly comfortable 
4= neither 
5= slightly uncomfortable 
6= moderately uncomfortable 
7= extremely uncomfortable 
8= not be prepared to witness this symptom 
e. g. If the symptom was vomiting and think witnessing this would on average 
make your friends and family feel moderately comfortable your response would 
look like this: 
Vomiting......... 2........... 
1. Belching ............................................................. 
2. Diarrhea ............................................................ 
3. Coughing .............................................................. 
4. Constipation ..................................................... 
5. Bloating .......................................................... 
6. Flatulence ........................................................ 7. Abdominal pain ................................................. 
8. Urgent need to defecate .......................................... 
Section 3 
Having IBS can affect the social activities you are able to engage in, depending on 
your illness sub-type and severity of your symptoms on different occasions. Below 
are a number of concessions that your friends and family may have to make when 
arranging social activities in order to allow you to be included. Please indicate on 
average (as with the previous section) how often you think your friends and family 
would be prepared to make these concessions. 
On average my friends and family would.... 
1) Be happy to avoid travelling on public transport if I did not want to 
due to worry about having an IBS attack 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
2) Be happy to cancel going out socially because of my IBS 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
3) Be happy to delay going out socially because of my IBS 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
4) Be sympathetic if I was reluctant to plan activities ahead of time 
because of my IBS symptoms 
/------------/------------/----------/----------/-------- -/----------/ 
0123456 
Never Always 
5) Be understanding if I was late because of my IBS 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
6) Be happy to collect IBS medication for me if I was too unwell to 
collect it myself. 
/------------/------------/----------/----------/----------/----------/ 
0123456 
Never Always 
Below is a list of common social activities that may be difficult for you to engage in. 
Please indicate the number which best represents on average how prepared you think 
your friends and family would be to avoid these activities when planning group social 
activities to allow you to be involved. As with the previous section the items are 
scored on a scale from 0-6, where 0 is never and 6 is always. It does not matter if a 
particular activity is one you do not engage in please mark it any way. 
e. g. If the activity was bowling and your friends and family were always prepared to 
avoid this when planning group activities your response would look like this: 
" Bowling ...... 6....... 
" Swimming ........................... 
" Going to night clubs ................ 
" Lazer quest ........................... 
" Long drives .......................... 
" Theme Parks ........................ 
" Water Parks ......................... 
" Going out to dinner ................ 
" Going abroad ........................ 
" Going on train journeys............ 
" Going to the cinema ................ 
" Going for long walks ............... 
" Team sports .......................... 
" Aerobics classes ..................... 
" Playing computer games............ 
APPENDIX 15 
DEMOGRAPHIC QUESTIONNAIRE 
FOR GENERAL POPULATION 
Demographic Questionnaire - Paper Version 
Please answer the questions below prior to completing the questionnaires 
1. Age in years ................................................................. 
2. Gender 
........................................................................ 
3. Country of Residence ...................................................... 
4. Nationality ................................................................... 
5. Religion 
....................................................................................... 
6. Highest Academic Qualification ......................................... 
7. Occupation .................................................................. 
8. Where did you hear about the research? ..................................... 
9. Do you smoke? ............................................................... 
10. Do you suffer from any chronic illness(s)?............ Yes / No 
11. If yes, please list the illness(s) below: 
APPENDIX 16 
LETTER AND INFORMATION SHEET FOR ATTITUDES STUDY, 
GENERAL POPULATION 
R7 
1 
Carly Jacobs University of Surrey Department of 
Bsc (lions) MSc Guildford Psychology 
Surrey GU2 7XH UK 
Tel: +44 (0)1483 686883 
Fax: +44 (0)1483 689553 
Email: c. jacobs@surrey. ac. uk 
20 December 2006 
Dear Sir / Madame 
My name is Carly Jacobs and I am a PhD student at the University of Surrey, I am currently 
conducting some research on attitudes to chronic illness. Please will you take part in my research by filling in a 
questionnaire for me it should take no more than 20 minutes and I need 1000 people to fill it in, so I am sure you 
can appreciate how grateful I would be for your participation. If you are unable to take part then please hand the 
questionnaire to someone you know who would be happy to take part (they must be 18 or over). 
Thank you for your time, I do look forward to hearing from you in due course. 
Carly Jacobs 
Y 
Carly Jacobs 
Bsc (lions) MSc 
University of Surrey 
Guildford 
Surrey GU2 7X1: 1 UK 
Tel: +44 (0)1483 686883 
Fax: +44 (0)1483 689553 
Email: c. jacobs@surrey. ac. uk 
Uni. Department of 
Psychology 
Participant information sheet for Attitudes to Chronic Illness Research 
Thank you for your interest in participating in this study. This study is interested in 
investigating people's attitudes towards chronic illness, specifically focused on attitudes 
towards three chronic illnesses, namely asthma, irritable bowel syndrome (IBS) and epilepsy. 
The study involves completion of a questionnaire, which should take no more than twenty 
minutes. 
There are three main objectives for this study. The first is to compare the attitudes to 
the three illnesses to see if attitudes are similar or different between illnesses. The second 
objective it to compare these attitudes with the perceptions sufferers of chronic illnesses have 
of people's attitudes. The third objective is to incorporate the information yielded into the 
designing of a chronic illness intervention study. 
There are many potential benefits from your participation in this study. The first is 
that by participating in this research knowledge of attitudes towards chronic illness will be 
increased, this is important as scientific discoveries and improvements in current management 
of chronic illness cannot be made unless people participate in research. Secondly one of the 
primary influences on how a sufferer views their illness is their perceptions of people's 
attitudes towards them. In psychological intervention studies inaccurate perceptions must be 
challenged and changed before improvements can result, however, there is currently no data 
detailing what people's attitudes actually are. Consequently the data from this study is vital, 
and a necessary precursor for designing effective illness interventions of this type. 
The research is designed to involve minimal constraints on your time, and can be 
completed quickly and at a location convenient to you. The total duration of your involvement 
is no more than twenty minutes. The questionnaire can either be returned to me in person, 
returned to my pigeon hole in the Psychology Department staff room (6AD02), or posted 
using the freepost address below. 
It is necessary for you to sign the consent form to indicate your consent, but this is the 
only place where your name will appear, all other data will be identified by coding only. If 
you would like to be contacted in the event of any further information regarding this research 
becoming available, then please include a contact address on the consent form. You have the 
right to withdraw from the study at any time without specifying your reason for doing so. 
All personal data will be anonymous and processed in the strictest of confidence and 
in accordance with the Data Protection Act (1988). By consenting to participate in this study 
you are indicating your agreement not to restrict the results of the study on the understanding 
that your anonymity is preserved. The results of this study will be available from myself at the 
conclusion of the study, and they may be published in academic journals, and presented at 
academic conferences. 
If you have any questions regarding any aspects of the study, or would like further 
information and advice please do not hesitate to contact me prior to starting the study. The 
signing of the consent form indicates that you fully understand the study, and therefore if this 
is not the case please contact me prior to indicating your consent. 
CARLYJACOBS 
FREEPOST G1197 
J3 - Dept of Psychology 
Guildford 
GU2 5ßR 
01 12040 DF3000 3204 
E-mail - c. jacobsnsurre . aac. uk Telephone (Office) 01483 686883 
Telephone (Mob) 07931565820 
APPENDIX 17 
CONSENT FORM FOR GENERAL POPULATION 
ý, ý ýý 
YY 
Carly Jacobs 
Bsc (lions) MSc 
University of Surrey 
Guildford 
Surrey GU2 7XH UK 
Tel: +44 (0)1483 686883 
Fax: +44 (0)1483 689553 
Email: c. jacobs@surrey. ac. uk 
Consent Form - Paper Version 
Department of 
Psychology 
I, the undersigned, voluntarily agree to take part in the study on "Attitudes to 
Chronic Illness". 
I have read and understood the infonnation sheet provided. I have been given 
a full explanation by the investigators of the nature, purpose, location and likely 
duration of the study, and of what I will be expected to do. I have been given the 
opportunity to ask questions on all aspects of the study and have understood the 
advice and information given as a result. 
I understand that all personal data relating to volunteers will be anonymous 
and will be processed in the strictest confidence, and in accordance with the Data 
Protection Act (1998). I agree that I will not seek to restrict the use of the results of 
the study on the understanding that my anonymity is preserved. 
I understand that I am free to withdraw from the study at any time without 
reason, without needing to justify my decision and without prejudice. 
I confirm that I have read and understood the above and freely consent to participating 
in this study. I have been given adequate time to consider my participation and agree 
to comply with the instructions and restrictions of the study. 
Name of Volunteer (Block Capitals) 
Signature / Date 
Address of volunteer (optional) 
APPENDIX 18 
INFORMATION SHEET FOR ATTITUDES STUDY, IBS 
PARTICIPANTS 
Carly Jacobs 
Bsc (lions) MSc 
tt 
University of Surrey 
Guildford 
Surrey GU2 7XH UK 
Tel: +44 (0)1483 686883 
Fax: +44 (0)1483 689553 
Email: cjacobs@surrey. ac. uk 
Department of 
Psychology 
20 December 2006 
INFORMATION SHEET FOR IBS PARTICIPANTS FOR THE ATTITUDE 
RESEARCH 
Version 1 07/04/2005 
Perceived Social Support Scale (PSSS) 
I am interested in your views concerning the level of social support you think your 
friends and family provide with regards to your suffering from Irritable Bowel 
Syndrome (IBS). Please answer the questions below honestly and in the order they 
are presented to you. As different friends and family members may respond 
differently you are required to think about all of their likely responses and record 
the average response of how you think your friends and family are likely to 
respond. In the case of a particular symptom not being relevant to your experience 
of IBS please write N/A next to the question. DO NOT JUST LEAVE IT BLANK 
APPENDIX 19 
CONSENT FORM AND ETHICS APPROVAL FOR IBS 
PARTICIPANTS IN THE 
ATTITUDE / INTERVENTION STUDY 
Version 17/04/05 Consent form for IBS Participants 
z. rY 
ýý 
rtG 
Carly Jacobs University of Surrey Bsc (Hons) MSc 
Guildford 
Surrey GU2 7XH UK 
Tel: +44 (0)1483 686883 
Fax: +44 (0)1483 689553 
Email: cjacobs@surrey. ac. uk 
Uni5 Department of 
Psychology 
20 December 2006 
CONSENT FORM 
Title of Project: Self Regulatory Model (SRM) based interventions in irritable bowel syndrome (IBS) 
Name of Researcher: Carly Jacobs 
Please initial box 
1. I confirm that I have read and understand the information sheet dated 9/06/05 
Q 
(version 2) for the above study and have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
11 
without giving any reason, without my medical care or legal rights being affected. 
3.1 agree to take part in the above study. 
Q 
Name of Volunteer 
(Block Capitals) 
Address of Volunteer (optional) 
Date Signature 
Researcher Date Signature 
Participant's Code word for identification 
05/Q1602/53 
U%IN 
Berkshire Research Ethics Committee 
Orchid Suite 
Prospect Park Hospital 
Honey End Lane 
Reading 
RG30 4EJ 
Telephone: 0118 960 5194 
Facsimile: 0118 960 5368 
24 June 2005 
Prof Richard Shepherd 
Department of Psychology 
University of Surrey 
Guildford 
Surrey 
GU2 7XH 
Dear Prof Shepherd, 
Full title of study: Self Regulatory Model (SRM) based interventions in 
irritable bowel syndrome (IBS) 
REC reference number: 051Q1602/53 
The Research Ethics Committee has reviewed the above application in accordance with the 
standard operating procedures for RECs. 
The Committee has issued a favourable ethical opinion of the application. 
The Chief Investigator has been notified of the Committee's opinion in our letter of 24 June 
2005. The letter gives full details of the documents reviewed. 
The Committee has designated this study as having no local investigators". There is no 
requirement for Local Research Ethics Committees to be informed or for site-specific 
assessment to be carried out at each site. 
Statement of compliance 
The Committee is fully compliant with the Regulations as they relate to ethics committees 
and the conditions and principles of good clinical practice. 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
05/Q1602/53 Please quote this number on all correspondence 
Yours sincerely 
I 
Mrs Jo Jones 
Committee Co-ordinator 
Email: jo. jones@berkshire. nhs. uk 
An advisory committee to Thames Valley Strategic Health Authority 
UniS 
Ethics Committee 
20 July 2005 
Ms Carly Jacobs 
Department of Psychology 
School of Human Sciences 
Dear Ms Jacobs 
Self Regulatory Model (SRM) based interventions in irritable bowel syndrome (IBS) 
(EC/2005/70/Psych) - FAST TRACK 
On behalf of the Ethics Committee, I am pleased to confirm a favourable ethical opinion for 
the above research on the basis described in the submitted protocol and supporting 
documentation. 
Date of confirmation of ethical opinion: 20 July 2005 
The list of documents reviewed and approved by the Committee under its Fast Track 
procedure is as follows: - 
Document Type: Application 
Dated: 03/07/05 
Received: 12/07/05 
Document Type: Approval Letter from the Berkshire Research Ethics Committee 
Dated: 24/06/05 
Received: 12/07/05 
Document Type: NHS REC Application Form 
Version: 4.0 
Dated: 07/04/05 
Received: 12/07/05 
Document Type: Research Protocol 
Version: 1.0 
Received: 12/07/05 
Document Type: Patient Information Sheet for IBS Participants 
Version: 2.0 
Dated: 01/07/05 
Received: 12/07/05 
This opinion is given on the understanding that you will comply with the University's Ethical 
Guidelines for Teaching and Research. 
The Committee should be notified of any amendments to the protocol, any adverse 
reactions suffered by research participants, and if the study is terminated earlier than 
expected with reasons. 
You are asked to note that a further submission to the Ethics Committee will be required in 
the event that the study is not completed within five years of the above date. 
Please inform me when the research has been completed. 
Yours sincerely 
Catherine Ashbee (Mrs) 
Secretary, University Ethics Committee 
Registry 
cc: Professor T Desombre, Chairman, Ethics Committee 
Professor R Shepherd, Supervisor, Dept of Psychology 
APPENDIX 20 
SHORT QUESTIONNAIRE FOR PEOPLE WHO 
DID NOT RETURN THEIR INTERVENTION PACKS 
Carly Jacobs 
`f Bsc (Hons) MSc 
ýt 
University of Surrey 
Guildford 
Surrey GU2 7X11 UK 
Tel: +44 (0)1483 686883 
Fax: +44 (0)1483 689553 
Email: c. jacobs@surrey. ac. uk 
Department of 
Psychology 
20 December 2006 
Dear sir / Madame, 
According to my records you have not yet returned your pre and post 
intervention pack for the self-help booklet based study in IBS. There may be a 
number of reasons as to why the pack has not been returned, and it would be 
really helpful if you could indicate the reason below. Once again I thank you for 
your time and if you have any further questions please do not hesitate to contact 
me. 
Name of Volunteer (Block Capitals) 
Date Signature 
Address of Volunteer (optional) 
I returned my pack; you sent me this letter by mistake 
[-] 
I never received my pack and I am still interested in taking part please send me 
another one 
M 
I have misplaced my pack please could you send me another one 
f-] 
I have not had the time / forgot about the study, but I still have the pack and will 
start filling it in now[: 
] 
I never received my pack but I am no longer interested in taking part 
F1 
Upon receiving the pack I have decided not to take part, and still do not wish to 
do so 
rI- Please Fill in the further boxes below to 
indicate your reasons 
It was discovered that I had something other then IBS 
I did not want to fill in the diary section of the pack 
Q Please select 
one option below 
I would be prepared to take part in the study as long as I could just fill in 
the questionnaires and the booklet, and not fill in the diaries 
Even without the diaries I still do not wish to take part in the study 
II- 
If you still do not wish to take part then I would like to thank you 
once again for your time and wish you well in the future. 
Included with this letter is a one page demographic 
questionnaire, if you are able to complete this and return it with 
this form it would be really helpful. 
Thank 
, you 
Carly Jacobs 
APPENDIX 21 
IBS SYMPTOM SCALE (ISS) 
Version 107/04/05 
IBS Symptoms Scale (ISS) 
Please circle the number that indicates how severe each of your symptoms has been over the past week. 
The scale is from 0 to 6 where 0 indicates that you have not experienced the symptom at all in the 
previous week and 6 indicates that you have experienced this symptom constantly. Some of the 
symptoms listed are not used specifically in the diagnosis of IBS, but if you have experienced them in the 
last week please circle the number that best applies. If you have never experienced a symptom since being 
diagnosed with IBS then please circle not applicable. 
Example: Not applicable 
0123456 
Not experienced Experienced this 
this symptom symptom constantly 
................................................................ 
IN TILE PAST WEEK I HAVE EXPERIENCED: 
1. I)IARRHIOEA 
Not applicable 
0123456 
Not experienced Experienced this 
this symptom symptom constantly 
2. CONSTIPATION 
Not applicable 
0I23456 
Not experienced Experienced this 
this symptom symptom constantly 
3. BLOATING 
Not applicable 
0123456 
Not experienced Experienced this 
this symptom symptom constantly 
4. ABDOMINAL PAIN 
Not applicable 0I234 56 
Not experienced Experienced this 
this symptom symptom constantly 
5. URGENT NEED TO DEFECATE 
Not applicable 
01234 56 
Not experienced Experienced this 
this symptom symptom constantly 
6. FEELINGS OF INCOMPLETE EVACUATION 
Not applicable 
01234 56 
Not experienced Experienced this 
this symptom symptom constantly 
7. PASSAGE OF MUCUS 
Not applicable 
01234 56 
Not experienced Experienced this 
this symptom symptom constantly 
8. FLATULANCE 
Not applicable 
01234 56 
Not experienced Experienced this 
this symptom symptom constantly 
9. BELCHING 
Not applicable 
01234 56 
Not experienced Experienced this 
this symptom symptom constantly 
10. NORMAL STOOLS 
Not applicable 
0I234 56 
Not experienced Experienced this 
this symptom symptom constantly 
11. THIN STOOLS 
0123 
Not experienced 
this symptom 
12. HARD (PELET LIKE) STOOLS 
0123 
Not experienced 
this symptom 
13. LOOSE STOOLS 
0123 
Not experienced 
this symptom 
14. JOINT PAIN 
0123 
Not experienced 
this symptom 
15. PAIN IN THE LOWER BACK 
0i23 
Not experienced 
this symptom 
16. NAUSEA 
0123 
Not experienced 
this symptom 
17. DIFFICULTY SLEEPING 
0I23 
Not experienced 
Not applicable 
456 
Experienced this 
symptom constantly 
Not applicable 
456 
Experienced this 
symptom constantly 
Not applicable 
456 
Experienced this 
symptom constantly 
Not applicable 
456 
Experienced this 
symptom constantly 
Not applicable 
456 
Experienced this 
symptom constantly 
Not applicable 
456 
Experienced this 
symptom constantly 
Not applicable 
456 
Experienced this 
this symptom 
18. FEELING DEPRESSED 
Symptom constantly 
Not applicable 
Not experienced 
this symptom 
19. FEELING STRESSED 
Experienced this 
symptom constantly 
Not applicable 
Not experienced 
this symptom 
Experienced this 
symptom constantly 
APPENDIX 22 
SHORT POST INTERVENTION QUESTIONNAIRE 
Version 1 7/04/2005 - Post-Intervention Questionnaire for IBS Sufferers 
Please answer the questions below prior to completing the questionnaires 
1. Code word ............................................. 
2. Please specify on average which sub-group of IBS most accurately describes your 
symptoms by circling below: 
predominately diarrhoea predominately constipation alternating 
It is really important that you are classified into one of these three groups, so please think 
carefully about your answers to this question, if you really feel that you do not fit into one of 
these categories, please provide an explanation of your primary symptoms 
below ......................................................................................................... 
............................................................................................................... 
................................................................................................ 
Have you made any changes since filling in the intervention? These can be changes in ways of 
thinking or in behaviour. These may be things you included in your action steps or something 
you thought of afterwards. Please write any changes below, you may continue on another 
page if you desire. 
............................................................................................................... 
............................................................................................................... 
............................................................................................................... 
............................................................................................................... 
............................................................................................................... 
............................................................................................................... 
............................................................................................................... 
............................................................................................................... 
............................................................................................................... 
............................................................................................................... 
............................................................................................................... 
APPENDIX 23 
IBS SELF-HELP BOOKLET 
Version 1 07/04/0 
IBS INTERVENTION BOOKLET 
Carle Jacobs (BSc, MSc) 
INSTRUCTIONS 
" This booklet is designed to provide a mixture of information and 
advice for actions you can take to help improve your symptoms. Some 
of the information will not be relevant to your particular type of lBS, 
when this is the case it will be clearly marked. 
" All of the information included in this booklet has been thoroughly 
researched and is accurate at the time of compiling. There is a 
footnote and reference section at the end detailing the sources of the 
original information. 
" In order to get the best out of this intervention it is necessary to work 
through the booklet in the order the sections are presented to you. In 
some cases you may already know the information, or have answered 
similar questions in the past, this is not important, as it is your feelings 
and behaviours now that the intervention will work on. 
" No one will see this booklet but you; you do not need to return it. 
With this in mind you should answer all sections honestly taking the 
time to reflect on your feelings and providing as much (or as little) 
information as you feel is beneficial for improving you 113S. 
Section 1- Illness Identity 
Your thoughts about being an IBS sufferer 
'W'hen people are first diagnosed with suffering from IBS they, may experience a 
variety of different emotions. Examples of positive emotions include feeling relieved 
the diagnosis is not Cancer, and being glad to finally have an explanation for the 
symptoms. Examples of negative emotions include feelings of embarrassment and 
concerns over sharing the diagnosis with others. Some people will think of their IBS 
as being a `handicap' where as others will think of it as being `just one of those 
things'. It can often be overlooked that these feelings surrounding being an IBS 
sufferer do not disappear after initial diagnosis, and moreover your feelings towards 
having 1135 may alter, perhaps even on a daily basis. It does not matter what your 
feelings regarding being an IBS sufferer have been in the past, what matters is how 
you feel about suffering from 1135 at this moment. 
For this exercise you are required to write below how you feel about being labelled 
an IBS sufferer. This might be something that you know straight away, or 
something you need to think about for a few minutes. It might be something that 
you have one main feeling about, or a number of different feelings (they may even 
he conflicting). There are no right or wrong answers just write about how you feel 
about being called an IBS sufferer. 
............................................................................................................ 
You may continue over the page if ncccstiarý. 
Action Step I- Identifying Positive Feelings towards being an 
1135 sufferer 
You will have now "ritten one or a number of thoughts on the previous page. Sonic 
of these thoughts may be some negative and some positive. As thinking about 
negative thoughts is not a good coping strategy for any illness' this section will focus 
on your positive thoughts regarding being an 1135 sufferer. For some people it may 
be hard at first to think of positive things but it is really important for the 
improvement of your 1135 to get out of a negative mind set, so really think about 
anything positive you can say about being labelled with IBS. This can include 
positive things relating to the illness in general, such as the fact that it is not 
terminal, or it can be positive things relating to your illness label, such as feeling 
happy that it is a genuine medical condition not something you are imagining. 
First look back at the comments you made in the previous section and write below 
any positive comments you made there first, and after this list any other positive 
things you can say. 
1) ......................................................................................................... 
2) ......................................................................................................... 
3) ......................................................................................................... 
4) ......................................................................................................... 
5) ......................................................................................................... 
6) ......................................................................................................... 
Ytºu may COOnti Ittc over tIIc page if necessary. 
Action Step 2- Encoura ; ing Positive Feelings about beinL, an 
IBS sufferer 
Is there any, action you have taken or think you could take that would help you to 
feel more positive about being an I13S sufferer. For example )'on could become a 
`befriender' (someone who other sufferers write to have someone to talk to about 
having IBS), or go to regular support groups. It is important to take a few minutes 
to think about this as there are many positive behaviours you can undertake though 
they might not automatically conic to mind. I have done the first one for you to get 
you started. 
1) Taking part in 1135 research is a really positive step both because it can help your 
individual symptoms to improve, and because you are being very helpful to both the 
other people who suffer from lBS and to the researchers who want to advance 
knows ledge of the illness. So b), taking part in this research you are already 
demonstrating one positive action about being an 1135 sufferer. 
zý ......................................................................................................... 
3) ......................................................................................................... 
ýý ......................................................................................................... 
5) ......................................................................................................... 
G) ......................................................................................................... 
Yrni may, continue over the luge if necessary. 
Action Step 3- How easy is it to act on the positive steps von 
have mentioned above? 
Think about the behaviours you have written on the previous page, below are a 
number of scales ranging from 1-6, where f indicates the behaviour is very easy to 
do and 6 indicates that it is very hard to do. Write the name of the behaviour on the 
dotted line above the scale and circle the number that most applies to your feelings 
about undertaking this behaviour. For a behaviour you have a (lone in the past 
please write any comments you think might be relevant, for example how it made 
you feel; if you changed anything as a result, or if you would do it again. For a 
behaviour that you have not done yet please write any things that would help you to 
achieve it, for example in order to he a` efriender' you would need to contact the 
IBS NETWORK. 
1) Taking part in 1135 research: 
/------------ /---------- /---------- /---------- /---------- /-----------/ 
(1) 23456 
V. easy v. hard 
Comments 
.............................................................................................. 
2> ........................................................................... 
------------ /---------- /---------- /---------- /---------- /----------- 
23356 
v. c ýsv v. hard 
Comments ............................................................................................. . 
6 
3) ........................................................................... 
23450 
%. easy v. hard 
Comments 
.............................................................................................. 
3) ........................................................................... 
------------/----------/----------/----------/----------/---------- 
23456 
v. easy v. hard 
Comments 
.............................................................................................. 
5) ........................................................................... 
------------ /---------- /---------- /---------- /---------- /----------- 
123456 
%'. easy v. hard 
('o nt m cnts .............................................................................................. 
G) ........................................................................... 
/------------ /---------- /---------- /---------- /---------- /-----------/ 
23456 
r. easy . ". hard 
Comments .............................................................................................. 
............................................................................................................ 
Yo I] nr. IV' continue over the page if necessary. 
7 
Section 2- Illness Knoýww ledge 
Your Knowled c about 1135 
Research suggests that it can sometimes be difficult for sufferers to get accurate 
knowledge about 1135 as sources of accurate information may not be readily 
available. " In order to clear up sonne of the areas of uncertainty keß' IRS FA('TS will 
he given below. For each fact that is listed tick or cross to indicate I%hether you 
knew or did not know this fact prior to being told. Remember nobody is going to see 
your answers except for you so be honest with your self as this is the only way to 
learn. 
1) 113S"' is very common, it affects about one in five people, this means that you 
most probably know at least two other people who suffer from IRS! 
2) 113S has a majority of female sufferers (in the UK and the USA)", it seems 
like that there are twice as many- female suffers as males'. However, as 113S 
affects so many, people this would still mean that around one in 15 men suffer 
from I13S. 
3) 1135 is not associated with getting older", it can start at any time, and the 
most usual time is early, adulthood'". 
4) 113S is called a functional illness, this means that nothing has so far been 
identified in the body to explain the symptoms, however this does not mean 
that the symptoms aren't real. ' iii 
5) There are 8 primary sy mptonis experienced by IBS" sufferers these are: 
abdominal pain, diarrhoea, constipation, bloating, passage of mucus, the 
urgent need to defecate, feelings of incomplete evacuation and flatulence. 
However, not all sufferers will experience all of these symptoms over the 
course of their having 1135. 
6) There are three main subtypes' of sufferers of IRS these are: diarrhoea 
predominant (I13S-1)), constipation predominant (1135-C) and alternating 
(IBS-A). As the categories suggest the sup-type of 1135 you have depends on 
your most frequent experience of diarrhoea or constipation, all of the other 
symptoms can occur in each sub-type. If you generally have diarrhoea then 
you have IBS-I), if you generally have constipation then you have IBS-C, if 
however you are constantly alternating between constipation and diarrhoea 
then you have IBS-A. On the first questionnaire you were asked to record 
which of these subtypes you fit into, tick if you think the answer you circled 
was right, and mark a cross if you now think that you are in a different 
subtype to the one you first thought. 
7) Each person's experience of I13S is unique, but the types of symptoms that 
-*, ou suffer front may actually alter on a daily basis. Therefore in some 
respects you are the best source of knowledge for your own IRS, and just 
because another sufferer is unable to cat a particular food or has found a 
certain tablet to he very helpful it does not mean that they- will necessarily 
Nvork for ), oil. On a daily basis it is therefore important to listen to your body, 
you are the expert. 
8) It is unusual for IRS sufferers to hasc blood in their stools". In most cases 
where there is blood in the stool it is nothing; more serious than a slight 
irritation of the skin in the back passage. However, if you do experience 
blood in the stools, especially if they are black and sticke it is important to go 
to the G1' and have a check-up. 
Action step I- Reflecting and making changes based on IBS 
FACTS 
Whilst reading the IBS facts you might have read some information you did not 
know previously. Because of this you might now feel that there are changes that you 
would like to make. These changes could take the form of feelings for example 
knowing that so many people suffer from IBS might make you feel less isolated. Or 
these changes could take the form of actions for example if you found blood in your 
stools but thought that this was a symptom of 1135 you night not have gone to the 
GP but reading the FACTS and discovering that it is not a normal symptom might 
now make up decide to go to the GP. Look back over the 1135 FACTS paying 
particular attention to any you did now know previously and write down any 
changes you are going to make to your behaviours or feelings on the action steps 
below. Please circle either feelings or behaviours prior to writing the action step. 
1) Action - feelings / behaviour 
2) Action - feelings / behaviour 
3) Action - feelings / behaviour 
4) Action - feelings / behaviour 
5) Action - feelings / behaviour 
6) Action - feelings / behaviour 
You may continue over the page if necessary. 
Action Step 2- How easy is it for you to make the changes you 
have mentioned above? 
Think about the actions you have written on the previous page. Below are a number 
of scales ranging from 1-6, where 1 indicates the action is very easy to do and 6 
indicates that it is very hard to do. Write the name of the action on the dotted line 
above the scale, including whether it is a feeling or behaviour. Circle the number 
that best applies to how easy it will be for you to make this change. Below the scale 
on the dotted line write any help that is needed for you to be able to achieve this 
behaviour, for example reducing feelings of isolation might involve speaking to 
other people with IBS, for which you would need access to another sufferer, for 
example through a self-help group. Please include any other comments you have too. 
1) Feeling / Behaviour 
(1) 23456 
v. easy v. hard 
Comments .............................................................................................. 
2) Feeling / Behaviour 
/. _------/_--/---------/-- -/ // 
(1) 23456 
v. easy v. hard 
Comments .............................................................................................. 
3) Feeling / Behaviour 
/---_-/---------/---------/------/ // 
(1) 23456 
v. easy v. hard 
Comments .............................................................................................. 
4) Feeling / Behaviour 
(1) 23456 
v. easy v. hard 
Comments .............................................................................................. 
5) Feeling /Behaviour 
(1) 23456 
v. easy v. hard 
Comments .............................................................................................. 
You may continue over the page if necessary. 
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Section 3- Your beliefs about the causes of your IRS 
Please write below a description of the factor or factors, which you think caused 
your IBS. Do not think about causes of IBS in general or what other people think 
caused their IBS this section is about what ou think caused your IBS. Remember 
only you have access to this booklet so be honest, even if you may think a possible 
suggestion is unlikely. 
Action step 1- Your beliefs about the causes of your IRS 
Looking back at the factors you have mentioned that you view as causing your IBS, 
list them over the page under the subheadings provided. Do not write any additional 
causes only write the ones you have written above. The subheadings are 1) Caused 
by an illness, e. g Gastroenteritis, 2) Caused by food, e. g. poor diet or food poisoning, 
3) Caused by myself, e. g. worrying too much, 4) Caused by other people, e. g. poor 
medical care 5), Caused by God / Fate, 6) Caused by genetic / hereditary factors or 
7) Caused by bad luck. If there are any you feel do not fit into these categories place 
them in the closest matching category, do not leave any of your listed causes out. 
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CAUSED BY AN ILLNESS 
CAUSED BY FOOD 
CAUSED BY MYSELF 
CAUSED BY OTHER PEOPLE 
14 
CAUSED BY GOD / FATE 
CAUSED BY GETIC / IIERIDITARY FACTORS 
CAUSED BY BAD LUCK. 
Action step 2- Learning about the possible causes of your 1135 
Of the causes that you have listed above it is possible that they might all be causes of 
your IBS. However, it is likely that some of them will be right and some of then will 
be wrong. It is important to know which causes are and are not likely as what you 
believe to cause your IBS will impact both on the symptoms you have and on the 
coping behaviours you undertake x'i. In order to clear up any areas of uncertainty 
`IBS CAUSES' will be listed overleaf. As with the IBS FACTS section for each cause 
you suggested that is listed below put a tick. Some commonly suggested causes for 
which there is no evidence are listed overleaf in the section labeled `NOT CAUSES 
OF IBS', if any of your suggestions are in this section tick to indicate that you have 
noticed this. If you have specified any possible causes that are not listed this means 
they are NOT causes of IBS and you should add then onto the NOT CAUSES list 
on the dotted lines below. 
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I13S CAUSES 
Current research suggests that there are a number of different factors that can 
result in the development of IBS, your own IBS may have been caused by one or a 
number of these factors. These are: 
"A biological abnormality that has not been identified yet="i 
" Following a bout of gastroenteritis" 
"A single extremely stressful or traumatic event"' 
" Sexual abuse"" 
"A tendency to turn negative thoughts inwards`"" 
" Major depression""' 
" Having severe anxiety"' 
" Following a course of antibiotics" 
" Following an unrelated abdominal operation' 
" Severe life stress"" 
" Severe food poisoning""' 
NOT CAUSES OF IRS 
" Ageing"'v 
" Alcohol 
" Hereditary` 
" Food allergy""' 
" Smoking 
" Pollution in the environment 
0 ................................................ 
0 ................................................ 
0 ................................................ 
9 ................................................ 
You may continue over the page if necessary. 
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Action step 3- Reflecting and making changes based on IBS 
CAUSES 
Whilst reading the facts about possible causes IBS you might have read some 
information you did not know previously. Because of this you might now feel that 
your views on what causes IBS are inaccurate, either because something you 
thought caused your IBS is not listed as a cause, or because you see a cause in the 
list that you had not previously considered but that now seems likely. Based on this 
write below if you have made any changes to your views on the cause of your IBS 
and if so in what way? 
Have you made any changes to your views on what caused your IBS? 
YES / NO 
If yes please specify below what these changes are: 
You may continue over the page if necessary. 
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Action step 4- Acting on changes to views on the cause of your 
LBS 
Has the section on causes of IBS made you think about any actions that you would 
now like to take? Think about any actions you would now like to take, below are a 
number of scales ranging from 1-6, where 1 indicates the action is very easy to do 
and 6 indicates that it is very hard to do. Write the name of the action on the dotted 
line above the scale, including whether it is a feeling or behaviour. Circle the 
number that best applies to how easy it will be for you to make this change. Below 
the scale on the dotted line write any help that is needed for you to be able to achieve 
this behaviour. For example if you now believe a possible cause of your IBS is severe 
depression you might choose an action step of seeing a counsellor to help your 
feelings of depression. Please include any other comments you have too. 
1) Feeling / Behaviour 
/-ýý-/__-----/- -_---/-----_/ -/--- / 
123456 
v. easy v. hard 
Comments .............................................................................................. 
2) Feeling /Behaviour 
" /--____--/-_-----/-------/--------/--. ------/- / 
(1) 23456 
v. easy v. hard 
Comments .............................................................................................. 
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3) Feeling/ Behaviour 
/------/------/--------/--------/--------/----__---/ 
(1) 23456 
v. easy v. hard 
Comments .............................................................................................. 
4) Feeling / Behaviour 
(1) 23456 
v. easy v. hard 
Comments .............................................................................................. 
5) Feeling / Behaviour 
/. --------/---_. --/ý_. ---/-. -. ---/--__----/-- / 
(1) 23456 
v. easy v. hard 
Comments .............................................................................................. 
..... 
ou.. may 
...... 
conti.... n... ue.. over...... the. page...... if. n. ecessa....... ry................................................... Y. 
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Section 4- Your beliefs about the course of your IBS 
Based on the information you have received from the GP and other health 
professionals; other sufferers, general information sources, and your own pattern of 
symptoms circle ONE of the below options to indicate which best describes how you 
would describe your illness. 
ACUTE -a short term illness which the body naturally cures or can be cured with 
medical or alternative help. 
TERMINAL-will ultimately result in death. 
CHRONIC BUT CURABLE -a long term condition which it is possible to cure with 
the right treatment. 
CHRONIC NOT CURABLE -a long term condition which it is not possible to cure. 
CHRONIC BUT CONTROLLABLE-a long term condition which it is possible to 
control with the right treatment. 
CHRONIC NOT CONTROLLABLE-a long term condition which it is not possible 
to control with any right treatment. 
CYCLICAL BUT UNEXPECTED - long periods with no symptoms but then can 
get symptoms for no apparent reason. 
CYCLICAL BUT EXPECTED - long periods with no symptoms but symptoms 
recur at expected points, such as during menstruation"`"". 
As IBS is a very individual illness"""i it is possible for the presentation of symptoms 
to take on a number the above options, however there were some that are not 
accurate. The options that are NOT ACCURATE ARE: 
" That IBS is terminal - this is not true 
" Chronic not curable-this is extremely unlikely 
0 Chronic not controllable-this is extremely unlikely 
20 
New developments are being made all the time to cure/ control IBS. In the mean 
time it has been shown that thinking positively about the cure / controlling of your 
symptoms actually can reduce the symptoms=""! So if you have circled one of the 
three options listed above go back and look at the list and pick an option that is 
more positive, write this below: 
If you arc still unsure what category your symptoms fit into, e. g. whether they are 
chronic or cyclic, try keeping a diary for a few weeks and see if you can spot any 
patterns. Can you think of any other things you can do? If so write them below: 
You may continue over the page if necessary. 
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Section 5- Your beliefs about the consequences of your IRS 
You may think that having IBS has a number of consequences (effects) on your life, 
this can include anything that you feel has happened since your developing IBS. 
This is going to be very individual as it will depend on your life experiences, 
symptoms and your interests. The consequences can be negative or they can be 
positive. They can be directly related to your symptoms or indirectly related. An 
example of a negative consequence is, not being able to go for long car journeys; an 
example of a positive consequence is having more time to read for pleasure. Next to 
the bullet points below list as many consequences as you can think of. 
" .................................................................................. 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
" ................................................................................... 
You may continue over the page if necessary. 
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Action step 1 -Identifying positive consequences of your IBS 
You will have now written a number of consequences of your IBS, some of which 
are probably positive, whilst others are negative. As thinking about positive 
thoughts is a good coping strategy". " this section will focus on your positive thoughts 
regarding the consequences of having IBS. For some people it may be hard at first 
to think of positive things but it is really important for the improvement of your IBS 
to get out of a negative mind set, so really think about anything positive you can say 
that has happened as a result of developing IBS, for example making new friends, 
e. g. at a support group. 
First look back at the points you made in the previous section and write below any 
positive comments you made there first, after this list any other positive things you 
think of. 
1) ......................................................................................................... 
2) ......................................................................................................... 
3) ......................................................................................................... 
4) ......................................................................................................... 
5) ......................................................................................................... 
6) ......................................................................................................... 
ýý ......................................................................................................... 
You may continue over the page if necessary. 
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Action step 2 -Remembering positive consequences of your 
lBS 
You should look back at these positive consequences whenever you are feeling 
unhappy because of your IBS. Even if you can't think of that many positive 
consequences now in the future things will arise which are positive and you should 
add these to the list. 
Action step 3 -Rethinking negative consequences 
In addition to the positive consequences of having IBS it is likely that some of the 
things you believe are negative consequences of IBS are either not actually a 
consequence of having IBS, or are things that can be make less problematic by 
taking simple steps. Below is a list of things that are NOT CONSEQUENCES of 
IBS. Look at the list below and put a tick near any point that you knew was not a 
consequence of having IBS. If there are any items of the list that you previously 
thought were consequences of IBS you should put a cross by these. You can now 
take comfort in the fact that these concerns are unnecessary. To make sure you 
remember the ones that you thought were consequences aren't write them out below 
on the dotted lines. For example if you thought Cancer was a possible consequence 
of having IBS you would write this on the dotted line. 
NOT CONSEOUENCES of IRS 
" Cancer is NOT a consequence of IBS"" 
" Crohns disease is NOT a consequence of IBS""' 
" Colitis is NOT a consequence of IBSm""' 
" Poor social support is not a necessary consequence of IBS""' 
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MINIMISING CONSEQUENCES of 1ßS 
In light of the information you have just been given you may have altered your view 
of the possible consequences of your IBS. However, there may be some things which 
you feel are negative consequences of your having HIS. If you no longer have any 
negative consequences in your mind then please skip the next section and go straight 
on to, SECTION 5. However, if there are still some things you consider to be 
negative consequences write these on the dotted lines below. 
1) ......................................................................................................... 
2) ......................................................................................................... 
3) ......................................................................................................... 
4) ......................................................................................................... 
5) ......................................................................................................... 
Action Step -4 Actions to minimize these consequences 
Even though some things may not be avoidable, in almost all cases it is possible to 
minimize the negative consequences. Below are some suggestions of possible 
consequences and action steps you could take to improve these. There are only a few 
listed as everyone's experience of IBS differs read the suggestions listed and tick any 
that match what you listed above. 
Consequence -Financial burden 
Possible Actions - Most over the counter medications are available on prescription 
so ask your GP. You are entitled to claim for disability allowance as IBS is 
recognised as a chronic condition, so find out how to apply for disability allowance, 
for example contact your local citizen's advice bureau. There are a number of jobs 
that can be conducted at home, and many employers are happy for people to work 
part time or on flexible hours, so speak to your Job Centre, or look in the local 
paper and see what options are available for you. 
Conscauence - Feeling a lack of support from family and friends 
Possible Actions - Research is emerging to show that people are happy to discuss 
IBS symptoms and are happy to make concessions to help friends and family who 
suffer from IBS. However, many sufferers worry that discussing their IBS can be 
embarrassing. It is easy to get stressed and feel isolated because of this. However, 
this is a worry that is unnecessary so if you feel this way push the feelings to one side 
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and speak to a close friend or family member about how you are feeling. If you do 
not feel able to do this there are a number of other possible actions you could take 
such as joining an IBS self-help group, contacting the IBS network to speak to a 
specially trained nurse, or to be put in touch with a `befriender'. Sometimes talking 
to someone impartial is also helpful so speaking to a counsellor about your worries 
is something you might find helpful. 
Consequence - Feeling that your quality of life has reduced 
Possible Actions - instead of dwelling on the things you cannot do that you could 
before think of all the things you are still able to do. Arrange things that you enjoy, 
such as inviting friends over to play board games, or taking up a hobby you can 
enjoy at home such as painting or craft making. The important thing is rather than 
focussing on negative aspects to think of the positive things that you can do instead. 
By now you should be thinking of action steps you can take to minimise the 
consequences you have listed. Using the same scale as before where I indicates the 
action is very easy to do and 6 indicates that it is very hard to do. Write the name of 
the action on the dotted line above the scale. Circle the number that best applies to 
how easy it will be for you to make this change. Below the scale on the dotted line 
write any help that is needed for you to be able to achieve this behaviour. For 
example if you now believe a possible action step you could take to minimise the 
financial burden of paying for medications is to ask your GI' to give you the 
medications on prescription make an action step talking to your GP about what 
over the counter medications, for example Imodium is available on prescription. 
1) Consequence ..................................................................... 
Action step ........................................................................... 
123456 
V. easy v. hard 
Comments .............................................................................................. 
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2) Consequence ..................................................................... 
Action step ........................................................................... 
123456 
v. easy v. hard 
Comments ........................................................................................... 
3) Consequence ..................................................................... 
Action step ........................................................................... 
123456 
v. easy v. hard 
Comments .............................................................................................. 
4) Consequence ..................................................................... 
Action step ........................................................................... 
123456 
V. easy Y. hard 
Comments .............................................................................................. 
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5) Consequence 
..................................................................... 
Action step ........................................................................... 
/--------/---------/----/-----/-------/----/ 
123456 
v. easy v. hard 
Comments ................. r............................................................................ 
6) Consequence ..................................................................... 
Action step ........................................................................... 
123456 
v. easy v. hard 
Comments .............................................................................................. 
7) Consequence ..................................................................... 
Action step ........................................................................... 
/-_. _____. _/_. _. ý-/---------/-------/ // 
123456 
v. easy v. hard 
Comments .............................................................................................. 
You may continue over the page if necessary. 
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Section 6- Ways of curing / controlling your II3S symptoms 
For many sufferers the ultimate question is how can my symptoms be cured 
or controlled? Although it can sometimes seem like this is a difficult task people 
often tell me that they used to have IBS and that they no longer have it. Therefore it 
is possible to recover from IBS. However, as it is such an individual illness it is not 
as simple as providing a quick fix as what works for one person will not necessarily 
work for you. The important issue is not to get disheartened by this, and instead of 
comparing your IBS to somebody else think about your own experiences of IBS. As 
IBS fluctuates you will have periods when you feel largely fine, it is important when 
this is the case to enjoy feeling well and to use these positive thoughts when you are 
feeling unwell. It is likely that you already do certain things which make your IBS 
seem better. These can either be things you think (such as thinking calming 
thoughts in difficult situations) or these can be things you do (such as avoiding a 
particular type of food). There may be some things that are unique to you, but they 
work. Below write any thoughts or actions you take that help you to feel better. 
................................................................................................... 
You may continue over the page if necessary. 
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Below are sonne suggestions for improving your IBS. The first section called 
GENERAL HELP lists suggestions that should be beneficial for all sufferers of II3S. 
The second section called SPECIFIC SYMPTOM HELP refers to things that are 
helpful depending on your symptoms of IBS at certain times. Look at the 
suggestions below and put a tick next the ones that you feel would be helpful for 
you, these might be things you have found helpful in the past or new things you 
would like to try. 
GENERAL IIELP 
" Thinking positively has been shown to improve IBS, so think 
positively and belief not only that your IBS is curable but that you are 
in control of your symptoms. So next time you are unwell, e. g. in 
severe pain, don't just give in to it, tell yourself that you can make it 
go away, think positively and you will see how much your symptoms 
improve both in the short term and the long term. """' 
" Medications can improve some of the symptoms, but if a particular 
medication is not working for you don't feel that you have to take it 
without questioning. Speak to your GP and ask if there are any 
alternatives that can be suggested and try these instead. 
Alternative therapies can be beneficial. Why don't you go to a Chinese 
herbal clinic and ask then to suggest something to help your 
Symptoms x... I 
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" Reflexology, Chiropractic and Aromatherapy have all been shown to 
be successful for some people and are readily available at most 
alternative clinics, so have a look in your local paper and see what is 
offered in your area""" 
" Relaxation is one of the most important things you can do to help your 
IBS. This can either take the form of learning how to meditate or 
gentle yoga, there are many books or videos available to teach you 
how, %%%""' or by relaxing by taking deep breaths, putting on calming 
music and allowing yourself time where you can forget all your 
worries. Relaxation is a very individual thing, and it really does not 
matter what you do as long as it is something that you enjoy. 
" Hypnosis has also been found to be helpful for some people. This can 
be particularly helpful if you suffer from anxiety, or if your IBS is the 
result of a traumatic event in your past. The hypnosis can work by 
helping you to use techniques to relax you when you are feeling 
anxious, and can also be beneficial for helping teach you distraction 
techniques when you are in severe pain==='x. Hypnosis might not be 
something that you want to do, but even without going to a hypnotist 
using distraction techniques can be very useful. 
" There is a connection between the brain and the gut, known as the 
brain gut axisXl this is why even people who don't suffer from IBS can 
have an upset stomach or `butterflies' when they are nervous. When 
you are experiencing symptoms of IBS, especially constipation and 
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bloating and pain it is possible to immediately improve them by 
visualising that you are improving them. So next time you are in pain 
instead of thinking about how much it hurts take some calming 
breaths and imagine yourself releasing the pain and pushing it away. 
" Cognitive Behaviour Therapy (CBT)"' has shown some benefits and 
many psychologists offer this as a course of treatment for a variety of 
illnesses. This type of therapy is focussed around changing negative 
thoughts and changing negative behaviours. Even if you don't want to 
go to a psychologist it is possible to practise basic CBT on your self. 
This can be as simple as some allowing yourself to get caught up in 
negative thoughts. Sometimes we can think about something stressful 
and we can't seem to let it go, this is especially problematic if you are 
finding it difficult to sleep. Get into practice of saying to yourself 
things like, "there is no point stressing over things I can't change", 
and "night time is for sleeping I can think about things again 
tomorrow". Once you let go of your stressors your symptoms should 
improver". If you find it difficult to let go of stress by stopping 
negative thoughts distract yourself by doing something to take your 
mind off it, you may be surprised to see you symptoms case up it your 
carry on as normal rather than concentrating on them. 
" Food eliminations are one of the most often talked about ways of 
controlling IBS. Unfortunately because of this they are usually one of 
the most difficult ways of controlling IBS symptoms because of all the 
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conflicting advice. The best way of using food elimination or 
moderation is to listen to your own body. Other people might advise 
you to eat high fibre food, but if every time you do it makes you feel 
worse then listen to your own body and don't feel like you have to 
continue to eat it. You probably already have a good idea of what 
foods you can't eat, and know that sometimes a particular food will be 
OK, and that other times you won't be able to eat it, this is perfectly 
normal. If you want to get a better idea of what foods are making 
your symptoms worse keep a food diary"" marking off whenever you 
have symptoms, you will then be able to look back and see if a 
particular food is making you feel worse most times you have it. Sonic 
general guidance for food is given below. 
" Finally Exercise -Many people with IBS find it difficult to do exercise 
because of worry over being ill. The important thing to remember is 
that exercise can be going for a walk, cleaning the house, gardening; 
basically anything that gets your body active and a little out of breath. 
Exercise is really important as it has lots of positive effects at reducing 
stress levels, improving fitness and generally helping the body to 
function properly. If you have not exercised for a while it is important 
to build it up slowly. You might notice your symptoms getting a little 
worse to begin with, although this thought might put you off it is 
really important to push past it and think of feeling a little worse in 
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the short term as a concession to feeling a great deal better in the long 
term"". 
Action Step -1 Which ieneral help do you want to try? 
Look back over the list of GENERAL HELP and pick up to three things that you 
would like to try in the next few weeks. You may think that all of the options seen 
good or that there are a few that you really feel drawn to. As you can't do them all 
at one and such a big list might seem daunting pick out up to three and list then) 
below. Using the same scale as before where 1 indicates the action is very easy to do 
and 6 indicates that it is very hard to do. Write the name of the action on the dotted 
line above the scale. Circle the number that most applies to how easy it will be for 
you to make this change. Below the scale on the dotted line write any help that is 
needed for you to be able to achieve this behaviour. For example if you want to take 
up gentle yoga you might need to go any buy a tape. 
1) Generallielp ..................................................................... 
Action step ........................................................................... 
123456 
V. easy v. hard 
Comments .............................................................................................. 
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2) General Help ..................................................................... 
Action step ........................................................................... 
123456 
v. easy v. hard 
Comments .............................................................................................. 
3) General help ..................................................................... 
Action step ........................................................................... 
/----------/------/--------/---. / --/--_- ----/ 
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SPECIFIC SYMPTOM IIELP 
Sometimes when you have a specific symptom of IBS you need something more than 
a general help. Therefore below arc some suggestions for dealing with specific 
symptoms. The suggestions should be effective both at reducing the frequency of 
these symptoms and also at helping them to reduce in severity when you are 
experiencing them"'. Remember if a particular suggestion makes your symptom 
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worse and it does not improve after a couple of days listen to your body, a particular 
suggestion might not be the one for you. 
Diarrhoea 
Helpful: 
" Black pepper 
" Ginger 
" Lavender 
" Peppermint 
" Rosemary 
Avoid: 
" Dairy 
" Seeded Fruits 
Constipation 
Helpful: 
" Black pepper 
" Camomile 
" Fennel 
" Increase fibre intake 
" Drink more fluid 
" Increase exercise 
" Bulking agents (like Bran) 
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Bloating and wind 
Helpful: 
" Basil 
" Bergamot 
" Black Pepper 
" Camomile 
" Clary Sage 
" Fennel 
" Ginger 
" Juniper 
" Lavender 
" Peppermint 
" Rosemary 
Avoid: 
9 Gas producing vegetables, such as Brussels sprouts 
" Fizzy Drinks 
Pain 
Helpful: 
" Basil 
" Bergamot 
" Black pepper 
" Juniper 
" Rosemary 
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Look back over the specific symptom advice, are there any suggestions that you 
would like to try? There may be other things that you have found work for you that 
are not listed. Below write up to five things that you would like to try. Remember if 
introducing something new do it slowly at first and let your body get used to it, this 
is particularly true of the herbs and essential oils. 
1) .............................................................. 
2) .............................................................. 
3) .............................................................. 
4) .............................................................. 
5) .............................................................. 
6) .............................................................. 
7) .............................................................. 
8) .............................................................. 
9) .............................................................. 
You may continue over the page if necessary. 
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Thank you very much for filling in this intervention booklet I hope you found it 
helpful. If you have any comments that you would like to make then please write 
them below, detach this page and return it to me. 
You may continue over the page if necessary. 
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Patient Information Sheet For IBS Participants 
1. Study Title 
SelfRe ug latory Model based intervention in IBS 
2. Invitation Paragraph 
You are being invited to take part in a research study. Before you decide if you would like to 
take part it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it with 
others if you wish. Contact me if there is anything that is unclear to you, or if you would like 
more information. Take time to decide whether or not you wish to take part. 
Thank you for reading this. 
3. What is the purpose of the study? 
Thank you for your interest in participating in this study. This study will investigate whether 
an intervention based on a psychological model relating to how you think and behave relating 
to your IBS affects the frequency of your IBS symptoms and quality of life. Research of this 
type is necessary to gain a better understanding of how to improve illness outcomes for 
sufferers. It will take up to four hours of your time spread over a period of five months 
(proposed duration of the study one year). 
4. Why have I been chosen? 
You have been chosen because you sufferer from IBS, with a confirmed diagnosis from a 
medical professional. You are one of approximately 100 patients participating in this study. 
5. Do I have to take part? 
It is up to you to decide Nxhether or not to take part. If you do decide to take part you will he 
given this inlornnation sheet to keep and he asked to sign a consent form, which you will have 
a cop}' of If y ou decide to take part you are still free to %N ithdraw at any time and %N ithout 
giving a reason. A decision to withdraw at any time, or a decision not to take part. will not 
affect the care you receive from the NI-IS. 
6. What will happen to nie if I take part? 
Your involvement in this research will be for a total of four hours spread over a period of five 
months. There are a number of stages to this research which will be numbered below: 
1. Stage 1. You will be sent two envelopes through the post one marked pre-intervention 
pack, and one marked post-intervention pack. You will also receive an intervention 
booklet. Firstly you need to fill in the pre-intervention pack. This needs to be 
completed in the order it is presented to you and prior to starting the `IBS intervention 
booklet'. If you have taken part in my research previously you may recognise the 
style of questionnaires and the diary. Despite having filled them in previously they 
need to be filled in again this time to see if the intervention is successful. Once you 
have completed the pre-intervention pack it needs to be returned to the envelope and 
posted back to me. Once you have completed the pre-intervention pack you can then 
start the intervention. The first page of the booklet contains instructions for filling in 
the booklet, which you need to read before taking part. Once you have completed the 
booklet it is yours to keep, although if you would like to send me a photocopy with 
any comments you have you are very welcome. Once you have completed the booklet 
you need to fill in the questionnaires contained in the envelope marked post- 
intervention questionnaires. Once completed you need to return them to the envelope 
and post back to me. Postage is free post therefore please do not put stamps on the 
envelope. 
2. Stage 2. Two months after I have received your completed pre and post intervention 
packs you will receive a pack containing questionnaires similar to those in the pre- 
intervention pack. This is necessary to assess the success of the intervention. 
7. What do I have to do? 
The research is designed to involve minimal disruption to your routine, and can be completed 
at a location convenient to you. There are no lifestyle restrictions and you can therefore 
continue to undertake all nonnal activities. 
S. What is the procedure that is being tested? 
The research is testing the usefulness of an intervention based on how you think and feel 
about issues relating to your illness. 
9. What are the alternatives for treatment? 
There are a number of alternative treatments available for IllS however, none so far have 
been found to have long-tern success. For the purposes of this study you are not required to 
alter any other treatments you arc currently receiving including medical care car any 
alternative treatments you are having. This intervention is designed to be administered in 
conjunction with you current treatments 
10. What are the possible disadvantages and risks of taking part? 
There are no disadvantages or risks from participating in this study. 
11. What are the possible benefits of taking part? 
The results of this study may help future treatments of IBS, in addition you may experience 
some berief it. The first is that hopefully the intervention will improve your IBS, however this 
cannot be guaranteed. Secondly the information from this study may help in the future 
treatment of IBS, this is important as many sufferers report frustration at the current lack of 
knowledge concerning this illness. No previous research has investigated the usefulness of an 
intervention of this type and therefore it is important to establish its usefulness in order to see 
if it improves illness outcomes. 
12. What if new information becomes available? 
In the event of further contact being necessary, inclusion of your address on the consent fomn 
will allow for you to be contacted. 
13. What happens when the research study stops? 
When the research study stops you are not required to have any further involvement. 
14. What if something goes wrong? 
In the unlikely event you are harmed by taking part in this research, there are no special 
compensation arrangements, but standard university insurance cover is in place. If you are 
harmed due to someone's negligence, then you may have grounds for a legal action, but you 
may have to pay for it. Regardless of this if you wish to complain, or have any concerns 
about any aspect of the way you have been approached or treated during the course of this 
study, the standard university complaints mechanisms should be available to you. 
15. Will my taking part in this study be kept confidential? 
Your doctor will not be informed of your participation in this study. All personal data will be 
anonymous and processed in the strictest of confidence and in accordance with the Data 
Protection Act (1988). By consenting to participate in this study you are indicating your 
agreement not to restrict the results of the study on the understanding that your anonymity is 
preserved. It is necessary for you to sign the consent florin to indicate your consent, but this is 
the only place %\here your name will appear, all other data will be identified by coding only. 
It is essential that you include an identifying code %\ord on the consent form, and the same 
word on the questionnaires and the diary, this will allow for all of your data to be matched 
together. If you would like to be contacted in the event of any further information regarding 
this research becoming available, then please include a contact address on the consent form. 
16. What happens to the results of the research study? 
It is anticipated that the results of this study will be published. Participants should note that 
they will not be able to be identified in any publication. Publication may he in academic 
journals, in the journal of the IBS NETWORK, and on the IBS NETWORK's website. The 
findings may also be presented at academic conferences. The IBS NETWORK's website has 
no access restrictions and can therefore be accessed by the general public. Requests can also 
be made to myself the chief investigator for a summary of the research findings. 
17. Who is organising and funding he research? 
The research is funded by the University of Surrey. 
18. Who has reviewed the study? 
This study has been reviewed by the Berkshire Research Ethics Committee who raised no 
objections on ethical grounds. 
17. Contact for further information 
If you have any questions regarding any aspects of the study, or would like further 
information and advice please do not hesitate to contact me prior to the start of the study. The 
signing of the consent form indicates that you fully understand the study, and therefore if this 
is not the case please contact me prior to indicating your consent. 
Carly Jacobs 
Psychology Department 
School of Human Sciences 
University of Surrey 
GU2 7XHH 
E-mail - c. iacobsnsurrey. ac. uk 
Tel: (University) +44 (01438) 686883 (Mob) 07931 565820 
APPENDIX 25 
LETTER TO IBS PARTICIPANTS FOR TWO MONTHS POST 
INTERVENTION STAGE 
ý1 R 
r 
ý ýý 
fi i 
Carly Jacobs 
Bsc (Hops) MSc 
Dear IBS study participant, 
uni: University of Surrey Department of Guildford Psychology 
Surrey GU2 7XII UK 
Tel: +44 (0)1483 686883 
Fax: +44 (0)1483 689553 
Email: c. jacobs@surrey. ac. uk 
20 December 2006 
Please find enclosed the follow up pack to the intervention 
study: 
Self Re ug latory Model based intervention in IBS (05/01602/53). 
which you kindly filled in the first stages of a two months ago. 
Please would you now fill in the information requested in 
these packs as without the follow up information I cannot 
assess the success of the intervention. You do you of course 
have the right to withdraw from the study at any time. 
Thank you once again for your time, and please don't hesitate 
to contact me if you have any questions. 
Carly Jacobs 
